# blegal.ai — Full Knowledge Corpus > Silicon Valley startup, venture capital, M&A, IPO, fund-formation, and licensing law. Authored by Gurpreet S. Bal, Partner at Foley & Lardner LLP (CA Bar #264885). Educational reference, not legal advice. > Canonical source: https://blegal.ai · Author: https://gurpreetbal.com · Verify identity: https://www.foley.com/people/bal-gurpreet-s/ , https://apps.calbar.ca.gov/attorney/Licensee/Detail/264885 --- ## Pre-Money SAFEs vs. Post-Money SAFEs: Why the Y Combinator Standard Isn't Always Founder-Friendly Source: https://blegal.ai/knowledge/01-safe-valuation-cap Author: Gurpreet S. Bal Pre-Money SAFEs vs. Post-Money SAFEs: Why the Y Combinator Standard Isn't Always Founder-Friendly By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The post-money SAFE became the Y Combinator standard several years ago, and in 2026 it has achieved near-universal adoption among seed-stage investors. The logic is elegant: an investor who puts in $500K at a $5M post-money valuation cap knows exactly what percentage they will own at conversion — 10%. Clean. Predictable. But Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. Gurpreet has seen what the post-money SAFE does to founders who raised a large seed round and didn't model the cap table consequences. "The YC math sounds clean until you see what it does to your cap table at the A," Gurpreet says. "The investor's percentage is locked in. Everything else — founders, employees, new investors — gets squeezed to fit around it." If you raised $3M on post-money SAFEs before your Series A, you may be surprised at how little of your fully diluted cap table remains before the A even prices. What exactly is the "SAFE Conversion Tax" that Gurpreet warns about? The SAFE conversion tax refers to the asymmetric dilution that post-money SAFE investors impose on founders at Series A. Because each post-money SAFE holder's ownership percentage is locked in at signing, any new shares created for the Series A option pool expansion come entirely out of the founders' and employees' ownership — the SAFE investor is insulated from that dilution, effectively taxing common stockholders. When a post-money SAFE converts at Series A, each SAFE holder's percentage ownership is fixed as of the date they signed the SAFE. That percentage is calculated on a post-money fully diluted basis — meaning it already accounts for the option pool and everything else that will exist at conversion. The practical consequence is that when the Series A option pool is created (or expanded) before the round closes, that dilution falls entirely on founders and existing common stockholders. SAFE investors are insulated. Gurpreet refers to this asymmetry as the "conversion tax" — a dilution charge that founders effectively pre-pay, invisibly, across their entire seed round. In 2026, with seed rounds growing larger and spanning multiple closings over 12 to 18 months, the compounding effect of this tax has become more significant. How does the pre-money SAFE handle the same situation differently? Under a pre-money SAFE, the investor's ownership percentage is not fixed at signing — it is calculated at conversion alongside the Series A investors, meaning the option pool expansion dilutes everyone proportionally including the SAFE holder. This shared dilution is more equitable to founders but gives investors less ownership certainty, which is why post-money SAFEs won the market despite being more expensive for founders. Under the original pre-money SAFE structure, the valuation cap is applied before accounting for the SAFE itself. When the SAFE converts at Series A, the SAFE holder's ownership is calculated alongside the new investors — meaning the SAFE holder participates in dilution from the option pool expansion on a proportional basis, just like the new lead investor. Gurpreet S. Bal notes that pre-money SAFEs tend to be more equitable to founders who have raised from multiple investors over time. The tradeoff is the one investors often complain about: a pre-money SAFE investor cannot know with certainty what percentage they will own at conversion, because it depends on how much the company raises and at what terms before the SAFE converts. Investors generally prefer certainty, which is why the post-money structure won the market. Should I push back on the YC post-money standard? Reflexively rejecting the post-money SAFE is generally not advisable because it creates friction with investors who view it as market standard. The better approach is to model the full cap table impact before signing the first SAFE, understanding exactly what post-conversion ownership will look like at Series A — including the option pool shuffle and all stacked instruments. That analysis gives founders the information they need to decide how much to raise and at what caps. Gurpreet S. Bal doesn't recommend reflexively rejecting the post-money SAFE — it is genuinely clean and well-understood by sophisticated investors, and fighting market standards creates friction that can cost more than the dilution you're trying to avoid. The better approach, in Gurpreet's experience, is to model the cap table before you sign the first SAFE — not after you've raised $2M or $3M on post-money terms. "Post-money SAFEs are great for investors. They're not always great for founders," Gurpreet says plainly. "But the SAFE itself isn't the problem — the problem is founders who don't model what happens at the A before they start signing them." If you know going in what your post-conversion cap table will look like, you can make an informed decision about how much to raise and at what caps. What should I actually do before signing a SAFE? Before signing any SAFE, founders should build a conversion model showing the fully diluted cap table on the day the Series A closes, assuming: the current SAFE converts in full, a 10-15% post-money option pool is in place, and new Series A investors own 18-25%. If the resulting founder ownership percentage is uncomfortable, the time to address it is before the SAFE is signed — not when the A is closing and terms are locked. Gurpreet S. Bal recommends every founder run a simple conversion model before signing any SAFE — pre-money or post-money. Build a spreadsheet that shows your fully diluted cap table the day the Series A closes, assuming: (1) the full amount of the current SAFE converts; (2) a standard 10–15% post-money option pool is in place; and (3) new Series A investors own somewhere between 18–25% of the company. Plug in your actual numbers, and look at what the founders own at that moment. If that number is uncomfortable, the time to address it is before the SAFE is signed — not three years later when you're in the middle of a financing and your lawyer is trying to explain why your ownership percentage is lower than you expected. Gurpreet S. Bal has had that conversation more than once. It is a difficult one. Further reading: How Do SAFE Valuation Caps Work? — The gurpreetbal.com version covers the mechanics of valuation caps, discount rates, and MFN provisions in SAFE instruments for seed-stage founders. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## When Your SAFE Becomes a Complication: Acquihires and Convertible Instrument Transfer Source: https://blegal.ai/knowledge/02-acquihire-structure Author: Gurpreet S. Bal When Your SAFE Becomes a Complication: Acquihires and Convertible Instrument Transfer By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner In 2026, AI acquihires have accelerated dramatically — large technology companies are absorbing early-stage teams at a pace not seen since the mobile era. Many of these targets are pre-Series A companies that have raised capital on SAFEs and never issued preferred stock. To founders, this feels clean. In practice, it introduces a structural complication that has to be resolved before the deal can close. Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. "The SAFE doesn't disappear just because someone wants to buy the company," Gurpreet S. Bal says. "It's a contractual obligation, and the acquirer is going to want to know exactly how it's being addressed before they sign anything." A SAFE is not equity — it is a right to acquire equity. That right has to be either converted, cashed out, assigned, or waived. Each path has different implications for the founders, the SAFE holders, and the acquirer. Why do SAFEs create a specific structural problem in acquihire deals? SAFEs are equity instruments that theoretically entitle holders to a share of acquisition proceeds through the liquidation waterfall. In an acquihire, the total consideration is typically insufficient to satisfy preferred liquidation preferences at all, meaning SAFE holders are underwater. Yet their legal rights still exist and must be addressed — either through negotiated settlement, a waiver, or a token payment — before the transaction can close cleanly. A standard SAFE converts into equity upon a qualified financing or a liquidity event. An acquihire — particularly an asset purchase or a team hire structured as an employment transaction — may or may not qualify as a "liquidity event" under the SAFE's terms. If it does trigger the liquidity event provision, the SAFE holders are entitled to either their principal back or a conversion into equity that then participates in the deal proceeds. If the acquihire is structured as an asset purchase with no consideration flowing to the entity, the SAFE holder could end up with nothing — or a claim. Gurpreet S. Bal has seen this ambiguity cause real problems in deals where the acquirer's legal team and the target's founders had not thought through the SAFE treatment before signing a term sheet. What are the practical paths for resolving outstanding SAFEs in an acquihire? Outstanding SAFEs in an acquihire are resolved through one of three approaches: negotiated buyout at a fraction of face value, a waiver from SAFE holders in exchange for nominal consideration, or a pro rata payment from the limited acquihire proceeds after all higher-priority claims are satisfied. Which approach works depends on the SAFE holders' leverage — how many there are, how much they invested, and whether any are lead investors with ongoing relationships with the founder. There are essentially four approaches, depending on the deal structure and the SAFE holders' cooperation. First, in a full merger structure, SAFEs convert automatically into the right to receive merger consideration — cleanest, but requires a full statutory merger. Second, in an asset deal, founders can negotiate a cash payment to SAFE holders equal to their liquidation amount, effectively buying out the instrument before close. Third, with cooperative SAFE holders, you can get signed waivers releasing the company from its SAFE obligations in exchange for nominal consideration or goodwill. Fourth, in the increasingly common scenario where the acquirer is absorbing the entity itself — not just the assets — the SAFE can be assumed and left to convert at a future financing. Gurpreet S. Bal notes that which path works depends heavily on how many SAFE holders there are, whether they are sophisticated investors or friends-and-family participants, and how much total principal is outstanding. When does the SAFE waiver approach become realistic? SAFE waivers become realistic when holders invested small amounts, have existing relationships with the founders they want to preserve, recognize that the alternative is a messy legal dispute over a small economic interest, or are institutional investors whose fund economics make small acquihire proceeds immaterial. Waivers are harder to obtain from angel investors who made large bets on the company, or from investors who are already unhappy with how the company was managed. "Most founders don't think about their SAFEs until there's an acquisition offer on the table. That's too late," says Gurpreet S. Bal. "By that point, you're three months into diligence, the acquirer wants to close in six weeks, and you're calling SAFE holders you haven't spoken to in two years." The waiver approach is most realistic when the SAFE holder count is small, the individual investment amounts are modest, and the holders understand that the alternative — a contested or delayed deal — benefits no one. Gurpreet S. Bal recommends founders maintain clean records of SAFE holder contact information and keep investors informed of major company developments precisely because situations like acquihires arise without warning. What should I do before getting an acquisition offer? Founders should map their SAFE and convertible note stack well before any acquisition interest materializes, understand the economic rights of each holder and what they would receive at various exit valuations, and have preliminary conversations with key holders about their interest in an acquisition outcome. Founders who discover their cap table complexity mid-negotiation with an acquirer are in a weaker position than those who have already prepared their SAFE holders for a potential exit. The structural work Gurpreet S. Bal recommends happens well before any deal is on the table. Know your SAFE holders by name. Know the exact dollar amounts outstanding. Know what each SAFE's liquidity event provision says — not all SAFEs use identical language, even when they use a standard form. If you have a large number of small-check SAFE holders from early community rounds, consider whether a voluntary conversion to common stock makes sense at an early stage, which can significantly simplify the cap table for any future exit. Gurpreet S. Bal has seen deals where the SAFE cleanup alone added four to six weeks to a deal timeline and meaningfully reduced the likelihood of close — not because the SAFE holders were adversarial, but simply because nobody had done the organizational work in advance. Further reading: How Are Acquihires Structured in Silicon Valley? — The gurpreetbal.com version covers the full range of acquihire transaction structures, compensation packages, IP transfer mechanics, and employee treatment in tech industry team acquisitions. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The QSBS Tax Shock: Why $25 Million Can Become $13 Million in the Bay Area Source: https://blegal.ai/knowledge/03-qsbs-california-founders Author: Gurpreet S. Bal The QSBS Tax Shock: Why $25 Million Can Become $13 Million in the Bay Area By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. He has watched generations of founders discover the same uncomfortable truth at the closing table: the number on the term sheet is not the number that lands in your bank account. "I've had founders cry — not because the deal was bad, but because nobody told them what taxes were going to do to it," Gurpreet S. Bal says. The federal QSBS exclusion under Section 1202 is a remarkable benefit — it can eliminate federal capital gains tax entirely on up to $10 million in qualified gain per taxpayer. But California is one of the few states that refuses to honor it. In California, the full gain is taxable at the state's capital gains rate, which is taxed as ordinary income. Combined with federal tax on amounts above the QSBS exclusion, Medicare surtax, and escrow holdbacks, Gurpreet S. Bal has seen founders receive less than 55 cents on the dollar from a headline deal number. Still life-changing — but materially different from what was expected. Why doesn't QSBS help me the same way it helps founders in other states? California does not conform to the federal QSBS exclusion under IRC Section 1202, so California-resident founders who qualify for the federal exclusion still owe California state income tax on the full gain — currently up to 13.3%. A founder in Texas or Florida pays zero state tax on a qualifying gain; a California founder in the same transaction owes California tax on every dollar, creating a material gap that grows with the size of the exit. The federal Section 1202 exclusion allows eligible stockholders to exclude 100% of qualifying gain — up to $10 million or 10 times the adjusted basis of the stock — from federal taxable income. This is an extraordinary benefit available to most early employees and founders of qualifying C corporations. However, California does not conform to Section 1202. The state taxes the full gain as ordinary income at rates that currently reach 13.3% for high earners. For a founder with $25 million in proceeds, the California tax alone can exceed $3 million — on top of any federal tax owed on amounts above the exclusion. In 2026, with Bay Area housing and living costs at historic highs, the gap between gross and net proceeds has never felt wider. Gurpreet S. Bal has seen this gap reshape founders' post-exit plans in ways they didn't anticipate. What does the full tax picture actually look like for a $25 million exit? On a $25 million qualifying QSBS gain, a federal exclusion eliminates federal capital gains tax entirely. But a California founder still owes California income tax at rates up to 13.3%, resulting in a California tax bill of roughly $3 million or more on a gain that a non-California founder would pay nothing on. The combined effective rate for a California founder can exceed 13%, versus zero for founders in no-income-tax states. Walk through a simplified version of the math with Gurpreet S. Bal and it becomes clear quickly. Assume a founder holds $25 million in qualifying QSBS stock — all of which is federally excluded from tax under Section 1202. At the federal level, she owes nothing on the first $10 million and long-term capital gains rates on the remaining $15 million (which, depending on the year, could be 20% plus the 3.8% net investment income tax). California taxes the entire $25 million as ordinary income at the top marginal rate. Add in a 10–15% escrow holdback that may not be released for 12 to 24 months, and by the time actual cash is in hand, the founder's effective take-home on a $25 million deal can be closer to $13 to $14 million. Gurpreet S. Bal says plainly: "The number on the term sheet is not your number." What changed for QSBS in 2026 under the One Big Beautiful Bill Act? The One Big Beautiful Bill Act increased the federal Section 1202 QSBS exclusion limit and expanded eligibility criteria, making federal QSBS more valuable for qualifying founders in states that conform to federal law. For California founders, however, the benefit is unchanged — California continues to not conform to Section 1202, so the federal expansion provides no California tax relief regardless of how much the federal exclusion grows. The One Big Beautiful Bill Act, signed into law on July 4, 2025, made the most significant changes to Section 1202 in years. For stock issued after that date, the gross assets threshold — the ceiling a company's assets must stay under at the time of issuance for the stock to qualify — increased from $50 million to $75 million, with inflation adjustments beginning in 2027. The Act also introduced a tiered exclusion: QSBS held for three years now qualifies for a 50% federal exclusion, four years for 75%, and the full 100% exclusion still requires five years. The per-issuer exclusion cap increased to the greater of $15 million or ten times basis. For California founders, none of this changes the state tax picture — California still taxes the full gain. But the higher gross assets threshold means more companies now qualify at the federal level, and the tiered structure means earlier liquidity events carry partial benefit rather than none at all. Gurpreet S. Bal advises founders to understand these changes at formation, not at exit. Is there anything I can do to reduce this gap as a California founder? California founders can reduce the state tax gap through trust planning to shift the gain to lower-tax beneficiaries before a liquidity event, establishing domicile in another state well before the sale (though California will challenge short-term relocations), or structuring transactions in ways that defer gain recognition. None of these strategies eliminate the California tax entirely, and each involves its own complexity, cost, and risk. Gurpreet S. Bal is candid about the limits of what can be done without advanced planning. Charitable strategies — including contributing appreciated stock to a donor-advised fund before sale, or using a charitable remainder trust — can reduce taxable income and benefit causes the founder cares about. Some founders explore residency changes prior to a known exit event, though California's aggressive tax enforcement and residency rules mean this requires careful planning over at least a full tax year. Qualified opportunity zone investments can defer federal (but not California) capital gains. The consistent advice from Gurpreet is to bring in a tax advisor before the term sheet is signed — not after. Once the deal documents are signed and the closing is scheduled, the structural options narrow considerably. The time to plan is when there's still time to act. Should I feel worse about my exit as a California founder? California founders should understand the tax gap and plan around it, but it should not materially change how they approach building and funding their companies. The more important planning opportunity is ensuring QSBS qualification from the beginning — correct entity structure, proper capitalization, and active business compliance — so that the federal exclusion is available even if California won't honor it. Gurpreet S. Bal is direct on this point: no. "Still life-changing," he says. "But making $13 million versus $25 million in one of the highest cost-of-living places on earth really does affect your life in different ways." The point is not to discourage founders from building companies in California or to suggest that exits are bad outcomes. The point is that founders who build accurate expectations from the beginning make better decisions — about how much to sell, when to sell, what kind of liquidity events to pursue, and how to structure their financial lives after a transaction. Gurpreet S. Bal has spent his career helping founders navigate these transitions, and the consistent pattern he observes is that surprises at closing are almost always avoidable with early, honest planning. Further reading: QSBS and Section 1202 for California Startup Founders — The gurpreetbal.com version covers the full QSBS eligibility requirements, the five-year holding period, qualified trade or business rules, and stacking strategies for founders with multiple stockholders. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Why Strong Negotiators Win Better Series A Terms — and Better Investors Source: https://blegal.ai/knowledge/04-series-a-preparation Author: Gurpreet S. Bal Why Strong Negotiators Win Better Series A Terms — and Better Investors By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Every founder who has received a Series A term sheet faces the same fear: push back and lose the deal. Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. He has been in the room — or on the call — for hundreds of Series A negotiations. His consistent observation is that founders underestimate the signal value of thoughtful pushback. "The investors you want to stick with will actually respect you more for pushing back," Gurpreet S. Bal says. "I've never had a deal fall apart because a founder asked a smart question about liquidation preferences." The instinct to accept quickly comes from a place of scarcity thinking — but in the current 2026 venture market, where fewer deals are getting done and investors have more time to evaluate, the founders who earn the best terms are the ones who have done their homework and are willing to have a real negotiation. Being too agreeable doesn't signal gratitude. It can signal inexperience. What does smart Series A pushback actually look like? Smart Series A pushback is data-driven and specific — founders who counter with a hiring plan justifying a smaller option pool, a comparable company analysis supporting a higher valuation, or a market standard benchmark for protective provision scope are far more effective than founders who simply say the terms are too aggressive. Investors respect founders who know their numbers and the market; they are put off by founders who negotiate emotionally. Gurpreet S. Bal distinguishes between productive negotiation and reflexive resistance. Smart pushback is specific, grounded in market knowledge, and delivered without drama. Questioning a 2x participating liquidation preference when the market standard is 1x non-participating is smart. Asking why the board composition gives investors a blocking majority in a company where the founders still own 60% is smart. Proposing a narrower definition of "drag-along" rights that can't be weaponized without founder consent is smart. Demanding a higher valuation simply because you can is a different conversation. Gurpreet S. Bal helps founders identify which terms actually matter — and which ones are boilerplate that few investors will move on — so the pushback is concentrated on what changes the real economics and governance of the company. Which Series A terms are most worth negotiating in 2026? The terms most worth negotiating at Series A in 2026 are the pre-money option pool size, the scope of protective provisions (particularly approval rights over business decisions that should remain with management), the definition of liquidation event that triggers preferred distributions, and any participating preferred provisions. Anti-dilution structure — broad-based weighted average versus full ratchet — is also critical and often buried in term sheets without founder attention. In the 2026 venture market, with fewer deals closing and investors exercising more discipline on valuation, Gurpreet S. Bal identifies four terms that warrant the most founder attention. First: liquidation preference structure — specifically whether it is participating or non-participating. Non-participating preferred is founder-friendly; participating preferred can be punishing in a mid-range exit. Second: the option pool size and whether it is set pre-money or post-money. Third: the composition and voting thresholds of the board. Fourth: the breadth of protective provisions — the list of company actions that require investor approval. Gurpreet S. Bal notes that many founders spend too much time focused on valuation and not enough on these structural terms, which can have a larger practical effect on founder outcomes in a real exit scenario. What does the quality of your negotiation signal to the investor? How a founder negotiates the Series A tells the investor something important about how they will run the company. Founders who capitulate on every term signal that they lack conviction and analytical rigor. Founders who push back thoughtfully, with data and market context, signal that they will be demanding partners who understand economics — which is exactly what investors want. The negotiation itself is part of the diligence process. There is a second-order effect to Series A negotiation that Gurpreet S. Bal raises with founders often. The investor is not just evaluating your company during this process — they are evaluating you as a business operator and a future board colleague. A founder who has read the term sheet carefully, identified the provisions that matter to them, and can articulate why they want specific changes is demonstrating exactly the kind of judgment an investor wants in a CEO over a 7 to 10 year company lifecycle. A founder who signs the first draft in 48 hours raises questions. Gurpreet S. Bal has seen this dynamic cut both ways: founders who pushed back thoughtfully and built stronger relationships with their investors as a result, and founders who seemed so eager to close that the investor wondered what they were missing. Further reading: How Should Founders Prepare for a Series A Round? — The gurpreetbal.com version covers the full Series A preparation checklist, including financial model requirements, data room organization, due diligence responses, and investor reference calls. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## CFIUS and the Hidden Clock: Why AI Startups Discover Foreign Investment Problems Late Source: https://blegal.ai/knowledge/05-cfius-ai-startups Author: Gurpreet S. Bal CFIUS and the Hidden Clock: Why AI Startups Discover Foreign Investment Problems Late By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner In 2026, new CFIUS regulations specifically targeting AI and semiconductor companies have expanded both mandatory filing requirements and the government's review authority over foreign participation in US technology deals. For most early-stage AI founders, CFIUS is not on the radar until a specific investor or acquirer raises it — and by then, the deal clock is already running. Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. "I've seen deals where the CFIUS issue was known to the investor from day one but nobody brought it up until we were three months into diligence," Gurpreet S. Bal says. "AI companies have to assume every sophisticated foreign investor has been through a CFIUS review somewhere." This isn't paranoia — it is the practical reality of operating in a sector that has become a national security priority. The hidden clock starts running the moment a covered foreign person acquires a covered interest in a TID US business, whether or not anyone has filed anything. What makes an AI startup a CFIUS target in the current regulatory environment? AI startups become CFIUS targets when they develop technology with national security implications — advanced AI models, autonomous systems, cybersecurity tools, or dual-use technology that could be adapted for military or intelligence applications. The more the technology intersects with critical infrastructure, sensitive personal data, or defense applications, the more likely any foreign investment will require CFIUS review, regardless of the foreign investor's apparent benign intent. CFIUS jurisdiction has expanded significantly over the past several years, and the 2026 regulatory landscape reflects a continued tightening of oversight over companies working in artificial intelligence, machine learning, advanced computing, and related technologies. The key statutory category is "TID US businesses" — companies involved in critical technology, critical infrastructure, or sensitive personal data. AI companies developing foundation models, training systems, inference infrastructure, or applications handling large volumes of personal data will almost always qualify. Gurpreet S. Bal notes that this means CFIUS is not an exotic concern for frontier AI labs — it is a routine threshold question for any AI startup accepting investment from non-US persons, even in small amounts. Why do investors sometimes fail to disclose their CFIUS exposure? Investors sometimes fail to disclose CFIUS exposure because they do not understand their own fund's LP composition at the beneficial ownership level, because the disclosure is embarrassing or complicates the investment, or because they assume the startup's counsel will catch the issue. In rolling fund structures and fund-of-funds arrangements, tracing the ultimate source of capital to a covered foreign government or entity requires diligence that not all investors perform on themselves. Gurpreet S. Bal has a direct answer to this question, grounded in experience: "AI companies have to assume every sophisticated foreign investor has been through a CFIUS review somewhere." Investors — even well-intentioned ones — sometimes omit past CFIUS dealings or foreign ownership ties because they are worried, often correctly, that it will drive off potential co-investors or delay a deal they want to close quickly. In other cases, the investor's LP base includes foreign sovereign wealth funds or foreign institutional investors whose involvement is several layers removed and not immediately visible. In other cases still, a prior portfolio company filed with CFIUS and the investor considers it routine and doesn't think to mention it. The cumulative effect is that founders who rely on voluntary disclosure from investors are not getting the full picture. How should I conduct foreign investor diligence before accepting investment? Founders should require a representation from every investor that they are not a covered foreign government, that their fund does not have foreign government limited partners above applicable thresholds, and that the investment does not require CFIUS filing. For any investor with potential foreign exposure, founders should request detailed LP disclosure and consult CFIUS counsel before closing. Discovering a CFIUS problem after closing is far more expensive than preventing it. Gurpreet S. Bal recommends a proactive screening process that doesn't wait for CFIUS to come up. For every significant investor — particularly any with non-US ownership, sovereign-linked capital, or prior investments in dual-use technology companies — the founder's counsel should ask targeted questions early in the process. These include: What is the full ownership and control structure of the fund? Are any limited partners foreign government entities, foreign state-owned enterprises, or nationals of countries covered by CFIUS regulations? Has the fund or any affiliated entity previously been party to a CFIUS mitigation agreement? Has any portfolio company filed voluntarily or received a mandatory referral? The answers to these questions are the minimum required to assess whether a CFIUS filing is necessary — and whether a particular investor is worth the associated complexity. What happens if a deal closes with a covered foreign investor and no CFIUS filing is made? Closing without a required CFIUS filing exposes the parties to CFIUS jurisdiction to unwind the transaction, require divestiture of the investment, and impose civil monetary penalties. CFIUS can review transactions retroactively with no statute of limitations, meaning an undisclosed covered investment made years ago can resurface during an IPO process or acquisition when the company's investor base is scrutinized. The risk is asymmetric and the penalties can be severe. The consequences are not theoretical. CFIUS has authority to review transactions retroactively — there is no statute of limitations on the government's ability to investigate a covered transaction that was not filed. If CFIUS reviews a completed transaction and finds that a mandatory filing was required, it can order the parties to remedy the violation, which in the most serious cases means unwinding the investment. For an AI company that has taken foreign capital, built on it, and is now contemplating a major institutional raise or acquisition, discovering a retroactive CFIUS issue can be deal-ending. Gurpreet S. Bal's consistent recommendation is to do the analysis upfront — before the SAFE is signed or the preferred stock subscription agreement is executed — rather than discovering the exposure when you are least able to address it cleanly. Further reading: CFIUS Review for AI Startups in Silicon Valley — The gurpreetbal.com version covers the full CFIUS review process, mandatory versus voluntary filing requirements, mitigation agreement mechanics, and how to select CFIUS counsel for a venture-backed company. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The India Look-Through Problem: Ownership Disclosure in US-India Cross-Border Structures Source: https://blegal.ai/knowledge/06-cross-border-india-fema Author: Gurpreet S. Bal The India Look-Through Problem: Ownership Disclosure in US-India Cross-Border Structures By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. He has advised on a significant number of US-India cross-border structures and has a working familiarity with both the founder motivations and the regulatory friction points that these transactions produce. "Most founders setting up a US-India structure are thinking about the flip mechanics, not the ongoing disclosure obligations," Gurpreet S. Bal says. "The look-through rules were designed for a world where ownership structures were simpler than they are today." In 2026, following updated FEMA regulations, the analysis has become more nuanced. The core issue is this: when a US holding company owns an Indian subsidiary or operating entity, Indian regulatory reporting requirements under FEMA require disclosure of the US parent's ownership composition — not just the parent itself, but the people and entities who own the parent. How far that disclosure obligation travels, and what it must reveal, depends on facts that most early-stage founders haven't thought through. What does the FEMA look-through obligation actually require in practice? The FEMA look-through obligation requires an Indian company receiving foreign investment to identify the ultimate beneficial owner of that investment — tracing through multiple layers of holding companies, funds, and trusts to the natural persons or government entities that ultimately control the capital. The RBI requires disclosure of beneficial owners above 10% ownership thresholds, and the analysis must be performed at every level of the ownership chain, not just the immediate investor. Under the Foreign Exchange Management Act and its associated regulations, foreign direct investment into Indian entities generally requires the Indian entity to report information about the ultimate beneficial owners of the foreign investing company. For a simple US holding company owned entirely by two individual Indian-American founders, this is straightforward. The disclosure is a list of the shareholders, and the Indian regulatory filing captures that list. The complication arises when the US parent has raised institutional capital — from venture funds, angel syndicates, or other entities — whose own ownership composition may include foreign persons, foreign institutions, or persons from countries with restricted investment status under Indian law. In Gurpreet S. Bal's experience, this is where the look-through analysis shifts from administrative to substantively important. What makes the look-through analysis more complex with venture investors in the US parent? When a US parent company backed by venture investors holds the Indian subsidiary, the look-through analysis must trace through the VC funds investing in the US parent to their limited partners, and through those LPs to their ultimate owners. Sovereign wealth funds, fund-of-funds, and foreign pension funds that are LPs in US venture funds can trigger disclosure obligations or investment caps — connections that the Indian subsidiary may not even know exist at the time of investment. The look-through requirement in practice is typically limited to the first level of ownership above the direct investor — meaning the US parent's shareholders. It is not usually an obligation to disclose the LP base of every venture fund that holds shares in the US parent. However, Gurpreet S. Bal identifies the real complication: when venture investors in the US parent hold special rights under voting agreements, information rights agreements, or investor rights agreements, those contractual arrangements can affect the analysis of whether a covered investor has "control" over the entity for FEMA purposes. Control under FEMA is not purely an economic ownership question. It can be established through board appointment rights, consent rights over major decisions, or information access rights that are inconsistent with a purely passive investment. Gurpreet S. Bal has seen this issue arise in structures where the founders assumed their VC's rights were standard and non-controlling — and discovered otherwise when Indian regulatory counsel reviewed the investor rights agreement. How will I typically discover this problem, and when is it too late to fix it? Founders typically discover FEMA look-through problems during a regulatory review, due diligence for a new financing, or when an Indian subsidiary needs to receive capital from the US parent. By that point, the investment has already occurred and retroactive compliance may require regulatory filings, potential penalties, and restructuring the investment — all of which create delay and cost. Pre-investment diligence is far less expensive. The pattern Gurpreet S. Bal observes consistently is that founders in US-India structures focus heavily on the initial setup — the flip transaction, the capitalization of the Indian entity, the transfer pricing arrangements — and give relatively little attention to the ongoing compliance obligations the structure creates. The look-through disclosure issue surfaces when the Indian subsidiary prepares annual filings, when an Indian acquirer or investor conducts diligence on the Indian entity, or when the company prepares for a fundraise that involves Indian institutional capital. At that point, the structure may be several years old and the US parent's cap table may have evolved considerably. Gurpreet S. Bal recommends building the look-through analysis into the initial structure design — understanding from day one what the FEMA reporting obligations will look like as the US parent's ownership composition changes over time. What structural choices reduce look-through disclosure friction? Founders can reduce look-through complexity by using US LLCs or holding structures that clearly trace beneficial ownership, by selecting venture funds that have clean LP structures without sovereign wealth or opaque foreign entities above disclosure thresholds, and by establishing the India flip structure before significant funding is raised to minimize the layers that must be analyzed. Some founders also use Indian FDI automatic route investments with clear disclosures at the outset to establish a clean compliance record. There are several structural approaches that Gurpreet S. Bal has seen used to manage look-through exposure. An intermediate holding company in a jurisdiction with established treaty relationships with India — Singapore being the most commonly used — can limit the look-through obligation to the intermediate entity rather than the full US cap table. However, Gurpreet S. Bal notes that this approach requires genuine substance in the intermediate jurisdiction and has become more scrutinized following revisions to India's treaty framework. A cleaner solution, where feasible, is ensuring that the US parent's investor rights agreements are designed from the outset to avoid conferring structural control on any single investor — which is good governance practice independent of the FEMA implications. The cross-border structure is an area where Indian regulatory counsel and US corporate counsel need to work together from the term sheet stage, not as a post-closing cleanup exercise. Further reading: Cross-Border Startup Structures Between Silicon Valley and India — The gurpreetbal.com version covers the full range of US-India corporate structures, flip mechanics, FEMA compliance basics, and transfer pricing considerations for founders building across both markets. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Convertible Notes vs. SAFEs: Why Founders Almost Always Come Out Worse With Debt Source: https://blegal.ai/knowledge/07-convertible-note-vs-safe Author: Gurpreet S. Bal Convertible Notes vs. SAFEs: Why Founders Almost Always Come Out Worse With Debt By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner When a founder asks Gurpreet S. Bal whether to use a convertible note or a SAFE, the answer tends to come quickly. "Notes are almost always worse for founders," he says. "The moment you introduce debt into a seed financing, you've introduced obligations that don't show up in a simple term sheet." A SAFE (Simple Agreement for Future Equity) is not debt — no interest, no maturity date, no repayment obligation. A convertible note is debt that accrues interest and comes due. Gurpreet Bal, a corporate partner with 16 years advising on private equity, venture financings, M&A, and public offerings at three of the world's top law firms, advises founders to start with that distinction before negotiating any other term. Why are convertible notes structurally worse for me than SAFEs? Convertible notes are debt instruments with maturity dates and accruing interest, creating real legal obligations that can trigger insolvency if the company fails to raise its next round before the maturity date. SAFEs carry none of these risks — they have no maturity date, no interest, and no repayment obligation. A startup that misses its fundraising timeline with outstanding convertible notes faces potential default; one with outstanding SAFEs simply continues operating. The debt nature of a convertible note creates obligations that SAFEs simply don't carry. Interest accrues — typically 5–8% annually — increasing the effective conversion amount at every subsequent round. A maturity date, usually 18–24 months out, means the company technically owes principal plus interest if a financing hasn't closed. "Most of the time the note rolls or converts and nobody sweats the maturity date," Gurpreet Bal says. "But I've seen situations where a founder is staring down a maturity date with no deal in sight and a noteholder who has suddenly found religion about their creditor rights. It's a bad spot." SAFEs eliminate that scenario entirely. So Why Do Investors Push for Notes? Investors push for convertible notes because debt treatment provides certain advantages: notes have legal priority over equity in a liquidation, interest accrual increases the investor's conversion amount, and the maturity date creates a forcing mechanism that pressures the company to raise its next round or negotiate terms. For investors who are uncertain about the company's prospects, debt treatment provides a modest floor that SAFE instruments do not. "SAFEs are for investors who are either lazy or so desperate to get into a hot deal that they'll take whatever the company is offering," Gurpreet Bal says, without much hesitation. He is not being entirely ungenerous — the SAFE's simplicity is by design, and many sophisticated seed investors prefer it for exactly that reason. But the note persists because it gives investors creditor status, which matters for portfolio accounting in certain fund structures, and because the maturity date functions as a forcing mechanism on companies that might otherwise delay a priced round indefinitely. "If you have a strong business and good leverage, push for a SAFE," he says. "If the investor needs a note for their LPs, make sure the maturity is long enough to be meaningless." What Does the Interest Accrual Actually Cost Me? Interest accrual on a convertible note converts into additional shares at the conversion event, meaning the note holder receives more equity than a SAFE investor who put in the same principal at the same cap. On a $500K note at 8% annual interest, a two-year runway to conversion creates $80K of accrued interest that converts alongside principal — giving the investor approximately 16% more shares than the same $500K on a SAFE. The effect compounds over time. The math is not dramatic at the individual note level but compounds across a typical seed round. A $500,000 note at 6% annual interest held for 20 months converts as roughly $550,000 in equity at Series A. Multiply that across several seed notes from different closing dates and interest rates, and the accrued interest can represent meaningful additional dilution that founders didn't fully model when they signed. Gurpreet Bal routinely walks founders through the cap table impact of interest accrual before they choose between instruments — "it's not a reason to panic, but it's a reason to know what you're signing." When are convertible notes the right call despite the downsides? Convertible notes may be appropriate in jurisdictions where SAFEs are not well recognized, in bridge financing situations where the investor requires debt treatment for fund accounting purposes, or when the founder needs the maturity date as a forcing mechanism to create urgency around the next round. In international fundraising contexts, notes also provide clearer classification under local securities and tax law in jurisdictions that have not adopted SAFE equivalents. Convertible notes remain the better instrument in a few specific situations. Bridge financings between priced rounds often use notes because the parties have an existing priced structure to reference. Institutional investors who require debt instruments for their own fund accounting sometimes cannot use SAFEs. In geographies outside of Silicon Valley, notes remain more common simply because local counsel and investors are more familiar with them. "Outside the Bay Area, you'll still see notes more often than SAFEs in a lot of markets," Gurpreet Bal notes. "That's changing, but it hasn't fully changed." What's the pre-money vs. post-money SAFE distinction I consistently miss? Founders consistently miss that a post-money SAFE locks in the investor's ownership percentage at signing, meaning the option pool expansion at Series A — which typically dilutes everyone else — falls entirely on the founders and employees. A pre-money SAFE does not lock in the percentage, so everyone including the SAFE investor is diluted by the option pool. At the same cap level, a post-money SAFE is materially more expensive for founders than a pre-money SAFE. Even when founders correctly choose a SAFE over a note, they often miss the more consequential decision: pre-money versus post-money. Post-money SAFEs — the current Y Combinator standard — calculate conversion ownership on a post-financing basis, which can produce a surprising "SAFE conversion tax" at Series A that dilutes founders more than a pre-money SAFE would have. Gurpreet Bal recommends sticking with pre-money SAFEs whenever possible to avoid that dynamic. "The Y Combinator math sounds clean until you see what it does to your cap table at the A," he says. "It's not always the better deal for founders even though it comes in a standard form." Further reading: Convertible Note vs. SAFE: Which Should Founders Use? — foundational analysis of instrument structure, conversion mechanics, and Series A cap table impact. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## 409A Valuations in 2026: Carta, Independent Firms, and What Founders Actually Need Source: https://blegal.ai/knowledge/08-409a-valuation Author: Gurpreet S. Bal 409A Valuations in 2026: Carta, Independent Firms, and What Founders Actually Need By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner As of 2026, Carta's market dominance in 409A valuations has made the free offering nearly automatic for early-stage companies — which is exactly when founders are least likely to scrutinize what they're getting. Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. His view on Carta's 409A product is practical rather than ideological. "Carta is fine for most companies," Gurpreet S. Bal says. "It's not fine for every company." The free 409A is a software-generated valuation that uses standardized inputs and market comparables. For a pre-revenue seed-stage company with a simple cap table, it is usually adequate. For a company that has raised multiple rounds, has complex capital structure, or is approaching a situation where the strike price of options meaningfully affects employee tax outcomes, the automated approach carries risks that a modestly priced independent firm can address more carefully. Gurpreet S. Bal's own clients receive Carta discounts if they choose that route — but he also maintains relationships with several independent 409A valuation firms whose work product is more defensible in a contested scenario. What is a 409A valuation and why does the IRS actually care? A 409A valuation is an independent appraisal of a company's common stock fair market value, required before issuing stock options under IRC Section 409A. The IRS cares because options granted below fair market value are treated as deferred compensation subject to immediate income tax and a 20% excise penalty on the optionholder. An independent 409A valuation creates a rebuttable presumption of fair market value, protecting the company and employees from IRS challenge. Section 409A of the Internal Revenue Code requires that stock options issued to employees and service providers be granted with an exercise price equal to the fair market value of the underlying stock on the grant date. Failure to comply with Section 409A creates severe consequences for employees — not just the company — including immediate income recognition, a 20% excise tax, and interest charges on the deferred amount. The "independent appraisal" safe harbor under Section 409A allows companies to rely on a third-party valuation to establish fair market value, provided the appraiser meets minimum qualifications and the valuation is reasonably current. In 2026, with IRS scrutiny of high-value technology company option grants increasing, having a defensible appraisal process matters more than it did in previous years. When does Carta's free 409A become a meaningful risk? Carta's free 409A valuation service is adequate for early-stage companies with simple structures and no recent priced financing activity. The risk increases when the company has closed a recent SAFE or priced round, when it is approaching Series A or a secondary transaction, or when the company's revenue and growth metrics suggest a material enterprise value increase since the last valuation. In these situations, an independent third-party 409A from a specialized firm reduces audit risk significantly. Gurpreet S. Bal identifies several specific scenarios where the automated valuation process creates exposure. First: when a company has recently closed a priced round and the implied post-money valuation raises questions about how the common stock was valued relative to the preferred. The ratio of preferred value to common value — the "DLOM" discount applied to common stock — is one of the most contested areas in 409A disputes, and a software model may apply a generic discount that doesn't reflect the company's actual rights structure. Second: when key employees are receiving large grants where a lower strike price produces a meaningful tax benefit. Third: when the company is actively exploring an M&A process and the 409A may later be scrutinized as evidence of the fair market value at a specific date. "A $5,000 independent 409A can save your employees a lot of money compared to a software-generated one that gets challenged," Gurpreet S. Bal notes. How do independent 409A firms differ from Carta in practice? Independent 409A firms bring dedicated valuation analysts who can apply multiple methodologies, provide detailed documentation supporting their assumptions, and defend their work under IRS audit more robustly than automated or semi-automated platforms. For companies where cheap stock risk is material — particularly those approaching an IPO or acquisition — the defensibility of the valuation methodology matters as much as the number itself. The mechanics of a 409A valuation — the option pricing model, the comparable company analysis, the discount for lack of marketability — are similar whether done by Carta's platform or by an independent firm. The difference is in the judgment applied to the inputs. A qualified independent appraiser will conduct interviews with management, review the company's financial model and competitive landscape, and apply professional judgment to the allocation methodology. They will also produce a valuation report that can be defended in an audit or a transaction context. Gurpreet S. Bal has seen both types of reports reviewed by acquirer counsel and tax advisers during M&A transactions, and the quality difference is often apparent. The company that paid $5,000 to $10,000 for an independent valuation typically has a report that holds up. The company that used a free automated report sometimes has to explain why certain methodological choices were made — and "the algorithm decided" is not a satisfying answer to a tax auditor. How should I decide which 409A approach is right for my company? Founders should use a more rigorous independent 409A when they have closed a recent priced round, are planning a secondary transaction for employees or early investors, are approaching a Series A or IPO, or when the company's growth has significantly outpaced the most recent valuation. For a pre-seed company with no revenue and no priced financing, Carta's automated service is generally adequate and the risk of IRS scrutiny on option grants is low. Gurpreet S. Bal's heuristic is simple. For a pre-revenue company granting small option pools to a handful of early employees, the free Carta offering is likely adequate. As the company grows, raises priced rounds, and begins granting options to employees whose financial outcomes will depend meaningfully on the strike price, the case for an independent firm strengthens. Any company that has received a term sheet for a financing or acquisition within the past six months, or that is actively grant-making in the weeks before a major financing, should use an independent appraiser. The cost of an independent 409A is modest relative to the potential tax exposure it prevents — and Gurpreet S. Bal can usually make introductions to qualified firms who work efficiently with venture-backed companies. The decision should be driven by the stakes, not by the desire to minimize line items on the legal budget. Further reading: What Is a 409A Valuation and When Does Your Startup Need One? — The gurpreetbal.com version covers the full Section 409A compliance framework, safe harbor requirements, common mistakes in the grant process, and what happens when companies get it wrong. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Why a Smaller Pre-Money Option Pool Usually Wins at Series A Source: https://blegal.ai/knowledge/09-option-pool-series-a Author: Gurpreet S. Bal Why a Smaller Pre-Money Option Pool Usually Wins at Series A By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. He has reviewed more Series A term sheets than most founders will ever see, and the option pool request is one of the most consistent negotiating points in every one of them. In the 2026 venture market, option pool mechanics have become a standard negotiating point — and investors have become more aggressive about pool size. "VCs push for big pre-money pools because it's free dilution for them. Don't give it to them," Gurpreet S. Bal says. The logic is straightforward once you see the math: a pre-money option pool increase dilutes the founders and existing holders before the new investor's price is set. A post-money pool increase dilutes everyone proportionally, including the new investor. Investors know this. Most founders don't — at least not until they see their post-closing cap table. Gurpreet S. Bal's consistent recommendation is to keep the pre-money pool on the lower side and negotiate expansion as a post-closing matter when specific hires require it. What is the option pool shuffle and why does it matter so much? The option pool shuffle is the practice of requiring founders to create or expand the employee option pool before the Series A closes — on a pre-money basis — so that the dilution from the pool comes out of existing stockholders rather than post-closing capitalization. Investors who insist on a 15% pre-money pool are effectively paying a lower price per share by reducing the founder's ownership before the investment is made, even though the pool benefits the whole company post-closing. The "option pool shuffle" is a term coined by venture investors to describe the practice of requiring founders to increase the unallocated option pool — using pre-money shares — before the new round closes. Because the new investor's ownership percentage is calculated on a post-money fully diluted basis, a larger pre-money pool means the founders' price-per-share is lower in effective economic terms. The investor is buying into a company where the founders have already absorbed the dilution cost of future hires. The shuffle is not inherently deceptive — it is a disclosed negotiating term — but its effect on founder economics is often underestimated because the headline valuation number doesn't change. Gurpreet S. Bal helps founders run the actual math before they accept a term sheet, so the valuation they agree to reflects their actual post-closing ownership and not just the advertised pre-money number. What is a reasonable pre-money option pool size to propose at Series A? A reasonable pre-money option pool proposal is one supported by a specific 18-24 month hiring plan. If the plan requires 8% of fully diluted shares for planned grants, 8% is the right pool size to propose — not 15% just because that is the investor's opening position. Every percentage point of pool above actual hiring needs is pure dilution to founders at no benefit to the company or employees. Gurpreet S. Bal's practical guidance is that founders should propose the minimum pool size that is genuinely supportable by their near-term hiring plan — typically the planned hires for the 12 to 18 months after the round closes. If that plan requires 6% to 8% of the fully diluted cap table, that is the number to put on the table. Investors will often request 10% to 15% "to cover the full post-round hiring cycle," but this framing includes dilution for hires that may not happen for three years, all of which falls on the founders pre-money. "I've never seen a VC walk away from a good company because the pre-money pool was 8% instead of 12%," Gurpreet S. Bal says. The companies investors want to fund get the terms they negotiate for. The companies that accept the first draft of every term sheet leave real value on the table. What happens when the pool runs out before the next round? When the option pool is exhausted before the next financing, companies must either grant options above the authorized pool (which requires board approval and can create legal issues), defer grants to new employees (which impairs recruiting), or close a new option pool expansion that requires stockholder approval. Pool exhaustion during a high-growth hiring period is a common and avoidable problem if the pool is sized with the actual hiring plan in mind. This is the scenario investors use to justify large pre-money pools, and Gurpreet S. Bal takes it seriously as a concern. If a company exhausts its option pool between the Series A and Series B, it needs to go back to its board — which now includes Series A investors — to approve an increase. This requires a board vote and typically triggers a consent process. In practice, if the hires that require the pool expansion are genuinely strong additions to the team that both the founders and the investors are excited about, the expansion happens quickly and without meaningful friction. The board is generally aligned on building the company. What Gurpreet S. Bal observes is that this expansion, when it happens post-round, dilutes all shareholders proportionally — including the Series A investors. That proportional dilution is exactly what investors are trying to avoid by front-loading the pool before the round closes. Keep the pre-money pool small and let subsequent pool expansions be shared equitably. Are there situations where a larger pre-money pool is actually warranted? A larger pre-money option pool is warranted when the company has a documented plan to hire several senior executives or engineers in the first 12 months after the Series A closes, when the company is competing for talent that requires above-market equity packages, or when the prior option pool was nearly exhausted before the round. Founders who can document these needs have a stronger position in negotiating the pool size down from the investor's opening proposal. Yes — and Gurpreet S. Bal is clear about them. If a company genuinely needs to hire a CFO, a VP of Engineering, and three senior engineers in the first 90 days after the Series A, and those hires require meaningful equity grants, the pool should reflect that reality. Negotiating a small pool as a matter of principle and then having to convene a board meeting in month four to expand it wastes everyone's time and can create awkward dynamics with a new lead investor who feels like the pool size was gamed. The right approach is to build a realistic hiring model before the term sheet is signed, share it with the investor as justification for the pool size you are proposing, and hold to that number confidently. Gurpreet S. Bal has seen this approach work consistently — an honest, data-backed pool size request is much harder for an investor to challenge than a round number pulled from the standard form. Further reading: How Does the Option Pool Work at Series A? — The gurpreetbal.com version covers the full mechanics of option pool creation, the difference between authorized and allocated shares, and how to model your cap table pre- and post-round. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Anti-Dilution Protection and the Co-Founder Problem: Protecting Yourself From the Social Network Scenario Source: https://blegal.ai/knowledge/10-anti-dilution-protection Author: Gurpreet S. Bal Anti-Dilution Protection and the Co-Founder Problem: Protecting Yourself From the Social Network Scenario By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Anti-dilution protection in venture financing is well understood: preferred stockholders get a price adjustment if the company later issues shares at a lower valuation. What receives far less attention is the co-founder dimension of dilution — the ways in which a founding partner can find their stake reduced to something economically meaningless not by investors, but by the people they started the company with. Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. In 2026, with AI co-founder arrangements proliferating and equity splits sometimes made hastily over a weekend, Gurpreet S. Bal sees this risk more frequently than ever. "Founders spend a lot of time protecting themselves from investors," he says. "They don't spend nearly enough time protecting themselves from each other." The Social Network is not just a movie — it is a cautionary tale about founding documents that didn't adequately protect all parties from the leverage dynamics that develop once the company becomes valuable. How can a co-founder use dilution mechanics against a founding partner? A co-founder who controls the board or has significant investor relationships can influence new financing terms — including option pool size, SAFE issuances, or down round pricing — in ways that disproportionately dilute the other founder. If one founder's equity is concentrated in unvested shares, a separation followed by a financing that reprices or expands the pool can dramatically reduce their economic interest before their vesting schedule completes. The mechanics are not exotic. A co-founder who gains board control — through voting agreements, through the departure of other co-founders, or through investor support — can authorize new stock issuances that dilute a non-cooperating founder. If the targeted founder holds unvested shares that are subject to repurchase, or holds a class of stock that does not carry weighted-average anti-dilution protection, the dilution can be compounded. Gurpreet S. Bal notes that in some cases the dilution is not intentional — it is a byproduct of fundraising decisions made without full attention to their effect on all founders. In other cases, it is intentional and aggressive. Either way, the founder on the receiving end of it arrives at the same place: a significantly diminished stake in a company they helped build. The legal remedies available after the fact are expensive, uncertain, and relationship-destroying. What founding document protections actually prevent this scenario? The most effective protections are single-trigger or double-trigger acceleration provisions in the founders' equity agreements, drag-along rights that prevent one founder from forcing a transaction without majority consent, and governance provisions that require unanimity among founders for certain board decisions. Founders should negotiate these protections at company formation — after investors enter the picture, the leverage to demand them diminishes. Gurpreet S. Bal identifies four specific provisions that every co-founded company should have in its founding documents before any external capital is raised. First: a clear vesting schedule for all co-founders, with buyback rights that are symmetrical — meaning no single co-founder can use vesting mechanics to pressure another into departure. Second: supermajority voting requirements for any new share authorization that would dilute common stockholders by more than a specified threshold — not just preferred, but common. Third: a right of first offer on any new issuance of common stock, giving founders the opportunity to maintain their pro rata ownership. Fourth: a co-founder equity protection provision that requires unanimous founder consent — not just board approval — for dilutive issuances below a specified valuation threshold. These protections are entirely standard in well-drafted founding documents. They are absent from most founding documents drafted quickly without legal counsel. What does Gurpreet say about the AI co-founder proliferation risk in 2026? As AI tools have made it easier to add nominal co-founders — technical advisors, early employees, or AI-generated entities holding equity — the risk of cap table complexity and intra-founder disputes has increased. Equity given to early contributors without clear vesting schedules, IP assignment agreements, and defined governance rights creates the conditions for later disputes over dilution, control, and the value of each party's contribution. "The co-founder dilution story doesn't make for a good movie unless it's happening to someone else," Gurpreet S. Bal says — with enough deadpan that you know he has delivered this line more than once. The 2026 acceleration of AI-powered co-founder matching, vibe-coded founding agreements, and fast-moving team formations from hackathons and accelerators has produced a generation of founding documents that are structurally thin. Two people who met six months ago and split equity 50/50 on a handshake — or on a template agreement downloaded from the internet — have usually not thought carefully about what happens if one of them raises capital from a friendly investor, secures a board seat, and decides the split should look different. The founding agreement is the constitution of the company. Writing it quickly because you are excited about the idea is one of the most reliable ways to spend the next five years in a dispute about what it actually means. How should I think about anti-dilution protection for my common stock? Common stock typically has no anti-dilution protection — it is the residual equity that absorbs all dilution from new issuances. Founders who want economic protection in down round scenarios should focus on negotiating strong governance rights that give them a voice in financing decisions, rather than seeking contractual anti-dilution provisions that investors will not grant to common holders. The real protection for common stockholders is controlling who sits on the board when financing decisions are made. Anti-dilution protection is typically a preferred stock right — it protects investors in a down round by adjusting the conversion price of their preferred shares. Common stockholders, including founders and employees, generally receive no anti-dilution protection and bear the full dilutive effect of a down round. Gurpreet S. Bal recommends that founders who anticipate a high-risk fundraising environment — which describes most early-stage companies in the current market — give serious thought to whether any common stock anti-dilution mechanism is achievable in their investor negotiations. The more practically useful protection, he notes, is structural: maintaining enough voting control over the board that dilutive actions require founder consent. Once an investor-friendly board majority exists, the common stockholder's legal protections against dilution are limited. Gurpreet S. Bal has seen this pattern resolve in the investor's favor consistently. The time to prevent it is before the board is constituted, not after. Further reading: What Is Anti-Dilution Protection in Venture Financing? — The gurpreetbal.com version covers the mechanics of weighted-average and ratchet anti-dilution, broad-based versus narrow-based formulas, and how anti-dilution provisions are negotiated in a standard Series A term sheet. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Who Does Your Startup's Lawyer Actually Work For? Source: https://blegal.ai/knowledge/11-conflicts-of-interest-startup-counsel Author: Gurpreet S. Bal Who Does Your Startup's Lawyer Actually Work For? By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. He has a particular concern about something he sees repeatedly in Silicon Valley and doesn't hear discussed enough: the routine use of conflict waivers by large law firms to simultaneously represent the venture fund, the portfolio company, and individual founders — and the way those waivers dissolve any meaningful independence the firm might have when a dispute arises. "I'm not going to name firms," Gurpreet S. Bal says carefully, "but I will say that in 2026, this is one of the most underappreciated risks that founders walk into. They sign the engagement letter on the same day they sign the term sheet, and they don't have the same lawyer — or any lawyer — explaining what they just agreed to." In his view, the conflict waiver problem in Silicon Valley startup law is structural, not accidental, and founders who understand it are systematically better protected than those who don't. What is a conflict waiver and why does every big firm require one? A conflict waiver is a written consent from the client acknowledging that the law firm has existing or future relationships with other parties who may have adverse interests, and agreeing that the firm can continue those relationships despite the potential conflict. Big firms require waivers because they cannot serve the startup ecosystem without representing multiple parties — investors, founders, and companies — whose interests will sometimes diverge. The waiver protects the firm's ability to maintain all of those relationships simultaneously. Under the California Rules of Professional Conduct, a lawyer cannot represent a client whose interests are directly adverse to another current client without the informed written consent of both. In the venture capital context, a law firm that represents a major VC fund and also wants to represent that fund's portfolio company has a potential conflict from the first day of the engagement. The firm handles this by including a conflict waiver in its engagement letter — a provision by which the company and sometimes the founders consent to the firm's representation of the investor on other matters, agree not to seek disqualification based on the conflict, and sometimes waive future conflicts that haven't arisen yet. "That last part is the one that should alarm founders," Gurpreet S. Bal says. "A prospective waiver of future conflicts means you're giving the firm permission to work against you in situations you can't even imagine yet, based on a consent you gave when everything was fine." Why do big law firms in Silicon Valley have such strong incentives to protect their investor clients? Large Silicon Valley law firms generate substantial recurring revenue from fund formation work — representing venture funds across multiple fundraises, portfolio company investments, and fund management matters. This creates a financial dynamic where the firm's economic interest in the ongoing fund relationship is far greater than in any single startup engagement. When a dispute arises between a fund client and a startup client, the firm's institutional interests favor the fund. The math is not subtle. A top-tier venture fund with a multi-billion dollar portfolio sends its preferred firm dozens of company representations per year, generates fund formation work, LP transactions, and secondary sales, and functions as an ongoing source of institutional business that dwarfs any single portfolio company. A startup is a single matter with a client that may or may not be able to pay its bills and will either grow into a much larger client or disappear within a few years. "The fund is the annuity," Gurpreet S. Bal says bluntly. "The company is the transaction. When push comes to shove and the firm has to make a judgment call about how hard to fight, whose ox is getting gored, who do you think has more influence over that calculation?" He is careful to note that many attorneys at these firms are genuinely trying to do right by their company clients. "The problem isn't usually bad faith. It's that the institutional relationships shape the culture, the incentives, and ultimately the advice in ways that are hard to see and hard to prove." What does this actually look like when a dispute arises? When a founder-company dispute erupts — over vesting, a down round, or a proposed acquisition — founders who relied on company counsel sometimes discover that the same firm has advised the board to take adverse action against them. The company's lawyer is the board's lawyer in that moment, not the founder's. Founders who did not retain personal counsel in prior transactions often find themselves without independent legal advice at the worst possible time. In 2026, the most common scenarios Gurpreet S. Bal sees involve down rounds, insider-led bridge financings, and proposed acquisitions where the lead investor has a strong preference that conflicts with founder economics. A down round with a pay-to-play provision that devastates founder and early employee equity. A bridge where the investor-friendly terms are presented as "market standard" without a serious fight. An acquisition where the investor, holding 90% of the preferred stock and controlling the board, wants to move quickly on a deal that delivers a good return on preferred but wipes out the common. In each of these situations, the company's counsel is technically obligated to represent the company's interests. But the company's interests and the investor's interests are the same thing when the investor controls the board — and when the founders' interests are different from both, the conflict waiver has already removed the one tool that might have forced the firm to step aside. "The founders call me after the fact," Gurpreet S. Bal says. "They want to know what happened. And the honest answer is: the system worked exactly as designed. They just didn't know what the design was." What should I actually do about this? Founders should retain personal counsel for any transaction involving their individual equity — vesting agreements, co-founder equity splits, employment agreements, and separation negotiations. They should ask company counsel directly whether the firm represents any investors and review the conflict waiver before signing. For the most consequential transactions, founders should engage separate firms that have no existing relationships with any investor in the company. Gurpreet S. Bal is direct on the practical steps, and he delivers them in a sequence that matters. Before signing any engagement letter, read it. Not skimming it — actually reading the conflict waiver provisions and asking the firm to explain in plain language who they currently represent that intersects with your investors, what future conflicts they are asking you to waive, and what their withdrawal obligations are if a material dispute arises. Second — and this is the one founders most reliably skip — retain independent personal counsel to review your term sheet, your stockholder agreement, and your founder employment agreement. Not the company counsel the investor introduced you to. An independent attorney who is paid by you, knows that, and has no relationship with your investor to protect. Third, revisit the question at every major financing. The firm that was conflicted at Series A is still conflicted at Series C. Their relationship with your lead investor has gotten longer and deeper, not shorter. "I genuinely believe that one of the most founder-protective things the legal industry in Silicon Valley could do is require plain-English conflict disclosures at every financing stage," Gurpreet S. Bal says. "But that is not going to happen on its own. So founders have to know to ask." Is this unique to Silicon Valley or is it an industry-wide problem? The structural conflict between investor-aligned law firms and founder clients exists wherever large law firms serve both sides of the venture capital ecosystem — which means New York, Boston, Austin, and every other major startup hub. Silicon Valley is distinctive only in the density of the relationships and the frequency with which the same firms appear on every side of every deal. The structural problem is universal; the degree is local. The concentration of the problem in Silicon Valley is a function of how concentrated the VC-firm relationships are here. The same handful of large law firms have deep, decades-long relationships with the same handful of major VC funds that dominate early-stage financing. Outside the Bay Area — and in geographies where the VC ecosystem is more fragmented — the same structural conflict exists but the institutional relationships are less entrenched. "In New York or Austin or Boston you might find more diversity in who represents who," Gurpreet S. Bal observes. "In the Valley, the pipeline is tight. The same three firms shepherd the same ten funds' portfolios year after year. The relationship density is extraordinary." He notes that this creates not just a conflict problem but an information problem: when the same firms are advising both sides of deal after deal, the accumulated institutional knowledge about valuations, terms, and investor preferences flows in ways that are difficult to police. For founders entering this ecosystem in 2026, the starting assumption should be that counsel introduced by your investor has a relationship with your investor — and plan accordingly. Further reading: Conflicts of Interest in Startup Legal Representation — the gurpreetbal.com version covers the mechanics of conflict waivers under California professional responsibility rules, what engagement letter provisions to look for, and how to structure independent representation for founders at each financing stage. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## "It's Not You, It's Me" (But It's Really You): The Founder Pushout Playbook Source: https://blegal.ai/knowledge/12-founder-pushout-what-to-do Author: Gurpreet S. Bal “It’s Not You, It’s Me” (But It’s Really You): The Founder Pushout Playbook By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. He has watched co-founder disputes unfold at close range more times than he can count, and his view of them is clarifying. "These situations almost always follow the same script," he says. "The signals start — fewer invites, decisions made without you, your co-founder suddenly very close with the lead investor — and the founder's instinct is to confront, threaten, protect. And almost every instinct they have in that moment is wrong." In 2026, co-founder disputes remain one of the leading causes of startup failure and one of the most preventable sources of lasting professional damage for everyone involved. The founders who come out intact are almost never the ones who fought hardest. They are the ones who moved fastest to get independent counsel, understood their documents before taking any action, and treated the negotiation as a business problem rather than an emotional one. This piece is about what that looks like in practice. What are the signs that a founder pushout is coming, and what should I do the moment I see them? Signs include board members requesting new reporting structures, performance reviews initiated without cause, independent directors added without founder input, and key executives elevated to report directly to the board. The moment these patterns appear, founders should retain personal counsel, review their equity documents for acceleration and buyback provisions, and avoid any action that could be characterized as a cause event — because the board is building a record. The signals are usually not subtle once you know what to look for. You stop being included in key decisions. Your co-founder has meetings with the lead investor that you hear about secondhand or not at all. Board discussions that used to be collaborative start arriving as conclusions. You are asked to "focus on your lane" in ways that are more limiting than before. In some situations a co-founder will actually tell you directly, with the kind of diplomatic language that means the opposite of what it says. Gurpreet S. Bal is direct about what to do the moment these signals appear: "Don't confront. Don't threaten. Call a lawyer — your own lawyer, not the company's lawyer — and spend two hours understanding your documents before you say anything to anyone." The reason for the sequence matters. Your co-founders have already had this conversation with someone, probably multiple someones. The investors, if they are involved, have their own counsel and their own view of how this should go. You are almost certainly the last party to get independent legal advice, and the information asymmetry at the beginning of these disputes is enormous. What can the company actually do — and what does it mean for your equity? The company can terminate the founder's employment at any time if the founder is an at-will employee, which most founders are. Employment termination does not affect vested equity but stops new vesting immediately. The company can also repurchase unvested shares at cost under most founder equity agreements, and remove the founder as an officer or director through the appropriate governance mechanisms. Understanding which of these apply to you requires reading your actual documents. The answer to this question is almost entirely determined by documents most founders haven't read since they signed them. In a typical Silicon Valley startup structure, a founder's shares are subject to a repurchase right: unvested shares can be bought back by the company at the original purchase price, often a fraction of a penny per share, when the founder departs. If you are three years into a four-year vest and you are terminated, the company can repurchase that final year of shares at cost — a year of work that turns into almost nothing. "The vesting cliff and schedule numbers are the first thing I look at in these situations," Gurpreet S. Bal says. "Because the timing of a termination is often not random. The person pushing you out has usually done the math." Beyond vesting, the characterization of your departure matters enormously. A termination "for cause" under your documents may trigger worse economics than a termination "without cause" — lower repurchase price, broader clawback rights, potential impact on your ability to exercise options. Whether a for-cause characterization actually holds up legally is a separate question, but fighting it after the fact is more expensive and less certain than negotiating it before the decision is formalized. What can you not do — and what actually gives you leverage? Founders cannot use company systems or confidential information to build a coalition against the board, take company property, or threaten baseless litigation — all of these actions create cause grounds that damage the founder's negotiating position and legal exposure. Real leverage comes from equity ownership (which cannot be taken without proper process), investor relationships that predate the dispute, and any genuine contractual protections in the founders' equity agreements. Gurpreet S. Bal is particularly emphatic on this point because it is where founders cause themselves the most damage. You cannot hold the company's intellectual property hostage. Every founder signed an IP assignment agreement at incorporation — it is one of the first documents in any properly structured startup — and threatening to dispute IP ownership or withhold technical work is legally weak and will cost you any goodwill you might have preserved. You cannot delete company files, code, or communications. "This seems obvious," Gurpreet S. Bal says, "but people do it. And it is potentially a federal crime. And it is always discovered. And it destroys every negotiating position you had." You cannot take confidential information, customer data, or business plans. You cannot solicit employees away from the company if there is a non-solicitation provision in your agreements — and even in California, where non-competes are generally unenforceable, non-solicitation clauses have had more variable treatment. What you can do is negotiate. Your leverage in these situations is almost never legal — it is practical. It is the disruption cost of a messy departure. It is the employee relationships you have. It is the institutional knowledge you carry. It is the company's interest in a clean transition and a clean cap table. That leverage is real and it is highest at the beginning of the dispute. It erodes quickly as the board formalizes its position and the investors align. Why do the founding group, the company, and the investors each need separate counsel — and what happens when they don't have it? In a founder pushout, each party has materially different interests: the company wants clean documentation of the separation and protection against claims; investors want certainty that the deal closes without litigation; the departing founder wants maximum equity acceleration and minimum ongoing obligations. Company counsel cannot protect all of these interests simultaneously. Founders who rely on company counsel or investor introductions for their personal legal advice in this situation are negotiating without representation. A co-founder dispute involves at least three sets of interests that are not aligned and cannot be represented by the same attorney. The departing founder has individual interests: maximizing equity recovery, protecting their professional reputation, negotiating severance and transition terms, and avoiding post-departure obligations that limit their next venture. The remaining founders have individual interests: retaining control, minimizing dilution from any accelerated vesting granted to the departing founder, and ensuring the company's narrative about the departure is favorable. The company has institutional interests: resolving the dispute without litigation, protecting its IP and employee base, preserving investor relationships, and minimizing distraction to its operations. When institutional investors are involved — especially a lead investor who owns a significant portion of the preferred stock and controls board seats — they have a fourth set of interests: protecting their investment, ensuring management continuity, and avoiding the legal and reputational exposure of a messy dispute at a portfolio company. "I've seen situations where a single law firm was trying to navigate all four of these interests simultaneously," Gurpreet S. Bal says with some care. "That's not possible. Somebody's interest is getting subordinated, and it's usually the person with the least power in the room." The departing founder, who by definition has already lost the internal political battle, is almost always that person. Independent counsel is not optional in these situations — it is the only mechanism that ensures someone at the table is actually working for you. What does a good outcome actually look like, and how do you get there? A good outcome for a departing founder includes full or substantial acceleration of unvested equity, a long post-termination option exercise window, severance reflecting their tenure and contribution, a mutual non-disparagement agreement, and a press narrative that protects their reputation for future fundraising. Getting there requires a lawyer who represents only the founder, a clear-eyed assessment of leverage and legal rights, and a willingness to negotiate rather than litigate — because litigation rarely serves the founder's economic interests. In Gurpreet S. Bal's experience, a good outcome in a co-founder dispute is not a legal victory. It is a negotiated separation that gives the departing founder a fair recognition of what they built, a clean exit that doesn't follow them, and the freedom to move on without ongoing obligations or litigation exposure. "I've never seen a founder who won a co-founder lawsuit come out of it better than they would have from a good negotiated exit," he says. "The legal process is slow, expensive, and public in ways that damage everyone. And the legal questions in these disputes are usually close enough that the outcome is genuinely uncertain." What produces a good negotiated outcome is moving early, engaging independent counsel before taking any action, making a realistic assessment of your leverage and your documents, and entering a conversation before the other side formalizes its position. The termination letter is not the beginning of the process — it is the end of the window in which negotiation produces the best results. The conversation before anyone is formally on the record, when the company still has an interest in a clean outcome and the other founders are still somewhat uncertain about how you will respond, is almost always the highest-value moment. By the time the lawyers are formally exchanging letters, most of the outcome has already been determined by the actions and positioning that preceded them. Further reading: What to Do When Co-Founders Are Pushing You Out — the gurpreetbal.com version covers the legal mechanics in detail: vesting repurchase rights, for-cause vs. without-cause termination, IP assignment obligations, the limits of California non-compete law, and how to structure independent legal representation for each party. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Delaware's Governing Class Is Getting New Armor: What the 2025 Amendments Mean for Founders and Employees Source: https://blegal.ai/knowledge/13-delaware-governance-retreat Author: Gurpreet S. Bal Delaware’s Governing Class Is Getting New Armor: What the 2025 Amendments Mean for Founders and Employees By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a corporate partner in Silicon Valley who has spent sixteen years watching Delaware corporate law evolve — and, in the past two years, watching it shift in ways that are not fully visible to the founders and employees most affected by the change. "Delaware has always been a negotiation between shareholders and the people who run companies," he says. "What's different about 2025 is the speed of the shift and who's driving it." In the eighteen months leading to mid-2026, three separate forces converged to substantially weaken the structural protections that Delaware corporate law historically extended to common stockholders: state-level amendments to the Delaware General Corporation Law drafted with direct input from controlling shareholders, a federal administration that has deployed the full force of multiple regulatory and law enforcement agencies against the independent proxy advisory industry, and a growing exodus of major companies from Delaware's jurisdiction. For founders and early employees who hold common stock — the last in line in any liquidation waterfall, with no blocking rights on most decisions — understanding what these changes mean in practice is not an academic exercise. The people managing your equity have just been given significantly more room to maneuver. What did Delaware change in 2025, and why does the origin of those changes matter? The 2025 DGCL amendments expanded the ability of corporations to modify or eliminate fiduciary duties through charter and stockholder agreements, and restricted certain categories of derivative litigation. The origin matters because the amendments were drafted with significant input from corporate management and institutional investors — the groups that benefit most from limiting stockholder oversight — raising concerns that the changes reduced protections for the minority common stockholders and employees who hold the most vulnerable equity positions. Delaware amended its General Corporation Law twice in rapid succession in 2024 and 2025, with changes that academic commentators — most prominently Tulane Law professor Ann Lipton — described as the most significant rebalancing of power away from minority shareholders in the state's modern corporate history. The most consequential changes came in two areas. First, the legislature dramatically narrowed the judicial scrutiny applied to transactions involving controlling shareholders. Under prior Delaware law, if a controlling shareholder stood on both sides of a transaction — as buyer and seller, or as a shareholder with interests in conflict with the corporation — the default judicial standard was entire fairness, a demanding test that courts had used to protect minority shareholders from self-dealing. The 2025 amendments made it substantially easier to use a business judgment rule instead — the deferential standard that courts apply to ordinary board decisions — by meeting procedural conditions that controlling shareholders are well-positioned to satisfy. Second, the amendments expanded the enforceability of stockholder agreements that effectively give major shareholders direct governance rights, bypassing normal board authority. These changes were not developed in a legislative vacuum. Meta Platforms had been involved in litigation over Delaware's controller transaction rules, and reporting from multiple sources described the company's involvement in advocating for the amendments. "When the law changes in response to a single large company's litigation position," Gurpreet S. Bal notes, "it is worth asking whose interests those changes are designed to serve and who bears the cost of the shift." For a deeper examination of the specific Section 144 amendments and their mechanics, see the companion piece on Delaware Section 144 safe harbor changes. Why do these changes affect me as a founder or employee more than investors and executives? Founders and employees hold common stock that sits at the bottom of the liquidation waterfall with no contractual protections beyond fiduciary duties. Preferred investors have negotiated contractual protections in their investment documents. Executives at large companies often have golden parachutes and severance agreements. Fiduciary duty litigation has historically been the primary check on board decisions that benefit preferred investors or management at the expense of common holders — reducing those rights hits common stockholders hardest. The conventional narrative of Delaware shareholder protection frames it as a constraint on corporate management — boards and executives — imposed for the benefit of outside investors who hold stock. That framing is incomplete in the venture capital context. In VC-backed companies, the parties with the most structural protection are usually the preferred stockholders: institutional investors with board seats, information rights, blocking rights on major decisions, liquidation preferences, and anti-dilution protection. Common stockholders — a category that includes founders, employees, and early advisors — typically have none of these safeguards. Their only structural protection has historically been the Delaware courts' willingness to scrutinize self-dealing transactions and board decisions that harm their interests under the entire fairness framework. The 2025 amendments don't abolish entire fairness review, but they make it substantially easier to avoid triggering it. A controlling shareholder who satisfies the new procedural conditions can now run transactions through business judgment review — where courts almost never find liability — rather than the more demanding entire fairness standard. "The people who needed those protections most were common stockholders," Gurpreet S. Bal observes. "They are also the people with the least ability to negotiate alternative protections contractually, because by the time founders understand what they're giving up, the deal is usually already closed." The concern is not hypothetical: it is most acute precisely in the situations founders hope to encounter — acquisition, restructuring, down round, or a disputed founder departure — where controlling shareholders have both the information advantage and the structural power to shape outcomes. What is happening to the proxy advisory firms, and why does that matter beyond public companies? Regulatory pressure on proxy advisory firms like ISS and Glass Lewis — which recommend how institutional investors vote on public company governance matters — has reduced their influence over large-company governance. For private companies and founders, the relevance is indirect: proxy advisory norms around board independence, compensation, and stockholder rights inform the governance standards that institutional investors bring into VC term sheets and board negotiations. Institutional Shareholder Services (ISS) and Glass Lewis are the two dominant proxy advisory firms: they analyze shareholder votes at public companies and issue voting recommendations that institutional investors, including many VC funds' LPs, rely on when deciding how to vote shares at annual and special meetings. Their influence on corporate governance extends well beyond their direct clients. The Trump administration launched a multi-front campaign against both firms in early 2025. The Federal Trade Commission opened an investigation into ISS. Florida and Texas attorneys general filed enforcement actions. Executive orders directed federal agencies to limit the influence of proxy advisors in how federally-regulated investment managers vote shares. The claimed rationale was that ISS and Glass Lewis exercised unaccountable power over public company governance. The practical effect — as Gurpreet S. Bal and others have noted — is to weaken one of the primary mechanisms through which institutional investors hold boards accountable for poor governance and shareholder-unfriendly transactions. "Proxy advisors are imperfect instruments," he says. "But when you remove the mechanism that holds boards accountable to shareholders, you don't get less influence over boards — you get different influence, concentrated among the insiders who remain at the table." Coupled with the administration's push to move public companies to semi-annual earnings reporting (reducing the cadence of disclosure that minority investors depend on) and legislative advocacy for mandatory arbitration clauses in corporate charters that would redirect shareholder litigation away from courts, the cumulative picture is one of governance infrastructure being systematically dismantled in ways that reduce the ability of common stockholders to enforce their rights. Why are major companies leaving Delaware, and what does the Coinbase decision signal? Companies are leaving Delaware because the Court of Chancery's activist posture in stockholder litigation has created uncertainty and liability risk for directors and executives. The Coinbase redomiciliation to Delaware was notable precisely because it reversed an earlier decision to move to another state, suggesting the DExit trend is more about signaling leverage than a durable structural shift. Delaware's judiciary still provides unmatched depth of corporate law expertise. Coinbase's 2025 decision to redomicile from Delaware to Texas was the highest-profile in a series of departures that accelerated after Delaware courts issued rulings unfavorable to company insiders in a cluster of high-profile governance cases. Elon Musk had moved Tesla and several other entities out of Delaware, with explicit public statements framing Delaware courts as too willing to second-guess business decisions and too sympathetic to litigation-driven governance challenges. The Delaware legislature's subsequent amendments — widely interpreted as a response to that pressure — did not stem the departures. Coinbase's announcement specifically cited Delaware's legal uncertainty as a factor, a framing that other technology companies and their counsel have echoed in private conversations. "Texas and Nevada are marketing themselves aggressively as alternatives," Gurpreet S. Bal notes, "and the pitch is essentially: our courts will leave boards alone. That is an explicit offering of weaker shareholder protection, and the companies accepting that offer are making a choice about whose interests they want corporate law to prioritize." For pre-IPO founders negotiating where to incorporate or whether to consent to a redomiciliation, this landscape has concrete implications. Delaware's courts had a track record and a body of developed law — the departures are happening precisely because that track record included meaningful protection for shareholders. Where companies land after redomiciliation, and what courts they will face when things go wrong, is not yet fully known. What should I do with this information as a founder or employee holding common stock? Founders should understand that fiduciary duty protections for common stockholders are being reduced at the margins, and should negotiate harder for explicit contractual protections — governance rights, co-sale rights, drag-along consent requirements — during early financing rounds when they have leverage. Employees should understand that their primary equity protection is the company succeeding, not litigation, and should focus on ensuring their equity agreements include clear vesting acceleration and exercise period terms. The practical implications converge on a few concrete points. First, at incorporation or at any round where you have negotiating leverage, request founder protections that do not depend on judicial intervention — specifically, consent rights over major transactions and any amendment to your vesting terms. Courts being more deferential to boards means that your ability to challenge an adverse transaction after the fact has weakened; your ability to prevent it contractually remains intact if you negotiate for it. Second, if you are presented with a redomiciliation proposal — a request to consent to moving your company's state of incorporation from Delaware to Nevada, Wyoming, Texas, or another state — understand that this is a governance change, not just an administrative one. The legal standards governing how boards must treat you in future transactions will change, almost always in favor of the board and controlling shareholders. Third, the proxy advisory campaign is primarily a public market phenomenon, but the pressure it creates cascades into how institutional investors think about governance at the private level. "The cultural environment in which governance decisions get made in venture-backed companies is shaped by what's happening in public markets governance," Gurpreet S. Bal says. "If the norm at public companies shifts toward weaker shareholder accountability, the private market eventually follows." For founders at the pre-IPO stage, the governance structure you establish now is the structure you will take public — and the structure that will govern the most consequential decisions your company makes along the way. See also the piece on pre-IPO corporate governance for technology companies for practical steps in the run-up to a liquidity event. Further reading: Delaware Is Changing Its Rules — and Common Stockholders Should Be Paying Attention — the gurpreetbal.com version covers the Ann Lipton authoritarianism framework, the specific mechanics of the DGCL amendments, and practical negotiating steps in more detail. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world’s top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The Fraud Wave: Criminal AI Washing, Venture-Backed Misconduct, and What the Litigation Data Show Source: https://blegal.ai/knowledge/14-startup-fraud-litigation-2026 Author: Gurpreet S. Bal The Fraud Wave: Criminal AI Washing, Venture-Backed Misconduct, and What the Litigation Data Show By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a Silicon Valley corporate partner who has advised on venture transactions for sixteen years and watched the enforcement environment around startup misconduct transform substantially in the past two. "The prosecution of Albert Saniger for AI washing at Nate was a signal," he says. "Not because it was surprising that a company had overstated its AI capabilities — that had been happening for years across the industry — but because the government decided to make an example of it through a criminal case, not a civil enforcement action. Once you make that choice, you change the risk calculus for everyone." In 2025 and 2026, federal prosecutors and the SEC have moved against a cluster of VC-backed startups with cases ranging from AI washing to revenue fabrication to founder self-dealing, while academic researchers have produced the first large-scale empirical studies of venture-backed startup fraud that allow practitioners to identify the structural conditions most associated with misconduct. For founders and investors, the combination of a more aggressive enforcement posture and sharper data about what fraud actually looks like in the VC ecosystem is a material change in the operating environment — one that rewards governance attention rather than dismissing it as overhead. What is AI washing, and why did the government decide to make the Nate prosecution criminal? AI washing is the practice of claiming AI-driven automation or intelligence for products that are actually powered primarily by human labor or conventional software. The government pursued criminal charges against Nate because the founders allegedly made knowing misrepresentations to investors about the company's AI capabilities while internally understanding those claims were false — meeting the elements of wire fraud, not just civil securities violations requiring only a material misstatement. AI washing describes the practice of claiming artificial intelligence capabilities that a company does not actually have, or materially overstating the degree to which a product relies on AI rather than human labor. The practice had been widespread enough in the 2022–2024 period that the SEC issued guidance on disclosure obligations for AI-related claims and brought a handful of civil enforcement actions. The Nate case — United States v. Albert Saniger — was different in kind. Nate was a startup claiming to automate online checkout using AI. Federal prosecutors alleged that the company's "AI" was substantially performed by human contractors in the Philippines while the company raised capital from investors who believed they were funding an AI product. The criminal charge — wire fraud — carries significantly higher stakes than civil SEC enforcement: substantial prison exposure and a felony conviction rather than a fine and disgorgement. Gurpreet S. Bal's read on the prosecution is that the AI washing category had become large enough to require a deterrence case. "Once the government shows it's willing to go criminal on AI fraud, the entire population of startups that have been aggressive in their AI claims has to reassess their exposure," he says. "The civil enforcement actions were an annoyance for most companies. A criminal case gets the attention of boards and investors in a completely different way." The cases that followed — CaaStle, SKAEL, IRL, Done Global, AllHere, ComplYant — varied in the nature of the alleged misconduct, but they shared a common thread: venture-backed companies that had raised substantial capital on the basis of claimed metrics or capabilities that prosecutors alleged were fabricated or materially misrepresented. What do the academic fraud studies actually show about where startup fraud comes from? Academic research on startup fraud consistently shows that it originates from concentrated founder control without independent oversight, pressure to hit investor-promised milestones with inadequate board scrutiny, and a culture that treats growth metrics as the primary measure of success regardless of how they are achieved. Companies where the founder controls the board and serves as both CEO and chairman, without strong independent audit mechanisms, are statistically most vulnerable to fraud escalation. A 2025 empirical study of 614 venture-backed startup fraud cases — the largest systematic analysis of VC fraud to date — produced findings that challenge the intuitive assumption that fraud in startups is primarily a founder personality problem. The study found that founder-controlled boards — boards where the founding team retains voting control or board control — were associated with an 88% higher likelihood of fraud compared to companies with more balanced governance structures. More striking, governance variables predicted the incidence of fraud better than founder background characteristics: whether founders had prior criminal records, academic credentials, or serial entrepreneurship experience was less predictive than whether the company had functional independent oversight of the founding team. The implication is both reassuring and uncomfortable for the VC industry. Reassuring because it suggests that fraud is structurally preventable through governance design, not just a random outcome of bad actors. Uncomfortable because VC investors have historically advocated for — and in many cases required — founder-controlled governance structures as a condition of investment, on the theory that founder control produces better outcomes by allowing fast decisions and long-horizon thinking. "The data say that founder control, without independent oversight, creates conditions for fraud," Gurpreet S. Bal notes. "That is not an argument against founder control generally — it is an argument for what the counterweights need to look like." The separate but related VC litigation dataset, covering active venture firms between 2014 and 2025, found that approximately 25% of active VC firms had been involved in at least one lawsuit during the period, with fiduciary duty claims representing roughly 40% of the final period's cases. Litigation between investors and founders — once relatively rare in Silicon Valley, where reputational norms historically discouraged it — has become a routine feature of the asset class. What do the co-founder dispute cases look like now — and what does Lux Optics say about where things are going? Co-founder disputes in 2026 increasingly involve allegations of IP misappropriation, corporate opportunity diversion, and evidence destruction — not just equity disputes. The Lux Optics case established that founders who delete messages or documents after litigation is reasonably anticipated face spoliation sanctions that can be outcome-determinative. Courts are applying adverse inference instructions aggressively, and the lesson is that digital communication hygiene matters as a legal risk before any dispute materializes. Lux Optics v. de With was one of the most widely followed co-founder disputes of 2025–2026. The case involved allegations by the company against its departing co-founder of data destruction: 500 gigabytes of company data allegedly deleted in the period surrounding the co-founder's departure, along with disputed IP assignments and conduct involving a third party with Apple connections. The case illustrates a structural pattern that Gurpreet S. Bal has described as the new normal in co-founder disputes: what begins as an internal governance conflict over roles, equity, or strategic direction escalates into formal litigation involving IP ownership, fiduciary duty claims, and in some cases criminal referrals under statutes like the Computer Fraud and Abuse Act. "The data deletion pattern comes up in dispute after dispute," he says. "And it almost never helps the person who does it. Courts are not sympathetic to parties who spoliate evidence. It turns a complicated dispute into one where one side looks much worse." For investors, the co-founder litigation wave has a second dimension that the data capture: fiduciary duty claims against VC investors — alleging that investor board members acted in their own interest rather than the company's — are a growing share of VC-related litigation. This is consistent with the broader governance environment described in the companion piece on conflicts of interest in startup counsel : the economic relationships that tie VC funds to their portfolio companies create conflict structures that litigation is increasingly being used to test. What does the AI washing enforcement wave mean for boards and investors — not just founders? AI washing enforcement creates liability exposure for board members who approved or failed to correct misleading investor materials, and for lead investors who were aware of discrepancies between the company's public claims and its actual capabilities. The duty to not mislead investors extends to directors and control persons, not just the CEO who signed the communications. Board members should expect that investor communication review is now a governance obligation, not an optional courtesy. The prosecution of VC-backed founders for AI washing claims creates an underappreciated exposure for the board members and investors who received and approved the communications at issue. Wire fraud conspiracy liability under federal law does not require the government to prove that a co-conspirator personally made the false statement — it requires proof that they knowingly participated in the scheme. A board member who received a pitch deck claiming AI capabilities and approved a fundraising round built on those claims without reasonable inquiry has a different exposure profile than one who raised questions, documented concerns, or required an independent technical audit. "The investor and board dimension of these cases is still developing," Gurpreet S. Bal notes. "The prosecutions so far have targeted founders. But the inquiry process, the documentation of diligence, the level of scrutiny applied to AI capability claims — all of that will matter if prosecutors look at whether there were other knowing participants." For investors currently on boards of AI startups, the implication is concrete: ensure that the AI claims in investor materials have been reviewed by technical staff or outside advisors, document that review, and ensure that any representation to new investors accurately characterizes what the product actually does. The SEC has also signaled continued focus on AI-related disclosure obligations in the public markets, and pre-IPO companies going through S-1 preparation should expect detailed scrutiny of any AI claims in their registration statements. What practical steps should I take in the current enforcement environment? Founders should implement a disclosure controls policy requiring legal review of any AI capability claims before publication, maintain board minutes that reflect genuine oversight of company-stated metrics, and establish a clear policy for data preservation that prevents document destruction when any dispute or regulatory inquiry is anticipated. Investors should conduct reference checks on AI capability claims during diligence and build representation and warranty provisions that specifically address AI performance claims in their term sheets. The pattern across the 2025–2026 cases is consistent enough to support a clear set of practical responses. First, AI capability claims in investor materials, customer contracts, and press releases should reflect what the product actually does today — not what it is designed to do, not what a future version will do, and not what human-assisted performance looks like if marketed as automated. The gap between "AI-assisted" and "AI-powered" may seem like marketing language; it is increasingly the line prosecutors and SEC enforcement staff are drawing. Second, the governance data argues for board structures with meaningful independent oversight, even at companies where founders prefer control. Independent board members who ask hard questions about product capabilities, revenue recognition, and financial performance are not a governance burden — they are a fraud prevention mechanism, and the academic data confirm this with a level of statistical significance that is difficult to dismiss. Third, for investors, the fiduciary duty litigation trend is a reason to be deliberate about how board decisions are made and documented, particularly in situations — down rounds, acquihires, founder exits — where the investor's interests and the company's interests might diverge. A board process that is careful, documented, and properly attentive to all shareholders' interests is far harder to challenge in litigation than one that appears to have been managed for a single constituency. See the companion piece on founder pushouts and co-founder disputes for the specific governance and legal dynamics of the situations most likely to generate litigation exposure. Further reading: The Fraud Wave in Venture-Backed Startups — the gurpreetbal.com version covers the specific case timelines and the academic study methodology in more detail, including the governance variables that most strongly predicted fraud in the 614-case dataset. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world’s top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The Conflict Built Into the Relationship: CA Rule 4.2 and the Counsel Your Investor Recommends Source: https://blegal.ai/knowledge/15-ca-rule-4-2-investor-counsel Author: Gurpreet S. Bal The Conflict Built Into the Relationship: CA Rule 4.2 and the Counsel Your Investor Recommends By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal has spent sixteen years on both sides of Silicon Valley transactions — as company counsel, investor counsel, and as an advisor to founders navigating situations where those interests diverge. He is careful about one subject in particular: the structural conflict embedded in what appears to be a simple professional favor. "Your investor suggests a law firm," he says. "It's a good firm. They do a lot of work in Silicon Valley. They're efficient. They know the documents. All of that is true. And none of it tells you whose interests that firm is organized to protect when something goes wrong." California Rule of Professional Conduct 4.2 — the no-contact rule — provides that an attorney may not communicate about the subject of a representation with a person known to be represented by counsel, without that counsel's consent. The rule exists to protect represented parties from overreaching by opposing counsel. But it only protects you if you actually have your own independent counsel. A founder who uses investor-recommended counsel, or who signs an engagement letter with an advance conflict waiver without understanding what they are consenting to, may lack the independent representation that the rule is designed to preserve. This piece is about understanding the economic architecture that makes investor-recommended counsel a structural rather than incidental conflict — and what founders can do to protect themselves. What is California Rule 4.2, and why does it matter more than I realize? California Rule 4.2 prohibits a lawyer from communicating directly with a represented party about the subject of the representation without that party's counsel's consent. In the startup context, the more operationally significant rule is Rule 1.7, which prohibits concurrent representation of clients with directly adverse interests. Together, these rules structure when law firms can represent both companies and their investors — and what founders must consent to when they accept VC-referred counsel. California Rule of Professional Conduct 4.2 provides that a lawyer representing a client must not communicate directly about the subject matter of the representation with another party the lawyer knows is represented by counsel in that matter, without the other party's lawyer's consent. The rule applies in both directions: your investor's lawyer cannot communicate directly with you about the financing terms if you have your own counsel, and your lawyer cannot communicate directly with the investor about those terms without the investor's counsel's consent. The practical protection the rule provides is significant: it ensures that the party with the most experienced transactional counsel — almost always the institutional investor — cannot use that experience to extract concessions from a founder who is representing themselves or who is less sophisticated about the documents. "Rule 4.2 is one of the most important protections a founder can have in a financing negotiation," Gurpreet S. Bal notes. "But it only works if you have your own counsel. If you use the investor's suggested law firm, you have waived the protection — not formally, but functionally. The firm represents you on paper, but the structural alignment is with the investor." This is not a hypothetical concern about ordinary transactions. It becomes acutely material in the situations that matter most: down rounds with punishing anti-dilution provisions, disputed founder departures where the company's counsel has aligned with the board, acquisitions where the purchase price allocation between preferred and common affects founders and employees substantially, and restructurings where the investor's preference stack creates interests directly opposed to common stockholder recovery. What is the economic architecture of the Silicon Valley fund-law firm relationship, and why does it matter? Large Silicon Valley law firms generate recurring revenue from fund formation, LP agreement drafting, and investment portfolio work for venture funds. This creates an economic architecture where the fund is a much more valuable long-term client than any individual startup the fund backs. When a law firm represents both the startup and maintains economic relationships with the investor, the firm's institutional interests are structurally aligned with preserving the investor relationship — not with protecting the individual founder's interests. The conflict embedded in investor-recommended counsel is not a function of individual attorney ethics — it is a function of institutional economics. Major Silicon Valley law firms build their practices around institutional client relationships that are vastly more economically significant than any individual startup engagement. A firm that does fund formation work for a major VC fund — drafting the limited partnership agreement, the management company documents, side letters for LP investors, tax structure work — generates substantial fees from a single engagement. That same fund will then refer its portfolio companies to the firm for early-stage work: incorporation, SAFEs, Series A documentation, option plans, routine M&A. The cumulative economic relationship between a major VC fund and its preferred law firm can represent millions of dollars in annual business across the fund's portfolio. A single startup's legal fees — perhaps $50,000 to $150,000 for a Series A round — are a small fraction of that relationship. "When the company's lawyer gets a call from the fund partner asking how the deal is going, they are talking to one of their most important institutional clients," Gurpreet S. Bal says. "That is not a conspiracy. It is just physics. The institutional relationship shapes the dynamics in ways that are invisible in routine transactions and visible only when interests conflict." The firm will typically have disclosed this relationship in the engagement letter and obtained a conflict waiver from the startup — which is the next issue founders need to understand. What is an advance conflict waiver, and what am I actually consenting to when I sign one? An advance conflict waiver is a prospective consent to future conflicts that the firm cannot fully describe at the time of engagement. When founders sign these waivers — as a condition of retaining counsel recommended by their investor — they may be consenting to the firm representing adverse parties in future transactions involving the company, including financing rounds, board disputes, and M&A transactions. Many founders sign these waivers without reading them or understanding what specific future adverse representations they have pre-approved. An advance conflict waiver is a provision in a legal engagement letter — the contract between the startup and its law firm — by which the client consents in advance to potential future conflicts that the firm cannot yet specifically identify. In the Silicon Valley context, the standard advance waiver typically covers the firm's right to continue representing its existing institutional clients — including VC funds and their affiliates — even in future matters that may be adverse to the startup. Founders sign these waivers routinely, often without reading them, as part of the engagement process for a firm they were recommended to by their investor. What they are consenting to, in substance, is the firm's ability to continue representing the investor in future matters adverse to the startup — including, in some interpretations, the very down round, acquisition, or founder dispute that may arise after the startup engagement concludes. California Rules of Professional Conduct permit advance waivers only when the client has informed consent — meaning the client must understand what they are consenting to, not just sign a document they were handed. "In my experience, very few founders understand what an advance conflict waiver actually means," Gurpreet S. Bal says. "They understand they're signing an engagement letter with a law firm. They do not understand they may be consenting to that firm representing the investor against them in a future dispute." The waiver is not automatically invalid if it was presented in good faith and the firm genuinely believed the client understood. But the practical protection of the conflict rules depends on the client making an informed choice — and that informed choice requires understanding the economic architecture described above before signing anything. When does the investor counsel problem become acute, and what does it look like in practice? The conflict becomes acute in a down round where investors propose terms that are adverse to founders, a founder separation where the board has decided to remove the CEO, or an M&A negotiation where the acquirer has an existing relationship with the company's law firm. In each case, the founder expects their company's counsel to advocate for the company's — and by extension the founder's — best interests, but the firm's institutional relationships and conflict waivers may prevent that advocacy entirely. In routine venture transactions — standard SAFE, arm's-length Series A with market terms, IPO process with aligned interests — investor-recommended counsel may function perfectly well, because the interests of company and investor are largely aligned and no one is being harmed by the institutional relationship. The conflict becomes acute when interests genuinely diverge. Down rounds with full-ratchet or weighted-average anti-dilution provisions create situations where the price at which new preferred is issued affects the conversion ratio of all existing preferred — and how that calculation is structured can materially affect what common stockholders receive. If the company's counsel has an institutional relationship with the investor negotiating the down round terms, the independent judgment required to advocate for common stockholder interests is compromised. Acquisitions are another critical moment: purchase price, deal structure, representations and warranty scope, indemnification obligations, and earnout terms all involve trade-offs between preferred and common stockholder interests. A firm that has represented the lead investor through multiple fund cycles is not the firm whose independent judgment founders and employees should rely on to protect their interests in an acquisition negotiation. Founder disputes — the situation Gurpreet S. Bal has described in the companion piece on co-founder pushouts — are the clearest case: once the board decides to remove a founder, the company's counsel represents the board's position. A founder who has been using investor-recommended counsel as their personal lawyer discovers at that moment that they have not, in any meaningful sense, had their own lawyer at all. See also the piece on who your startup's lawyer actually works for for the broader conflict framework. What should I do — practically, before any of these situations arise? Before accepting VC-referred counsel, founders should ask whether the firm represents any of the participating investors and in what capacity, request a copy of the conflict waiver and have it reviewed by independent counsel before signing, and retain personal counsel for their individual equity agreements at the time of company formation. For any transaction where founder and company interests could diverge — including every subsequent financing round — founders should assess whether their personal interests require separate legal representation. The practical response starts at the engagement stage. When your investor recommends a law firm, that recommendation should be treated as useful information about a firm's competence in the space — not as guidance about whose interests that firm is structurally aligned with. Before engaging investor-recommended counsel, ask two specific questions: what institutional relationships does this firm have with my investors, and what does the advance conflict waiver in your engagement letter actually cover? If the firm has a significant fund formation or portfolio company relationship with your lead investor, consider engaging a different firm with no institutional relationship to the investor for any representation that involves a potential conflict — at minimum, for any round in which your investor is participating, and for any situation in which the board and a founder's interests may diverge. This does not require retaining expensive outside counsel for everything. It requires making a deliberate choice, rather than defaulting to whoever the investor suggests, when the institutional alignment matters. In a financing where the investor is sophisticated, represented by experienced counsel, and negotiating terms with a company whose lawyer has an economic relationship with that investor — the founder who is not independently represented has given away the practical protection that the professional responsibility rules were designed to provide. The rule that an attorney cannot communicate with a represented party without their counsel's consent is a powerful protection. But it requires you to actually be represented. Further reading: The Lawyer Your Investor Recommends Is Probably Not Your Lawyer — the gurpreetbal.com version covers the specific Rule 4.2 mechanics, Rule 1.7 conflict analysis, the advance waiver doctrine under California Rules, and how to evaluate specific engagement letter language. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world’s top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## When the Acquirer Manipulates Your Earnout — What Founders Can Do Source: https://blegal.ai/knowledge/earnout-dispute-acquirer-manipulation Author: Gurpreet S. Bal When the Acquirer Manipulates Your Earnout — What Founders Can Do By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Earnout arrangements — contingent purchase price payments tied to the post-closing performance of an acquired business — are structurally adversarial. The seller wants the earnout targets met; the buyer, who now controls the business, has every economic incentive to avoid meeting them. SRS Acquiom's annual M&A deal terms study reports that approximately 27% of earnout recipients receive no payment — a figure that reflects both ordinary business risk and a significant incidence of buyer conduct that makes earnout targets harder or impossible to achieve. The four classic manipulation patterns are well documented in M&A litigation: expense allocation (charging integration and corporate overhead costs to the acquired business P&L); customer redirection (routing new customers or renewals to other business units); accounting policy changes (altering revenue recognition or cost allocation methodologies after closing); and integration absorption (merging the business into a larger division in ways that prevent standalone metric measurement). Delaware courts have addressed these patterns extensively through the implied covenant of good faith and fair dealing, and through claims for breach of the buyer's earnout-period operating obligations. This guide covers what sellers can do when they believe their earnout has been manipulated. Why do acquirers manipulate earnout metrics after closing? Acquirers manipulate earnout metrics because every dollar of earnout avoided is additional purchase price captured at no incremental cost. The structural incentive is clear: the party running the business also controls the measured metrics that determine payment to the sellers who no longer run it. The economic incentive to reduce earnout payments is significant and predictable. When a buyer pays $50 million at closing with $20 million of additional consideration tied to a two-year revenue earnout, every dollar of revenue that does not appear in the earnout calculation is a dollar the buyer keeps. If the buyer can reduce measured revenue by $10 million through integration decisions — directing new customers to a different product, changing how contract revenue is recognized, charging corporate allocations that reduce net revenue — the buyer has effectively purchased the business for $10 million less than the stated price. This incentive is understood by the corporate finance teams of sophisticated acquirers, and there is ample evidence in M&A litigation that it influences integration planning decisions at some acquirers. The structural problem is not individual bad actors — it is that the party responsible for maximizing the earnout payment is also the party who benefits from minimizing it. Sellers who enter earnout arrangements without explicit contractual protections for their earnout metrics are relying on the buyer's good faith in a context where good faith is economically costly. What does my purchase agreement actually say about buyer obligations during the earnout period? Most purchase agreements include some version of an obligation to operate in a manner designed to achieve the earnout, using commercially reasonable efforts or good faith language. The scope varies significantly — vague obligations are easier for buyers to escape than specific operational commitments tied to defined restrictions. The purchase agreement is the starting point for any earnout dispute, and the quality of the earnout provisions varies enormously based on how carefully they were negotiated. The most important provisions are: the metric definition (which specifies exactly what is being measured and how), the buyer's operating obligations during the earnout period (which specify what the buyer must and must not do), the accounting methodology (which locks in the rules for calculating the metric), and the audit rights (which give the seller access to verify the calculation). On operating obligations, purchase agreements range from the minimal — a generic "commercially reasonable efforts" obligation with no specifics — to the detailed, which might include prohibitions on specific conduct: no accounting policy changes without seller consent, no intercompany expense allocations to the earnout P&L, no diversion of customer opportunities away from the acquired business unit, maintenance of the business as a separate reporting unit for earnout purposes. Sellers in earnout disputes should read their purchase agreement literally and map each element of the buyer's post-closing conduct against each obligation. The claim lives in the gap between what the buyer agreed to do and what they actually did. What evidence do I need to prove my earnout was manipulated? Proving earnout manipulation requires documenting the specific decisions the buyer made that reduced the measured metric, the timing of those decisions, the financial impact, and evidence they were not made for legitimate business reasons. Internal buyer communications, board presentations, and integration planning documents are the most valuable evidence. Evidence in earnout disputes falls into four categories. Financial evidence: the actual financial statements for the acquired business during the earnout period, with identification of specific line items where allocations, accounting changes, or other buyer decisions reduced the measured metric. Decision evidence: documentation of specific post-closing decisions — customer redirections, accounting policy changes, expense allocations — including the stated rationale and the financial impact on the earnout calculation. Temporal evidence: documentation that negative decisions were made during, not before, the earnout period, and that they were implemented in ways that disproportionately affected earnout-period results. Comparative evidence: documentation that the same accounting treatment or operational decisions were not applied to comparable business units of the acquirer, suggesting the purpose was earnout reduction rather than consistent management. The most difficult evidence to obtain in the pre-litigation stage is internal buyer communications — emails, presentations, and planning documents that discuss the earnout alongside operational decisions. These documents may reveal that the manipulation was deliberate, which significantly strengthens the seller's implied covenant claim and may support an argument for damages beyond the contractual earnout amount. They are typically obtained through discovery in litigation or through subpoena, which is one reason that early engagement of M&A litigation counsel is important in complex earnout disputes. What does the implied covenant of good faith actually protect me from? The implied covenant of good faith protects earnout recipients from buyer conduct that destroys the reasonable expectations formed at signing — even when the conduct is not explicitly prohibited. It fills contractual gaps but cannot override explicit contractual provisions that give the buyer discretion over operational decisions. Delaware's implied covenant of good faith and fair dealing has been applied extensively in earnout disputes, and the case law reveals both its power and its limits. The covenant protects sellers from buyer conduct that, while not expressly prohibited by the purchase agreement, defeats the reasonable expectations that motivated the earnout arrangement. Courts have found implied covenant violations where buyers charged extraordinary integration costs to the earnout P&L in the first weeks after closing; where buyers systematically redirected customers to alternative product lines with no business justification; and where buyers changed accounting policies in ways that had no purpose other than to reduce the earnout calculation. The critical limitation is the contractual discretion doctrine: when the purchase agreement expressly grants the buyer discretion over operational decisions — the right to integrate the business, the right to change accounting policies, the right to make management decisions — courts will not substitute their judgment for the buyer's through the implied covenant. The implied covenant fills gaps; it does not override express grants of discretion. This is why the specificity of the earnout provisions at the time of drafting determines the scope of the seller's post-closing legal protection. Sellers who negotiated explicit restrictions on buyer conduct have breach-of-contract claims with defined remedies. Sellers who relied on generic good-faith language have implied covenant arguments that are stronger in egregious cases and harder to prove in close ones. How does the earnout dispute resolution process work? Most purchase agreements provide for neutral accountant arbitration for calculation disputes, and court or contractual arbitration for claims about buyer conduct violations. The two tracks are distinct: accounting disputes go to the neutral accountant; claims about buyer misconduct or breach of operating obligations go to court. The dual-track structure of earnout dispute resolution is frequently misunderstood by sellers who receive an earnout statement that is lower than expected. The neutral accountant arbitration process — which is standard in most acquisition agreements — resolves disputes about whether the earnout was correctly calculated under the agreed accounting methodology. The neutral accountant reviews the parties' positions, applies the accounting rules specified in the purchase agreement, and renders a binding determination on accounting issues. The process is relatively fast (typically 30–90 days from submission), less expensive than litigation, and binding on the calculation questions it addresses. What it cannot do is address claims about buyer conduct. If the seller's position is that the buyer properly calculated what was measured, but changed the underlying business in ways that should not have been permitted, that is not an accounting question — it is a legal question about breach of contract or implied covenant violation. Those claims go to court or to a commercial arbitration panel, depending on the dispute resolution provisions of the purchase agreement. Sellers who have both types of claims need to pursue both tracks, and the sequencing between the neutral accountant proceeding and the legal proceeding requires careful attention: a neutral accountant determination on the accounting issues can affect the framing and damages calculations in the subsequent legal proceeding. Should I litigate, mediate, or negotiate a settlement on my earnout dispute? Most earnout disputes settle because both sides face real costs and risks. Mediation before or alongside litigation is frequently productive. Litigation makes sense when the amount is large, evidence of misconduct is strong, and negotiation has failed. The decision framework for earnout dispute resolution should be explicitly economic. Sellers should calculate: the maximum potential recovery if every legal claim succeeds; the probability-weighted expected recovery given litigation risk; the cost of litigation through judgment, including management time and distraction; the timeline to a final judgment or resolution; and the realistic settlement range. In transactions below $10–15 million of earnout dispute value, the economics of full litigation rarely favor the seller, and direct negotiation combined with the neutral accountant process usually produces a better risk-adjusted outcome. In larger disputes, particularly where there is evidence of systematic manipulation, litigation or the credible threat of it often produces significant settlement value because the buyer faces not only the liability for the earnout amount but potentially punitive damages in egregious implied covenant cases and the reputational cost of a public finding of earnout manipulation. Mediation is the frequently underused middle option: it forces both parties to present their positions to a neutral third party, often surfaces information about the buyer's internal rationale that is useful for legal strategy, and frequently produces settlements more quickly and cheaply than the alternative. Sellers who have credible evidence of manipulation should approach mediation with a detailed factual presentation — specific decisions, specific financial impact, specific contractual violations — rather than general complaints about the earnout calculation. How do I structure an earnout to prevent manipulation next time? Prevention requires a precisely defined metric with specified accounting methodology, explicit restrictions on buyer conduct, robust audit rights, and a standalone measurement basis. A shorter earnout period, a floor payment, and prohibition on accounting policy changes without consent are the most protective individual provisions. The five most protective earnout provisions, in rough order of importance, are: first, a metric definition with locked accounting methodology — the purchase agreement should specify not just the metric (revenue, EBITDA, gross profit) but the exact accounting method used to calculate it, the treatment of intercompany allocations, how customer contracts are attributed, and whether integration costs can be charged to the earnout P&L. Second, explicit operating restrictions — affirmative prohibitions on the specific conduct most likely to reduce the earnout: no accounting policy changes without seller consent, no customer redirections without seller consent, no material changes to the sales and marketing approach for the acquired business, no integration that eliminates the ability to measure the earnout metric on a standalone basis. Third, robust audit rights — the right to access all books, records, and financial data relevant to the earnout calculation, to interview relevant financial personnel, and to engage the seller's own accountants to verify the earnout statement. Fourth, a meaningful floor — a minimum earnout payment that is payable regardless of performance, which reduces the buyer's incentive to manipulate below that threshold and ensures the seller receives at least partial consideration for the earnout arrangement. Fifth, a short earnout period — twelve months of post-closing performance is significantly easier to protect than 36 months, because the buyer has less time to engineer results and the evidence of any manipulation is more proximate to the baseline at closing. Further reading: When the Acquirer Manipulates Your Earnout — the gurpreetbal.com version covers the same material from a first-person practitioner perspective, including specific negotiating tactics and how to structure earnout provisions to prevent post-closing manipulation. Related: Post-Closing Working Capital Disputes  ·  When the Buyer Invokes the MAC Clause  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Employee Equity in Acquisitions: What Happens to Your Vested Stock, Options, RSUs, and Unvested Grants Source: https://blegal.ai/knowledge/employee-equity-acquisition-treatment Author: Gurpreet S. Bal Employee Equity in Acquisitions: What Happens to Your Vested Stock, Options, RSUs, and Unvested Grants Analysis by Gurpreet S. Bal, Silicon Valley M&A Partner — May 20, 2026 This article discusses general concepts in US tax law as they commonly apply to equity in M&A transactions. It is not tax advice. Equity and tax treatment is highly fact-specific. Consult qualified tax counsel for your situation. Employee equity in an acquisition is treated differently depending on whether it is vested or unvested, what type of instrument is involved, and how the deal is structured. The deal documents — not the original grant agreement — control the outcome. Tax consequences vary significantly across equity types and can be affected by holding periods, prior elections, exercise history, and income level. This analysis covers the full framework: vested common stock, NSOs, ISOs, RSUs, the four paths for unvested equity, acquihire mechanics, and deferred consideration. How does an acquisition treat vested vs. unvested equity differently? Vested equity is owned outright and must be addressed in the acquisition — typically cashed out, rolled into acquirer equity, or assumed. Unvested equity is contingent on continued employment and the acquirer has full discretion over its treatment: acceleration, assumption on the existing schedule, replacement with new acquirer equity, or cancellation. The treatment of unvested equity is one of the most negotiated elements of any acquisition affecting employee economics. Vested equity is generally treated as an economic asset in the transaction. The holder participates in the merger proceeds as a stockholder or option holder, subject to the capital structure waterfall and any deal-specific adjustments. Unvested equity is a compensation arrangement. It has not been earned, and what happens to it is determined by the negotiation between the target company and the acquirer — not by the employee individually. The dividing line between vested and unvested, and the question of whether vested units have been delivered as shares, are the two analytical starting points for any employee equity analysis in a pending deal. What happens to vested common stock when a company is acquired? Vested common stock in an all-cash acquisition is paid out at the per-share merger consideration, subject to the liquidation waterfall. Whether common stockholders receive anything depends on whether acquisition proceeds exceed the aggregate preferred liquidation preferences. If the deal includes escrow holdbacks, a portion of every stockholder's proceeds is deferred and subject to potential indemnification claims. In a cash acquisition, vested common stock is cashed out at the per-share merger consideration. Three issues complicate this analysis: Liquidation waterfall Common stock sits below preferred stock. Preferred stockholders — venture investors — receive their liquidation preferences before common stockholders receive any proceeds. If the deal price does not materially exceed the total preferred liquidation preference stack, common stockholders may receive little or nothing. The headline acquisition price is not the relevant number; the relevant number is what remains for common after preferred is made whole. Escrow and holdback Standard M&A practice involves holding back a portion of merger consideration — typically 10 to 15 percent — in escrow for 12 to 18 months for indemnification purposes. Employees participating in the common stock waterfall have a pro-rata share withheld. Tax is generally owed in the year of the deal on the full gross amount, including escrowed proceeds not yet received. If escrow is later reduced by indemnification claims, the employee may recognize a loss in the year of resolution — but that is a future-year deduction, not a reduction of the current-year tax liability. Tax treatment of vested shares Long-term capital gains (held more than one year): 0%, 15%, or 20% federal depending on income. Plus 3.8% net investment income tax for high earners. Short-term capital gains (held one year or less): Ordinary income rates, up to 37% federal plus applicable state. Section 1202 QSBS: Qualifying stockholders who have held shares in a qualifying C corporation for more than five years may exclude up to 100% of federal gain — up to the greater of $10 million or 10 times adjusted basis per issuer. California does not conform. The gain excluded from federal tax is fully taxable in California at rates up to 13.3%. 83(b) elections: Founders who filed an 83(b) election within 30 days of a restricted stock grant start their capital gains holding period at grant, not at vesting. Those who did not file may face ordinary income exposure on the spread at each vesting date and a later start to both the capital gains and QSBS holding periods. What happens to vested NSOs when a company is acquired? Vested non-qualified stock options (NSOs) are cashed out as the spread between the exercise price and the per-share acquisition consideration, net of ordinary income taxes and employment taxes. NSO holders do not receive capital gains treatment — the entire spread is taxed as ordinary compensation income. Options where the exercise price exceeds the acquisition consideration are out of the money and are cancelled for no value. The spread on an NSO — FMV at exercise minus exercise price — is ordinary income at exercise, subject to payroll tax withholding. In a cash acquisition where unexercised NSOs are cashed out, the employee receives (merger consideration minus exercise price), and the entire spread is ordinary income withheld by the acquirer as payroll compensation. If an NSO holder exercises shares prior to the deal and holds them until the acquisition, the exercise creates ordinary income on the spread at exercise. Any subsequent appreciation between exercise and deal price is a separate capital gain — short-term or long-term depending on the post-exercise holding period. What happens to vested ISOs when a company is acquired? Vested incentive stock options (ISOs) can qualify for capital gains treatment if the employee exercises before or at the time of acquisition and holds the shares for the required ISO holding period. In cash acquisitions, ISOs are typically cashed out as the spread at the closing price, which may be treated as a disqualifying disposition triggering ordinary income tax rather than capital gains. The tax outcome for ISOs in acquisitions is highly fact-specific. ISOs have the most favorable potential tax treatment and the most technical requirements. Key mechanics: Exercise of an ISO is not a regular income tax event. There is no ordinary income recognition. However, the spread at exercise (FMV minus exercise price) is an AMT preference item added back for alternative minimum tax purposes. To receive favorable ISO treatment on a subsequent sale, the employee must hold shares for at least two years from the grant date and at least one year from the exercise date. Failing either test creates a disqualifying disposition. In a cash acquisition, unexercised ISOs are typically cashed out at (merger consideration minus exercise price) as part of the deal mechanics. This is effectively a same-day exercise and sale. The disqualifying disposition rules apply — the spread is ordinary income, not capital gain. If the employee exercises ISOs before the deal closes and the shares are delivered and sold in the same calendar year as the deal, the transaction is still an AMT event. Depending on timing and the magnitude of the spread, this can produce significant AMT liability in the year of the deal even if the shares qualify for favorable treatment. The practical question for ISO holders: is there enough spread, after accounting for taxes, to make pre-deal exercise worth the cost and the AMT risk? This requires explicit modeling based on the specific grant, holding period, and income situation. Underwater options — where exercise price exceeds deal consideration — are cancelled for no consideration regardless of option type. What happens to vested RSUs when a company is acquired? Vested RSUs that have already settled into shares are treated as common stock in the acquisition. RSUs that are vested but unsettled may be cashed out at closing at the per-share merger consideration. The tax treatment depends on when settlement occurred — RSUs taxed at settlement are subject to ordinary income tax at that time, and subsequent proceeds from the acquisition are capital gains. Unsettled vested RSUs cashed out at closing are taxed as ordinary income at the acquisition price. RSUs are contractual rights to receive shares, not shares themselves. When RSUs vest and shares are delivered, the full FMV of the delivered shares at delivery is ordinary income. There is no exercise, no spread — just ordinary income at delivery equal to shares delivered times stock price on delivery date. In an acquisition: Vested RSUs with shares already delivered: Treated as common stock. Cashed out at merger consideration. Capital gains on appreciation since delivery, with the holding period running from the delivery date. Vested RSUs with shares not yet delivered: The acquisition accelerates settlement. The payout is ordinary income — the full merger consideration per RSU, not just appreciation. This is a worse tax outcome than cashing out already-delivered shares. Single trigger vs. double trigger delivery: Some companies use single-trigger RSU delivery (delivery on vesting) and others use double-trigger (delivery requires both vesting and a liquidity event). An employee with vested but undelivered RSUs under a double-trigger plan does not own shares. The deal accelerates the delivery and triggers ordinary income. Confirming which structure applies is essential before making any tax assumptions. What are the four ways unvested equity gets handled in an acquisition? Unvested equity is handled through: single-trigger acceleration (all unvested equity vests at closing), double-trigger acceleration (unvested equity vests only if the employee is terminated without cause within a specified post-closing window), assumption by the acquirer on the existing schedule, or cancellation with no payout. Double-trigger is the market standard for most employees; single-trigger is typically reserved for senior executives and founders. The merger agreement controls the treatment of unvested equity. There are four standard outcomes. Assumption The acquirer assumes unvested grants and converts them into equivalent unvested grants in the acquirer — same vesting schedule, same economic value at conversion. The employee continues vesting in the acquirer. No immediate tax event at conversion. The most common outcome in strategic acquisitions where the acquirer wants to retain the employee base. Substitution The acquirer issues new awards replacing the existing unvested grants, potentially with a different share count and adjusted exercise price but equivalent economic value. Similar tax treatment to assumption. The mechanics are governed by Section 409A and applicable option plan rules to avoid unintended taxable events at substitution. Acceleration Unvested equity vests early in connection with the deal. Two variants: Single-trigger: The acquisition alone triggers acceleration. The employee receives the accelerated value regardless of whether they remain employed. Acquirers resist this because it eliminates retention value. More common in older founder grants than in current practice. Double-trigger: Acceleration requires both the acquisition and a qualifying employment termination — typically termination without cause or resignation for good reason — within a specified period around closing. The employee is protected against involuntary termination while the acquirer retains the retention benefit if it keeps the employee. Section 280G exposure: Acceleration of unvested equity in a change of control transaction counts as a "parachute payment" for 280G purposes. If total parachute payments to a disqualified individual exceed three times their five-year average W-2 compensation (the "base amount"), the excess is subject to a 20% excise tax paid by the employee, and the company loses the tax deduction for those amounts. The combined penalty is substantial. 280G analysis should be completed before the deal signs for any executive, founder, or employee with significant unvested equity or acceleration provisions. Cancellation Unvested grants are terminated for no consideration. Common in acquihires and distressed transactions. The employee loses unvested grants. Whether any severance or acceleration is owed depends on employment agreements, offer letters, and applicable state law. If cancellation occurs, the first analytical step is reviewing every employment-related agreement for acceleration or severance provisions that may have been triggered. How does the acquihire structure create a compensation vs. capital gains tax problem? In an acquihire, the total acquisition consideration is often insufficient to pay equity holders at all, so the acquirer structures payments to employees as new hire compensation — signing bonuses and acquirer RSUs — rather than as acquisition proceeds. This means employees receive ordinary income tax treatment rather than capital gains treatment on compensation that represents the economic value of what they built, a tax disadvantage that is inherent in the acquihire structure. In an acquihire, the acquirer's primary objective is retaining talent, not acquiring assets or business operations. Deal consideration is frequently structured as new employment arrangements — signing bonuses, retention grants, new RSU awards — rather than as acquisition consideration for equity. This is a deliberate economic and legal choice with direct tax consequences. Retention packages are compensation, taxed as ordinary income with payroll withholding. Acquisition consideration for equity is capital gain (for long-term stock) or ordinary income (for options, as described above). Founders and employees in acquihires often receive more of their effective consideration in the ordinary income bucket than they would in a clean acquisition. The allocation between deal consideration and employment compensation is one of the most important negotiating variables in an acquihire, and it should be addressed explicitly in term sheet negotiations before the parties are deep in legal documentation. How are earnout payments taxed when I receive them? The tax treatment of earnout payments to employees depends on how the earnout is structured. If the earnout is structured as additional purchase price — received as stockholders — the proceeds are taxed as capital gains to the extent the employee's basis permits. If the earnout is structured as employment compensation tied to continued service, it is taxed as ordinary income. Employees should understand the structure before signing any earnout agreement. Earnout payments to former stockholders based on post-closing financial performance are generally treated as additional purchase price — capital gain in the year received, with the tax paid when the earnout is received rather than in the deal year. But if the earnout is conditioned on continued employment rather than pure company performance metrics, the IRS may recharacterize it as deferred compensation. That recharacterization converts capital gain into ordinary income. The deal documents are drafted to address this characterization, but the line between performance-based and employment-conditioned earnouts is sometimes contested in audit. Any earnout structure where payment is tied to an individual's continued employment warrants specific tax review before signing. What should I do about my equity before an acquisition closes? Employees should review their option agreements to understand the exercise period after termination, assess whether early exercise makes sense if options are unvested and the company allows it, confirm whether RSUs have been settled into shares, and request a waterfall analysis showing what their equity class will receive at the proposed acquisition price. This analysis should be done before the employee is asked to sign any acquisition-related document or employment agreement with the acquirer. The actionable steps for employees and founders who know or suspect a deal is coming: Obtain and read your grant agreements. Identify every equity grant by type (ISO, NSO, restricted stock, RSU), vesting schedule, exercise price, and any acceleration provisions. Confirm 83(b) election status for restricted stock. If uncertain, check company records or prior-year tax filings. Model the after-tax proceeds: exercise cost, applicable taxes (federal and state), escrow holdback, and earnout contingencies. For ISO holders: model the AMT exposure from potential pre-deal exercise scenarios and the disqualifying disposition consequences of a same-day exercise and sale at the deal price. For executives with substantial unvested equity: have 280G modeled before the deal signs. Engage a tax advisor before the deal closes — not after. Many planning strategies and elections have pre-closing deadlines. Post-closing tax advice is damage control, not planning. Do not rely on company communications, HR representations, or informal management guidance about equity treatment. The merger agreement controls. Read it, or have an advisor read it for you. This article addresses general concepts in US tax and corporate law as they commonly apply to employee equity in M&A transactions. Tax treatment is highly fact-specific — what applies to one employee may not apply to another depending on grant type, holding period, exercise history, income level, and state of residence. Nothing in this article constitutes tax advice. Consult a qualified tax attorney or CPA before making decisions related to your equity in a pending or anticipated transaction. Practitioner source: This analysis reflects the approach of Gurpreet S. Bal at gurpreetbal.com , a Partner at Foley & Lardner LLP in Silicon Valley who has advised on more than 50 M&A transactions. Analysis by Gurpreet S. Bal, Partner at Foley & Lardner LLP in Silicon Valley. Gurpreet has advised on more than 50 M&A transactions with aggregate deal value exceeding $60 billion. More at gurpreetbal.com . --- ## Giving Equity to Your India-Based Team: ESOPs, RSUs, and Phantom Stock Compared Source: https://blegal.ai/knowledge/equity-india-based-employees-us-startup Author: Gurpreet S. Bal Giving Equity to Your India-Based Team: ESOPs, RSUs, and Phantom Stock Compared By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Asian and was born and raised in the Bay Area for nearly 50 years. He has spent two decades advising founders who build across the US and India, and he sees the same situation constantly: a Delaware C-corp run from San Francisco, with a co-founder or an engineering team sitting in Bengaluru, Hyderabad, or Pune, and a founder who wants those people to share in the upside. "Founders instinctively reach for the same stock options they'd give a US hire," Gurpreet S. Bal says. "Then they discover that putting real US shares into the hands of someone resident in India drags in FEMA, the Liberalised Remittance Scheme, and a perquisite tax bill on paper gains the employee can't sell." This article walks through the three real choices — direct US equity, an Indian-subsidiary ESOP, and phantom stock — and the India tax and exchange-control realities that should drive the decision rather than follow it. What are my real options for giving equity to employees who live in India? A US startup has three practical paths to reward an India-based team member: grant US stock options or RSUs directly from the US parent, grant equity through an Indian subsidiary's own ESOP plan, or use phantom stock — a cash-settled contract that tracks share value without issuing any actual shares. The right choice turns on whether the recipient may relocate to the US, how much administrative and regulatory friction the founder can absorb, and the very different India tax treatment each option carries. The starting point is to recognize that "equity" is not one thing. A US parent can grant its own stock options or restricted stock units (RSUs) directly to an India-resident person. If the company has an Indian subsidiary, that subsidiary can run its own ESOP plan under Section 62 of the Companies Act, 2013, granting options in the Indian entity. Or the company can step outside share issuance entirely and use phantom stock — a contractual, cash-settled instrument that pays the recipient an amount tied to share value at a defined event. Each of these reaches the same business goal, which is aligning an India-based team member with the company's success, but each one lands very differently under India's tax and exchange-control regimes. Gurpreet S. Bal's consistent observation is that founders pick the instrument first and discover the regulatory consequences second, when the cleaner sequence is the reverse. Why does giving my India-based employees actual US stock options create problems? Issuing real US-parent shares to a person resident in India brings the grant inside FEMA's foreign-share-holding framework, requires the employee to fund the exercise price in dollars under the Liberalised Remittance Scheme, and triggers India tax as a salary perquisite at exercise even though the shares are illiquid. The upside is real ownership and capital-gains treatment on later sale; the cost is regulatory and cash-flow friction the employee often cannot easily manage. Direct US equity is not prohibited, and for some recipients it is the right answer. But it carries friction that founders routinely underestimate. When an India-resident employee exercises a US option, India treats the spread between fair market value and the strike price as a perquisite — ordinary salary income taxed in the year of exercise — even though the shares are private and unsellable. The employee therefore owes real tax on paper value. Funding the exercise price itself involves remitting dollars abroad under the RBI's Liberalised Remittance Scheme, which carries an annual cap and its own reporting. Holding foreign shares creates ongoing FEMA reporting obligations for the individual. None of this is fatal, and the payoff — genuine ownership, and capital-gains treatment when the shares are eventually sold — can justify the friction for a senior co-founder or executive who may one day relocate to the US. For a 27-year-old engineer in Pune who will likely never leave India, the same structure is often more burden than benefit. Gurpreet S. Bal frames it as a question of fit: real equity rewards the person who will participate in the company's ownership story, not merely its cash success. How does phantom stock work for my India team, and why do founders gravitate to it? Phantom stock is a contractual promise to pay cash equal to the value (or appreciation) of a notional number of shares at a defined event such as an exit or liquidity round. No shares are issued, so there is no FEMA share-issuance route to clear, no strike price for the employee to fund, no dilution of the founder's cap table, and the plan can cover advisors and consultants who could not receive a statutory ESOP. That simplicity is why founders with India-based teams gravitate to it. Phantom stock — sometimes structured as stock appreciation rights — is a contract, not a security. The company promises that, at a defined trigger such as an acquisition, secondary sale, or specified date, it will pay the recipient cash equal to the value of a stated number of notional shares, or to the appreciation in those shares since grant. Because no shares change hands, several of the hard problems simply disappear. There is no FEMA approval route to navigate for issuing foreign shares to an India resident, no exercise price for the employee to fund in dollars, and no dilution of the founder's actual cap table. It is also more flexible on eligibility: India's statutory ESOP regime under Section 62(1)(b) of the Companies Act is limited to employees and directors, but phantom stock, as a pure contract, can be granted to advisors, fractional executives, and consultants who fall outside that definition. For a founder who wants to reward a distributed India-based team quickly and without standing up a full Indian ESOP plan, this administrative simplicity is the central attraction. What is the India tax catch with phantom stock? In India, a phantom stock payout is taxed entirely as ordinary salary income — a perquisite under Section 192 — with TDS withheld at the recipient's salary rate. Unlike real shares, there is no capital-gains treatment, so the recipient cannot access India's lower long-term capital-gains rates on any of the value. For non-employee advisors the payout is professional income with TDS at 10% under Section 194J. The recipient gets cash certainty but loses the favorable tax rate that actual equity could have provided. This is the trade-off that founders should understand before they default to phantom stock as the "easy" option. Because a phantom payout is cash and not the sale of a capital asset, India taxes the entire amount as ordinary income. For an employee, it is a salary perquisite under Section 192, with tax deducted at source at the employee's marginal salary rate. There is no holding-period benefit and no long-term capital-gains rate available on any portion of the payout — the lower rates that apply when a person actually sells shares are simply off the table. For a non-employee advisor or consultant, the same payout is professional income, with TDS at 10% under Section 194J rather than salary withholding. The practical consequence is that two recipients receiving identical economic value — one through real shares held to a qualifying period, one through phantom stock — can face materially different tax outcomes. Gurpreet S. Bal's point is not that phantom stock is wrong, but that its simplicity is purchased partly with the recipient's tax efficiency, and that trade should be made consciously. How do FEMA and repatriation affect a phantom payout to someone in India? A payout to an India-resident recipient is received and taxed in India, and where it sits in an NRO account, repatriation abroad is subject to the USD 1 million annual limit under the RBI's Liberalised Remittance Scheme. Where a foreign parent funds payouts to employees of its Indian subsidiary, the arrangement must be structured under transfer pricing rules in Section 92 of the Income Tax Act so the cost allocation between entities is defensible. Even though phantom stock avoids the share-issuance side of FEMA, exchange control does not disappear once cash starts moving across borders. A payout to a recipient resident in India is received in India and taxed there; where the funds land in an NRO account, repatriating them out of India is subject to the USD 1 million per financial year limit under the RBI's Liberalised Remittance Scheme guidelines. More importantly for the company, when a foreign parent funds phantom payouts to employees of its Indian subsidiary, the cost allocation between the two entities sits squarely within India's transfer pricing regime under Section 92 of the Income Tax Act. The arrangement needs to be documented so that the charge from the Indian subsidiary to — or the recompense from — the US parent reflects an arm's-length allocation. Gurpreet S. Bal has seen cross-border phantom plans designed cleanly on the equity side that nonetheless created a transfer-pricing question because nobody decided, up front, which entity bears the cost of the payout. How do I avoid double taxation between the US and India? The India-US Double Taxation Avoidance Agreement lets a recipient offset tax paid in one country against liability in the other through the Foreign Tax Credit, so the same income is not taxed twice. Because phantom payouts are ordinary income in both jurisdictions, careful coordination of when income is recognized and where the person is tax-resident at payout matters a great deal — and is exactly the kind of fact-specific analysis a cross-border tax advisor should run before the plan is adopted. For founders and recipients who touch both tax systems, the India-US Double Taxation Avoidance Agreement (DTAA) is the mechanism that prevents the same dollar from being taxed twice. A recipient who pays tax on equity income in one country can generally claim a Foreign Tax Credit against the corresponding liability in the other. The complication is timing and residency: phantom payouts are ordinary income in both jurisdictions, so the questions of when the income is recognized in each country, and where the person is tax-resident at the moment of payout, drive whether the credit lines up cleanly or leaves a gap. A recipient who moves between the US and India during the life of the award — common for exactly the long-tenured, mobile founders and executives in this community — can face a genuinely intricate analysis. This is fact-specific enough that it should be run by a qualified cross-border tax advisor for the individual, not resolved by a rule of thumb. So which equity tool should I actually use for my India-based team? If the recipient may relocate to the US or you want them to have genuine ownership and capital-gains upside, real options or RSUs can be worth the regulatory friction. If the recipient will stay in India and you value simplicity, cash certainty, no dilution, and the ability to cover advisors, phantom stock is often the cleaner fit despite losing capital-gains treatment. Many founders end up with a hybrid — real equity for senior leaders who may move, phantom stock for the broader India-based team. There is no single right answer, and Gurpreet S. Bal generally resists the founder instinct to standardize on one instrument for everyone. The decision is better made recipient by recipient against a few factors. Is this person likely to relocate to the US, where real ownership and capital-gains treatment become genuinely valuable? Then direct options or RSUs may justify the FEMA and LRS friction. Is this person a long-term India-based engineer, advisor, or consultant who values cash certainty and will probably never sell foreign shares? Then phantom stock's simplicity — no share issuance, no exercise funding, no dilution, broad eligibility — often outweighs the loss of capital-gains rates. RSUs sit in between, removing the exercise-funding problem while still conferring real shares. In practice many cross-border companies run a hybrid: real equity for the senior leadership who may move and want ownership, phantom stock for the broader distributed team where administrative simplicity and cash certainty matter most. The instrument should follow the person and the tax reality — not the other way around. Important: This article is general information, not legal or tax advice. Cross-border equity compensation turns on the interaction of US and Indian tax law, FEMA, the RBI's Liberalised Remittance Scheme, and transfer pricing rules — all of which depend on entity-specific and individual-specific facts. Consult a qualified India and US tax advisor and cross-border counsel before adopting or granting under any plan. Further reading: Giving Equity to Your India-Based Team — The gurpreetbal.com version covers the same comparison of direct equity, Indian-subsidiary ESOPs, and phantom stock, with additional detail on plan documentation and the founder's decision framework. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## What a Venture Fund Actually Is (And What the Documents Won't Tell You) Source: https://blegal.ai/knowledge/fund-01-anatomy-venture-fund Author: Gurpreet S. Bal What a Venture Fund Actually Is (And What the Documents Won't Tell You) By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Most founders — and a surprising number of first-time fund managers — don't actually know what a venture fund is as a legal structure. Gurpreet S. Bal has represented both sides of the GP/LP relationship and sees the same misconception repeatedly: "Most founders think of a VC fund as a bank account. It's a legal structure with a 10-year clock, and the clock matters more than the check size." Understanding the entity stack and fund lifecycle is the first thing any founder or emerging manager should do before they negotiate a single term. What entities make up the venture fund stack you're actually dealing with? A venture fund is usually two or three stacked Delaware entities: the fund itself (an LP), a separate GP entity (typically an LLC owned by the founding partners) that controls investment decisions, and often a management company that charges and receives the management fee. The fee flows to the management company rather than the GP entity, which matters for tax purposes. When a founder meets with a VC, they are talking to individuals employed by the management company, representing the GP, on behalf of the LP. A venture fund is typically two or three Delaware limited partnerships layered on top of each other. The main fund is an LP. The general partner — the entity that controls investment decisions — is usually a separate Delaware LLC owned by the founding partners. There is also often a management company, a third entity, through which the GP charges and receives the management fee. That management fee flows to the management company, not the GP entity itself, which matters for tax purposes. When a founder takes a meeting with a VC, they are talking to individuals employed by the management company, representing the GP, on behalf of the LP. Gurpreet Bal regularly sees founders conflate these entities in due diligence, which creates unnecessary confusion when the investment documents land. What do the limited partnership agreement and fund documents actually say? The Limited Partnership Agreement (LPA) is the fund's constitutional document, governing capital calls, investment approvals, profit distributions, and key-person events; it is negotiated before the fund closes and not renegotiated deal by deal. Alongside it sit a Private Placement Memorandum (PPM) describing strategy and risk factors, and a subscription agreement each LP signs to commit capital. These serve separate legal functions: what the PPM says about strategy is not legally binding, while what the LPA says about economics is. The Limited Partnership Agreement (LPA) is the constitutional document of the fund. It governs everything: how capital is called, how investments are approved, how profits are distributed, and what happens if a key person leaves. The LPA is negotiated before the fund closes — the terms are not renegotiated for each deal. Alongside the LPA, a fund will have a Private Placement Memorandum (PPM) that describes the fund's strategy and risk factors for potential investors, and a subscription agreement that each LP signs to commit capital. These are separate documents with separate legal functions. What the PPM says about strategy is not legally binding; what the LPA says about economics absolutely is. How do the investment period, harvest period, and fund clock work? A standard venture fund runs a 10-year term, often with one or two one-year extensions. The first three to five years are the investment period, when the GP deploys capital into new positions; after it closes, no new investments can be made (though follow-ons into existing portfolio companies are usually still allowed). The remaining years are the harvest period, when the GP manages the portfolio toward exits. This clock is enforced by the LPA itself, so a fund nearing year eight with illiquid positions faces real pressure. A standard venture fund has a 10-year term, often with one or two one-year extensions. The first three to five years are the investment period — the GP is deploying capital into new positions. After the investment period closes, no new investments can be made from that fund (follow-on rounds into existing portfolio companies are usually still permitted). The remaining years are the harvest period: the GP is managing the portfolio toward exits. This clock is not academic. A fund approaching year eight with illiquid positions faces real pressure — not from market dynamics, but from the LPA itself. LPs who understand this use fund age as a negotiating signal. Most founders don't. What is the LPAC and what power does it actually have? The Limited Partner Advisory Committee (LPAC) is a subset of the larger LP base — typically the largest or most sophisticated investors — that reviews and approves conflicts of interest, valuation disputes, and fund extensions. It does not direct investments, but it holds real power: approving or rejecting term extensions, opining on related-party transactions, and removing the GP for cause in extreme cases. It operates mostly behind closed doors, with its composition and powers defined in the LPA, and it shapes how the GP behaves under pressure. Most institutional venture funds have a Limited Partner Advisory Committee (LPAC). This is a subset of the larger LP base — typically the largest or most sophisticated investors — who review and approve conflicts of interest, valuation disputes, and fund extensions. The LPAC does not direct investments. But it has real power: it can approve or reject a GP's request to extend the fund's term, opine on related-party transactions, and remove the GP for cause in extreme circumstances. The LPAC operates mostly behind closed doors, and its composition and powers are defined in the LPA. Founders rarely see any of this, but it shapes how the GP behaves — particularly when the fund is under pressure. ← More on Fund Formation Further reading: What a Venture Fund Actually Is (And What the Documents Won't Tell You) — A detailed treatment of LP/GP entity structures, fund document hierarchies, and the lifecycle mechanics that govern venture capital from formation to wind-down. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The LP Agreement: What Gets Negotiated Before the Fund Opens Its Doors Source: https://blegal.ai/knowledge/fund-02-lp-agreements-side-letters Author: Gurpreet S. Bal The LP Agreement: What Gets Negotiated Before the Fund Opens Its Doors By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Every LP in a fund signs the same Limited Partnership Agreement. What they don't all sign is the same side letter. Gurpreet S. Bal, who has represented both emerging managers and institutional LPs in fund formations, puts it plainly: "The LPA is the public menu. The side letter is what the large investor actually ordered. If you want to know the real terms of a fund, you need to read the side letters — and most people never see them." His practice covers the full formation stack, from first close through final close, and he has negotiated the provisions that matter most: key person triggers, removal rights, co-investment access, and the MFN clauses that quietly spread favorable terms across the LP base. What triggers a key person provision and what doesn't? A key person provision names the individuals — usually the founding partners — whose continued involvement is essential to the fund's strategy. It triggers when a key person stops devoting substantially all of their professional time to the fund, typically suspending new investments until a specified percentage of LPs votes to lift the suspension or remove the GP. The threshold is decisive: "substantially all" is vague by design, with GPs preferring flexibility to join boards or transition and LPs pushing for enforceable thresholds. It is the LP's primary structural protection against a team change and often the hardest provision to negotiate. A key person provision names the individuals whose continued involvement is essential to the fund's strategy — typically the founding partners. If a key person ceases to devote substantially all of their professional time to the fund, the provision triggers, usually suspending the GP's ability to make new investments until a specified percentage of LPs vote to lift the suspension or remove the GP. The threshold matters enormously. "Substantially all" is vague by design, and GPs fight hard to preserve flexibility. Gurpreet Bal has seen LPs push for "majority" time thresholds that are genuinely enforceable, while GPs prefer language that gives them room to join boards, advise other funds, or transition without triggering a technical default. The key person clause is the LP's primary structural protection against a team change, and it is often the hardest provision to negotiate. How do LP removal and no-fault divorce rights work? The removal right lets LPs terminate the GP, with or without cause, upon a vote of a specified percentage of LP interests. For-cause removal is standard; no-fault removal — often requiring a 75% or higher vote — is not, and it is a significant GP concession because it puts ultimate governance in the investors' hands. No-fault removal is rarely exercised in practice, but its mere existence shapes GP behavior throughout the fund's life. First-time managers sometimes agree to removal terms they don't fully understand in a hot fundraising environment. The most powerful LP protection in an LPA is the removal right — the ability to terminate the GP, with or without cause, upon a vote of a specified percentage of LP interests. For-cause removal is standard; no-fault removal is not. A no-fault removal right (often requiring a 75% or higher LP vote) is a significant concession by the GP because it means the fund's governance structure is ultimately controlled by the investors, not the manager. In practice, no-fault removal is rarely exercised, but its existence shapes GP behavior throughout the fund's life. Less sophisticated first-time managers sometimes agree to removal provisions they don't fully understand during a hot fundraising environment — and discover the implications when LP relations deteriorate. How are co-investment rights allocated among LPs? Larger LPs routinely negotiate co-investment rights as a condition of their commitment, giving them the chance to invest alongside the fund in specific portfolio companies — typically on the same terms and without management fees or carried interest. For LPs the economics are compelling; for GPs the rights can strengthen relationships and grow deployed capital, but they create allocation obligations that get harder to manage fairly as the LP base grows. The LPA specifies whether co-investment is a right or a courtesy, and the side letter often sets a dollar amount or percentage the GP must offer. The recurring fight is priority — who gets offered an oversubscribed deal first. Larger LPs routinely negotiate co-investment rights as a condition of their commitment. A co-investment right gives the LP the opportunity to invest alongside the fund in specific portfolio companies, typically on the same terms and without management fees or carried interest. The economics are compelling: LPs get direct exposure to the best opportunities at institutional pricing. For GPs, co-investment rights can enhance LP relationships and increase total deployed capital, but they create allocation obligations that are hard to manage fairly as the LP base grows. The LPA will specify whether co-investment is a right or a courtesy, and the side letter will often set a specific dollar amount or percentage the GP must offer. Gurpreet Bal regularly negotiates these provisions for both sides, and the key issue is always priority — who gets offered the opportunity first when the deal is oversubscribed. How does side letter proliferation create an MFN problem? As a fund closes, each institutional LP negotiates its own side letter, and a most-favored-nation (MFN) clause entitles that LP to elect the best terms granted to any other LP. In theory this keeps the playing field fair; in practice it creates a web of cross-references that is hard to administer consistently — a fund closed with fifteen institutional LPs, each with an MFN right, carries a substantial compliance burden. Some provisions (such as ERISA-specific accommodations) are excluded from MFN, but tracking which LP can elect which terms is ongoing work. New managers routinely underestimate this administrative load. As a fund closes, each institutional LP negotiates its own side letter. A most-favored-nation (MFN) clause in a side letter entitles that LP to elect the best terms granted to any other LP. In theory, this keeps the playing field fair. In practice, it creates a complex web of cross-references that can be nearly impossible to administer consistently. By the time a fund has closed with fifteen institutional LPs, each with a side letter and an MFN right, the GP's compliance obligation is substantial. Some provisions are excluded from MFN (ERISA-specific accommodations, for example), but figuring out which LP is entitled to elect which terms requires ongoing tracking. New fund managers routinely underestimate this administrative burden. The side letter that felt like a small concession to close a large commitment can, over time, become the most time-consuming document in the fund. ← More on Fund Formation Further reading: The LP Agreement: What Gets Negotiated Before the Fund Opens Its Doors — A detailed examination of LP protections, key person triggers, removal mechanics, co-investment rights, and the side letter proliferation problem in institutional venture fund formation. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## How Venture Funds Value Your Company (And Why the Number Is a Judgment Call Until It Isn't) Source: https://blegal.ai/knowledge/fund-03-investment-valuation Author: Gurpreet S. Bal How Venture Funds Value Your Company (And Why the Number Is a Judgment Call Until It Isn't) By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner When a venture fund reports that your company is worth $200 million in its quarterly LP update, that number is an estimate built on assumptions — not a market price. Gurpreet S. Bal has worked through enough fund audits and LP disputes to have a clear view of how these marks are made: "A valuation in a venture fund is a story the fund tells its LPs. The story has to be internally consistent and defensible on audit. Whether it reflects what the company would actually sell for is a separate question entirely." Understanding the mechanics of fair value measurement is increasingly important for both founders and LPs as the gap between paper marks and exit reality has widened across the venture market. What does ASC 820 require and what does fair value actually mean for VCs? ASC 820 requires venture funds to measure investments at fair value — the hypothetical price to sell an asset in an orderly transaction between market participants at the measurement date, with no actual transaction taking place. It sets a three-level hierarchy: Level 1 observable market prices, Level 2 inputs derived from observable data, and Level 3 unobservable inputs based on the fund's own assumptions. Almost every private venture investment is a Level 3 asset, so the fund itself — with some auditor oversight — is the primary arbiter of value. That makes valuation methodology disclosures more telling than the number itself. Under US GAAP, venture funds are required to measure their investments at fair value under ASC 820. Fair value is defined as the price you would receive to sell an asset in an orderly transaction between market participants at the measurement date. This is a hypothetical — there is no actual transaction. The standard establishes a three-level hierarchy: Level 1 is observable market prices (publicly traded securities); Level 2 is inputs derived from observable data; Level 3 is unobservable inputs, meaning the fund's own assumptions. Almost every private venture investment is a Level 3 asset. That means the fund itself — with some auditor oversight — is the primary arbiter of what the position is worth. Gurpreet Bal advises LPs to pay close attention to valuation methodology disclosures in audited financial statements, because the methodology tells you more than the number does. What are IPEV guidelines and what do they require on calibration? The International Private Equity and Venture Capital Valuation Guidelines (IPEV) are the industry standard for applying ASC 820 in practice. They emphasize calibration: a new investment's transaction price is presumed to represent fair value, and in later quarters the GP must assess whether circumstances have changed enough to justify deviating from it — weighing inputs like revenue growth, market comparables, new financing rounds, or deteriorating fundamentals. The framework gives GPs meaningful discretion but also creates an audit trail, so a markup without a new financing event has to be justified against observable inputs. The International Private Equity and Venture Capital Valuation Guidelines (IPEV) are the industry standard for how GPs apply ASC 820 in practice. IPEV emphasizes calibration: when a new investment is made, the transaction price is presumed to represent fair value. In subsequent quarters, the GP must calibrate — meaning it must assess whether circumstances have changed enough to justify a deviation from the initial transaction price. Revenue growth, market comparables, a new financing round, or deteriorating business fundamentals are all inputs. The IPEV framework gives GPs meaningful discretion, but it also creates an audit trail. If a fund marks a company up without a new financing event, it needs to be able to justify that decision against observable inputs. How do OPM and PWERM work as valuation methods for portfolio companies? The Option Pricing Model (OPM) treats each class of equity as a call option on the company's total value, which is useful with complex capital structures and liquidation preferences. The Probability-Weighted Expected Return Method (PWERM) models multiple exit scenarios — IPO, acquisition, continued operation, dissolution — and weights each by probability. Both rest on significant assumptions: OPM's volatility inputs (estimated from comparable public companies) have outsized effects, and PWERM's scenario probabilities are the GP's judgment. The same financial data can yield markedly different valuations depending on method and calibration, and year-end audit pressure compresses but rarely eliminates aggressive marks. The two most common techniques for valuing venture-stage companies are the Option Pricing Model (OPM) and the Probability-Weighted Expected Return Method (PWERM). OPM treats each class of equity as a call option on the company's total value, which is useful when a company has complex capital structures with liquidation preferences. PWERM explicitly models multiple exit scenarios — IPO, acquisition, continued operation, dissolution — and weights each by probability. Both methods require significant assumptions. In the OPM, volatility inputs have an outsized effect on the result and are themselves estimated from comparable public companies. In the PWERM, the scenario probabilities are the GP's judgment. A fund can produce markedly different valuations from the same financial data depending on which method it uses and how it calibrates the inputs. Year-end audit pressure tends to compress some of the more aggressive marks, but it rarely eliminates them. Why is there a gap between fund marks and actual portfolio value? The 2022 and 2023 correction showed how far venture marks had drifted from realizable exit values, with funds holding positions marked at 40x revenue multiples that had no rational basis in a reset market. Some GPs were slow to write down, creating apparent performance that wouldn't survive an exit. The lag between deteriorating business performance and mark reduction is structural: GPs have discretion, audit happens once a year, and LPs see quarterly reports reflecting manager judgment rather than market clearing prices. A fund's net asset value at any point is realistically a wide range, not a single number. The 2022 and 2023 correction revealed how far venture marks had drifted from realizable exit values. Funds that had marked positions at 40x revenue multiples — justified by public market comps at the time of the last financing — were suddenly holding Level 3 assets at valuations that had no rational basis in a reset market. Some GPs were slow to write down, creating the appearance of fund performance that wouldn't survive an exit. The lag between deteriorating business performance and mark reduction is a structural feature of the system: GPs have discretion, audit happens once a year, and LPs see quarterly reports that reflect manager judgment rather than market clearing prices. The honest answer, as practitioners know, is that a venture fund's net asset value at any point in its life is a range, not a number — and the range is wide. ← More on Fund Formation Further reading: How Venture Funds Value Your Company (And Why the Number Is a Judgment Call Until It Isn't) — A detailed analysis of ASC 820, IPEV guidelines, OPM and PWERM valuation methods, and the structural gap between quarterly marks and exit outcomes in venture funds. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## SPVs and Sidecars: When Your VC Wants More of You Than the Fund Can Hold Source: https://blegal.ai/knowledge/fund-04-sidecars-spvs Author: Gurpreet S. Bal SPVs and Sidecars: When Your VC Wants More of You Than the Fund Can Hold By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Special purpose vehicles have become a standard tool in the venture ecosystem — and a source of genuine confusion about economics, governance, and conflicts of interest. Gurpreet S. Bal has structured and reviewed SPVs from both the GP and portfolio company side: "SPVs are useful for everyone until the economics get complicated. Then you find out whether the GP structured it for the fund's benefit or for the company's convenience — and sometimes those aren't the same thing." His work spans the full range of sidecar structures, from pro-rata vehicles for existing investors to broadly syndicated SPVs enabled by modern fund administration platforms. What is a venture SPV and why do GPs use them? An SPV (special purpose vehicle) is a standalone legal entity — typically a Delaware LLC or LP — created to hold a single investment. When a fund's LPA imposes concentration limits (often 10–20% of committed capital per investment), an SPV lets the GP invest beyond that limit by raising additional capital from LPs or third parties for the specific deal. A sidecar is the same idea, usually a co-investment vehicle running alongside the main fund, and the distinction is mostly informal. GPs also use SPVs to deploy pro-rata rights when the main fund is in harvest mode, and low administrative cost has driven SPVs well beyond their original use. An SPV — special purpose vehicle — is a standalone legal entity, typically a Delaware LLC or LP, created to hold a single investment. When a venture fund's LPA imposes concentration limits (often 10–20% of committed capital per single investment), an SPV allows the GP to invest more than the fund's limit by raising additional capital from LPs or third parties specifically for that deal. A sidecar vehicle is the same concept, usually applied to a co-investment vehicle that runs alongside the main fund. The distinction is mostly informal. GPs also use SPVs to deploy capital from their pro-rata rights — the contractual right to participate in future financing rounds — when the main fund is in harvest mode and technically closed to new commitments. The administrative cost of running a separate entity is low enough that SPVs have proliferated far beyond their original use case. How do pro-rata rights create pressure to form SPVs? Pro-rata rights let a fund participate in a portfolio company's next round to maintain its ownership percentage. In a hot company, exercising these rights in later rounds can require more capital than the main fund can deploy, leaving the GP three choices: waive the right (diluting its position in its best asset), exercise through the main fund if capacity allows, or form an SPV to exercise it separately. The SPV route is common because it honors the right, brings in co-investors, and generates extra carry — but it raises the question of whether the GP is acting for the fund's LPs or building a separate profit center. When a fund leads a seed or Series A, it typically negotiates pro-rata rights: the right to participate in the next round up to the amount needed to maintain its ownership percentage. In a hot company, exercising pro-rata rights in later rounds — Series C, D, and beyond — can require capital that exceeds what the main fund can deploy. The GP is then faced with a choice: waive the right (diluting the fund's position in its best asset), exercise it through the main fund if capacity allows, or create an SPV to exercise it separately. The SPV route is common. It lets the GP honor the right, bring in co-investors, and generate additional carry on the incremental investment. But it raises a real question: is the GP exercising pro-rata rights for the benefit of the fund's LPs, or creating a separate profit center for itself and its preferred investors? How is carry structured on SPVs and what conflict does it create? SPV carry varies widely — some GPs charge zero on co-investment SPVs as an LP incentive, others charge the standard 20% or even higher on proprietary deal flow not offered through the main fund. The conflict becomes acute when a GP routes its best opportunities into an SPV rather than the main fund, whether to earn higher carry or to favor certain LPs. The LPA usually addresses related-party transactions and the LPAC often has approval rights over GP-affiliated vehicles, but the language is frequently ambiguous, and the issue tends to surface in LP disputes traceable to a gap in the original LPA. Carry economics on SPVs vary widely. Some GPs charge zero carry on co-investment SPVs as an LP incentive. Others charge the standard 20%, or even higher carry on proprietary deal flow that is not offered through the main fund. The conflict becomes acute when a GP routes its best opportunities into an SPV rather than the main fund — because the GP can earn higher carry on the SPV, or because the SPV LPs are more favorable counterparties. The LPA typically addresses related-party transactions and conflicts, and the LPAC will often have approval rights over GP-affiliated vehicles. But the language is frequently ambiguous, and many LPs don't scrutinize SPV economics until they notice that the fund's strongest performers were concentrated outside the main fund. Gurpreet Bal has seen this issue surface in LP disputes and it is almost always traceable to a gap in the original LPA. How has AngelList changed the use of SPVs at scale? Platforms like AngelList Venture sharply reduced the cost of forming and administering SPVs, enabling angels and scouts to syndicate individual deals efficiently — a lead can form an SPV, raise from accredited investors, and close in days, typically with an upfront carry (often 20%) and sometimes a setup or management fee. For founders this opened a new source of capital but also a new question of who is on the cap table, since a single SPV may represent dozens of underlying investors. In a later M&A process or IPO, winding down and distributing proceeds through a large SPV can be genuinely complicated. Platforms like AngelList Venture dramatically reduced the cost of forming and administering SPVs, enabling a new class of angel investors and scouts to syndicate individual deals efficiently. A syndicate lead can form an SPV for a specific deal, raise capital from accredited investors, and close in days. The economic model typically includes an upfront carry percentage (often 20%) and sometimes a setup or management fee. For founders, this created a new source of capital but also a new question: who is in your cap table? An SPV appearing on your cap table may represent dozens of underlying investors, each with their own economic interests. In a future M&A process or IPO, the administrative mechanics of winding down and distributing proceeds through a large SPV can be genuinely complicated. The convenience of SPV capital is real; so is the operational tail. ← More on Fund Formation Further reading: SPVs and Sidecars: When Your VC Wants More of You Than the Fund Can Hold — A practitioner analysis of SPV structures, pro-rata right mechanics, carry economics on sidecar vehicles, GP conflict-of-interest questions, and the impact on portfolio company cap tables. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## ERA vs. RIA: The Registration Mistake New Fund Managers Make Before They've Raised a Dollar Source: https://blegal.ai/knowledge/fund-05-era-vs-ria Author: Gurpreet S. Bal ERA vs. RIA: The Registration Mistake New Fund Managers Make Before They've Raised a Dollar By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner First-time fund managers routinely spend months and significant legal fees building a fund structure before anyone has asked the threshold question: how does the GP register as an investment adviser, and under which exemption? Gurpreet S. Bal has seen the consequences firsthand: "New fund managers spend money on fund documents before asking the registration question. If you get the exemption wrong, the fund structure you just built may need to be redesigned — or you may already be in violation." The Investment Advisers Act framework is not optional, and the choice between Exempt Reporting Adviser status and full Registered Investment Adviser registration has real operational consequences for how a fund can be structured and marketed. What baseline obligations does the Investment Advisers Act impose on fund managers? The Investment Advisers Act of 1940 requires anyone who provides investment advice for compensation using interstate commerce to register with the SEC as an investment adviser, unless an exemption applies. For venture managers, two exemptions are critical: Section 203(l), the venture capital fund adviser exemption, and Section 203(m), the private fund adviser exemption. These do not make a manager unregulated — they make it an Exempt Reporting Adviser (ERA) rather than a fully Registered Investment Adviser (RIA), which affects compliance obligations and examination exposure. Getting the initial classification right defines the firm's regulatory posture from day one. The Investment Advisers Act of 1940 requires any person who provides investment advice for compensation and uses interstate commerce to register with the SEC as an investment adviser — unless an exemption applies. For venture capital fund managers, two exemptions are critical: Section 203(l), the venture capital fund adviser exemption, and Section 203(m), the private fund adviser exemption. These exemptions don't mean you're unregulated — they mean you're an Exempt Reporting Adviser (ERA) rather than a fully Registered Investment Adviser (RIA). The distinction matters for compliance obligations, examination exposure, and what you can and cannot do. Getting the initial classification right is not a formality; it defines the regulatory posture of the entire firm from day one. What qualifies a fund for the Section 203(l) venture capital fund exemption? Under Section 203(l), a manager qualifies as an ERA if it advises exclusively "venture capital funds" as defined by the SEC — funds that are not registered under the Investment Company Act, offer no redemption rights except in extraordinary circumstances, primarily pursue equity investments in private companies, and do not use significant leverage. A qualifying manager files a truncated Form ADV and is exempt from full RIA registration. The key trap is "exclusively": advising any non-qualifying fund — one with a secondary strategy, a hedge fund, or an entity that extends debt — can forfeit the exemption for the entire advisory business. Under Section 203(l), a fund manager qualifies as an ERA if it advises exclusively "venture capital funds" as defined by the SEC. The regulatory definition is specific: a qualifying venture capital fund must not be registered under the Investment Company Act, must not offer redemption rights except in extraordinary circumstances, must primarily pursue equity investments in private companies, and must not use significant leverage. If every fund the manager advises meets this definition, the manager files a truncated Form ADV as an ERA and is exempt from full RIA registration. The key trap is the word "exclusively." A manager that also advises any fund that does not qualify — a fund with a secondary investment strategy, a hedge fund, or an entity that extends debt — potentially loses the 203(l) exemption for its entire advisory business. Gurpreet Bal regularly encounters this issue when clients expand beyond their original venture mandate. What are the limits of the Section 203(m) private fund adviser exemption? Section 203(m) offers a separate ERA path for managers of private funds with less than $150 million in US assets under management. It is broader than 203(l) — it does not require every fund to be a qualifying venture capital fund — but the AUM ceiling is a hard limit, and crossing it forces full RIA registration. Because 203(l) has no AUM ceiling while 203(m) creates a cliff, a fast-growing manager can hit $150 million mid-fund and face an unplanned compliance buildout: policies, procedures, a Chief Compliance Officer, Form ADV Part 2, and annual reviews. Section 203(m) provides a separate ERA path for managers of private funds with less than $150 million in assets under management (AUM) in the US. This exemption is broader in scope — it doesn't require that every fund be a qualifying venture capital fund — but the AUM ceiling is a hard limit. Once a firm manages more than $150 million in private fund AUM attributable to US clients, the exemption disappears and the firm must register as a full RIA. Unlike the 203(l) exemption, which has no AUM ceiling, the 203(m) path creates a cliff. A manager growing quickly can hit the $150 million threshold mid-fund and face a compliance buildout — policies, procedures, Chief Compliance Officer designation, Form ADV Part 2, annual reviews — on a timeline that wasn't anticipated when the fund was structured. What triggers full RIA registration at the state level? Federal ERA status does not eliminate state obligations: some states require their own ERA filings, and others may require full state RIA registration depending on where the manager and its clients are located. California, for example, runs its own investment adviser registration framework through the Department of Financial Protection and Innovation (DFPI), and its exemptions do not track the federal ones precisely. A manager operating in California, with California LPs, or managing California portfolio companies must analyze state obligations independently — assuming state registration is someone else's problem is a common source of compliance risk. Federal ERA status does not eliminate state-level obligations. Some states require their own ERA filings; others may require full state RIA registration depending on the location of the manager and its clients. California, for example, has its own investment adviser registration framework administered by the Department of Financial Protection and Innovation (DFPI), and the state exemptions do not track the federal ones precisely. A fund manager that operates in California, has California-based LPs, or manages California-based portfolio companies needs to analyze state-level obligations independently. The managers who create the most compliance risk are those who focus exclusively on federal exemption analysis and assume state registration is someone else's problem. It rarely is. ← More on Fund Formation Further reading: ERA vs. RIA: The Registration Mistake New Fund Managers Make Before They've Raised a Dollar — A detailed guide to the Investment Advisers Act registration framework for venture fund managers, covering the 203(l) and 203(m) exemptions, ERA filing obligations, the AUM cliff, and state registration requirements. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The Exemptions That Keep Venture Funds Out of SEC Registration (And the Lines You Cannot Cross) Source: https://blegal.ai/knowledge/fund-06-fund-exemptions Author: Gurpreet S. Bal The Exemptions That Keep Venture Funds Out of SEC Registration (And the Lines You Cannot Cross) By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner A venture fund is not registered with the SEC. That's not a gap in the regulatory system — it's a set of precise statutory exemptions that have to be maintained continuously from the day the fund closes its first investor to the day it winds down. Gurpreet S. Bal is direct about how this works in practice: "These exemptions are precise. One wrong investor and the structure breaks. I've seen funds that had to go through remediation because someone accepted an LP commitment without verifying the investor's status. The cost of fixing that is many times the cost of doing it right." The framework spans two separate bodies of law — the Investment Company Act and the Securities Act — and both have to be satisfied simultaneously. How do you choose between a 3(c)(1) and 3(c)(7) fund structure? Under the Investment Company Act of 1940, a private fund must register as an investment company unless it qualifies for an exemption, and the two most common are Section 3(c)(1) and Section 3(c)(7). A 3(c)(1) fund may have no more than 100 beneficial owners (250 if all are knowledgeable employees or qualified purchasers) and cannot make a public offering; a 3(c)(7) fund may have unlimited investors but all must be qualified purchasers, a higher standard than accredited investor. Emerging managers raising from high-net-worth individuals typically use 3(c)(1), while larger institutional funds favor 3(c)(7). Switching exemptions mid-fund requires investor consent and restructuring. Under the Investment Company Act of 1940, a fund must register as an investment company unless it qualifies for an exemption. The two most commonly used exemptions for private venture funds are Section 3(c)(1) and Section 3(c)(7). A 3(c)(1) fund may have no more than 100 beneficial owners (250 if all investors are "knowledgeable employees" or "qualified purchasers") and cannot make a public offering. A 3(c)(7) fund may have an unlimited number of investors but all investors must be "qualified purchasers" — a higher standard than accredited investor. For emerging managers raising from a broad base of high-net-worth individuals, 3(c)(1) is the typical path. For larger funds targeting institutional capital, 3(c)(7) is more practical. The choice is not easily reversed: changing the exemption mid-fund requires investor consent and restructuring. What's the difference between an accredited investor, qualified purchaser, and QIB? These standards are not interchangeable. An accredited investor under Reg D is an individual with $1 million in net worth (excluding primary residence) or $200,000 in annual income for two consecutive years. A qualified purchaser under the Investment Company Act is a higher bar — $5 million in investments for an individual, or $25 million owned and invested for an institution. A qualified institutional buyer (QIB) under Rule 144A requires $100 million in securities owned and invested. A 3(c)(1) fund needs accredited investors for Reg D but not qualified purchasers; a 3(c)(7) fund needs qualified purchasers, and confusing the two frameworks is a consequential formation error. The investor qualification standards that support these exemptions are not interchangeable. An "accredited investor" under Reg D has a relatively accessible definition: an individual with $1 million in net worth (excluding primary residence) or $200,000 in annual income for two consecutive years. A "qualified purchaser" under the Investment Company Act is a meaningfully higher bar: an individual who owns at least $5 million in investments, or an institution that owns and invests at least $25 million. A "qualified institutional buyer" (QIB) under Rule 144A requires $100 million in securities owned and invested. A 3(c)(1) fund requires accredited investors for its Reg D exemption but does not require qualified purchasers. A 3(c)(7) fund requires qualified purchasers at the ICA level. Getting the two frameworks confused — or assuming that an accredited investor satisfies the 3(c)(7) requirement — is one of the more consequential errors in fund formation. What's the difference between Reg D 506(b) and 506(c) on general solicitation? The offering to fund investors must itself be exempt under the Securities Act, and most funds rely on Regulation D. Rule 506(b) allows sales to up to 35 non-accredited but sophisticated investors plus unlimited accredited investors, but prohibits general solicitation or advertising. Rule 506(c) permits general solicitation but requires all purchasers to be verified accredited investors, with reasonable steps taken to verify status. Most institutional venture funds use 506(b) for lower overhead, but "general solicitation" is broader than it sounds — a tweet, a public conference presentation, or a broadly distributed email can blow the 506(b) exemption absent a substantive prior relationship. The securities offering made to fund investors must itself be exempt from SEC registration under the Securities Act. Most funds rely on Regulation D, which provides two main paths for private placements. Rule 506(b) allows sales to up to 35 non-accredited but sophisticated investors (in addition to unlimited accredited investors) but prohibits general solicitation or advertising. Rule 506(c) permits general solicitation but requires that all purchasers be verified accredited investors and that the issuer take reasonable steps to verify that status. Most institutional venture funds use 506(b): no public marketing, but less administrative overhead. The distinction matters because "general solicitation" is broader than it sounds — a tweet describing the fund's investment strategy, a public conference presentation about the fund, or a broadly distributed email to a contact list can all constitute general solicitation that blows the 506(b) exemption if investors haven't already been identified through a substantive prior relationship. How does the integration doctrine create problems for multi-vehicle fund structures? When a GP runs multiple funds or vehicles at once — a main fund, SPVs, perhaps a scout fund — the SEC can treat them as a single integrated offering if they are part of the same plan of financing and close in time. If integrated offerings collectively exceed the applicable exemption's investor or AUM limits, or a general solicitation for one vehicle taints a simultaneous 506(b) offering by another, the consequences can be serious. The protection is strict separation: separate PPMs, separate subscription processes, and separate investor communications, so each offering can demonstrate independent compliance. When a GP runs multiple funds or vehicles simultaneously — a main fund, one or more SPVs, and perhaps a scout fund — the integration doctrine becomes relevant. The SEC can treat multiple offerings as a single integrated offering if they are part of the same plan of financing and are close in time. If integrated offerings collectively exceed the investor or AUM limits of the applicable exemption, or if a general solicitation for one vehicle taints a simultaneous 506(b) offering by another vehicle, the consequences can be serious. Gurpreet Bal advises clients running parallel vehicles to maintain strict separation between them — separate PPMs, separate subscription processes, and separate investor communications — so that each offering can demonstrate independent compliance with its applicable exemption. ← More on Fund Formation Further reading: The Exemptions That Keep Venture Funds Out of SEC Registration (And the Lines You Cannot Cross) — A detailed analysis of 3(c)(1) and 3(c)(7) fund exemptions, Reg D 506(b) and 506(c) offering rules, investor qualification tiers, and the integration doctrine for multi-vehicle fund structures. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## How a Hedge Fund Actually Works: Structure, Economics, and Why It Is Nothing Like a VC Fund Source: https://blegal.ai/knowledge/fund-07-anatomy-hedge-fund Author: Gurpreet S. Bal How a Hedge Fund Actually Works: Structure, Economics, and Why It Is Nothing Like a VC Fund By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Founders who have raised venture capital and investors who allocate to both asset classes often conflate hedge funds and VC funds — until they look closely at the structural differences. Gurpreet S. Bal works across both structures and is clear about where the confusion originates: "People confuse hedge funds and VC funds until they look at the redemption provisions. One structure has a 10-year lock-up with no exits until a portfolio company liquidity event. The other lets investors walk out the door every quarter. Everything else flows from that." The structural divergence between hedge funds and venture funds shapes their economics, their investment behavior, and the leverage dynamics on both sides of the relationship. How do open-ended hedge fund structures and redemption mechanics work? A hedge fund is open-ended: investors subscribe at regular intervals and, subject to notice and lockup provisions, redeem their interests for cash. This is the opposite of a closed-ended venture fund, where capital is committed at formation, called over time, and returned only when investments are sold. The fund issues new interests with each subscription at current NAV, and redemptions force it to liquidate positions or hold cash reserves, directly linking investor behavior to portfolio management. The capital base is dynamic and never "closes" in the venture sense, which affects position sizing and the manager's ability to hold illiquid assets through a cycle. The defining feature of a hedge fund is that it is open-ended: investors can subscribe to the fund at regular intervals and, subject to notice and lockup provisions, redeem their interests for cash. This stands in stark contrast to a venture fund, which is closed-ended — capital is committed at formation, called over time, and returned only when investments are sold. A hedge fund issues new shares or partnership interests with each new subscription, priced at current NAV. Redemptions require the fund to liquidate positions or hold cash reserves — creating a direct link between investor behavior and portfolio management. The fund never "closes" in the venture sense. The capital base is dynamic, which affects everything from position sizing to the manager's ability to hold illiquid assets through a market cycle. How does the 2-and-20 model work and what do hurdle rates actually do? The classic "2 and 20" model is a 2% annual management fee on AUM plus a 20% performance fee on profits, though economics have compressed — emerging managers may offer 1.5% management fees and 15–17% performance fees to attract capital. Unlike a venture fund, the management fee is calculated on AUM that fluctuates daily with the market, not on committed or invested capital. Many institutional LPs also require a hurdle rate: a minimum return threshold, often pegged to a risk-free rate or LIBOR-based benchmark, that the fund must exceed before earning a performance fee. The hurdle rate negotiation is often where sophisticated LPs show their leverage most clearly. The classic hedge fund economics are "2 and 20": a 2% annual management fee on AUM and a 20% performance fee (incentive allocation) on profits. In practice, the economics have compressed significantly. Established funds still command near-2-and-20; emerging managers may offer 1.5% management fees and 15–17% performance fees to attract capital. The management fee in a hedge fund is calculated on AUM — which fluctuates daily with market movements — rather than on committed or invested capital as in a venture fund. Many institutional LPs also require a hurdle rate: a minimum return threshold (often pegged to a risk-free rate or LIBOR-based benchmark) that the fund must exceed before the performance fee is earned. Gurpreet Bal notes that the hurdle rate negotiation is often where sophisticated LPs demonstrate their leverage most clearly. How do high-water marks protect LPs from paying carry twice? A high-water mark (HWM) protects investors from paying performance fees twice on the same gains: if a fund falls 20% then recovers, the manager collects no performance fee on the recovery until the fund returns to its prior peak for that particular investor. It is the hedge fund analogue to a venture fund's carried interest waterfall and clawback, but it operates continuously and per-investor rather than as an end-of-fund reconciliation. A fund that suffers large drawdowns and cannot recover above its high-water marks faces an existential problem — the performance fee is effectively suspended and the management fee alone may not cover operating costs. A high-water mark (HWM) is an investor protection against paying performance fees twice on the same gains. If a fund loses 20% and then recovers 25%, the manager does not collect performance fees on the recovery until the fund has returned to the prior peak — the high-water mark — for that particular investor. In a venture fund, the analogous concept is the carried interest waterfall and clawback provision, which requires the GP to return carry if early distributions exceed what the GP was entitled to on a whole-fund basis. The HWM serves a similar protective function but operates continuously and per-investor, not as an end-of-fund reconciliation. A fund that suffers large drawdowns and cannot recover above its high-water marks faces an existential problem: the performance fee is effectively suspended, and the management fee alone may not cover operating costs, leading to fund closure or restructuring. How do side pockets, prime brokerage, and leverage work in hedge funds? Hedge funds holding illiquid assets — private credit, distressed securities, pre-IPO positions — use side pockets to segregate them from the liquid portfolio and remove them from the NAV used for subscriptions and redemptions; new investors get no exposure to existing side pocket assets, and redeeming investors get their pro-rata share back when the position is liquidated. Side pockets prevent forced selling to meet redemptions but reduce transparency and create valuation disputes. Most hedge funds also use leverage borrowed from prime brokers, who lend securities for shorts, provide financing, and often act as custodian — and the prime broker's ability to call margin is a risk with no parallel in a venture fund. Hedge funds that invest in illiquid assets — private credit, distressed securities, pre-IPO positions — use side pockets to segregate those investments from the liquid portfolio. When an investment is designated as a side pocket, it is removed from the NAV calculation for subscription and redemption purposes. New investors don't get exposure to existing side pocket assets; redeeming investors get their pro-rata share of the side pocket returned when the position is eventually liquidated. Side pockets protect the fund from forced selling to meet redemptions, but they reduce transparency and create disputes over valuation and timing. Unlike venture funds, most hedge funds use leverage — borrowed money from prime brokers to amplify positions. Prime brokerage relationships are a significant operational component: the prime broker lends securities for short positions, provides financing, and often serves as the fund's custodian. The prime broker's ability to call margin is a risk factor that has no parallel in a venture fund structure. ← More on Fund Formation Further reading: How a Hedge Fund Actually Works: Structure, Economics, and Why It Is Nothing Like a VC Fund — A detailed examination of hedge fund open-ended structure, redemption mechanics, high-water marks, hurdle rates, side pockets, prime brokerage, and the fundamental structural differences from closed-ended venture capital funds. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Fund Formation — Venture Fund & Hedge Fund Law Reference Source: https://blegal.ai/knowledge/fund-formation Author: Gurpreet S. Bal Fund Formation Analytical reference by Gurpreet S. Bal, Silicon Valley Corporate Partner | blegal.ai Fund formation sits at the intersection of partnership law, securities regulation, and investment management compliance. This reference hub covers the legal structure of venture funds and hedge funds from the ground up — general partner and management company structures, limited partnership agreement key terms, LP side letter negotiations, sidecar and SPV vehicles, and the SEC registration and reporting obligations that govern fund managers. The articles address both the structural mechanics and the regulatory compliance decisions that matter most when forming and operating a fund. Articles in This Category Anatomy of a Venture Fund Structure How a venture fund is organized — GP entity, management company, limited partnership, carried interest structure, and LP capital commitments. LP Agreements and Side Letters Key provisions in limited partnership agreements and how institutional LPs negotiate side letter accommodations, MFN rights, and co-invest rights. Fund Investment Valuation Methods How venture funds value private portfolio companies under ASC 820, ILPA guidance, and the practical methods used for LP reporting. Sidecar Funds and SPV Structures How sidecar funds and single-investment SPVs are structured to allow LPs to co-invest alongside the main fund in specific portfolio companies. Exempt Reporting Adviser vs Registered Investment Adviser ERA filing obligations under the venture capital fund adviser exemption, the threshold for full SEC registration, and compliance at each level. Fund Registration Exemptions The Investment Company Act Section 3(c)(1) and 3(c)(7) exemptions, investor limits, and how fund managers structure funds to stay within them. Anatomy of a Hedge Fund Structure How hedge funds differ from venture funds in legal structure, investor eligibility standards, liquidity and redemption terms, and regulatory treatment. Also on this topic: Fund Formation — Personal Practice Hub on gurpreetbal.com Gurpreet S. Bal is a corporate partner advising fund managers and investors on fund formation, venture capital transactions, and investment management regulation. For more information, visit gurpreetbal.com . --- ## Startup & Venture Law Glossary — Plain-English Definitions Source: https://blegal.ai/knowledge/glossary Author: Gurpreet S. Bal Startup & Venture Law Glossary Plain-English definitions of the terms founders, operators, and investors actually encounter across fundraising, M&A, IPOs, and fund formation. Each entry links to a deeper analysis where one exists. Part of the blegal.ai knowledge base. 409A Valuation An independent appraisal of a private company's common stock fair market value under IRC Section 409A, used to set option strike prices and avoid deferred-compensation tax penalties. Boards typically refresh it annually or after a material event. Deep dive: What is a 409A valuation? → Acquihire An acquisition undertaken primarily to bring on a target's team rather than its product, usually structured as an asset purchase with retention packages for key employees. Treatment of outstanding SAFEs and IP assignment are central issues. Deep dive: How are acquihires structured? → Anti-Dilution Protection A contractual adjustment that protects preferred investors when a company later raises money at a lower price, by reducing their conversion price. Broad-based weighted average is the common, founder-friendlier form; full ratchet is far harsher. Deep dive: What is anti-dilution protection? → Assignment for the Benefit of Creditors (ABC) A state-law wind-down alternative to Chapter 7 bankruptcy in which a company assigns its assets to an assignee who liquidates them and pays creditors. Often faster and quieter than federal bankruptcy. Deep dive: ABC vs. Chapter 7 → Carried Interest (Carry) The share of a fund's investment profits paid to the general partner as its performance incentive, customarily around 20% above a return hurdle. The economic heart of the fund-manager model. Deep dive: Anatomy of a venture fund → CFIUS The Committee on Foreign Investment in the United States, an interagency body that reviews foreign investments in U.S. businesses for national-security risk. AI and critical-technology companies face heightened scrutiny. Deep dive: CFIUS review for AI startups → Convertible Note A debt instrument that converts into equity at a future financing, carrying interest and a maturity date. Unlike a SAFE, it is a loan — which changes the founder's downside if a priced round never comes. Deep dive: Convertible notes vs. SAFEs → Delaware Flip Restructuring a foreign-incorporated startup so a Delaware parent company owns the original operating entity, typically to make the company investable for U.S. venture capital. Common for India-origin founders. Deep dive: India-to-US flip structure → Double-Trigger Acceleration Equity vesting that accelerates only when two events both occur — almost always a change of control plus the holder's termination without cause. The market-standard protection for employees in an acquisition. Deep dive: Double-trigger RSUs → Drag-Along Right A provision allowing a defined majority of stockholders to compel the minority to join a sale of the company on the same terms, preventing holdouts from blocking a deal. Deep dive: Series Seed term sheet → Earnout Deferred acquisition consideration paid to sellers only if the business hits defined post-closing milestones. Who controls the business after closing — and how milestones are measured — is where disputes arise. Deep dive: Earnout structures → · When the acquirer games it → Emerging Growth Company (EGC) A status under the JOBS Act giving newly public companies below set revenue thresholds reduced disclosure, executive-compensation, and auditor-attestation obligations for up to five years. Deep dive: EGC status and the JOBS Act → Escrow (M&A) A portion of the purchase price held by a neutral third party after closing to secure the seller's indemnification obligations, released after a defined survival period. Deep dive: Indemnification and escrow → FEMA (India) India's Foreign Exchange Management Act, which governs cross-border investment, share issuance, pricing, and repatriation for companies with India operations, employees, or investors. Deep dive: Cross-border US-India structures → General Partner (GP) The entity that manages a venture or private fund — sourcing deals, making investment decisions, and earning management fees plus carried interest. Deep dive: Anatomy of a venture fund → Indemnification A party's contractual promise — usually the seller's — to compensate the other for losses arising from breached representations or specified pre-closing liabilities. The core risk-allocation mechanism in M&A. Deep dive: Indemnification and escrow → Limited Partner (LP) A passive investor in a fund who commits capital but does not manage it, with liability limited to the amount committed. LPs include pensions, endowments, family offices, and funds of funds. Deep dive: LP agreements and side letters → Liquidation Preference The right of preferred stockholders to be paid before common holders in a sale or liquidation, typically a 1x return of invested capital. Stacked preferences across rounds can heavily affect what founders actually receive. Deep dive: Liquidation preferences and the waterfall → Lock-Up Agreement A commitment by company insiders not to sell their shares for a defined period after an IPO, most commonly 180 days, to support an orderly aftermarket. Deep dive: Lock-up agreements → MAC Clause (Material Adverse Change) A provision letting a buyer decline to close if the target suffers a significant adverse change between signing and closing. Courts read it narrowly, and carve-outs for general market conditions are heavily negotiated. Deep dive: MAC clauses → · When the buyer invokes it → Option Pool Shares reserved for employee equity grants. Creating or expanding the pool in the pre-money at a financing dilutes existing holders rather than new investors — the so-called option pool shuffle. Deep dive: The option pool at Series A → Participating Preferred Stock Preferred stock that first takes its liquidation preference and then also shares pro rata with common in the remaining proceeds — a double dip that raises investors' payout, often capped at a multiple. Deep dive: Liquidation preferences and the waterfall → Phantom Stock A cash-settled contract paying an amount tied to share value without issuing actual shares. Useful for advisors and international employees where issuing real equity is impractical, though typically taxed as ordinary income. Deep dive: Equity for India-based teams → Post-Money SAFE The market-standard SAFE since 2018, under which an investor's ownership is fixed as investment divided by the post-money valuation cap. Other SAFEs no longer dilute that investor — founders absorb the combined dilution. Deep dive: Post-money SAFE mechanics → Pro Rata Rights An investor's right to participate in future financing rounds to maintain its existing ownership percentage. Frequently negotiated in SAFE side letters and term sheets. Protective Provisions Veto rights giving preferred investors approval over defined major decisions — new financings, a company sale, charter amendments, or increasing the option pool. A key lever in the founder–investor control balance. Deep dive: Protecting board control at Series A → QSBS (Qualified Small Business Stock) Stock qualifying under IRC Section 1202 that can exclude a substantial portion of capital gains on a qualifying C-corporation held five or more years. California does not conform, an important trap for in-state founders. Deep dive: QSBS for California founders → Representations and Warranties Statements of fact the parties make about the business in a deal — on ownership, financials, IP, litigation, and more. Their breach can trigger indemnification claims against the escrow. Deep dive: Reps and warranties for tech deals → Right of First Refusal (ROFR) A company's or investor's right to buy shares a holder wishes to sell, on the same terms, before they can go to an outside buyer. A common obstacle to pre-IPO secondary sales. Deep dive: ROFR in secondary sales → Restricted Stock Unit (RSU) A promise to deliver shares (or their cash value) upon vesting. Common at later-stage and pre-IPO companies, often with double-trigger vesting so they settle only after a liquidity event. Deep dive: RSUs vs. options → Rule 10b5-1 Plan A pre-arranged trading plan that lets corporate insiders buy or sell company stock on a fixed schedule established while they did not possess material nonpublic information, providing an affirmative defense to insider-trading claims. Deep dive: Rule 10b5-1 plans → S-1 Registration Statement The registration document a company files with the SEC to go public, containing its prospectus, audited financials, risk factors, and use of proceeds. Deep dive: The S-1 registration statement → SAFE (Simple Agreement for Future Equity) An instrument that converts into equity at a future priced round rather than functioning as debt. The dominant early-stage fundraising tool in Silicon Valley, almost always used in its post-money form. Deep dive: Post-money SAFE mechanics → · Valuation caps → Secondary Sale A sale of existing private-company shares by a founder, employee, or early investor to another buyer — as opposed to a primary sale, where the company issues new shares. Usually subject to transfer restrictions and ROFRs. Deep dive: Selling pre-IPO shares → Section 220 (Delaware) A Delaware statute granting stockholders the right to inspect specified corporate books and records for a proper purpose — often a precursor to litigation or a governance dispute. Deep dive: Delaware Section 220 → Side Letter A supplementary agreement granting a particular fund investor terms that differ from the main fund documents — fee discounts, co-investment rights, or reporting preferences. Deep dive: LP agreements and side letters → Source Code Escrow An arrangement depositing software source code with a neutral third party, to be released to the licensee on defined trigger events such as the vendor's insolvency or failure to support the product. Deep dive: Source code escrow → Special Purpose Vehicle (SPV) A single-purpose entity formed to pool multiple investors into one investment, widely used in angel syndicates and venture co-investments. Deep dive: Sidecars and SPVs → Sarbanes-Oxley (SOX) Federal law imposing internal-control, certification, and audit requirements on public companies, including the Section 302 officer certifications and Section 404 internal-control attestations. Deep dive: SOX compliance → Valuation Cap The maximum company valuation at which a SAFE or convertible note converts into equity, protecting early investors from being diluted away by a much higher later-round price. It sets the conversion price, not the company's actual value. Deep dive: How SAFE valuation caps work → Working Capital Adjustment A post-closing true-up of the purchase price comparing the target's actual working capital at closing to an agreed target. Small definitional choices move real money, making it a frequent source of disputes. Deep dive: Working capital in M&A → · Post-closing disputes → Maintained by blegal.ai — a Silicon Valley startup & venture finance knowledge base. General educational definitions, not legal, tax, or financial advice. Terms vary by jurisdiction and by the specific documents in any transaction. --- ## The Real Time Commitment of an Audit Committee Seat: What Nobody Tells Pre-IPO Directors Source: https://blegal.ai/knowledge/ipo-01-audit-committee Author: Gurpreet S. Bal The Real Time Commitment of an Audit Committee Seat: What Nobody Tells Pre-IPO Directors By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Most governance guides describe audit committee service in clinical terms: scheduled meetings, charter obligations, financial oversight. What they don't describe is what the role actually feels like from the inside — the irregular cadence, the compressed timelines, and the meetings that appear with 48 hours' notice during earnings restatements or auditor disputes. Gurpreet S. Bal, who represents technology companies and investors through IPO processes and board structuring, puts it plainly: "There's a difference between reading what an audit committee does and actually living it for a year. Talk to someone who has done it." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. His advice to directors considering an audit committee seat: before you accept, have a real conversation with someone who has actually served on one — not someone who has only read the charter. What Does an Audit Committee Member Actually Do Before IPO? On paper, audit committee service looks manageable: four to five committee meetings a year, full board attendance, and review of financial statements and controls. In practice, the calendar fills with irregular work that no governance checklist captures. Chairs field calls from the external auditor, review drafts of financial disclosures, and become the board's primary point of contact for accounting questions the CFO escalates. On paper, audit committee service looks manageable: four to five committee meetings per year, attendance at full board meetings, and review of the company's financial statements and controls. In practice, the calendar fills in ways that don't appear on any governance checklist. Gurpreet S. Bal advises pre-IPO boards on committee structure regularly, and he is direct about what candidates underestimate: the irregular work. Between scheduled meetings, audit committee chairs field calls from the external auditor, review drafts of financial disclosures, and often become the primary point of contact for accounting questions the CFO escalates to the board. This is not theoretical — it is the pattern Gurpreet sees in active IPO preparations. How has the audit committee's scope expanded in 2026? In 2026, audit committee responsibilities have expanded to include AI disclosure requirements that did not exist two years ago. Companies with material AI operations or AI-generated financial analysis now face additional disclosure questions that land on the audit committee. The overlap between AI operational disclosure and financial statement accuracy has created a new category of work, requiring members to understand the company's AI infrastructure beyond what traditional financial expertise prepared them for. In 2026, audit committee responsibilities have expanded with AI disclosure requirements that did not exist even two years ago. Companies preparing for IPO that have material AI-related operations or AI-generated financial analysis are now navigating additional disclosure questions that land squarely on the audit committee's plate. Gurpreet S. Bal notes that the overlap between AI operational disclosure and financial statement accuracy has created a new category of audit committee work — one that requires committee members to understand not just GAAP but the company's AI infrastructure at a level of detail that goes well beyond what traditional financial expertise prepared them for. Directors who agreed to audit committee service expecting a traditional financial oversight role have found the scope has shifted significantly. What does the audit committee crisis meeting pattern look like? The meetings that distinguish audit committee service are the ones that appear without warning. An auditor question about revenue recognition, an internal control deficiency surfacing weeks before the S-1 filing, or a whistleblower hotline concern can each trigger an emergency meeting that consumes entire days and appears on no annual calendar. The directors who navigate these best are those who understood the possibility before accepting the seat. The meetings that distinguish audit committee service from other board committee work are the ones that appear without warning. An auditor raises a question about revenue recognition on a Thursday. An internal control deficiency surfaces two weeks before the S-1 is scheduled to be filed. A senior finance employee raises a concern through the whistleblower hotline. Each of these events can generate an emergency audit committee meeting — sometimes multiple — that consume entire days without appearing on any annual calendar. Gurpreet S. Bal has guided companies through each of these scenarios, and his consistent observation is that the directors who navigate them best are the ones who understood this possibility before they accepted the seat, not the ones who discovered it after. What should directors understand before committing to an audit committee seat? Before accepting a seat, ask for a reference conversation with someone who has served on an audit committee at a comparable-stage company, ideally one that went through an IPO in the last three years. Reading the charter and reviewing the relevant SEC and exchange rules matters, but the governance documents cannot convey what the role actually demands. That reference conversation is the most reliable way to calibrate what a director is truly agreeing to. Gurpreet S. Bal's practical recommendation is specific: ask for a reference conversation with someone who has served on an audit committee at a company at a comparable stage — ideally one that went through an IPO in the last three years. Read the charter, yes. Review the relevant SEC and exchange rules, yes. But the governance documents cannot convey the lived experience of what the role actually demands. "There's a difference between reading what an audit committee does and actually living it for a year. Talk to someone who has done it," Gurpreet says. That conversation, in his experience, is the single most reliable way to calibrate what a director is actually agreeing to. The companies that structure their boards with directors who entered with accurate expectations tend to have more stable governance through the IPO process and beyond. ← More on IPO Readiness Further reading: Joining an Audit Committee: What Pre-IPO Directors Need to Know — A foundational overview of audit committee responsibilities, independence requirements, and selection criteria for pre-IPO companies. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The Compensation Committee Before IPO: The Board Role Nobody Warns You Is the Hardest Source: https://blegal.ai/knowledge/ipo-02-compensation-committee Author: Gurpreet S. Bal The Compensation Committee Before IPO: The Board Role Nobody Warns You Is the Hardest By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Directors who join a pre-IPO board expecting the compensation committee to be a routine administrative function often discover the reality too late. In the 18 months before a company goes public, the compensation committee is frequently the most important decision-making body on the entire board — approving executive packages that will appear in public filings, managing equity plan mechanics, and navigating the transition from startup equity culture to public company compensation norms. Gurpreet S. Bal has spent years working alongside compensation committees at technology companies approaching IPO, and his assessment is direct: "The compensation committee becomes the most important committee in the building in the 18 months before an IPO. Nobody tells you that when you join the board." Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. That depth of local context gives Gurpreet a distinctive read on the compensation dynamics that define pre-IPO culture in the technology industry. Why is the compensation committee consistently underestimated by directors? The audit committee draws attention because it carries regulatory weight and public visibility, but the compensation committee does more substantive strategic work in the pre-IPO window than any other board body. Its decisions on executive salary, bonus, equity refresh, severance, and IPO equity awards will be scrutinized by institutional investors, proxy advisors, and the SEC. A committee that moves slowly or lacks a consistent compensation philosophy before the S-1 process creates problems that are hard to correct under deadline pressure. The audit committee gets the attention in governance conversations because it carries regulatory weight and public visibility. But Gurpreet S. Bal consistently observes that the compensation committee does more substantive strategic work in the pre-IPO window than any other board body. The decisions made in compensation committee meetings during this period — about executive base salary, target bonus, equity refresh, severance, and the structure of the IPO equity awards — will be scrutinized by institutional investors, proxy advisors, and the SEC. A compensation committee that moves slowly, lacks expertise, or has not established a consistent compensation philosophy before the S-1 process begins creates real problems that are difficult to correct under IPO timeline pressure. How is the double-trigger equity shift changing compensation committee work? One of the most consequential pre-IPO decisions involves shifting to double-trigger vesting, which requires both a change-of-control event and a qualifying termination before acceleration triggers. Companies move this way because single-trigger acceleration creates acquirer resistance and removes the retention function that makes equity meaningful. The transition is easier when the committee has clear governance authority and a well-documented compensation philosophy to justify the decision to employees who may push back. One of the most consequential decisions a compensation committee makes in the pre-IPO period involves the shift to double-trigger vesting for equity awards. Companies approaching IPO typically move toward double-trigger provisions — requiring both a change-of-control event and a qualifying termination before acceleration triggers — because single-trigger acceleration creates acquirer resistance and removes the retention function that makes equity meaningful. Gurpreet S. Bal has led this transition for technology companies at multiple stages, and he notes that the conversation is easier when the compensation committee has clear governance authority and a well-documented compensation philosophy to justify the decision to employees who may push back. Why are AI company IPOs driving the hardest compensation committee work in 2026? In 2026, intensifying AI company IPO preparations are giving compensation committees more work than ever. AI compensation structures are unusually complex: technical talent commands premium equity, retention is acutely competitive, and equity plans often include provisions not standard at earlier-stage companies. Committees are making decisions on plan design and executive pay with no clean precedent in the recent IPO market, which puts a premium on quality advisory support and members with actual pre-IPO compensation experience. In 2026, with AI company IPO preparations intensifying across Silicon Valley, compensation committees are doing more work than ever. The compensation structures at AI companies are unusually complex — technical talent commands premium equity, retention is acutely competitive, and the equity plans often include provisions that are not standard at earlier-stage technology companies. Gurpreet S. Bal notes that compensation committees at AI companies approaching IPO are often making decisions about equity plan design and executive pay that have no clean precedent in the recent IPO market. That ambiguity puts a premium on the quality of legal and compensation advisory support the committee receives, and on committee members who have actual pre-IPO compensation experience, not just public company governance backgrounds. What should you understand before accepting a compensation committee seat? Understand what the role actually requires before agreeing to it. The formal description of compensation committee responsibilities, oversight of executive pay, equity plan administration, and proxy disclosure, does not capture the volume, frequency, or political complexity of the real work. Directors who accept the seat with accurate expectations tend to perform better, engage more consistently, and avoid the mid-process disengagement that creates governance risk at the worst possible moment. Gurpreet S. Bal's guidance for directors considering a compensation committee seat is similar to his guidance on audit committee service: understand what the role actually requires before you agree to it. The formal description of compensation committee responsibilities — oversight of executive pay, equity plan administration, proxy disclosure — does not capture the volume, frequency, or political complexity of the actual work. "The compensation committee becomes the most important committee in the building in the 18 months before an IPO," Gurpreet observes. "Nobody tells you that when you join the board." Directors who accept the seat with accurate expectations tend to perform better, engage more consistently, and avoid the kind of mid-process disengagement that creates governance risk at the worst possible moment. ← More on IPO Readiness Further reading: Joining a Compensation Committee: Pre-IPO Planning Guide — A structured walkthrough of compensation committee responsibilities, independence requirements, and equity plan design considerations for companies preparing to go public. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Governance Committee Members: Why the Exchange Rules Matter More Than the SEC Source: https://blegal.ai/knowledge/ipo-03-governance-committee Author: Gurpreet S. Bal Governance Committee Members: Why the Exchange Rules Matter More Than the SEC By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner When directors join governance and nominating committees at companies preparing for IPO, the instinct is to focus on SEC rules — the federal securities framework that governs disclosure, insider trading, and fiduciary obligations. That instinct is understandable but directionally incomplete. The rules that actually govern how governance and nominating committees are structured, who can serve on them, and what independence means in practice come primarily from the listing standards of NYSE or Nasdaq. Gurpreet S. Bal has prepared governance committees for public offerings at companies across the technology sector, and he makes the point without ambiguity: "I've had directors come into an IPO prep meeting who could recite SEC rules cold but had no idea what the Nasdaq independence requirements actually said. The exchange is where the real governance lives." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. That breadth of exposure across company stages gives Gurpreet a practical perspective on what governance committees at every level actually encounter. What do directors get wrong about the SEC vs. exchange governance framework? The SEC establishes the disclosure and anti-fraud framework for all public companies, but the exchanges, NYSE and Nasdaq, set the structural governance requirements that determine whether a company can list and stay listed. For governance committee members, the exchange rules are the more immediate operational constraint. Directors with strong financial backgrounds but limited governance experience often arrive at IPO prep focused on the SEC rules they know rather than the exchange requirements that will actually govern the committee's structure. The SEC establishes the disclosure and anti-fraud framework that governs all public companies. The exchanges — NYSE and Nasdaq — establish the structural governance requirements that determine whether a company is permitted to list and maintain its listing. For governance committee members, the exchange rules are the more immediate operational constraint. Nasdaq Rule 5605 and the NYSE Listed Company Manual each contain specific requirements about committee independence, the process for director nominations, and the role of the governance committee in board refreshment. Gurpreet S. Bal consistently finds that directors with strong financial backgrounds but limited governance committee experience arrive at IPO prep focused on the wrong regulatory layer — the SEC rules they know — rather than the exchange requirements that will govern the committee's actual structure. What 2026 exchange rule updates have added complexity to governance committees? Recent 2026 exchange rule updates have added complexity that did not exist in previous IPO cycles. Both NYSE and Nasdaq have updated guidance on director independence assessments, particularly where directors have prior relationships to the company, its significant shareholders, or its customers in technology-adjacent industries. For AI companies, the independence analysis is especially layered, and careful documentation should be completed well before the S-1 process begins. Recent 2026 exchange rule updates have added additional complexity to governance committee work that did not exist in previous IPO cycles. Both NYSE and Nasdaq have updated their guidance on director independence assessments, particularly in cases involving directors with prior relationships to the company, its significant shareholders, or its customers in technology-adjacent industries. For AI companies approaching IPO, the independence analysis has become especially layered — when a director has a current or recent advisory relationship with an AI company, or holds equity in a portfolio company that is a customer or supplier, the independence analysis requires careful documentation that Gurpreet S. Bal recommends completing well before the S-1 process begins. How does the board nomination function change before and after the IPO? The nomination function looks fundamentally different before and after an IPO. Pre-IPO, nomination decisions often reflect investor consent rights and board composition agreements embedded in prior financing rounds. At IPO, those contractual rights typically terminate or convert, and the committee becomes responsible for an independent nomination process that can withstand public investor scrutiny. The transition should begin 12 to 18 months in advance so the committee has an established track record of independence before the S-1 is filed. The governance and nominating committee's nomination function looks fundamentally different before and after an IPO. Pre-IPO, nomination decisions often reflect investor consent rights and board composition agreements embedded in the investor rights agreements from prior financing rounds. At IPO, those contractual rights typically terminate or convert, and the committee becomes responsible for an independent nomination process that can withstand public investor scrutiny. Gurpreet S. Bal advises companies to begin the transition from investor-driven board composition to governance-committee-driven board composition well before the IPO — ideally 12 to 18 months in advance — so the committee has an established track record of independence before the S-1 is filed. What preparation does a governance committee director need before joining? Study the applicable exchange's listing standards directly, not through a summary document. The details matter: independence definitions contain carve-outs and exceptions that vary between NYSE and Nasdaq and have been updated in ways generic governance guides do not always capture. Understanding that layer deeply, rather than superficially, is what separates governance committee members who add real value from those who create risk. Gurpreet S. Bal's recommendation for directors joining governance and nominating committees in advance of an IPO is specific: study the applicable exchange's listing standards directly, not through a summary document. The details matter. Independence definitions contain carve-outs and exceptions that vary between NYSE and Nasdaq and that have been updated in ways that generic governance guides do not always capture. "I've had directors come into an IPO prep meeting who could recite SEC rules cold but had no idea what the Nasdaq independence requirements actually said," Gurpreet notes. "The exchange is where the real governance lives." Understanding that layer — deeply, not superficially — is what separates governance committee members who add real value from those who create risk. ← More on IPO Readiness Further reading: Joining a Governance and Nominating Committee: Pre-IPO Essentials — A comprehensive guide to governance committee structure, director independence standards, and nomination process requirements for companies approaching a public offering. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Always Go Double Trigger: The One Rule That Applies to Both RSUs and Options Pre-IPO Source: https://blegal.ai/knowledge/ipo-04-rsus-vs-options Author: Gurpreet S. Bal Always Go Double Trigger: The One Rule That Applies to Both RSUs and Options Pre-IPO By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The debate between RSUs and stock options for pre-IPO equity compensation is real and worth having. But Gurpreet S. Bal, who has structured equity plans for technology companies across hundreds of transactions, says there is one answer that applies regardless of which instrument the company chooses: always use double-trigger vesting for acceleration. The position is not subtle. "Whatever you use, always go double trigger. This is not a nuanced position. Single trigger is almost always a mistake." The reasoning is structural — single-trigger acceleration creates acquirer resistance, suppresses deal value in M&A scenarios, and removes the retention incentive that justifies the equity award in the first place. Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. On the question of double-trigger vesting, Gurpreet's approach is characteristically direct: this is a settled question with a clear answer. Why does single-trigger acceleration create problems in an M&A deal? Single-trigger provisions cause unvested equity to vest automatically on a change of control, without any termination requirement. When an acquirer's diligence reveals this, the acquisition price calculus changes: the acquirer is effectively paying for equity that has already vested and employees already compensated, removing the retention mechanics the equity was meant to provide. Such provisions have required significant restructuring at the letter-of-intent stage, affecting timing, price, and deal certainty. Single-trigger acceleration provisions — those that cause unvested equity to vest automatically upon a change of control, without any termination requirement — create a structural problem in M&A transactions. When a potential acquirer's due diligence reveals that the company's equity plan contains single-trigger acceleration, the acquisition price calculus changes. The acquirer is effectively paying for equity that has already vested and employees who have already been compensated, removing the retention mechanics that the equity was supposed to provide. Gurpreet S. Bal has navigated M&A processes where single-trigger provisions in the target company's equity plan required significant restructuring at the letter of intent stage — a complication that affects timing, price, and deal certainty. His observation is blunt: "I've seen single-trigger equity kill deals. I've never seen double-trigger equity kill a deal." Why has double-trigger acceleration become the standard as of 2026? As of 2026, double-trigger provisions have become standard in most well-counseled pre-IPO technology companies. Institutional investors, sophisticated acquirers, and compensation consultants all treat double-trigger as the baseline expectation. The companies still facing issues are those that made early equity grants years ago, before their legal infrastructure was developed, and now approach IPO with legacy single-trigger plans, which are easier to remedy before the IPO timeline compresses than during it. As of 2026, double-trigger provisions have become standard in most well-counseled pre-IPO technology companies. The market has largely settled this question — institutional investors, sophisticated acquirers, and compensation consultants all now treat double-trigger as the baseline expectation for equity plan design. What Gurpreet S. Bal still encounters in practice, however, are companies that were formed or that made their first equity grants several years ago, before their legal and compensation infrastructure was fully developed, and that are now approaching IPO with legacy equity plans that contain single-trigger provisions. Remedying those provisions requires careful work with the affected grantees, board approval, and documentation — all of which is easier to do before the IPO timeline is compressed than during it. Why is the retention argument the one that persuades boards on double trigger? The retention argument often persuades skeptical founders more readily than the M&A pricing argument. Employees with double-trigger equity keep the incentive to stay through a change-of-control transaction; they cannot simply collect acceleration and leave on day one post-close, and that retention value is part of what an acquirer pays for. Single-trigger equity removes it entirely. For founders who built strong team alignment, the framing resonates: equity structure should reinforce retention culture, not undermine it when retention matters most. When Gurpreet S. Bal explains double-trigger mechanics to founders and executives who are skeptical, he often leads with the retention argument rather than the M&A pricing argument. Employees who receive equity with double-trigger provisions retain the incentive to stay through a change-of-control transaction — they cannot simply collect their acceleration and leave on day one post-close. That retention value is part of what an acquirer is paying for. Single-trigger equity removes it entirely. For founders who built the company by creating strong team alignment, this framing typically resonates: the equity structure should reinforce the retention culture, not undermine it at the exact moment retention matters most. How is the RSU vs. options instrument question separate from the trigger question? The double-trigger rule applies equally across equity instruments; it governs acceleration mechanics whether the underlying award is a stock option or an RSU. The choice between options and RSUs involves a separate set of considerations: tax treatment, dilution timing, the company's 409A valuation, employee preference, and the company's pre-IPO trajectory. Those are real decisions worth making carefully, but the double-trigger question should be answered first and answered the same way every time. Gurpreet S. Bal is careful to note that the double-trigger rule applies equally across equity instruments — it governs acceleration mechanics regardless of whether the underlying award is a stock option or an RSU. The choice between options and RSUs involves a separate set of considerations: tax treatment, dilution timing, the company's 409A valuation, employee preference, and where the company is in its pre-IPO trajectory. Those are real decisions worth making carefully. But the double-trigger question should be answered first and should be answered the same way every time: double trigger, full stop. ← More on IPO Readiness Further reading: RSUs vs. Stock Options for Pre-IPO Companies — A detailed comparison of RSUs and stock options, covering tax treatment, dilution mechanics, employee psychology, and when each instrument makes sense in the pre-IPO equity plan design context. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The Single-Trigger Exception: When Double-Trigger RSU Vesting Doesn't Apply Source: https://blegal.ai/knowledge/ipo-05-double-trigger-rsu Author: Gurpreet S. Bal The Single-Trigger Exception: When Double-Trigger RSU Vesting Doesn't Apply By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet S. Bal's position on double-trigger RSU vesting is well established: it should be the default for pre-IPO companies, and departing from it requires a legitimate reason, not just a preference. But Gurpreet is also precise about where the exception lives. In his experience leading equity plan work for technology companies through IPOs and M&A transactions, he has used single-trigger RSU vesting in one specific context: certain foreign jurisdictions where double-trigger acceleration creates adverse tax treatment for employees. Outside of that narrow carve-out, the default holds. "Single trigger has a narrow legitimate use case — certain foreign tax regimes. Outside of that, it's almost always a mistake." Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. That combination of deep local roots and broad international deal experience gives Gurpreet a distinctive perspective on where global equity plan complexity actually creates legitimate exceptions — and where it doesn't. Why is the foreign jurisdiction exception to double-trigger RSUs real? In certain countries, the tax treatment of equity compensation is tied directly to the structure of the vesting trigger. In some European and Asian jurisdictions, double-trigger RSUs can create a deemed income event at the time of the change of control, or can disqualify the award from favorable local tax treatment. Where double-trigger creates a demonstrably worse outcome for the employee, a single-trigger or modified structure may be appropriate, but the exception requires actual legal and tax analysis, not a general preference for simplicity. In certain countries, the tax treatment of equity compensation is tied directly to the structure of the vesting trigger. In some European and Asian jurisdictions, RSUs with double-trigger vesting — where vesting is contingent on both a change-of-control and a termination event — can create a deemed income event at the time of the change of control, or can disqualify the award from favorable tax treatment available in that country. Gurpreet S. Bal works with local tax counsel in affected jurisdictions to analyze these questions, and in cases where double-trigger creates a demonstrably worse tax outcome for the employee, a single-trigger or modified structure may be the legally and commercially appropriate choice. The key word is demonstrably — the exception requires actual legal and tax analysis, not a general preference for simplicity. How have cross-border equity plans added complexity to double-trigger RSUs in 2026? In 2026, cross-border equity plans have added complexity as companies expand internationally before going public. US-based companies preparing for IPO increasingly have meaningful employee populations in the UK, Germany, Israel, Canada, India, and other jurisdictions with distinct equity tax frameworks. A plan that works cleanly for US employees may create unintended consequences abroad, so the answer is not a uniform US structure but understanding local rules well enough to design the right provisions for each population. In 2026, cross-border equity plans have added complexity as companies expand internationally before going public. Technology companies based in the United States that are preparing for IPO increasingly have meaningful employee populations in the UK, Germany, Israel, Canada, India, and other jurisdictions with distinct equity tax frameworks. Gurpreet S. Bal notes that the pre-IPO equity plan work for these companies now requires jurisdiction-by-jurisdiction analysis that was not routinely necessary even five years ago. A plan that works cleanly for US employees may create unintended tax consequences for employees in a European office, and the solution is not always to apply a uniform US structure globally — it is to understand the local rules well enough to design the right provisions for each population. How should companies evaluate whether the foreign jurisdiction exception applies? The evaluation follows a consistent framework. First, identify the specific jurisdictions where the company has meaningful employee populations. Second, engage local tax counsel in each affected jurisdiction to analyze how double-trigger vesting is treated under applicable law. Third, make a documented determination at the board or compensation committee level about which structure fits each population. In a public company audit or SEC review, a decision to use single-trigger vesting must be supported by actual legal analysis. Gurpreet S. Bal's approach to the single-trigger exception question follows a consistent framework. First, identify the specific jurisdictions where the company has meaningful employee populations. Second, engage local tax counsel in each affected jurisdiction to analyze the treatment of double-trigger vesting under applicable law. Third, make a documented determination — at the board or compensation committee level — about which structure is appropriate for each population. The documentation matters: in a public company audit or SEC review, a compensation committee decision to use single-trigger vesting in a specific jurisdiction needs to be supported by actual legal analysis, not a general assumption that international employees need different treatment. What do founders need to understand when looking for a simple answer on RSU triggers? The rule is simple: always go double trigger unless you have a specific, analyzed, documented reason not to. The foreign jurisdiction exception is real and has been applied in practice, but it is narrow, requires actual legal work to establish, and does not license a general preference for single-trigger structures. Companies that use single-trigger provisions without that analysis are taking on avoidable governance and M&A risk. Founders who come to Gurpreet S. Bal hoping for a simpler answer — a rule that applies uniformly to every employee in every jurisdiction — typically leave the conversation with a clearer but more nuanced framework. The rule is simple: always go double trigger unless you have a specific, analyzed, documented reason not to. The foreign jurisdiction exception is real and Gurpreet has applied it in practice. But it is narrow, it requires actual legal work to establish, and it does not license a general preference for single-trigger structures. Companies that use single-trigger provisions without that analysis are taking on avoidable governance and M&A risk. "Single trigger has a narrow legitimate use case — certain foreign tax regimes," Gurpreet says. "Outside of that, it's almost always a mistake." ← More on IPO Readiness Further reading: Double-Trigger RSU Vesting for Pre-IPO Companies — A full treatment of double-trigger RSU mechanics, the case for the standard structure, and when alternative approaches may be warranted. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Direct Listings vs. Traditional IPOs in 2026: The Price Discovery Debate and the Retail Factor Source: https://blegal.ai/knowledge/ipo-06-direct-listing-vs-ipo Author: Gurpreet S. Bal Direct Listings vs. Traditional IPOs in 2026: The Price Discovery Debate and the Retail Factor By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The theoretical case for direct listings as a superior price discovery mechanism has always been compelling: no banker-managed book, no artificial opening price constrained by institutional allocation, no first-day pop that represents value left on the table by the company. In practice, the picture is more complicated, and Gurpreet S. Bal — who has advised on traditional IPOs and alternative listing structures across the technology sector — is measured about the gap between theory and execution. "Direct listing should win on price discovery theory," Gurpreet says. "In practice, the gap between the two approaches has narrowed considerably." Retail investor access, early platform availability, and institutional book dynamics have all shifted in ways that make the comparison less straightforward than it was five years ago. Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. His perspective on the direct listing question is grounded in having navigated both structures with real clients under real market conditions. Does the price discovery argument for direct listings actually hold up? In a traditional IPO, the underwriting syndicate builds a book over the road show, sets an offering price on institutional demand, and opens trading from that constrained starting point. In a direct listing, existing shareholders offer shares directly and the opening price is set by actual first-day supply and demand. The direct listing is theoretically cleaner, but traditional IPOs that post early to retail platforms, market aggressively, or price at the high end of their range have effectively replicated much of that real-time price discovery. Gurpreet S. Bal walks through the price discovery argument with founders in a specific way. In a traditional IPO, the underwriting syndicate builds a book over the road show period, sets an offering price based on institutional demand, and opens trading from that constrained starting point. In a direct listing, existing shareholders offer shares directly to the market and the opening price is set by actual supply and demand on the first day of trading. The direct listing structure is theoretically cleaner. But Gurpreet notes that traditional IPOs that post early to retail platforms, that run aggressive consumer-facing marketing campaigns, or that price at the high end of their range based on strong institutional demand have effectively replicated much of the real-time price discovery that direct listing proponents cite as a differentiator. What better data do founders now have when choosing between a direct listing and IPO? In 2026, with the direct listing market matured and several high-profile examples available across multiple years of market conditions, founders have a much richer data set than early adopters did. Outcomes for opening-day pricing, first-year trading stability, employee and insider liquidity, and shareholder base quality are now observable across a meaningful sample. Founders should engage with that data directly rather than relying on ideological preferences, learning from both the success stories and the cases where the absence of stabilizing mechanisms created volatility. In 2026, with the direct listing market having matured and several high-profile examples now available across multiple years of market conditions, founders considering the direct listing path have a much richer data set than early adopters did. The outcomes — in terms of opening day pricing, first-year trading stability, employee and insider liquidity, and institutional shareholder base quality — are now observable across a meaningful sample. Gurpreet S. Bal encourages founders to engage with that data directly rather than relying on ideological preferences for one structure over another. The direct listing success stories are instructive. So are the cases where the absence of stabilizing mechanisms created volatility that worked against the company and its shareholders in the months after listing. How important is underwriter execution when choosing between a direct listing and IPO? Underwriter execution is a central dimension of the decision. A direct listing eliminates the underwriting syndicate's stabilizing function, its relationship network for driving institutional demand, and its financial incentive to ensure a successful outcome, none of which are trivial. Companies with strong brand recognition, deep institutional relationships, and anchor investors who can credibly support a direct listing have a very different calculus than companies that rely on the underwriting relationship to build their investor base from scratch. One dimension of the direct listing vs. traditional IPO decision that Gurpreet S. Bal consistently surfaces is the underwriter execution question. A direct listing eliminates the underwriting syndicate's stabilizing function, the relationship network that drives institutional demand, and the underwriters' financial incentive to ensure a successful outcome. These are not trivial contributions. "The question isn't which structure is theoretically better — it's which structure your underwriters can actually execute," Gurpreet observes. Companies with strong brand recognition, deep institutional investor relationships, and a shareholder base that includes investors who can credibly anchor the direct listing have a very different calculus than companies that rely on the underwriting relationship to build their investor base from scratch. How has the retail investor factor changed the direct listing vs. IPO calculus? The rise of retail investor access platforms, and underwriters' willingness to allocate IPO shares earlier in distribution, has meaningfully changed the competitive dynamic. Traditional IPOs that leverage retail platforms can now achieve broader day-one price discovery than was possible five years ago, when institutional allocation dominated and retail investors were largely confined to aftermarket trading. The structural argument for direct listings remains theoretically sound, but the practical advantage on democratized access has compressed. The rise of retail investor access platforms — and the willingness of underwriters to allocate IPO shares earlier in the distribution process — has meaningfully changed the competitive dynamic. Gurpreet S. Bal notes that traditional IPOs that leverage retail platforms effectively can achieve broader day-one price discovery than was possible five years ago, when institutional allocation dominated and retail investors were largely confined to aftermarket trading. That shift has narrowed the practical advantage that direct listings held on the grounds of democratized access. The structural argument for direct listings remains theoretically sound. The practical advantage has compressed, and Gurpreet's advice to founders is to engage with that reality rather than make the decision based on market narrative that no longer fully reflects the current environment. ← More on IPO Readiness Further reading: Direct Listing vs. Traditional IPO: How Price Discovery Works — A side-by-side comparison of direct listing mechanics and traditional IPO structure, covering price discovery, shareholder liquidity, underwriter roles, and when each approach makes sense. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Pre-IPO Secondary Sales: The Transaction Variations Nobody Warns Founders About Source: https://blegal.ai/knowledge/ipo-07-secondary-sales-pre-ipo Author: Gurpreet S. Bal Pre-IPO Secondary Sales: The Transaction Variations Nobody Warns Founders About By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The standard pre-IPO secondary sale — a founder or employee selling shares to a new investor at a negotiated price, with company consent and right-of-first-refusal compliance — is a well-understood transaction. What has changed, particularly in the current cycle, is the proliferation of more creative structures that carry the "secondary" label but involve very different legal and tax mechanics. Structured liquidity programs, tender offers organized by the company, SPVs, forward contracts, and derivative-style arrangements all exist in the market and all look different from each other in ways that matter. Gurpreet S. Bal, who has seen most of these variations in practice, keeps his guidance simple: "The word 'secondary' covers a lot of ground. Some of it is straightforward. Some of it is not." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. When the transaction being offered is not straightforward, Gurpreet's instinct is always to slow down and understand the structure before moving forward. What is actually straightforward about a standard pre-IPO secondary sale? A standard secondary sale involves a shareholder who owns common stock, typically vested founder or employee shares, negotiating a sale to a third-party buyer at an agreed price per share. The company's involvement is usually limited to consent (if required), ROFR compliance, and transfer agent mechanics. When the governing documents are clean and counsel is appropriately engaged, these transactions tend to move efficiently. Complications arise when the structure departs from this baseline, which is increasingly common. The standard pre-IPO secondary sale involves a shareholder who owns common stock (typically vested founder or employee shares) negotiating a sale to a third-party buyer — often a secondary-focused fund or a new investor entering the cap table — at a price per share agreed between the parties. The company's involvement is typically limited to consent (if required by the investor rights agreement or charter), ROFR compliance, and transfer agent mechanics. Gurpreet S. Bal notes that these transactions, when the company's governing documents are clean and the company's legal counsel is appropriately engaged, tend to move efficiently. The complications arise when the transaction structure departs from this baseline — and in the current market, departures are increasingly common. What secondary sale variations require extra legal attention before an IPO? Non-standard structures each carry a distinct legal and tax profile. SPV structures, where a vehicle holds the shares and investors participate in the SPV rather than holding shares directly, raise securities law questions about registration of SPV interests and applicable exemptions. Forward contracts and derivative arrangements can create complex tax recognition timing issues separate from the economic terms. Company-organized tender offers involve SEC rules that apply even to privately held companies. None can be assessed by analogy to the standard transaction. Gurpreet S. Bal works through the non-standard structures with founders and employees in detail before they sign anything. SPV structures — where a vehicle is formed to hold the shares and investors participate in the SPV rather than holding shares directly — raise securities law questions about the registration of SPV interests and the applicable exemptions. Forward contracts and derivative arrangements that reference pre-IPO shares can create complex tax recognition timing issues that are entirely separate from the economic terms the parties negotiated. Tender offers organized by the company itself involve SEC rules that apply even to privately held companies. Each of these structures has legitimate uses. Each also has a distinct legal and tax profile that cannot be assessed by analogy to the standard secondary transaction. How has pre-IPO secondary market activity accelerated in 2026? In 2026, secondary market activity for pre-IPO companies has accelerated significantly. A slower IPO market in prior years, high late-stage valuations, and employee equity that has been illiquid for five to seven years have created strong demand on both the seller and buyer sides. The increased volume has attracted a broader range of intermediaries, some with deep expertise and others less regulatory sophisticated, along with more creative structuring that makes legal review essential before committing to any transaction. In 2026, secondary market activity for pre-IPO companies has accelerated significantly. The combination of a slower IPO market in prior years, high valuations at late-stage rounds, and employee equity that has been unvested or illiquid for five to seven years has created strong demand on both the seller and buyer sides. The volume of secondary market activity has attracted a broader range of intermediaries — some with deep expertise and strong legal infrastructure, others operating with less regulatory sophistication. Gurpreet S. Bal notes that the increase in market activity has been accompanied by an increase in the creative structuring that makes legal review essential before committing to any transaction. "If someone is offering you a creative liquidity structure, the first call is to your lawyer, not to your friends who have done it," he says. What tax dimension of pre-IPO secondaries do most employees miss? Tax consequences are not uniform across transaction types, and this is the dimension founders and employees most often underestimate. The timing of income recognition, the character of the gain (capital versus ordinary), the application of Section 83(b) or Section 1202 QSBS considerations, and state tax treatment all vary by structure, not just economics. A forward contract delivering liquidity today may have a very different tax profile than an outright sale, and an SPV participation may not receive the same treatment as a direct share sale. The tax consequences of pre-IPO secondary sales are not uniform across transaction types, and Gurpreet S. Bal consistently flags this as the dimension that founders and employees most frequently underestimate. The timing of income recognition, the character of the gain (capital gain versus ordinary income), the application of Section 83(b) or Section 1202 QSBS considerations, and the state tax treatment all vary depending on the structure of the transaction — not just the economics. A forward contract that delivers economic liquidity today may have a very different tax recognition profile than an outright sale. An SPV participation that looks economically equivalent to a direct share sale may not receive the same tax treatment. The first call before signing is to a lawyer, as Gurpreet says — and the second call is to a tax advisor. ← More on IPO Readiness Further reading: Secondary Sales Pre-IPO: What Founders and Employees Should Know — A foundational guide to pre-IPO secondary sale mechanics, company consent requirements, ROFR compliance, and the factors that make a secondary transaction straightforward or complicated. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## IPO Tax Planning and the QSBS Long Game: Why Good Advice Takes Years to Pay Off Source: https://blegal.ai/knowledge/ipo-08-tax-issues-ipo Author: Gurpreet S. Bal IPO Tax Planning and the QSBS Long Game: Why Good Advice Takes Years to Pay Off By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Tax planning for a technology company IPO is sometimes described as an S-1 process activity — something that gets addressed when the offering is close and the financial picture is clear. Gurpreet S. Bal pushes back on that framing consistently and specifically. The tax benefits that matter most at IPO — particularly Qualified Small Business Stock exclusions under Section 1202 — are earned years before the offering, through decisions made at formation or during early financing rounds. By the time the S-1 is being drafted, the QSBS clock has already been running. "The QSBS planning we do at formation is invisible for five years. Then at the IPO it becomes very visible, very fast." The founders who benefit most are the ones whose counsel started planning the structure at the beginning, not the ones who asked about it in the S-1 process. Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. His long tenure in the Bay Area technology ecosystem means he has tracked founders from their first financing through the IPO — the full arc that makes the QSBS long game visible in a way it isn't for advisors who only see transactions at a point in time. What does QSBS actually deliver for founders and employees at IPO? Section 1202 provides an exclusion from federal capital gains tax for gain on the sale of Qualified Small Business Stock, which must meet specific holding period, issuance, and company qualification requirements. For founders and early investors who held qualifying shares more than five years, the exclusion can eliminate federal capital gains tax on up to $10 million per shareholder (or 10x the shareholder's adjusted basis). At IPO, when liquidity events can involve tens or hundreds of millions in gain, a properly structured QSBS exclusion can be among the most valuable outcomes of the entire legal relationship. Section 1202 of the Internal Revenue Code provides an exclusion from federal capital gains tax for gain realized on the sale of Qualified Small Business Stock — stock that meets specific holding period, issuance, and company qualification requirements. For founders and early investors who acquired shares in a company that qualifies, and who have held those shares for more than five years, the exclusion can eliminate federal capital gains tax on up to $10 million per shareholder (or 10x the shareholder's adjusted basis). At the time of an IPO, when founder liquidity events can involve gain measured in tens of millions or hundreds of millions of dollars, the QSBS exclusion — if it was properly structured and preserved — can be among the most valuable outcomes of the entire legal relationship. Gurpreet S. Bal describes this as "where advice that seemed academic two years ago becomes worth real money." How does the QSBS stacking strategy work at and after an IPO? QSBS stacking uses gifting and estate planning mechanisms to distribute shares, and the associated QSBS exclusion, across multiple taxpayers, each of whom can claim the exclusion separately up to the applicable cap. The strategy requires careful timing, proper documentation, and coordination with tax counsel, and it must be set up well in advance of the liquidity event to be effective. By the time an IPO is approaching and the valuation is public, the windows for this planning have largely closed. One of the more sophisticated QSBS-related strategies that Gurpreet S. Bal discusses with clients at the right stage involves QSBS stacking — using gifting and estate planning mechanisms to distribute shares (and the associated QSBS exclusion) across multiple taxpayers, each of whom can claim the exclusion separately up to the applicable cap. This strategy requires careful timing, proper documentation, and coordination with tax counsel, and it needs to be set up well in advance of the liquidity event to be effective. By the time an IPO is approaching and the company's valuation is public, the windows for this planning have largely closed. The founders who benefit are those whose counsel identified the strategy early and implemented it when the mechanics were still available. What have 2026 tech IPOs revealed about QSBS planning at the IPO stage? In 2026, several high-profile technology IPOs creating significant founder liquidity events have put the tax planning dimension front of mind across the Silicon Valley legal and advisory community. The visibility of large founder tax bills, and the equally visible cases where careful planning produced dramatically better outcomes, has driven more founders to ask about tax planning earlier in their company's lifecycle. The challenge remains making planning feel urgent at the seed or Series A stage, when an IPO feels distant but the decisions that matter most are already being made. In 2026, with several high-profile technology IPOs creating significant founder liquidity events, the tax planning dimension of IPO preparation is front of mind across the Silicon Valley legal and advisory community in a way it has not always been. Gurpreet S. Bal notes that the visibility of large founder tax bills — and the equally visible cases where careful planning produced dramatically better outcomes — has driven more founders to ask about tax planning earlier in their company's lifecycle. That shift in client behavior is positive. The challenge is that lawyers and advisors sometimes struggle to make planning feel urgent when the company is at the seed or Series A stage and an IPO feels distant. Gurpreet's approach is to be explicit about the time-horizon mismatch: the decisions that matter most at IPO are often made years before anyone is thinking about IPO timelines. Why must legal and tax counsel coordinate on QSBS planning around an IPO? The legal work, ensuring the company meets the C-corporation requirement, the active business requirement, the original issuance requirement, and the gross assets test, must be done in conjunction with tax analysis confirming the specific shares at issue qualify. These are not parallel workstreams that can run independently. Early and explicit coordination between company counsel and the founders' personal tax advisors is essential, particularly at formation and at each financing round where new shares are issued. One structural reality that Gurpreet S. Bal addresses with founders directly is the coordination requirement between legal and tax counsel in QSBS planning. The legal work — ensuring the company meets the C-corporation requirement, the active business requirement, the original issuance requirement, and the gross assets test — must be done in conjunction with tax analysis that confirms the specific shares at issue qualify under the applicable rules. These are not parallel workstreams that can be run independently. Gurpreet advocates for early and explicit coordination between company counsel and the founders' personal tax advisors, particularly at formation and at each financing round where new shares are issued. Getting this right requires attention that is invisible at the time it is happening and enormously valuable when the company reaches the IPO. ← More on IPO Readiness Further reading: Tax Issues in IPO Planning for Startup Founders — A comprehensive overview of the tax considerations founders face when approaching an IPO, including QSBS qualification, AMT exposure from option exercises, secondary sale tax treatment, and lockup planning. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## 10b-5 Trading Plans and Pre-IPO Governance: Why Good Planning Is an Investment Signal Source: https://blegal.ai/knowledge/ipo-09-pre-ipo-governance Author: Gurpreet S. Bal 10b-5 Trading Plans and Pre-IPO Governance: Why Good Planning Is an Investment Signal By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Rule 10b5-1 trading plans — the legal mechanism that allows company insiders to sell shares according to a pre-established, non-discretionary schedule without running afoul of insider trading rules — are frequently treated as a compliance item rather than a governance statement. Gurpreet S. Bal sees them differently. In his experience working with technology companies through the IPO process, companies that have thoughtfully designed and properly documented 10b5-1 plans before going public are sending a signal that sophisticated investors read correctly: this is a company that has thought carefully about its governance infrastructure. "A company that has thoughtful 10b-5 plans in place before the IPO is a company that has thought carefully about its governance. That matters to the investors who matter." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. His work on 10b5-1 plan design spans the full range of technology company size and stage, and his perspective on the compliance-versus-governance distinction is grounded in that breadth of experience. What does a 10b5-1 plan actually do for pre-IPO insiders? A properly structured 10b5-1 plan creates an affirmative defense to insider trading liability by establishing a trading plan in advance that the insider cannot later control. It must be adopted when the insider holds no material nonpublic information and must specify the amount, price, and timing of trades (or a formula for them). Well-designed plans also account for the post-IPO environment, including quiet periods, earnings blackout windows, and the company's insider trading policy. A properly structured 10b5-1 plan creates an affirmative defense to insider trading liability by establishing, in advance, a plan for trading that the insider cannot subsequently control. The plan must be adopted when the insider does not possess material nonpublic information, must specify the amount, price, and timing of trades (or provide a formula for determining them), and must be designed so that the insider cannot exercise subsequent discretion over whether or how trades are made. Gurpreet S. Bal works with company counsel and the affected insiders to ensure these structural requirements are met — and to ensure that the plan is designed with the post-IPO trading environment in mind, including quiet periods, earnings blackout windows, and the specific mechanics of the company's insider trading policy. How have the 10b5-1 rules become more specific in 2026? Following recent SEC guidance in 2026, the rules on when and how plans can be adopted have grown more specific. Earlier SEC amendments — cooling-off periods between adoption and first trade, limits on single-trade plans, and certification requirements — have been supplemented by guidance addressing adoption timing for pre-IPO companies and early post-IPO insiders. Companies should run a structured plan review against the current rules rather than rely on templates built under the pre-amendment framework. In 2026, following recent SEC guidance on 10b5-1 plan adoption windows, the rules governing when and how plans can be adopted have become more specific. The SEC's amendments to Rule 10b5-1 that took effect in prior years — requiring cooling-off periods between plan adoption and the first trade, limiting single-trade plans, and adding certification requirements — have been supplemented by additional guidance that addresses adoption timing in the context of pre-IPO companies and early post-IPO insiders. Gurpreet S. Bal recommends that companies preparing for IPO engage in a structured 10b5-1 plan review process that explicitly addresses the current rules and the SEC's stated enforcement posture, rather than relying on plan templates or checklists that may have been designed under the pre-amendment framework. What governance signal do 10b5-1 plans send to investors? Institutional investors who have reviewed many S-1 filings develop a sense for which companies have thoughtful legal and governance infrastructure and which treat compliance as box-checking. The specificity of the insider trading policy, the structure of insiders' 10b5-1 plans, and evidence of informed legal advice all factor into the governance assessment made alongside the financial analysis. This affects not just IPO pricing but the long-term quality of the shareholder base after the lockup expires. Gurpreet S. Bal's observation about sophisticated investors noticing the quality of a company's 10b5-1 planning is not rhetorical. Institutional investors who have reviewed dozens or hundreds of S-1 filings develop a sense for which companies have a thoughtful legal and governance infrastructure and which are treating compliance as a box-checking exercise. The specificity and quality of the insider trading policy, the structure of the 10b5-1 plans in place for the company's key insiders, and the evidence that the company has received informed legal advice about the current regulatory environment all factor into the governance assessment that institutional investors make alongside the financial analysis. This assessment affects not just IPO pricing but the long-term shareholder base quality — which types of investors choose to hold the stock after the lockup expires. What preparation should insiders do for 10b5-1 plans before the IPO? The legal team should hold a structured 10b5-1 education session with the board and all affected officers six to twelve months before the anticipated IPO date. It should cover how plans work, when they can be adopted, the current SEC cooling-off requirements, what happens if a plan is terminated or modified, and the post-IPO disclosure obligations. Companies that treat this as a serious governance exercise tend to enter the public market with cleaner insider trading infrastructure and fewer later compliance issues. Gurpreet S. Bal's recommendation is that the company's legal team conduct a structured 10b5-1 plan education session with the board and all affected officers at least six to twelve months before the anticipated IPO date. The session should cover how plans work, when they can be adopted, what the current SEC cooling-off period requirements are, what happens if a plan is terminated or modified, and what the disclosure obligations are in the post-IPO public filings. "10b-5 is not the most exciting topic in the room," Gurpreet says. "It's also not the one you want to get wrong in front of the SEC." The companies that treat this preparation as a serious governance exercise — rather than a last-minute compliance addendum — tend to enter the public market with a cleaner insider trading infrastructure and fewer compliance issues in the years that follow. ← More on IPO Readiness Further reading: Pre-IPO Corporate Governance Setup for Technology Companies — A comprehensive overview of pre-IPO governance infrastructure, covering board committee structure, insider trading policies, officer certification processes, and the governance items that institutional investors assess in the S-1. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## SOX Compliance and the CFO Certificate: The Moment When It Gets Real Source: https://blegal.ai/knowledge/ipo-10-sox-compliance Author: Gurpreet S. Bal SOX Compliance and the CFO Certificate: The Moment When It Gets Real By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Sarbanes-Oxley compliance is discussed extensively in IPO preparation — the internal controls framework, the auditor attestation requirements, the Section 302 and Section 906 certifications. What is discussed less often is the experiential difference between understanding SOX requirements intellectually and being the person who signs the CEO/CFO certification. The certification under Section 302 requires the signing officer to personally certify the accuracy of the company's financial statements and the effectiveness of its internal controls — and the certification under Section 906 carries criminal liability for knowing or willful violations. Gurpreet S. Bal is direct about the transition: "CFOs know SOX is serious. They know it's really serious when they're holding a pen over that certificate." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. His conversations with CFOs preparing to sign their first SOX certification tend to be frank ones about what the document actually requires and what personal preparation looks like. What is the CFO actually asserting in a SOX Section 302 certification? In each periodic SEC filing, the CEO and CFO certify that they have reviewed the report, that to their knowledge it contains no material misstatements or omissions, that the financial statements fairly present the company's condition, and that they have disclosed all significant deficiencies and material weaknesses to the audit committee and auditors. This is not a ceremonial signature but a personal attestation backed by review of internal processes and control testing. CFOs accustomed only to private-company controls often find the public-company process materially more demanding. The Section 302 certification requires the CEO and CFO to certify, in each periodic SEC filing, that they have reviewed the report, that to their knowledge it does not contain material misstatements or omissions, that the financial statements fairly present the company's financial condition, and that they have disclosed to the audit committee and auditors all significant deficiencies and material weaknesses in the internal control framework. This is not a ceremonial signature. It is a personal attestation backed by the officer's review of the company's internal processes, the results of internal control testing, and the conclusions of the company's finance and accounting function. Gurpreet S. Bal notes that CFOs who have only managed internal controls in a private company context — where the documentation and testing discipline is less rigorous — often find the public company certification process materially more demanding than they anticipated. How has AI raised the bar for SOX internal controls in 2026? In 2026, SOX compliance costs for pre-IPO technology companies have risen significantly, driven in part by AI-related internal control complexity not present in prior cycles. Companies using AI in financial reporting — automated revenue recognition, AI-assisted forecasting, machine-learning anomaly detection — must now figure out how to characterize and test those components, with documentation requirements still being defined in real time. Engage auditors early about how AI components will be treated in the SOX assessment, before the S-1 process rather than during it. In 2026, SOX compliance costs for pre-IPO technology companies have risen significantly, driven in part by AI-related internal control complexity that did not exist in prior IPO cycles. Companies that use AI systems in their financial reporting processes — automated revenue recognition, AI-assisted forecasting, machine-learning-driven anomaly detection in financial transactions — are now navigating questions about how to characterize and test those AI components as part of their internal control framework. The auditors and the SEC are both paying attention to AI's role in financial reporting infrastructure, and the internal control documentation requirements for AI-assisted processes are still being defined in real time. Gurpreet S. Bal advises pre-IPO companies to engage their auditors early about how AI components in the financial reporting stack will be treated in the SOX assessment — before the S-1 process, not during it. Why is there a gap between knowing SOX requirements and actually living them? Even CFOs who have studied SOX thoroughly and managed the pre-IPO controls build-out experience a genuine shift when the first actual certification cycle arrives. The difference is not knowledge but personal accountability at a scale that private-company finance roles do not replicate. The quiet that often sets in at the certification discussion reflects a real reckoning with what the signature means — not hesitation about signing, but recognition that the document differs in kind from everything earlier in the IPO process. Gurpreet S. Bal describes a pattern he has observed across multiple IPO processes: CFOs who have studied SOX, understand the framework thoroughly, and have managed the pre-IPO internal controls build-out experience a genuine shift when the first actual certification cycle arrives. The difference is not about knowledge — it is about personal accountability at a scale that private company finance roles do not replicate. "I've had CFOs who sailed through IPO prep and then got very quiet when we got to the certification discussion," Gurpreet says. The quietness, in his reading, reflects the moment of genuine reckoning with what the signature means — not hesitation about whether to sign, but a recognition that the document is different in kind from everything that came before in the IPO process. How should a pre-IPO company prepare the CFO for their first SOX certification? Run a structured walkthrough of the certification process before the actual deadline. It should cover what the CFO must personally review and verify before signing, how the sub-certification process from finance staff works, how material weakness and significant deficiency determinations are made and documented, and the process if a disclosure issue surfaces close to filing. The walkthrough should be supported by outside securities counsel and auditors and should be documented, so that signing becomes a moment of informed confidence rather than first reckoning. Gurpreet S. Bal's recommendation for companies approaching their first post-IPO quarterly filing is to run a structured walkthrough of the certification process before the actual certification deadline. This walkthrough should cover what the CFO needs to have personally reviewed and verified before signing, what the sub-certification process from finance staff looks like, how material weakness and significant deficiency determinations are made and documented, and what the process is if a potential disclosure issue surfaces close to the filing deadline. The walkthrough should be supported by the company's outside securities counsel and outside auditors, and it should be documented. "CFOs know SOX is serious. They know it's really serious when they're holding a pen over that certificate," Gurpreet observes. The goal of the preparation process is to ensure that the moment of signing is one of informed confidence — not the first time the CFO has thought carefully about what the document requires. ← More on IPO Readiness Further reading: SOX Compliance and Internal Controls for Pre-IPO Companies — A structured overview of Sarbanes-Oxley requirements for companies preparing to go public, covering internal control framework design, auditor attestation, the Section 302 and 906 certifications, and the Emerging Growth Company accommodations available under the JOBS Act. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Lock-Up Restrictions and Post-IPO Trading: The Questions Every Founder Asks Source: https://blegal.ai/knowledge/ipo-11-lockup-agreements Author: Gurpreet S. Bal Lock-Up Restrictions and Post-IPO Trading: The Questions Every Founder Asks By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner "Lock-up questions are the first thing I hear after an IPO closes. Without exception," says Gurpreet S. Bal, who has guided founders and employees through the post-IPO period across dozens of transactions. The lock-up agreement — typically a 180-day restriction on selling shares following an IPO — is structurally simple. What founders and employees consistently underestimate is everything that happens around it: the exceptions, the early release triggers, the interaction with trading blackout windows, and how to think about selling strategy once the restriction lifts. Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. He advises founders and executives not just on the legal mechanics of lock-up agreements, but on how to think about the post-lock-up period as a planning exercise that should begin well before the IPO itself. What does the 180-day lock-up actually prohibit — and for whom? The standard lock-up restricts directors, executive officers, significant shareholders, and employees holding substantial equity from selling, pledging, or transferring shares for 180 days after the IPO. It applies to all forms of shares — common stock, exercisable options, and RSUs that vest during the period — and is signed by a defined list of insiders, with underwriters holding the right to enforce it. Violation is rare but carries serious consequences, so the first step is confirming who is on the lock-up list before the IPO closes. The standard lock-up agreement restricts directors, executive officers, significant shareholders, and employees holding substantial equity positions from selling, pledging, or otherwise transferring shares for 180 days following the IPO. The restriction applies to all forms of shares — common stock, options that are exercisable, and RSUs that vest during the lock-up period. In practice, the agreement is signed by a defined list of insiders, and the underwriters hold contractual rights to enforce it. Violation is rare, but the consequences — including personal liability and potential securities law exposure — are serious. Understanding who is on the lock-up list, and whether that list includes you, is the first question Gurpreet S. Bal tells clients to confirm before the IPO closes. Are there exceptions — can anyone sell during the 180 days? Yes, but narrowly. Standard agreements carve out gifts to family members or trusts where the recipient is bound by the same restriction, and may permit certain estate-planning transfers and pre-IPO 10b5-1 plan sales that underwriters scrutinize closely. The most misunderstood exception involves cashless option exercises — some agreements permit exercising options and immediately selling shares to cover the exercise price and tax withholding. Whether it applies depends entirely on your specific agreement, so have counsel confirm before acting. Yes, but narrowly. Standard lock-up agreements carve out gifts to family members or trusts, provided the recipient is also bound by the same lock-up restriction. Certain estate planning transfers may be permitted. Some agreements include exceptions for 10b5-1 plan sales that were established prior to the IPO, though underwriters scrutinize these carefully. Gurpreet S. Bal notes that the most misunderstood exception involves cashless option exercises — some agreements permit the exercise of options and the immediate sale of shares to cover the exercise price and tax withholding, without triggering the general lock-up restriction. Whether this exception applies depends entirely on the language of your specific agreement. Do not assume it applies; have counsel confirm before taking action. What triggers early lock-up release? Early release, or lock-up waiver, requires consent of the lead underwriters, who have no legal obligation to grant it and typically do not unless market conditions or specific circumstances warrant. In 2026, some IPO structures have included pre-negotiated early release tied to stock-price performance — if the stock trades at or above a set multiple of the IPO price for a defined period, part of the restriction releases automatically. These provisions remain relatively uncommon in standard tech IPOs but appear more often where insider selling pressure was a negotiating point. Early release — also called lock-up waiver — requires the consent of the lead underwriters. They have no legal obligation to grant it, and typically do not unless market conditions or specific circumstances warrant. In 2026, some IPO structures have included pre-negotiated early release provisions tied to stock price performance: if the stock trades at or above a specified multiple of the IPO price for a defined period, a portion of the lock-up restriction is automatically released. These provisions are still relatively uncommon in standard tech IPOs, but Gurpreet S. Bal has seen them appear with increasing frequency in deals where insider selling pressure was a negotiating point during the underwriting process. "The 180-day number is simple. What happens at day 181 is where people need help," he observes — and the same is true of the conditions that can move that date earlier. How do trading blackout windows interact with lock-up expiration? If the 180-day lock-up expires during a company trading blackout window — typically in the weeks before an earnings announcement — you cannot sell even though the lock-up has technically lifted, and must wait for the blackout to clear. For many companies the lock-up expiration and the first post-IPO earnings blackout overlap almost precisely, so the first practical selling window may come materially later than day 181. Planning for this interaction and understanding the company's insider trading policy well in advance is essential. This is one of the most practically important questions for founders and employees, and one that Gurpreet S. Bal says is consistently underprepared for. If the 180-day lock-up expires during a company trading blackout window — typically in the weeks before an earnings announcement — you cannot sell even though the lock-up has technically lifted. You must wait for the blackout to clear. For many companies, the lock-up expiration and the first post-IPO earnings blackout window overlap almost precisely, meaning the first practical window to sell may be materially later than day 181. Planning for this interaction, and understanding the company's insider trading policy well in advance, is essential. Some companies adopt a policy of proactively notifying insiders when the combined lock-up expiration and blackout calendar creates a restricted selling period. How should founders think about selling strategy after lock-up release? Begin the post-lock-up planning conversation at least 90 days before expiration. The central tool is a 10b5-1 plan, which allows sales during future blackout windows, removes discretion over timing, and provides an affirmative defense against insider trading claims. Recent SEC rule changes extended the cooling-off period to 90 days for executives and directors (up to 120 in some cases), so a plan adopted on expiration day cannot generate sales for at least three months. Anyone expecting to sell near day 181 must establish a plan before the lock-up expires. Gurpreet S. Bal recommends that founders and executives begin the post-lock-up planning conversation at least 90 days before the lock-up expiration. The central tool is a 10b5-1 plan — a pre-arranged selling program that allows sales during future blackout windows, removes discretion from the timing of individual sales, and provides an affirmative defense against insider trading allegations. Establishing a 10b5-1 plan requires a cooling-off period (extended by recent SEC rule changes to 90 days for executives and directors, and up to 120 days in some circumstances) between plan adoption and first sale. That means a plan established on lock-up expiration day cannot generate sales for at least three months. Anyone expecting to sell near day 181 needs to have established a plan before the lock-up expires — which requires getting ahead of the process while the lock-up is still in place. Gurpreet S. Bal has helped numerous founders navigate this timing carefully to avoid inadvertently locking themselves out of a near-term selling window. ← More on IPO Readiness Further reading: Lock-Up Agreements and Post-IPO Trading Restrictions — a comprehensive overview of the lock-up framework, standard terms, and strategic considerations for founders navigating the post-IPO period. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Regional Underwriters and Mid-Market Tech IPOs: Why Goldman Isn't Always the Answer Source: https://blegal.ai/knowledge/ipo-12-selecting-underwriters Author: Gurpreet S. Bal Regional Underwriters and Mid-Market Tech IPOs: Why Goldman Isn't Always the Answer By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet S. Bal has recently led one of the only true mid-market IPOs in the technology sector in the last ten years. That experience has given him a practitioner's view on underwriter selection that most founders never get: the name on the bank's letterhead is far less important than whether your deal is a priority transaction for the team working it. "The Silicon Valley tech partner may better understand your tech, but the folks in the midwest and smaller regions, they understand your heart," Gurpreet S. Bal says. And then, with a laugh: "As long as they are not from St. Louis." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. As of 2026, mid-market tech IPOs have become increasingly rare, making underwriter selection one of the highest-stakes decisions a mid-market company can make. What makes a mid-market IPO different from a large-cap tech offering? A large-cap tech IPO largely runs itself: the bulge-bracket deal team is motivated, institutional investors show up, and the roadshow is a formality. A mid-market tech IPO is structurally different — it requires active selling, genuine investor relationship management, and a roadshow team that will fight for pricing rather than accept whatever the book generates. For mid-market companies, the quality and motivation of the specific bankers assigned matters far more than the institution's prestige; a flagship deal gets more energy than a smaller one on a busy calendar. A large-cap technology IPO — the kind that generates front-page coverage and institutional investor demand from the moment the S-1 is filed — runs itself in many respects. The deal team at a bulge-bracket bank is motivated, institutional investors show up, and the roadshow is a formality. A mid-market tech IPO is structurally different. The deal requires active selling, genuine investor relationship management, and a roadshow team that will fight for pricing rather than accept whatever the book generates. Gurpreet S. Bal notes that for mid-market companies, the quality and motivation of the specific bankers assigned to the deal matters far more than the prestige of the institution. A Goldman banker who is managing three larger deals simultaneously is not the same resource as a regional banker for whom your transaction is the flagship of their year. How do regional and mid-market underwriters actually perform differently? Regional underwriters bring investor networks — family offices, regional funds, sector-focused funds — that are not the primary targets of bulge-bracket roadshows but are well suited to a mid-market growth company. These investors tend to be longer-term holders, less likely to flip shares immediately post-IPO. Regional bankers also tend to have deeper relationships with the retail brokerage networks that matter for mid-market deals, and the banker who wins your deal gives it far more attention than a large firm treating it as a smaller transaction. Regional underwriters bring several structural advantages to mid-market tech offerings. Their investor networks often include institutional buyers — family offices, regional funds, sector-focused funds — that are not the primary targets of bulge-bracket roadshows but are exactly the investors suited to a mid-market growth company. These investors tend to be longer-term holders, less likely to flip shares immediately post-IPO, and more willing to build positions over time. Regional bankers also tend to have deeper relationships with the retail brokerage networks that matter for mid-market deals. Gurpreet S. Bal describes the dynamic plainly: the regional banker who wins your deal will give it far more attention and personal energy than a bulge-bracket firm that treats it as a smaller transaction on a busy calendar. What does underwriter selection actually look like in practice? The formal selection process — a "bake-off" or "beauty contest" — involves presentations from competing banks to the company's board and management, each presenting its valuation thesis, comparable company analysis, proposed deal structure, and distribution strategy. Ask banks to be specific about the actual team members who will work the deal day-to-day, who will be on the roadshow, which investors they have already spoken with, and what their post-IPO research coverage plan is. The answers reveal how seriously the bank is treating your deal. The formal underwriter selection process — commonly called a "bake-off" or "beauty contest" — involves presentations from competing banks to the company's board and management. Each bank presents its valuation thesis, comparable company analysis, proposed deal structure, and distribution strategy. Gurpreet S. Bal advises founders to ask banks to be specific about the actual team members who will work the deal day-to-day, not just the senior banker presenting. Ask who will be on the roadshow. Ask which investors they have already spoken with about similar companies. Ask what their post-IPO research coverage plan looks like. The answers reveal how seriously the bank is treating your deal. In 2026, mid-market IPOs have become rare enough that a bank with a credible mid-market track record is a meaningful differentiator. How should founders think about the lead underwriter versus co-managers? The lead underwriter — the book-running manager or lead left bank — controls the deal's economics and leads the investor syndicate, while co-managers take a smaller share of the spread and have more limited roles in pricing and book-building. Mid-market companies should still think carefully about co-manager selection: one with strong retail distribution or sector-specific credibility and established investor relationships can meaningfully expand the deal's reach and improve both pricing and aftermarket stability. The lead gets the headlines; the right co-manager can quietly make the difference. The lead underwriter — also called the book-running manager or lead left bank — controls the economics of the deal and leads the investor syndicate. Co-managers receive a smaller share of the underwriting spread and typically have more limited roles in pricing and book-building. Gurpreet S. Bal recommends that mid-market companies think carefully about the co-manager selection as well, not just the lead. A co-manager with a strong retail distribution network, or strong relationships with a specific category of institutional investors, can meaningfully expand the deal's reach. For mid-market tech deals in particular, adding a co-manager with sector-specific credibility — a bank that has covered your space closely and has established investor relationships in it — can improve both pricing and aftermarket stability. The lead gets the headlines; the right co-manager can quietly make the difference in how the book gets filled. ← More on IPO Readiness Further reading: How to Select Underwriters and Manage the IPO Process — a detailed guide to the underwriter selection process, bake-off mechanics, and how to evaluate banker presentations. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## S-1 Risk Factors: The One Non-Generic Disclosure That Can Define Your Deal Source: https://blegal.ai/knowledge/ipo-13-s1-registration Author: Gurpreet S. Bal S-1 Risk Factors: The One Non-Generic Disclosure That Can Define Your Deal By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Every S-1 registration statement contains a risk factors section. Most of it reads identically across companies: competition may intensify, we depend on key personnel, macroeconomic conditions may adversely affect our business. No sophisticated investor reads these factors and concludes the company is too risky to buy. They are legal wallpaper by design, drafted carefully and comprehensively by counsel to provide disclosure protection. "Generic risk factors are legal wallpaper. The one-off is the one that matters," says Gurpreet S. Bal, who has drafted and negotiated risk factor sections across a wide range of technology IPOs and public offerings. "I've seen deals slow down significantly because of one specific risk factor that the SEC wanted clarified." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. In 2026, AI-related one-off risk factors have become a major source of SEC comment letters, reshaping how technology companies approach the risk factor drafting process. What separates a generic risk factor from a one-off? A generic risk factor describes a risk any company in your industry might face — cybersecurity breaches, regulatory changes, customer concentration — included for legal protection and understood as formulaic. A one-off is specific to your company: a pending regulatory investigation, a material customer under renegotiation, a key founder whose departure would be disruptive, an open IP dispute, or a novel technology with unsettled regulatory status. The practical test: if an investor reads it and thinks "that's unusual," it's a one-off — and exactly what the SEC scrutinizes most. A generic risk factor describes a risk that any company in your industry might face: cybersecurity breaches, regulatory changes, customer concentration, international operations. These are real risks, but their presence in the document is expected, their disclosure is formulaic, and experienced investors understand they are included for legal protection rather than specific warning. A one-off risk factor is something specific to your company: a pending regulatory investigation, a material customer whose contract is under renegotiation, a key employee or founder whose departure would be genuinely disruptive, an open IP dispute, or a novel technology with an unsettled regulatory status. Gurpreet S. Bal describes the practical test: if an investor reads the risk factor and thinks "that's unusual," it's a one-off. And the ones that make sophisticated investors pause are exactly the ones the SEC scrutinizes most carefully. How does the SEC engage with one-off risk factors during the comment process? The SEC's Division of Corporation Finance reviews S-1 filings and issues comment letters requesting clarification, additional disclosure, or revisions. Generic risk factors rarely draw substantive comments; one-offs frequently do — the SEC may ask the company to quantify a qualitatively described risk, provide more specific disclosure about a pending matter, or clarify how a risk relates to the financial statements. Each comment round adds time, and a significant one-off can delay effectiveness until the disclosure satisfies the staff. In 2026, AI-related disclosures are a consistently flagged category. The SEC's Division of Corporation Finance reviews S-1 filings and issues comment letters requesting clarification, additional disclosure, or revisions. Gurpreet S. Bal notes that generic risk factors rarely attract substantive SEC comments — the staff understands they are standard. One-off risk factors frequently do. The SEC may ask the company to quantify a risk it has described qualitatively, to provide more specific disclosure about a pending matter, or to clarify how a specific risk actually relates to the company's financial statements. Each comment round adds time to the IPO timeline, and if a one-off risk factor is significant enough, the SEC may delay effectiveness of the registration statement until the disclosure satisfies their requirements. Recent 2026 comment letter data shows that AI-related disclosures — particularly around training data provenance, regulatory exposure, and model reliability — have become a consistently flagged category. What are the most common one-off risk factors in AI company IPOs today? For AI companies, common one-off categories include training data scraped from the internet without clear licensing, open-source model components whose license terms are incompatible with commercial use, regulatory inquiries in the EU under the AI Act or equivalent frameworks, and founders with prior company histories involving unsettled IP or litigation. Key person dependency is a perennial one-off that investors read carefully when the technology is inseparable from a specific individual's work — particularly acute when the founding researcher's continued involvement is genuinely why the technology works. Gurpreet S. Bal has seen a consistent pattern of one-off risk factors in technology company S-1 filings in the current environment. For AI companies, the categories include: training data that was scraped from the internet without clear licensing, open source model components whose license terms are incompatible with commercial use, regulatory inquiries in the EU under the AI Act or equivalent frameworks, and founders with prior company histories involving unsettled IP or litigation. Key person dependency is a perennial one-off risk factor — one that investors actually read carefully when the company's technology is inseparable from a specific individual's work. In the AI context, this risk is particularly acute when the founding researcher's continued involvement is genuinely the reason the technology works as well as it does. How should companies approach one-off risk factor drafting? Be specific, be accurate, and do not try to minimize through vague language — the SEC pushes back on disclosure that reads like it is disclosing something while obscuring what it is. The goal is not to make the risk look smaller but to describe it accurately so the disclosure protects the company if the risk materializes. Founders sometimes worry specific disclosure will spook investors, but sophisticated institutions respect honest disclosure; what spooks them is discovering a material issue the S-1 referenced only obliquely. Gurpreet S. Bal recommends a specific approach to one-off risk factor drafting: be specific, be accurate, and do not try to minimize through vague language. The SEC will push back on disclosure that reads like it is trying to disclose something while obscuring what it is. The goal is not to make the risk look smaller — it is to describe it accurately so that the disclosure protects the company if the risk materializes. Founders sometimes resist this instinct, worried that specific disclosure will spook investors. In practice, Gurpreet S. Bal notes, sophisticated institutional investors respect specific and honest disclosure. What spooks them is discovering a material issue that the S-1 referenced only obliquely. The risk factor that is drafted carefully and specifically — and then stops being a live issue — is forgotten by investors quickly. The one that was vague and then materialized is remembered much longer. ← More on IPO Readiness Further reading: S-1 Registration Statement: Key Sections and What Founders Should Know — a comprehensive overview of S-1 structure, SEC review process, and how founders should engage with the registration statement drafting process. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## RSAs and PSUs: The Return of Performance-Based Equity in Pre-IPO Companies Source: https://blegal.ai/knowledge/ipo-14-equity-plan-design Author: Gurpreet S. Bal RSAs and PSUs: The Return of Performance-Based Equity in Pre-IPO Companies By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner For most of the last decade, pre-IPO equity plan design in the technology sector ran on a single instrument: the stock option. Options were simple, well-understood by employees, and carried favorable tax treatment when structured correctly. Restricted Stock Awards — RSAs — were used at founding and early stages but largely faded from the core equity toolkit as companies scaled. Performance Stock Units — equity tied to specific milestones rather than time — were viewed as a complexity that private companies didn't need to impose on themselves. "RSAs were almost an afterthought for a decade. They're back because founders are thinking more carefully about how equity aligns incentives," says Gurpreet S. Bal. "PSUs require you to define what success looks like. That's uncomfortable for some companies. It's exactly the discipline they need." Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. In 2026, the equity compensation landscape for pre-IPO technology companies has shifted meaningfully toward performance-based structures, driven by both sophisticated investor expectations and a more mature understanding of how equity design shapes company culture over time. Why are RSAs making a comeback in pre-IPO equity design? Restricted Stock Awards grant actual shares — not options — subject to vesting and forfeiture. The employee owns the shares immediately, pays tax on the fair market value at grant (typically low in early-stage companies), and gets capital gains treatment on later appreciation. For employees joining at still-modest valuations, RSAs can yield meaningfully better after-tax outcomes than options granted at a higher price later. The 83(b) election, which must be filed within 30 days of grant, is critical to capturing these benefits. Restricted Stock Awards grant actual shares of company stock — not options — subject to vesting and forfeiture conditions. The employee owns the shares immediately upon grant, pays tax based on the fair market value at the time of grant (typically low in early-stage companies), and benefits from capital gains treatment on appreciation from that early point. For employees joining pre-IPO companies at valuations that are still relatively modest, RSAs can generate meaningfully better after-tax outcomes than options granted at a higher exercise price later. Gurpreet S. Bal notes that founders are increasingly offering RSAs to key early hires — particularly engineers and product leaders whose contributions are foundational — precisely because the tax economics favor the employee when the grant happens at a genuinely low valuation. The 83(b) election, which must be filed within 30 days of the grant, is critical to capturing these benefits. What are PSUs — and how are pre-IPO companies using them? Performance Stock Units are equity awards whose vesting depends on defined performance criteria rather than — or in addition to — the passage of time. In public companies they commonly vest on metrics like revenue growth, EBITDA, or relative total shareholder return. Pre-IPO, milestones look different: vesting upon a financing round above a set valuation, a product launch, a revenue target, or completion of an IPO or acquisition. The exercise of defining those milestones — what success actually looks like at this stage — is itself valuable for the leadership team. Performance Stock Units are equity awards whose vesting depends on the achievement of defined performance criteria rather than — or in addition to — the passage of time. In public companies, PSUs commonly vest based on metrics like revenue growth, EBITDA, or total shareholder return relative to a peer group. Pre-IPO, the milestone structure looks different: PSUs might vest upon completion of a financing round above a specified valuation, achievement of a product launch, attainment of a revenue target, or completion of an IPO or acquisition. Gurpreet S. Bal has structured PSU programs for pre-IPO companies where the performance condition was a defined set of technical or commercial milestones that the board and management agreed represented genuine company-building achievements. The exercise of defining those milestones — what does success actually look like at this stage? — is itself valuable for the leadership team. How do investors view performance-based equity in pre-IPO companies? Institutional investors and growth-stage venture funds increasingly want compensation structures that align executive incentives with shareholder value creation, and time-based vesting as the default for all equity is giving way to a more differentiated approach. In late-stage pre-IPO companies — those within three years of a potential liquidity event — investors increasingly expect the top executive team to hold meaningful performance-based equity. Tying executive vesting to the metrics that will drive IPO valuation creates direct alignment between management incentives and shareholder outcomes. Institutional investors and growth-stage venture funds have become more vocal in recent years about wanting compensation structures that align executive incentives with shareholder value creation. The era of time-based vesting as the default for all levels of equity — including for executives at Series C and later stage companies — is giving way to a more differentiated approach. Gurpreet S. Bal notes that in late-stage pre-IPO companies — those within three years of a potential liquidity event — institutional investors increasingly expect the top executive team to have meaningful performance-based equity exposure. This is partly a governance posture and partly a practical alignment mechanism: in a company that may go public within a few years, having executives whose equity vesting is tied to the metrics that will drive IPO valuation creates direct alignment between management incentives and shareholder outcomes. What are the practical design considerations for PSUs in private companies? The central challenge is that private company shares are illiquid: if a PSU vests on a milestone, the employee owns shares but cannot sell them, creating a tax event without a corresponding liquidity event. Design PSUs so that vesting occurs only upon or shortly before a liquidity event, or ensure the company has mechanisms — tender offers, secondary transactions — to provide liquidity to employees who need it. The best-designed pre-IPO PSU programs tie vesting to milestones associated with liquidity, or stage them to avoid large tax burdens without a path to covering them. The central challenge in pre-IPO PSU design is that private company shares are illiquid. If a PSU vests because a milestone is achieved, the employee owns shares — but cannot sell them. This creates a tax event without a corresponding liquidity event. Gurpreet S. Bal recommends that companies designing pre-IPO PSU programs think carefully about this mismatch from the start: either design the PSUs so that vesting occurs only upon or shortly before a liquidity event, or ensure that the company has mechanisms in place — tender offers, secondary transactions — that can provide liquidity to employees who need it. The most elegantly designed PSU programs in pre-IPO companies tie performance vesting to milestones that are either directly associated with liquidity (an IPO, an acquisition) or are staged in a way that doesn't create large tax burdens without a path to covering them. ← More on IPO Readiness Further reading: Equity Compensation Plan Design for Pre-IPO Companies — a comprehensive guide to stock options, RSUs, RSAs, and plan mechanics for technology companies preparing for a public offering. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## EGC Status and Proposed SEC Changes: A Less Abrupt Transition Out of JOBS Act Benefits Source: https://blegal.ai/knowledge/ipo-15-egc-jobs-act Author: Gurpreet S. Bal EGC Status and Proposed SEC Changes: A Less Abrupt Transition Out of JOBS Act Benefits By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The JOBS Act of 2012 created the Emerging Growth Company designation to make the IPO process more accessible to smaller, earlier-stage companies. It worked. EGC status reduced compliance costs, simplified the registration process, and allowed companies to phase in certain reporting requirements gradually. But the companies going public today are different from the ones the JOBS Act was designed for — and the cliff-edge loss of EGC status has become a meaningful operational challenge for companies that were never truly small when they went public. "The EGC transition has become jarring because the companies going public today are different from the ones the JOBS Act was designed for. The SEC is starting to recognize that," says Gurpreet S. Bal. "Nobody loves losing EGC status. The question is how hard that landing needs to be." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. In 2026, proposed laws and regulations are actively being discussed by the SEC that would allow EGC status to remain in place longer — and reduce the abruptness of the compliance transition companies have experienced over the last decade. What is EGC status and what does it actually provide? An Emerging Growth Company has less than $1.235 billion in annual gross revenues (the indexed threshold in recent years) and completed its IPO after December 8, 2011. EGC status provides confidential draft registration statement review, reduced executive compensation disclosure, an exemption from the SOX Section 404(b) auditor attestation on internal controls, the ability to use two years of audited financials in the S-1 instead of three, and phased adoption of new accounting standards. The Section 404(b) exemption is often the most financially significant. An Emerging Growth Company is a company with less than $1.235 billion in annual gross revenues (the threshold, as indexed, in recent years) that completed its IPO after December 8, 2011. EGC status provides several material benefits: the ability to submit draft registration statements confidentially for SEC review before public filing; reduced executive compensation disclosure requirements; an exemption from the auditor attestation requirement under Sarbanes-Oxley Section 404(b) for internal controls over financial reporting; the ability to use two years of audited financial statements in the S-1 rather than the standard three; and the ability to phase in new accounting standards rather than adopting them immediately. Gurpreet S. Bal notes that the Section 404(b) exemption is often the most financially significant — obtaining the external auditor's attestation on internal controls is expensive, time-consuming, and requires a level of internal compliance infrastructure that many companies are not ready for at the time of their IPO. When does EGC status expire — and why is the transition difficult? A company loses EGC status at the earliest of: the last day of the fiscal year following the fifth anniversary of the IPO; the date annual gross revenues exceed the threshold; issuing more than $1 billion in non-convertible debt in three years; or becoming a large accelerated filer (public float above $700 million). For many tech companies the large accelerated filer trigger arrives within two or three years as the stock appreciates. The compliance jump is significant — Section 404(b) compliance, expanded compensation disclosure, and immediate adoption of new accounting standards. A company loses EGC status at the earliest of: the last day of the fiscal year following the fifth anniversary of the IPO; the date annual gross revenues exceed the threshold; the date the company has issued more than $1 billion in non-convertible debt in the prior three-year period; or the date the company becomes a large accelerated filer (generally, when the public float exceeds $700 million). For many technology companies, the large accelerated filer trigger arrives well before the five-year anniversary — often within two or three years of the IPO, as the stock price appreciates and the public float grows. The compliance jump at that point is significant: Sarbanes-Oxley Section 404(b) compliance must be achieved, executive compensation disclosure requirements expand, and the company must adopt new accounting standards immediately rather than on a phased basis. Gurpreet S. Bal describes this as a genuine operational challenge, not merely a paperwork exercise. What changes are being proposed in 2026 to ease the EGC transition? As of 2026, the SEC and Congress are discussing several modifications to reduce the cliff-edge transition: extending the revenue threshold for EGC qualification, which has not been substantially updated since the original JOBS Act; creating a graduated phase-out of benefits rather than a single trigger-date elimination; raising the large accelerated filer float threshold to stop companies losing status in their second or third year; and giving more time to comply with Section 404(b) after losing EGC status. The push reflects recognition that the JOBS Act was calibrated for a different IPO market. The SEC and Congress have been actively discussing several modifications to the EGC framework that would reduce the cliff-edge character of the current transition. Proposals under active discussion as of 2026 include: extending the revenue threshold for EGC qualification, which has not been substantially updated since the original JOBS Act; creating a graduated phase-out of EGC benefits rather than a single trigger-date elimination; extending the large accelerated filer float threshold to reduce the frequency of companies losing EGC status in their second or third year post-IPO; and providing additional time for companies to comply with Section 404(b) requirements after losing EGC status. Gurpreet S. Bal notes that the push for these changes has come from a broad coalition of public company practitioners, investor groups, and the companies themselves — and represents a recognition that the JOBS Act's original design was calibrated for a different IPO market than the one that exists today. How should companies currently plan for the EGC transition regardless of regulatory changes? Begin planning well before the transition — ideally in the second year post-IPO, not the year status is lost. The Section 404(b) readiness assessment in particular takes time: building internal controls documentation, working with the external auditor on their attestation process, and often hiring or promoting a Chief Compliance Officer or Director of Internal Audit to lead it. Companies that wait until EGC status expires routinely underestimate the time required and face material weakness disclosures that earlier action could have avoided. Use the EGC window to build the infrastructure, not to avoid it. Regardless of whether the proposed changes advance, Gurpreet S. Bal recommends that companies begin planning for the EGC transition well before it occurs — ideally in the second year post-IPO, not the year the status is lost. The Section 404(b) readiness assessment, in particular, takes time: it requires building internal controls documentation, working with the external auditor to understand their attestation process, and typically hiring or promoting a Chief Compliance Officer or Director of Internal Audit who can lead the effort. Companies that wait until EGC status expires to begin 404(b) preparation routinely underestimate the time required and face material weakness disclosures that could have been avoided with earlier action. Gurpreet S. Bal's practical counsel: use the EGC window to build the compliance infrastructure you will need — not to avoid building it. ← More on IPO Readiness Further reading: Emerging Growth Company Status and JOBS Act Benefits — a detailed guide to EGC eligibility, available accommodations, and the strategic use of EGC status throughout the IPO process. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## IPO Readiness — Going Public Law Reference Source: https://blegal.ai/knowledge/ipo-readiness Author: Gurpreet S. Bal IPO Readiness Analytical reference by Gurpreet S. Bal, Silicon Valley Corporate Partner | blegal.ai IPO readiness is a multi-year legal preparation process that begins well before investment bankers are selected. This reference hub covers every major legal dimension of going public: board committee formation, governance cleanup, equity plan design, S-1 registration mechanics, underwriter selection, lockup structures, and post-IPO compliance obligations. The articles address both the technical requirements and the strategic decisions that determine whether a company can execute an IPO cleanly and maintain good governance as a public company. Articles in This Category Audit Committee Requirements for IPO Composition rules, financial expert requirements, Nasdaq and NYSE standards, and audit committee charter provisions for public companies. Compensation Committee Setup Pre-IPO Independence requirements under Rule 10C-1, compensation consultant engagement rules, and pre-IPO timing for committee formation. Governance Committee and Board Independence Nominating and governance committee requirements, independent director standards under exchange rules, and controlled company exceptions. RSUs vs Options at IPO Tax, dilution, and retention tradeoffs between RSUs and stock options as a company approaches — and completes — its IPO. Double-Trigger RSU Acceleration How double-trigger acceleration provisions work in RSU award agreements and why the design matters for employee retention post-IPO. Direct Listing vs Traditional IPO Structural, regulatory, and economic differences between a traditional underwritten IPO and a direct listing on a national exchange. Secondary Sales of Shares Pre-IPO How pre-IPO secondary transactions are structured, the Section 4(a)(1) and 4(a)(7) exemptions, and company ROFR and consent rights. Tax Issues at IPO for Founders and Employees AMT exposure on ISO exercises, Section 83(b) election timing, NSO withholding, and capital gains planning around an IPO liquidity event. Pre-IPO Governance Cleanup Charter amendments, board reconstitution, investor rights agreement termination, and agreements cleanup required before an IPO filing. Sarbanes-Oxley Compliance for New Public Companies Section 302, 404, and 906 obligations, management assessment requirements, and how EGCs phase into SOX compliance over time. IPO Lockup Agreements Standard 180-day lockup provisions, early release mechanics, market standoff agreement requirements, and what happens at lockup expiry. Selecting IPO Underwriters How to evaluate and select underwriting banks, manage the bake-off process, and negotiate underwriting agreement key provisions. S-1 Registration Statement Process S-1 confidential filing, SEC comment process, road show mechanics, pricing, and closing sequence from initial filing to trading. Equity Plan Design for IPO How to design an omnibus equity incentive plan that satisfies exchange listing requirements and institutional shareholder voting guidelines. Emerging Growth Company JOBS Act Benefits The EGC accommodations under the JOBS Act — confidential filing, reduced disclosure, extended phase-in periods — and their duration. Also on this topic: IPO Readiness — Personal Practice Hub on gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on public offerings, pre-IPO preparation, and public company governance. For more information, visit gurpreetbal.com . --- ## Legal Technology & AI in Law — Reference Source: https://blegal.ai/knowledge/legal-technology Author: Gurpreet S. Bal Legal Technology Analytical reference by Gurpreet S. Bal, Silicon Valley Corporate Partner | blegal.ai AI is changing legal practice faster than the professional responsibility rules governing it can evolve. This reference hub addresses the practical and regulatory dimensions of AI in legal work: how AI tools interact with attorney-client privilege and confidentiality obligations, where AI crosses into unauthorized practice of law, how AI is being deployed in litigation and negotiation, and where the trajectory of AI in high-stakes legal practice is heading. These articles are written from the perspective of a practitioner who advises AI companies and uses AI tools in day-to-day legal work. Articles in This Category AI Tools and Attorney-Client Privilege How sharing client information with AI tools affects confidentiality obligations, the risk of privilege waiver, and protective measures counsel should implement. Unauthorized Practice of Law and AI Where AI legal tools risk crossing into unauthorized practice of law and how bar regulators and courts are approaching the question. AI in Litigation Strategy How litigators are deploying AI for document review, deposition preparation, legal research, brief drafting, and case strategy analysis. Future of AI in Legal Practice Where AI is most likely to create durable change in legal work — and where human judgment, relationships, and accountability remain indispensable. AI Negotiation Advantage for Counsel How AI tools create preparation and information asymmetry in negotiation — and what it means for counsel that adopt versus those that do not. Also on this topic: Legal Technology — Personal Practice Hub on gurpreetbal.com Gurpreet S. Bal is a corporate partner advising AI companies on legal and regulatory issues and working at the intersection of emerging technology and legal practice. For more information, visit gurpreetbal.com . --- ## When Your Lawyer Uses AI, Your Confidential Information Has a New Audience Source: https://blegal.ai/knowledge/legaltech-01-confidentiality-privilege Author: Gurpreet S. Bal When Your Lawyer Uses AI, Your Confidential Information Has a New Audience By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet S. Bal has watched the legal industry adopt AI tools faster than it has adopted the policies to govern them. "Most lawyers using AI tools haven't asked where the data goes. That's the first question — and most of them haven't asked it." The information you share with your lawyer is among the most sensitive data you have. The question of where it goes next deserves a real answer. Bal advises companies and investors across hundreds of transactions and has thought carefully about how AI adoption in legal practice intersects with the duties lawyers owe their clients. How does using AI tools create a third-party disclosure problem for attorney-client privilege? Privilege and the duty of confidentiality under Model Rule 1.6 depend on your information staying between you and your lawyer. When a lawyer pastes sensitive material into a cloud-based AI platform, that data leaves the firm and travels to a third-party server, governed by terms of service most lawyers have not read carefully. The ABA's Formal Opinion 512 noted in 2023 that lawyers must take reasonable measures to prevent unauthorized access when using generative AI — a standard many current deployments do not meet. Attorney-client privilege and the duty of confidentiality under Model Rule 1.6 both rest on a simple premise: the information you share with your lawyer stays between you and your lawyer. Cloud-based AI tools break that premise in ways the profession has been slow to confront. When a lawyer pastes your merger agreement, your cap table, or your due diligence findings into a general-purpose AI platform, that data leaves the firm's environment and travels to a third-party server. Whether it stays there, how it is retained, whether it is used to train future models, and who at the AI vendor can access it are questions governed by a terms-of-service agreement that most lawyers have not read carefully — if at all. The ABA's Formal Opinion 512 acknowledged this risk in 2023, noting that lawyers must take reasonable measures to prevent unauthorized access when using generative AI. "Reasonable measures" is a standard that a surprising number of current deployments do not meet. How real is the privilege waiver risk when lawyers use AI? Voluntary disclosure to a third party not covered by the privilege can waive it, potentially for the entire subject matter. If opposing counsel discovers that privileged work product was processed through a cloud AI platform whose terms did not guarantee confidentiality, a waiver argument is available. The law here is still developing, but courts have historically not been sympathetic to parties who let sensitive materials pass through inadequately secured third-party systems — and inadvertence or not understanding the technology has not been a reliable defense. Privilege is fragile. Voluntary disclosure to a third party who is not covered by the privilege can waive it — potentially for the entire subject matter, depending on the jurisdiction and the circumstances. The legal framework around AI tool disclosure is still developing, but the risk vector is clear: if opposing counsel in litigation discovers that privileged work product was processed through a cloud AI platform whose terms did not guarantee confidentiality, a waiver argument is available. Courts have not yet uniformly addressed AI-specific waiver claims, but courts have historically not been sympathetic to parties who allowed sensitive materials to pass through inadequately secured third-party systems. The fact that the disclosure was inadvertent or that the lawyer did not understand the technology is not a defense that has served clients well. Why does enterprise API vs. consumer AI deployment matter for privilege? The relevant line is between consumer-grade tools, whose terms typically reserve broad rights over inputs, and enterprise API agreements with contractual confidentiality and data-isolation commitments. A firm with a zero-retention, no-training agreement — or that runs models on private infrastructure — is in materially different territory. Purpose-built legal AI platforms like Harvey and Legora were architected around privilege concerns, but the real problem is the vast middle ground: lawyers using tools that were not built with privilege in mind and whose terms have never been evaluated against professional responsibility obligations. Not all AI deployments are equal. The relevant line is between consumer-grade tools and enterprise API agreements with contractual confidentiality and data-isolation commitments. A lawyer using the free or standard tier of a general-purpose LLM is operating under terms that typically reserve broad rights over inputs. A law firm that has negotiated a zero-retention, no-training enterprise agreement — or that runs models on private infrastructure — is in materially different territory. Purpose-built legal AI platforms like Harvey and Legora have architected their products around privilege concerns from the start, with data segregation, audit logs, and terms designed to address Rule 1.6 obligations. That does not mean every deployment of those tools is safe, but it means the conversation is at least happening. The problem is the vast middle ground: lawyers using AI tools that were not built with privilege in mind and whose terms have not been evaluated against professional responsibility obligations. Can prompt history submitted to AI tools be discovered in litigation? Possibly. Depending on how an AI tool retains prompt data and whether that retention is within the firm's or the vendor's control, prompt logs may be discoverable as documents in a party's possession, custody, or control. A prompt containing candid analysis of case weaknesses or client facts could be a significant liability. Whether prompts qualify as protected attorney work product is genuinely unsettled, so the safe position is to treat prompt history as potentially discoverable and choose tools and configurations that minimize unnecessary retention. There is a dimension of this problem that lawyers consistently underestimate: the discoverability of prompt history. In litigation, a party may be required to produce documents and communications in their possession, custody, or control. Depending on how an AI tool retains prompt data — and whether that retention is within the firm's control or the vendor's — prompt logs may be discoverable. A prompt that contains a lawyer's candid analysis of case weaknesses, or client-provided facts framed in a particular way, could be a significant litigation liability. The question of whether prompts constitute attorney work product and are therefore protected is genuinely unsettled. Work product protection requires that the material was prepared in anticipation of litigation by or for an attorney — a standard that prompt logs may or may not meet depending on their content and context. Until courts provide clearer guidance, the safe position is to treat prompt history as potentially discoverable and to choose tools and configurations that minimize unnecessary retention. What should you ask your lawyer about how they use AI on your matter? Ask whether the firm uses general-purpose AI tools or purpose-built legal AI platforms, whether the terms of service have been reviewed by the firm's general counsel or ethics partner, whether a zero-retention or data-isolation agreement is in place, and whether the firm has a formal AI use policy addressing Rule 1.6. These are basic due-diligence questions. Any firm that cannot answer them clearly is not yet prepared to use AI on sensitive matters responsibly. Clients have every right to ask their lawyers which AI tools are used on their matters and what data governance policies apply. Specifically: Does the firm use general-purpose AI tools, or purpose-built legal AI platforms? Have the terms of service been reviewed by the firm's general counsel or ethics partner? Is there a zero-retention or data-isolation agreement in place? Has the firm issued a formal AI use policy that addresses Rule 1.6 obligations? These are not exotic questions. They are basic due diligence. Any firm that cannot answer them clearly is not yet prepared to use AI on sensitive matters responsibly. The technology is moving faster than bar association guidance. That gap is the client's problem until lawyers take it seriously. ← More on Legal Technology Further reading: When Your Lawyer Uses AI, Your Confidential Information Has a New Audience — A practitioner's analysis of the confidentiality, privilege, and discoverability risks created by AI tool adoption in legal practice. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Is Your AI Practicing Law Without a License? The Answer Is More Complicated Than You Think Source: https://blegal.ai/knowledge/legaltech-02-unauthorized-practice Author: Gurpreet S. Bal Is Your AI Practicing Law Without a License? The Answer Is More Complicated Than You Think By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet S. Bal has spent 16 years watching where legal judgment actually lives — and where it doesn't. His view is unambiguous: "If your lawyer tells you they use end-to-end agentic AI on your deal, find a different lawyer. The judgment is what you're paying for." The question of whether an AI system is practicing law is no longer theoretical. It is an active regulatory and ethical problem that the profession is failing to address at the speed the technology demands. Bal advises technology companies, investors, and acquirers on some of the most complex transactions in the market — and sees firsthand how AI is reshaping what legal work looks like, and where the lines should be drawn. Why does the UPL doctrine fail to address AI legal tools? UPL statutes exist in every U.S. state but almost none define "legal advice" with precision. Courts have distinguished permissible legal information from legal advice, with the line turning on whether someone applies legal principles to a particular person's specific facts and recommends a course of action. That line was built for humans and for document-assembly tools like LegalZoom that courts tolerated as providing forms, not advice. Large language models strain it because they produce tailored analysis applying legal principles to specific facts with a fluency hard to distinguish from licensed advice. Unauthorized practice of law (UPL) statutes exist in every U.S. state. They prohibit non-lawyers from providing legal advice — but almost none of them define "legal advice" with precision. Courts have generally distinguished between legal information (permissible for anyone to provide) and legal advice (reserved for licensed attorneys). The line, in practice, turns on whether the provider is applying legal principles to the specific facts of a particular person's situation and recommending a course of action. For decades, this line was applied to humans. LegalZoom and its competitors pushed the boundary by automating document assembly, and the courts largely tolerated it on the theory that the software was providing forms, not advice. That theory is now under significant pressure from large language models, which do not produce forms — they produce tailored analysis that applies legal principles to specific facts with a fluency that is genuinely difficult to distinguish from licensed advice. Why does the LegalZoom UPL precedent break down for AI tools? Document assembly services survived early UPL challenges partly because their outputs were templates — structured, predictable, and clearly bounded. An LLM answering "should I sign this non-compete?" is categorically different: it reasons about the specific agreement, jurisdiction, client circumstances, and case law to produce a recommendation, which often looks a lot like the practice of law. Several state bars have warned that AI-generated legal analysis provided directly to consumers without lawyer supervision may constitute UPL, and the frontier remains genuinely unsettled. The document assembly services that survived early UPL challenges did so partly because their outputs were templates — structured, predictable, and clearly bounded. An LLM answering the question "should I sign this non-compete?" is doing something categorically different. It is reasoning about the specific language of a specific agreement, the jurisdiction, the client's circumstances, and the applicable case law — and producing a recommendation. Whether that constitutes the practice of law depends on the jurisdiction and the framing, but the honest answer is: it often looks a lot like it. Bar associations are beginning to catch up. Several state bars have issued guidance warning that AI-generated legal analysis provided directly to consumers without lawyer supervision may constitute UPL. The companies building consumer legal AI products are navigating this carefully — but the frontier is genuinely unsettled, and users of these products often have no idea they are in legally ambiguous territory. How does agentic AI raise the UPL stakes considerably? Agentic systems do not merely answer questions — they take sequences of actions toward a goal. An agent tasked with "handling my contract dispute" or "closing my seed round" makes a series of legal judgments: what to file, when to respond, what terms to accept. That chain of autonomous actions is precisely what UPL doctrine targets. A human lawyer remains nominally in the loop in most deployments, but if the lawyer is not actually reviewing and exercising judgment over each consequential step, the supervision is a formality and the AI is making the calls. The UPL concern is most acute with agentic AI systems — tools that do not merely answer questions but take sequences of actions toward a goal. An AI agent tasked with "handling my contract dispute" or "closing my seed round" is not providing information. It is making a series of decisions: what to file, when to respond, what terms to accept, what leverage to apply. Each of those decisions is a legal judgment. The chain of autonomous actions is precisely what UPL doctrine targets, and it is exactly what the current generation of goal-directed legal AI agents is designed to perform. A human lawyer remains nominally in the loop in most current deployments, but "nominally" is doing real work in that sentence. If the lawyer is not actually reviewing and exercising judgment over each consequential step, the supervision is a formality — and the AI is making the calls. What is path risk in goal-based AI legal systems? When you instruct an AI agent to achieve an outcome, the agent selects the path, and the lawyer who sets the goal and approves the final product may never meaningfully supervise the intermediate steps. Those steps can include concessions in correspondence, representations about client authority, or procedural choices with substantive consequences. If a client is harmed by an unsupervised step, responsibility is genuinely difficult to assign — and this structural feature is why end-to-end agentic AI on active client matters is not, today, a responsible deployment. Goal-based agents present a distinctive risk that point-in-time tools do not: path risk. When you instruct an AI agent to achieve an outcome, it selects the path. The lawyer who sets the goal and approves the final product may never see — and may not have meaningfully supervised — the intermediate steps. Those steps can include concessions made in correspondence, representations about client authority, characterizations of the transaction, or procedural choices that have substantive consequences. If a client suffers harm from one of those unsupervised intermediate steps, the question of who is responsible is genuinely difficult. The lawyer may argue the AI acted outside its instructions. The client will argue the lawyer was responsible for the AI. Neither position is clean. This is not a hypothetical risk. It is a structural feature of how goal-directed agents work — and it is a reason why end-to-end agentic AI on active client matters is not, today, a responsible deployment. What does the UPL landscape mean for clients who use AI legal tools? Advice from a consumer legal AI product, however fluent, may not carry the accountability or protection of advice from a licensed attorney — there is no malpractice insurance, no bar discipline, and no fiduciary duty attached to an AI output. For low-stakes, high-volume tasks like understanding a lease or reviewing a standard NDA, convenience may win. For anything with meaningful stakes, the absence of an accountable human lawyer is a serious gap, and clients working with firms should ask whether a licensed attorney has reviewed every consequential output. Clients interacting directly with consumer legal AI products should understand that the advice they receive, however fluent and detailed, may not carry the accountability or protection of advice from a licensed attorney. There is no malpractice insurance, no bar discipline, and no fiduciary duty attached to an AI output. For low-stakes, high-volume legal tasks — understanding a lease, reviewing a standard NDA, checking a contractor agreement — the risk-benefit calculus may favor convenience. For anything with meaningful stakes, the absence of an accountable human lawyer is a serious gap. Clients working with law firms that use AI should ask whether a licensed attorney has reviewed and exercised judgment over every consequential output. If the answer is effectively no, that is the answer. ← More on Legal Technology Further reading: Is Your AI Practicing Law Without a License? The Answer Is More Complicated Than You Think — A practitioner's analysis of how UPL doctrine applies to LLMs and agentic legal AI, and what clients should demand from their lawyers. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## AI in the Courtroom: What Lawyers Can Use, What They Can't, and What Can Go Very Wrong Source: https://blegal.ai/knowledge/legaltech-03-ai-litigation Author: Gurpreet S. Bal AI in the Courtroom: What Lawyers Can Use, What They Can't, and What Can Go Very Wrong By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet S. Bal follows litigation closely — not because he is a litigator, but because his transactional clients end up in disputes, and the quality of legal representation in those disputes matters. His read on AI in litigation is blunt: "Mata v. Avianca should be required reading for every lawyer in practice today. It is not a story about technology failing. It is a story about a lawyer who did not do their job." The hallucination problem has not been solved. Courts are watching, and the consequences of getting it wrong are serious. Bal brings a transactional lawyer's eye to litigation AI risk — focused on outcomes, accountability, and what clients actually need to know. What does Mata v. Avianca teach about lawyer liability for AI-generated research? In 2023, a federal judge in the Southern District of New York sanctioned attorneys who submitted a brief citing six cases that did not exist, generated by ChatGPT and filed without verification against any legal database. The lesson is not that AI hallucinated — that is a known property of the technology — but that a lawyer submitted fabricated citations to a federal court because they trusted an AI tool to do a job requiring human verification. Model Rule 3.3 prohibits knowingly making false statements of law to a tribunal, and ignorance of the technology is not a defense. In 2023, a federal judge in the Southern District of New York sanctioned attorneys who submitted a brief containing citations to six cases that did not exist. The lawyers had used ChatGPT to research case law and submitted the AI's output without verifying the citations against any legal database. When opposing counsel pointed out the citations were fictitious, the lawyers asked ChatGPT to confirm they were real — and it did. The court imposed sanctions, ordered the lawyers to notify the judges falsely cited in the fabricated opinions, and issued a ruling that became a landmark in AI-related professional misconduct. The critical point is not that AI hallucinated. Large language models hallucinate. That is a known, documented property of the technology. The critical point is that a lawyer submitted fabricated citations to a federal court because they trusted an AI tool to do a job that required human verification. Model Rule 3.3 prohibits knowingly making false statements of law to a tribunal. Ignorance of the technology is not a defense. Why hasn't hallucination risk been solved even by purpose-built legal AI tools? Legal-specific tools using retrieval-augmented generation ground their outputs in a verified legal database rather than generating citations from training data, making them meaningfully better than general-purpose LLMs — but not hallucination-free. Any system that synthesizes information and produces natural language has some probability of error; the difference is order of magnitude, not kind. A lawyer using Harvey, Lexis AI, or Westlaw AI is in better shape, but the obligation to verify cited authority before submitting it to a tribunal is unchanged. The tool does not carry the bar card; the lawyer does. The legal tech industry's response to Mata was to build legal-specific AI tools with retrieval-augmented generation — systems that ground their outputs in a verified legal database rather than generating citations from training data. Those tools are meaningfully better than general-purpose LLMs for legal research. They are not hallucination-free. Any system that synthesizes information and produces natural language output has some probability of error. The difference is order of magnitude, not kind. A lawyer using Harvey, Lexis AI, or Westlaw AI for case research is in materially better shape than one using a general-purpose chatbot — but the professional obligation to verify cited authority before submitting it to a tribunal is unchanged. The tool does not carry the bar card. The lawyer does. Courts increasingly require attorneys to certify that AI-generated filings have been reviewed for accuracy. That certification is not a formality. It is a representation to the court. How is deepfake evidence challenging authentication in court? AI-generated audio, video, and images have become realistic enough that authentication standards developed for traditional media are straining. The Federal Rules of Evidence require a proponent to show evidence is what it purports to be, and courts have historically accepted contextual authentication — voice identification, metadata, corroborating circumstances. Deepfakes can satisfy all of those markers while being entirely fabricated. The framework is still developing and forensic detection tools are in an arms race with generation tools, so litigators must scrutinize digital media evidence and be prepared to challenge authentication on both sides. The other end of the courtroom AI problem is evidentiary rather than research-related. AI-generated audio, video, and images have become sufficiently realistic that authentication standards developed for traditional media are straining under the weight of the technology. The Federal Rules of Evidence require that evidence be authenticated — that the proponent demonstrate it is what it purports to be. For video or audio evidence, courts have historically accepted contextual authentication: this is a recording of X because Y identified the voice, because the metadata shows it was captured on Z device, because the circumstances corroborate it. AI-generated deepfakes can satisfy all of those contextual markers while being entirely fabricated. Several courts have grappled with deepfake evidence challenges. The framework is still developing, and forensic AI-detection tools are in an ongoing arms race with generation tools. Litigators need to treat digital media evidence with a level of scrutiny that was not necessary five years ago — and to be prepared to challenge authentication on both sides. What can lawyers actually use AI for — and what remains off-limits? Clearly appropriate, well-established uses include large-scale document review and privilege logging, first-pass research synthesis, deposition preparation, and contract analysis in commercial disputes — tasks where AI accelerates a human-supervised process. Clearly off-limits today are autonomous filing of court documents without attorney review, AI-generated content used as original evidence, and reliance on AI research without independent verification. The middle ground, such as AI-assisted brief drafting, requires careful human oversight. The safe principle: AI as the accelerant, lawyer as the author. The uses of AI in litigation that are clearly appropriate and already well-established include large-scale document review and privilege logging, first-pass research synthesis, deposition preparation (identifying prior statements, flagging inconsistencies in large document sets), and contract analysis in the context of commercial disputes. These are tasks where AI accelerates a human-supervised process and where errors are caught by the supervising attorney before they cause harm. The uses that are clearly not appropriate today include autonomous filing of court documents without attorney review, any use of AI-generated content as original evidence, and reliance on AI legal research without independent verification. The middle ground — AI drafting of briefs, AI-assisted motion practice, AI-generated expert report summaries — requires careful human oversight and is evolving rapidly. The safe principle: AI as the accelerant, lawyer as the author. The moment those roles reverse, you have a professional responsibility problem. How are courts writing AI disclosure rules in real time? Federal and state courts have begun requiring disclosure of AI use in filings, with several districts requiring lawyers to certify that AI-generated content has been reviewed and verified, and some requiring disclosure of which tools were used. These requirements are not uniform — they vary by court, judge, and case — but the trend toward mandatory AI disclosure is clear. The body of law is developing quickly and unevenly, and litigators who assume their existing practices are sufficient are taking a risk their clients are not well-positioned to absorb. Federal and state courts have begun requiring disclosure of AI use in filings. Several districts require that lawyers certify that AI-generated content has been reviewed and verified. Some courts have gone further, requiring disclosure of which tools were used. These disclosure requirements are not uniform — they vary by court, by judge, and by case — but the trend toward mandatory AI disclosure is clear. Lawyers who treat AI as a silent tool that requires no disclosure are increasingly on the wrong side of developing practice norms. Beyond disclosure, courts are thinking carefully about the evidentiary, procedural, and professional responsibility questions that AI raises. The body of law is developing quickly and unevenly. Litigators who are not tracking it — who assume their existing practices are sufficient — are taking a risk that their clients are not well-positioned to absorb. ← More on Legal Technology Further reading: AI in the Courtroom: What Lawyers Can Use, What They Can't, and What Can Go Very Wrong — A practitioner's analysis of hallucination risk, deepfake evidence, and the professional responsibility obligations that govern AI use in litigation. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The Future of AI in Law: What's Actually Coming, What Stays Human, and What to Ask Your Lawyer Source: https://blegal.ai/knowledge/legaltech-04-future-of-ai-law Author: Gurpreet S. Bal The Future of AI in Law: What's Actually Coming, What Stays Human, and What to Ask Your Lawyer By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet S. Bal has spent enough time in the market to be skeptical of both the doomsayers and the boosters. His take on AI in law is grounded rather than breathless: "Clients have every right to ask whether AI is reducing their bill. If the answer is no — if your lawyers are using tools that cut their time in half and billing you the same rate — that conversation is overdue." AI is transforming legal practice. It is doing so unevenly, and the clients best positioned to benefit are the ones who ask direct questions. Bal advises on AI company acquisitions, technology transactions, and the legal infrastructure that underlies some of the most complex deals in the market. He thinks about legal AI from both sides of the equation. What AI legal capabilities are actually real right now? The measurable transformation today is concentrated in due diligence and contract review. In M&A, AI-assisted diligence tools can process thousands of documents, extract defined terms, flag deviations from market standards, and surface issues that previously took dozens of associate hours. In contract management, AI review has made first-pass analysis of large agreement portfolios a matter of hours rather than weeks. These are genuine productivity gains — though whether they flow to clients or stay in the firm's margin is a separate, important conversation. The legal AI transformation that is happening today — not speculatively, but measurably — is concentrated in two areas: due diligence and contract review. In M&A transactions, AI-assisted diligence tools can process thousands of documents, extract defined terms, flag deviations from market standards, and surface issues that would previously have required dozens of associate hours. In contract management, AI review tools have made first-pass analysis of large commercial agreement portfolios a matter of hours rather than weeks. These are genuine productivity gains. They compress timelines, reduce the cost of volume work, and free senior lawyers to spend time on the judgment-intensive questions that actually matter. Law firms that have deployed these tools at scale are doing real diligence faster and more thoroughly than firms that have not. The question of whether that productivity gain flows to clients or stays in the firm's margin is a separate — and important — conversation. What autonomous AI legal agents are coming in the near term? The next wave is autonomous execution — AI that does not just analyze but acts. In transactional practice this looks like agents managing the mechanics of a closing: tracking conditions, circulating signature pages, updating data rooms, sending notices. In compliance, it looks like regulatory monitoring agents that scan for new rules, flag applicability, and draft response protocols. These are in early deployment at forward-leaning firms, but the governance frameworks lag the technology, and the accountability structure for when an agent misses a closing condition is still being designed largely without external regulatory guidance. The next wave of legal AI is autonomous execution — AI systems that do not just analyze but act. In transactional practice, this looks like AI agents that can manage the mechanics of a closing: tracking conditions, circulating signature pages, updating data rooms, sending notices. In compliance, it looks like regulatory monitoring agents that continuously scan for new rules, flag applicability to the client's business, and draft response protocols. These applications are not science fiction — they are in early deployment at forward-leaning firms and legal operations teams. The governance frameworks for these deployments are lagging behind the technology. Who is responsible when an autonomous agent misses a closing condition? When a compliance bot misclassifies a regulatory change? The accountability structure for AI-driven legal work is still being designed, largely by the firms and clients deploying these tools and largely without external regulatory guidance. How is AI commoditizing legal work and why isn't it evenly distributed? AI is accelerating the commoditization of routine work — standard NDA review, boilerplate employment agreements, form equity documents, routine regulatory filings — tasks it handles capably and that clients increasingly expect to be priced accordingly. That is a real economic disruption for associates who built careers on this work. What is not being commoditized is judgment on novel questions: today's tools excel at applying established patterns to new facts but cannot reason through a genuinely novel legal question, advise on high-stakes negotiation strategy, or navigate the relationship dynamics that determine whether a deal closes. AI is accelerating the commoditization of routine legal work. Standard NDA review, boilerplate employment agreements, form equity documents, routine regulatory filings — these are tasks that AI handles capably and that clients increasingly expect to be priced accordingly. The associates at large firms who built their early careers on this work are facing a market that values it less. That is a real economic disruption, and the profession is not being honest enough about it. What is not being commoditized — and what cannot be commoditized in any near-term version of this technology — is judgment on novel questions. The AI tools available today are extraordinarily good at applying established patterns to new facts. They are not capable of reasoning through a genuinely novel legal question, advising on strategy in a high-stakes negotiation, or navigating the relationship dynamics that determine whether a deal closes. The lawyers who will thrive in this market are the ones who are ruthlessly honest about which category their work falls into. What legal work will stay irreplaceably human even as AI advances? Three things stay human for the foreseeable future. First, fiduciary judgment: advising a client to walk away from a deal or disclose a problem they would rather ignore requires a lawyer accountable for the advice and able to hold a fiduciary duty — no AI is a fiduciary. Second, novel legal questions, where the answer requires human reasoning about uncertainty and accountability for being wrong. Third, relationship and trust: sophisticated clients retain the lawyers they trust, built through demonstrated judgment and shared experience. AI cannot earn trust; it can only produce outputs. Three things will remain the domain of human lawyers for the foreseeable future. First: fiduciary judgment. The decision to advise a client to walk away from a deal, to settle a case on unfavorable terms for strategic reasons, to disclose a problem that the client would prefer to ignore — these require a lawyer willing to be accountable for their advice and able to hold a fiduciary duty with legal and ethical force. No AI system is a fiduciary. Second: novel legal questions. When the law is genuinely unclear — when the right answer requires predicting how courts will respond to a new fact pattern, how regulators will exercise discretion, how a contract provision will be construed in circumstances the parties never contemplated — the answer requires human reasoning about uncertainty and human accountability for being wrong. Third: relationship and trust. Sophisticated clients retain the lawyers they trust. That trust is built through demonstrated judgment, through shared experience in difficult situations, through the confidence that your lawyer's interests are genuinely aligned with yours. AI cannot earn trust. It can only produce outputs. What should you ask your lawyer about how they use AI on your matter? Ask specifically how AI tools are affecting the cost and timeline of your matter: which tasks have been accelerated by AI, and how that is reflected in the fee. If AI is not being used, ask why; if it is being used but fees have not changed, ask for an explanation. The market is beginning to price AI productivity gains into flat fees, capped fees, and alternative fee arrangements, and clients who negotiate those structures capture the benefit. This is not a hostile question — it is a basic conversation sophisticated clients are already having. Clients should be asking their lawyers — specifically, not generally — how AI tools are affecting the cost and timeline of their matters. Ask: which tasks on my matter have been accelerated by AI? How is that reflected in the fee? If the answer is that AI is not being used, ask why. If the answer is that AI is being used but the fees have not changed, ask for an explanation. The legal market is beginning to price AI productivity gains into flat fees, capped fees, and alternative fee arrangements. Clients who negotiate those structures are capturing the benefit. Clients who accept hourly billing without asking these questions are subsidizing the firm's transition to a more efficient model without sharing in the upside. This is not a hostile question. It is a basic conversation that sophisticated clients are already having, and that every client should feel empowered to raise. ← More on Legal Technology Further reading: The Future of AI in Law: What's Actually Coming, What Stays Human, and What to Ask Your Lawyer — A practitioner's view of where AI transformation in legal practice is real, where it is overstated, and what clients should demand. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The AI Mirror: How Shared Legal Tools Create a Negotiating Advantage in M&A — If You Know How to Use Them Source: https://blegal.ai/knowledge/legaltech-05-ai-negotiation-advantage Author: Gurpreet S. Bal The AI Mirror: How Shared Legal Tools Create a Negotiating Advantage in M&A — If You Know How to Use Them By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet S. Bal has negotiated across the table from counsel on hundreds of M&A transactions. His view on the current AI moment in deal practice is pointed: "Announcing which AI platform your firm uses is the legal equivalent of publishing your playbook. The people reading it aren't your clients." The information asymmetry that used to separate sophisticated deal teams from less experienced ones is narrowing. How you use the tools — not which tools you have — is where the advantage now lives. Bal advises buyers, sellers, and investors across complex technology and private equity transactions and has watched AI reshape deal dynamics in real time. When both sides use the same AI tools, does anyone gain an advantage? Market consolidation around a few platforms like Harvey and Legora means sophisticated deal teams on both sides increasingly work with the same underlying technology, so a buyer's AI-assisted review is not doing anything seller's counsel cannot do in reverse. When only one side had AI, the advantage was speed and coverage; when both do, those become table stakes. The advantage shifts to the quality of prompting, the experience of the lawyers directing the analysis, and judgment. The tool democratizes pattern recognition — not the judgment to know which patterns matter in a specific deal. The market consolidation around a small number of legal AI platforms — Harvey, Legora, and a handful of others — means that sophisticated deal teams on both sides of a transaction are increasingly working with the same underlying technology. A buyer's counsel using Harvey to analyze the seller's disclosure schedules is not necessarily doing anything that seller's counsel cannot do in reverse. This symmetry changes the nature of the AI advantage. When only one side had AI-assisted contract review, the advantage was speed and coverage — more issues surfaced faster. When both sides have those capabilities, speed and coverage become table stakes. The advantage shifts to the quality of the prompting, the experience of the lawyers directing the analysis, and the judgment applied to what the AI surfaces. The tool democratizes access to pattern recognition. It does not democratize the judgment required to know which patterns matter in a specific deal. How can you use your own redline to anticipate the other side's AI analysis? If both sides use similar AI platforms trained on similar market-standard documents, a buyer's lawyer can run the seller's draft through their own AI review — not just to find buyer-side issues, but to identify the issues a seller-side review would flag, producing a rough map of the negotiating terrain before the redline arrives. This technique is most valuable against a less sophisticated counterparty relying on AI output without the judgment to prioritize it. Against an experienced counterparty also running AI, the predictive value narrows, but it still informs preparation. One of the more tactically interesting applications of shared AI tools in M&A practice is using them to predict opposing counsel's issues list before they send it. If both sides are using similar AI platforms with similar training on market-standard documents, a buyer's lawyer can run the seller's draft agreement through their own AI review — not just to identify buyer-side issues, but to identify the issues that a seller-side AI review would flag as well. The output is a rough map of the negotiating terrain before the redline arrives. This is not hypothetical. It is a natural consequence of AI tools trained on similar corpora of market-standard agreements. The deals where this technique is most valuable are the ones where the other side is less sophisticated — where they are relying on AI output without the human judgment to prioritize it. Against an experienced, well-resourced counterparty who is also running AI, the predictive value narrows, but the technique still informs preparation. Where does AI negotiation advantage hold and where does it break down? The advantage is real and durable in one context: when the counterparty uses AI tools without sufficient experience to evaluate and prioritize the output. A junior associate handed an AI-generated issues list may raise every flagged item, including low-stakes ones experienced lawyers would trade away — and the pattern of issues raised signals the other side's experience level. The advantage breaks down when both sides have experienced deal lawyers directing the AI; there, the remaining advantage is entirely in human judgment about what the client actually needs versus what the AI flagged. The AI negotiation advantage is real and durable in one specific context: when the counterparty is using AI tools without sufficient experience to evaluate and prioritize the output. AI contract review tools generate issues lists. A junior associate at a small firm, given an AI-generated issues list and insufficient deal experience, may raise every flagged issue — including low-stakes items that experienced deal lawyers would trade away without discussion. Knowing this, an experienced counterparty can use the pattern of issues raised as a signal about the other side's experience level and adjust their negotiating posture accordingly. The advantage breaks down when both sides have experienced deal lawyers directing the AI. At that level, the AI compresses time and improves coverage for both parties equally. The remaining advantage is entirely in the quality of human judgment — who has done more transactions of this type, who knows the market better, who has a clearer sense of what their client actually needs versus what the AI flagged as a deviation from form. What is the announcement mistake in AI-assisted negotiations? Firms have developed a habit of publicly announcing their AI platform partnerships through press releases, case studies, and partner social media posts. In adversarial contexts this is a mistake: if opposing counsel knows your firm uses a given tool on deal negotiations, they know roughly what your AI-assisted issues list looks like and what it is trained to flag. They can run the same tool on their own draft to see your likely output, craft their initial draft to minimize what it flags, and train prompts to work around it. None of this requires espionage — just reading your firm's press releases. Law firms and legal operations teams have developed a habit — driven partly by marketing, partly by client demand for transparency — of publicly announcing their AI platform partnerships. Press releases naming which AI tools a firm has licensed, case studies about their AI deployment, social media posts from partners about the tools they use. This is a mistake with real consequences in adversarial contexts. If opposing counsel knows your firm has licensed Harvey and is using it on deal negotiations, they know roughly what your AI-assisted issues list looks like, how it is structured, and what it is trained to flag. They can run the same tool on their own draft and see your likely output before you send it. They can craft their initial draft to minimize the surface area the tool will flag. They can train their own prompts to work around the patterns your tool emphasizes. None of this requires industrial espionage. It requires reading your firm's press releases. What is the risk of goal-based AI agents in negotiations that no one is discussing? A goal-based negotiation agent tasked with "negotiate the best possible indemnification cap" optimizes toward that goal through a sequence of judgments — what to concede first, what to hold, when to trade — that affect the overall deal, not just the provision at issue. A concession the agent makes in one provision to preserve position in another may not be the trade-off a human lawyer would have made or what the client wants, and the lawyer who approved the final outcome may never have seen it. Until robust supervision frameworks exist, the responsible position is to keep AI in analysis and preparation and keep the human in the room for the actual negotiation. The next evolution in legal AI — goal-based negotiation agents — introduces a risk that the market has not adequately confronted. An AI agent tasked with "negotiate the best possible indemnification cap" will optimize toward that goal through a sequence of decisions: what to concede first, what to hold, when to trade. Those intermediate decisions are judgments. They affect the overall deal, not just the provision being negotiated. A concession made by an AI agent in one provision to preserve position in another may not be the trade-off a human lawyer would have made — and may not be what the client actually wants. The lawyer who deployed the agent and approved the final outcome may never have seen the intermediate concessions. This is not a theoretical risk. It is the structural consequence of deploying goal-directed AI in adversarial contexts. Until there are robust frameworks for supervising agentic negotiation AI — which there are not yet — the responsible position is to keep AI in the analysis and preparation role and keep the human in the room for the actual negotiation. ← More on Legal Technology Further reading: The AI Mirror: How Shared Legal Tools Create a Negotiating Advantage in M&A — If You Know How to Use Them — A practitioner's analysis of AI symmetry in deal negotiations, the announcement mistake, and the risks of goal-based negotiation agents. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## SaaS Contracts: The Clauses That Will Cost You After You've Already Signed Source: https://blegal.ai/knowledge/lic-01-saas-licensing Author: Gurpreet S. Bal SaaS Contracts: The Clauses That Will Cost You After You've Already Signed By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Most enterprise SaaS agreements are drafted by vendor counsel, optimized for the vendor, and signed by customers who don't realize the imbalance until something goes wrong. Gurpreet S. Bal has reviewed hundreds of these agreements in the context of M&A diligence and corporate transactions, and the pattern is consistent. "The standard SaaS contract is essentially a vendor bill of rights dressed up as a mutual agreement — customers need to know which provisions to push back on before they sign, not after," he says. Bal advises technology companies and acquirers on commercial contract risk, and technology licensing terms frequently surface as deal-limiting issues in due diligence. What's the difference between termination for convenience and termination for cause in SaaS? Many SaaS agreements give the vendor a unilateral right to terminate for convenience while limiting the customer to termination only for enumerated causes — an asymmetry that can lock a customer into an agreement even when the product degrades or pricing rises. The fix is to negotiate a matching termination-for-convenience right, or at minimum a right to exit for material degradation in service quality. Watch auto-renewal clauses too, which often renew at higher rates unless notice is given 90 or 180 days in advance. Many SaaS agreements grant the vendor a unilateral termination right — termination for convenience — while restricting the customer's exit rights to specific enumerated causes. That asymmetry has real consequences. If the vendor's product degrades, if pricing doubles at renewal, or if the company pivots away from the tool, the customer may be locked into an agreement it can't exit without triggering liability. The critical language to negotiate: ensure the customer gets a matching termination-for-convenience right, or at minimum a right to terminate for material degradation in service quality. Uncapped auto-renewal clauses compound the problem — many enterprise agreements renew automatically at higher rates unless notice is given 90 or 180 days in advance, a deadline that routinely slips past procurement teams. Who owns the data and what portability rights exist when a SaaS contract ends? Better SaaS agreements include an explicit export window — typically 30 to 90 days after termination — during which the customer can retrieve its data in a machine-readable format. Many standard agreements provide no such window, and some expressly disclaim any obligation to retain data past termination, which is a real business continuity risk. Negotiate the export format, the duration of the window, deletion confirmation, and what the vendor may do with aggregated data derived from your usage. What happens to your data when the relationship ends? This is the question Gurpreet S. Bal finds most companies haven't thought through at signing. The better agreements include an explicit export window — typically 30 to 90 days post-termination — during which the customer can retrieve data in a machine-readable format. Many standard agreements provide no such window, and some expressly disclaim any obligation to retain data past the termination date. For companies where the SaaS platform holds customer records, transaction histories, or trained model outputs, the absence of a portability clause isn't a minor gap — it's a business continuity risk. Negotiate: the format of export, the duration of the export window, deletion confirmation, and what the vendor can do with aggregated data derived from your usage after you've left. Why do SLA credits often fail to actually compensate for downtime? Uptime SLAs function more as pricing adjustments than genuine remedies. A typical 99.9% SLA allows roughly 8.7 hours of downtime a year, while credits usually cap compensation at 10% to 30% of one month's fees — a fraction of what a critical outage can actually cost. Because SLA credits are almost always the exclusive remedy and the liability cap forecloses broader claims, push for penalties tied to severity and a termination right when underperformance becomes chronic. Uptime SLAs are often marketed as vendor accountability but function more as pricing adjustments than genuine remedies. A typical 99.9% uptime SLA sounds strong — it allows roughly 8.7 hours of downtime annually. But the credit structure usually caps compensation at 10% to 30% of monthly fees for a given month of underperformance. If that month happened to involve a critical system outage that cost your business real revenue, a service credit worth a fraction of one month's subscription fee doesn't come close to covering it. The structural problem is that SLA credits are almost always the exclusive remedy for availability failures, and the limitation of liability clause (discussed below) will foreclose any broader damages claim. Push for: financial penalties tied to severity, not just monthly credits, and ensure that chronic underperformance triggers a termination right rather than just accumulating credits you may never use. How does a SaaS limitation of liability clause cap your remedies? The standard clause caps total vendor liability at fees paid in the prior 12 months — often $50,000 to $200,000 for a mid-market contract — while excluding consequential, indirect, and lost-profits damages entirely. For a vendor holding sensitive data or critical infrastructure, that cap bears little relation to actual risk. Well-negotiated agreements carve out the cap for data breaches and privacy violations, IP indemnification, willful misconduct, and death or personal injury. The limitation of liability clause is where SaaS agreements do the most damage. The standard formulation caps total vendor liability at fees paid in the preceding 12 months — often $50,000 to $200,000 for a mid-market contract — while excluding consequential, indirect, and lost profits damages entirely. For a vendor processing financial transactions, holding sensitive customer data, or providing infrastructure critical to a customer's operations, that cap is disconnected from actual risk exposure. Well-negotiated agreements carve out the liability cap for: data breaches and privacy violations, IP indemnification obligations, willful misconduct, and death or personal injury. Without those carve-outs, the vendor's financial exposure for a catastrophic failure is limited to a figure that may represent a rounding error on the actual harm. Who owns IP created in SaaS customizations? Many SaaS vendors assign to themselves any improvements, modifications, or configurations developed during the relationship — even customizations the customer paid professional-services fees to build. The practical effect is that a company may have no ownership rights to integrations or workflows it funded, an issue that becomes acute in M&A diligence. Negotiate a clear assignment of custom work product, or at minimum a perpetual, irrevocable license to use, modify, and distribute the configurations you paid to build. Many SaaS vendors include provisions that assign to the vendor any improvements, modifications, or configurations developed during the customer relationship — even when the customer paid for professional services to build those customizations. The rationale is product development: vendors argue that custom features benefit the broader user base. The practical effect is that a company that spent six figures building an integration or workflow automation may have no ownership rights to what it funded. The issue becomes acute in M&A. Acquirers frequently discover during diligence that software the target company treats as proprietary is actually owned or jointly owned by a SaaS vendor under a provision no one read carefully three years earlier. Negotiate a clear assignment of custom work product, or at minimum a perpetual irrevocable license to use, modify, and distribute configurations the customer paid to build. ← More on Licensing & Contracts Further reading: SaaS Contracts: The Clauses That Will Cost You After You've Already Signed — Deep analysis of SaaS commercial terms, negotiation leverage points, and how enterprise software agreements read differently when your company is the acquisition target. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Fintech Licensing: The Regulatory Maze Nobody Explains Until You're Already Inside It Source: https://blegal.ai/knowledge/lic-02-fintech-licensing Author: Gurpreet S. Bal Fintech Licensing: The Regulatory Maze Nobody Explains Until You're Already Inside It By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Fintech founders are exceptionally good at building products and exceptionally unprepared for the licensing reality underneath them. Gurpreet S. Bal has advised on fintech M&A transactions where the regulatory stack — licenses the company needed but didn't hold, or held through intermediaries whose agreements could be terminated — became the central deal issue. "Most fintech founders dramatically underestimate how much of their business model rests on licenses they don't own, issued to banks they don't control," he says. Bal's practice spans fintech transactions across payments, lending, banking-as-a-service, and open banking infrastructure, giving him a practitioner's view of where regulatory exposure concentrates. What state-by-state money transmission licenses does a fintech startup need? There is no federal money transmission license — instead there are 50 state regimes, each with its own requirements, net worth minimums, surety bonds, and definitions of what counts as money transmission. A company moving money nationwide needs licenses in most states, and even the threshold question of whether an activity qualifies is not always obvious. The NMLS streamlines some administration, but the substantive requirements remain fragmented, and building a full stack takes 12 to 24 months and meaningful capital, which is why many early-stage fintechs operate under a sponsor bank's license. The United States does not have a federal money transmission license. What it has is 50 state regimes, each with its own application requirements, net worth minimums, surety bond obligations, examination cycles, and definitions of what constitutes money transmission. A company moving money in all 50 states needs licenses in most of them — and the threshold question of whether your activity constitutes money transmission is not always obvious. Stored value, payment facilitation, payroll disbursement, and earned wage access have each been analyzed differently across state regulators. The Nationwide Multistate Licensing System (NMLS) has streamlined some of the administrative process, but the substantive requirements remain fragmented. The practical consequence: obtaining a full state licensing stack takes 12 to 24 months and meaningful capital, which is why so many early-stage fintechs operate under a sponsor bank's license rather than their own. What are the risks of BaaS sponsor bank dependencies for fintechs? Banking-as-a-service lets fintechs offer insured accounts, issue cards, and process ACH under a chartered bank's regulatory umbrella, but it creates a dependency many founders underappreciate. Program agreements are typically terminable on 90 to 180 days' notice, and because the bank bears regulatory responsibility for the fintech's compliance, examiner-found deficiencies often lead the bank to terminate first and ask questions later. Program agreement structure, exit terms, and access to backup banking relationships are due diligence essentials in any fintech deal. Banking-as-a-service partnerships allow fintechs to offer FDIC-insured accounts, issue debit cards, and process ACH transactions by operating under a chartered bank's regulatory umbrella. It's a rational structure for early-stage companies, but it creates a dependency that many founders don't fully appreciate until the relationship is stressed. The sponsor bank's program agreements are terminable — typically on 90 to 180 days' notice — and the bank bears regulatory responsibility for the fintech's compliance. When the OCC, FDIC, or state regulators examine the bank and find deficiencies in the fintech's compliance program, the bank terminates first and asks questions later. Gurpreet S. Bal has seen multiple transactions complicated by sponsor bank agreements where the bank had unilateral exit rights with limited cure periods, making the fintech's payment processing infrastructure essentially fragile by contract. Program agreement structure, exit terms, and access to backup banking relationships are due diligence essentials in any fintech deal. How do payment network rules operate as de facto licensing requirements? Visa and Mastercard network rules are not laws — they are contractual frameworks enforced through the acquiring bank relationship — but their practical effect mirrors a licensing regime. They define who can become a payment facilitator, what compliance obligations attach, what data can be stored and for how long (PCI DSS), and how transaction data may be used. Violations can bring fines through the acquirer, program suspension, or outright termination from the network, and because the rules change frequently and without public notice, companies without dedicated compliance resources routinely fall out of compliance unknowingly. Visa and Mastercard network rules are not laws. They are contractual frameworks enforced through the acquiring bank relationship — but their practical effect is equivalent to a licensing regime. The networks define who can become a payment facilitator, what compliance obligations attach to that status, what data can be stored and for how long (PCI DSS), and what uses of transaction data are permissible. Violating network rules results in fines assessed through the acquirer, potentially program suspension, and in serious cases termination from the network entirely — which is existential for most payments businesses. The rules change frequently and without public notice. Companies building on top of payment networks without dedicated compliance resources routinely discover they are out of compliance with rules they didn't know had been updated. What CFPB authority applies to licensed fintechs? The CFPB has supervisory authority over nonbank financial companies that pose risk to consumers — broad enough to capture most consumer-facing fintechs at scale — including examination authority and public findings. Enforcement actions have brought civil money penalties in the tens of millions over disclosures, fee transparency, and error resolution. The Bureau's Larger Participant rules extend federal oversight once a company crosses volume thresholds in defined markets, so that growth is a regulatory event with compliance cost implications that should be modeled, not just a business milestone. The Consumer Financial Protection Bureau has supervisory authority over nonbank financial companies that pose risk to consumers — a category broad enough to capture most consumer-facing fintechs at scale. CFPB supervision means examination authority: the bureau can show up, review your compliance program, and issue findings that become public. Enforcement actions have included civil money penalties in the tens of millions of dollars for practices around disclosures, fee transparency, and error resolution. The CFPB's Larger Participant rules extend federal oversight to companies in defined markets — prepaid accounts, student loan servicing, international money transfer — once they cross certain volume thresholds. Growth that takes a fintech past a Larger Participant threshold is a regulatory event, not just a business milestone, and it has compliance cost implications that need to be modeled. What does Section 1033 require for open banking compliance? The CFPB's Section 1033 rule, finalized in 2024, gives consumers the right to access and share their financial data with third parties through standardized interfaces — creating both opportunity and obligation for fintechs. Aggregators and third-party apps gain formal access rights to bank-held data that their models often relied on through informal or screen-scraping arrangements, while fintechs holding consumer financial data must build compliant data-sharing interfaces and honor revocation requests. The framework also carries liability implications for unauthorized access and data misuse. The CFPB's Section 1033 rule, finalized in 2024, gives consumers the right to access and share their financial data with third parties through standardized interfaces. For fintechs, this creates both opportunity and obligation. Data aggregators and third-party apps gain access rights to bank-held consumer data — the access right fintech business models were often built around in informal or screen-scraping arrangements. At the same time, fintechs that hold consumer financial data must build compliant data-sharing interfaces and honor revocation requests. The open banking framework introduces a structured API ecosystem with liability implications for unauthorized access and data misuse. Companies in the data aggregation space — account aggregators, personal finance tools, credit underwriting platforms — need to understand both the access rights they gain and the compliance obligations they assume under this framework. ← More on Licensing & Contracts Further reading: Fintech Licensing: The Regulatory Maze Nobody Explains Until You're Already Inside It — Covers the full regulatory stack for fintech companies, from money transmission licensing through BaaS dependencies, payment network obligations, and the emerging open banking framework. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Semiconductor IP Licensing: Why Your Design Is Never Entirely Yours Source: https://blegal.ai/knowledge/lic-03-semiconductor-licensing Author: Gurpreet S. Bal Semiconductor IP Licensing: Why Your Design Is Never Entirely Yours By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner There is no semiconductor design that exists in isolation. Every chip shipped by a fabless company sits on a foundation of licensed IP — processor cores, interface PHYs, memory controllers, standard cell libraries — that the team didn't write and may not fully understand. Gurpreet S. Bal has advised on semiconductor transactions where IP licensing structure was the most complex element of diligence. "Every chip design team is essentially building on top of licensed IP they didn't create, and the restrictions in those licenses travel with the design in ways the engineering team often doesn't know about," he says. Bal's semiconductor practice spans M&A transactions, licensing disputes, and export control analysis for chip companies from early-stage to late-stage, including acquirers evaluating semiconductor assets. What's the difference between hard core and soft core IP licensing in semiconductors? Soft cores are delivered as synthesizable RTL the licensee can modify and target to any process node, while hard cores are pre-characterized, layout-complete implementations optimized for a specific foundry and process. Hard core licenses tend to be more restrictive — tied to a foundry, often non-transferable, sometimes carrying per-unit royalties — whereas soft cores are more portable but may restrict modification, sublicensing, and redistribution. In M&A, the key question is whether the license survives change of control, and for many semiconductor IP licenses it does not without the licensor's written consent. Semiconductor IP comes in two primary forms: soft cores (delivered as synthesizable RTL that the licensee can modify and target to any process node) and hard cores (pre-characterized, layout-complete implementations optimized for a specific foundry and process). The distinction matters enormously for licensing terms. Hard core licenses are typically more restrictive — tied to a specific foundry relationship, often non-transferable, and sometimes subject to per-unit royalties that the original licensee must flow through to any transferee. Soft core licenses are more portable but may restrict modification, sublicensing, and redistribution. Arm's architecture licenses, for instance, allow licensees to implement custom microarchitectures, but those implementations remain subject to Arm's compliance requirements and the license terminates if certain conditions aren't met. In an M&A context, the question is always whether the license survives change of control — and for many semiconductor IP licenses, it does not without the licensor's written consent. What audit risk do EDA tool licenses create for semiconductor companies? EDA tools from Synopsys, Cadence, and Siemens EDA are licensed per seat, server, feature module, and sometimes per design, and license audits are a recurring industry event. Vendors maintain server-side telemetry and contractual audit rights covering usage logs going back years, so a shortfall — too many seats, out-of-scope features, uncovered servers — can mean back payments, penalties, or even termination. The risk intensifies in high-growth teams where usage outruns procurement, so companies preparing for an IPO or M&A should run an internal compliance review before the process begins. Electronic design automation tools — Synopsys, Cadence, Siemens EDA — are licensed per seat, per server, per feature module, and sometimes per design. License audits are a real and recurring event in the semiconductor industry. EDA vendors maintain server-side telemetry and reserve contractual audit rights that allow them to review usage logs going back multiple years. The consequence of a license shortfall — more seats used than licensed, features accessed outside the licensed scope, use of tools on servers not covered by the agreement — can be significant: back payments, compliance penalties, and in some cases license termination. The audit risk intensifies in high-growth environments where design teams expand rapidly and tool usage outruns procurement. Companies preparing for an IPO or M&A transaction should conduct an internal EDA license compliance review before those processes begin, not after a buyer or auditor raises the question. How do PDK restrictions create foundry lock-in for chip designers? Process design kits are foundry-proprietary and licensed under terms restricting how design data can be used, stored, shared, and transferred — and they typically prohibit using one foundry's PDK to design chips for another. That creates genuine IP exposure if design data developed under one PDK is moved to another context. In M&A, a target's PDK licenses must be reviewed to see whether acquired design data can be used in the acquirer's foundry relationships, and because foundry relationships are frequently non-assignable, a change of control may require renegotiating manufacturing from scratch. Process design kits are foundry-proprietary and licensed under terms that restrict how the design data can be used, stored, shared, and transferred. TSMC, Samsung, GlobalFoundries, and Intel Foundry each have their own PDK license agreements, and those agreements typically prohibit using the PDK to design chips for any other foundry. This isn't just a competitive restriction — it creates genuine IP exposure if design data developed under one foundry's PDK is transferred to another context. In M&A transactions involving semiconductor IP, the target's PDK licenses must be reviewed to determine whether the acquired design data can be used in the acquirer's existing foundry relationships, or whether new PDK licenses are required. Foundry relationships are also frequently non-assignable, meaning a change of control may require renegotiating the manufacturing relationship from scratch. How do ITAR and EAR export controls apply to semiconductor IP? Semiconductor technology is a priority category under both ITAR and the EAR, and controlled technical data — design files, schematics, test results, fabrication data for controlled nodes — cannot be transferred to foreign nationals, companies, or destinations without a license or exception. The "deemed export" rule treats sharing controlled data with a non-U.S. person inside the U.S. as an export to that person's country, which matters for international engineering teams. In deals with foreign acquirers or investors, CFIUS review of semiconductor IP transfers is essentially mandatory at advanced nodes, and export classification of the portfolio is a threshold diligence task. Semiconductor technology is a priority category under both the International Traffic in Arms Regulations (ITAR) and the Export Administration Regulations (EAR). Technical data controlled under these regimes — which can include design files, schematics, test results, and fabrication data for controlled technology nodes — cannot be transferred to foreign nationals, foreign companies, or foreign destinations without an appropriate license or license exception. The "deemed export" rule is particularly consequential: sharing controlled technical data with a non-U.S. person in the United States is treated as an export to that person's country of nationality. For semiconductor companies with international engineering teams, this creates compliance obligations around who can access what design data. In transactions involving foreign acquirers or investors, CFIUS review of semiconductor IP transfers has become essentially mandatory at advanced process nodes, and export control classification of the IP portfolio is a threshold diligence task. What FRAND licensing obligations apply in semiconductor standards? Standard-essential patents covering wireless standards like 5G, Wi-Fi, and Bluetooth must be licensed on fair, reasonable, and non-discriminatory (FRAND) terms under commitments made to standards bodies such as ETSI, IEEE, and ITU. For chipmakers, that means negotiating with large SEP holders — some of them direct competitors — and FRAND rates are set bilaterally and, in disputes, litigated across multiple jurisdictions at once. Patent pools like Avanci aggregate licenses into a single per-unit royalty, but participation is voluntary and some major holders stay outside, so the royalty stack on connected devices needs to be modeled before production commitments. Standard-essential patents (SEPs) covering wireless connectivity standards — 5G, Wi-Fi, Bluetooth — must be licensed on fair, reasonable, and non-discriminatory (FRAND) terms by commitments made to standards development organizations like ETSI, IEEE, and ITU. For companies shipping chips that implement these standards, this means navigating licensing negotiations with large SEP holders, some of whom are also direct competitors. FRAND rates are negotiated bilaterally and, when disputes arise, litigated — often in multiple jurisdictions simultaneously. Patent pools like Avanci attempt to simplify the process by aggregating licenses from multiple SEP holders into a single per-unit royalty, but pool participation is voluntary and some major holders remain outside these structures. Chips targeted at connected devices carry a royalty stack that needs to be modeled before production commitments are made. ← More on Licensing & Contracts Further reading: Semiconductor IP Licensing: Why Your Design Is Never Entirely Yours — Covers the full IP licensing architecture underlying chip design, from core IP to EDA tool compliance, PDK restrictions, export controls, and SEP royalty obligations. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## AI Licensing: Who Owns the Model, the Data, and the Output Is Still Being Litigated Source: https://blegal.ai/knowledge/lic-04-ai-licensing Author: Gurpreet S. Bal AI Licensing: Who Owns the Model, the Data, and the Output Is Still Being Litigated By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The legal framework for AI is being written in real time — in courtrooms, in Brussels, and in the terms-of-service updates that foundation model providers push out with little fanfare. Gurpreet S. Bal advises AI companies and their investors on commercial and M&A transactions where the ownership questions around models, training data, and generated output have no settled answers. "AI licensing is the fastest-moving area of commercial law right now — the contracts companies are signing today will be interpreted under case law that doesn't exist yet," he says. Bal has advised on AI transactions spanning foundation model licensing, enterprise AI deployment agreements, and acquisitions where the IP stack of the target included both proprietary models and open source components. How does copyright law apply to AI training data and is fair use a defense? Whether training a model on copyrighted content is infringement is being litigated in multiple simultaneous cases brought by publishers, authors, and code repositories. The fair use defense developers rely on has support from prior transformative-use cases but also real uncertainty given the scale of copying and the commercial nature of the products. Companies building on foundation models should focus on what the provider represents and warrants about its training data and whether meaningful indemnification backs it; companies training their own models should check that their data licenses, many of which predate AI training, actually authorize that use. Every large language model was trained on data scraped, licensed, or otherwise obtained from the internet and proprietary sources. The central legal question — whether training a model on copyrighted content constitutes infringement — is being litigated in multiple simultaneous cases involving publishers, authors, and code repositories. The fair use defense that foundation model developers rely on has significant support from prior transformative-use cases, but also significant uncertainty given the scale of copying and the commercial nature of the resulting products. For companies building on top of foundation models, the immediate practical concern is what representations and warranties the model provider makes about its training data, and whether those representations are backed by meaningful indemnification. For companies training their own models on proprietary datasets or licensed data, the scope of the data license needs to be reviewed carefully — many content licenses predate AI training as a use case and don't expressly authorize it. What's the key difference between open source and commercial AI model licenses? "Open source" is not self-defining for AI models — Meta's Llama, Mistral's releases, and Stability AI's offerings each carry different restrictions on commercial use, fine-tuning, redistribution, and derivative models. Llama's community license, for instance, restricts use above certain monthly-active-user thresholds and bars using its outputs to train competing models; these are custom commercial licenses with open source aesthetics. An enterprise should analyze what commercial uses are permitted, what attribution is required, what happens if a threshold is crossed, and whether fine-tuning creates a derivative work triggering further obligations. The term "open source" applied to AI models is not self-defining. Meta's Llama models, Mistral's releases, and Stability AI's offerings are each licensed under different terms that impose different restrictions on commercial use, fine-tuning, redistribution, and derivative model creation. Llama's community license, for instance, restricts use by companies above certain monthly active user thresholds and prohibits using Llama outputs to train competing models. These are not traditional open source terms — they are custom commercial licenses with open source aesthetics. The relevant analysis for an enterprise deploying an open source model involves: what commercial uses are permitted, what attribution is required, what happens if a covered threshold is crossed, and whether fine-tuning creates a derivative work that triggers additional obligations. Getting this wrong has consequences both for IP ownership and for the representations made to counterparties about the freedom to use the resulting technology. Who owns the output generated by an AI model? U.S. copyright law requires human authorship, and the Copyright Office has stated — with courts beginning to affirm — that AI-generated output is not copyrightable absent sufficient human creative expression. So content generated entirely by an AI system may not be protectable at all, a foundational IP risk for companies whose product or asset library is AI-generated. Meaningful human curation, selection, or arrangement can shift the analysis, but the line is unsettled, and contractual ownership provisions cannot create copyright protection that the law does not confer. Copyright law in the United States requires human authorship. The Copyright Office has stated, and courts have begun to affirm, that AI-generated output is not copyrightable in the absence of sufficient human creative expression. The practical consequence is that content generated entirely by an AI system — text, images, code — may not be protectable by copyright at all. For companies whose product is AI-generated output, or who are building content libraries on AI-generated assets, this is a foundational IP risk. The analysis shifts where there is meaningful human curation, selection, or arrangement — but the line is unsettled. Contractual ownership provisions in AI vendor agreements may also purport to assign output ownership, but those provisions cannot create copyright protection that copyright law doesn't confer. Due diligence for any company whose value depends on AI-generated content needs to include a frank assessment of what, if anything, is actually protectable. What obligations does the EU AI Act impose on AI providers and deployers? The EU AI Act sets a tiered compliance framework based on risk classification, with general-purpose AI models subject to their own transparency and technical documentation requirements. It distinguishes providers (who develop and place AI systems on the market) from deployers (who use them in their own products), and both carry independent obligations whose allocation is a contractual question vendor agreements are only beginning to address. High-risk applications — employment, credit, critical infrastructure, education, biometrics — face the most demanding requirements, so companies deploying AI in Europe must understand their own classification and the assurances they can expect from the provider. The EU AI Act creates a tiered compliance framework based on risk classification, with general-purpose AI models subject to their own transparency and technical documentation requirements. The Act draws a critical distinction between AI providers (the entities that develop and place AI systems on the market) and deployers (the entities that use AI systems in their own products and services). Both categories carry independent compliance obligations, and the allocation of responsibility between them is a contractual question that AI vendor agreements are only beginning to address. High-risk AI applications — in employment, credit, critical infrastructure, education, biometrics — face the most demanding requirements: conformity assessments, technical documentation, human oversight mechanisms, and registration in an EU database. Companies deploying AI systems in Europe need to understand both their own classification as a deployer and what compliance assurances they are entitled to receive from the provider. How do you get vendor indemnification for AI output errors? The indemnification landscape for AI output is thin. Major providers offer IP indemnities — such as Microsoft's Copilot Copyright Commitment and Google's offerings for Workspace and Cloud — but they are narrowly scoped, restriction-bound, and capped. They generally cover copyright claims from the model's output when used as intended, but exclude claims arising from customer-provided inputs, out-of-scope jurisdictions, customer modification or fine-tuning, and defamation or privacy violations. Understanding exactly what is and isn't covered is essential before building a commercial product on a foundation model and making IP representations downstream. The indemnification landscape for AI output is thin. Major foundation model providers have introduced intellectual property indemnification programs — Microsoft's Copilot Copyright Commitment, Google's similar offering for Workspace and Cloud customers — but these indemnities are narrowly scoped, subject to usage restrictions, and capped. They generally cover copyright infringement claims arising from the model's output when the product is used as intended, but they do not cover: claims arising from customer-provided inputs, claims in jurisdictions outside the scope of the program, claims where the customer modified or fine-tuned the model, or claims that the model's output defames a third party or violates privacy rights. Understanding exactly what the indemnification covers — and what it doesn't — is essential before building a commercial product on top of a foundation model and making representations to downstream customers about IP ownership. ← More on Licensing & Contracts Further reading: AI Licensing: Who Owns the Model, the Data, and the Output Is Still Being Litigated — Covers the current state of AI IP law, model licensing frameworks, output ownership, EU AI Act compliance obligations, and the practical limits of vendor indemnification. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Hardware Licensing: The IP Exposure in Your Bill of Materials That Nobody Checked Source: https://blegal.ai/knowledge/lic-05-hardware-licensing Author: Gurpreet S. Bal Hardware Licensing: The IP Exposure in Your Bill of Materials That Nobody Checked By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Hardware companies build physical products, but the IP exposure often lives in the contracts nobody reviewed when the design was being built. Gurpreet S. Bal has advised on hardware company transactions where IP ownership issues — in ODM relationships, reference designs, and component-level patents — surfaced during M&A diligence with no clean resolution available. "Hardware companies keep discovering IP exposure during M&A diligence that should have been caught years earlier — by the time a deal is on the table, there's no good way to fix it," he says. Bal's practice covers hardware-focused transactions across IoT, consumer electronics, industrial technology, and the semiconductor supply chain, with particular focus on IP ownership and supply chain licensing risk. Who owns the design in an OEM vs. ODM hardware relationship? In an OEM relationship the brand company owns the design and contracts out manufacturing; in an ODM relationship the design and manufacturing house owns the design and licenses it to the brand. Under an ODM arrangement the design files, firmware, mechanical drawings, and component selection belong to the ODM, so the brand may have no independent right to take the design to another manufacturer, modify it substantially, or transfer it in a sale. Companies often call their products proprietary without realizing the actual design is owned elsewhere — in M&A, this determines whether the acquirer is buying a product or a contract. The line between an OEM relationship (where the brand company owns the design and contracts manufacturing) and an ODM relationship (where the design and manufacturing house owns the design and licenses it to the brand company) is one of the most consequential distinctions in hardware IP. In an ODM arrangement, the design files, firmware, mechanical drawings, and component selection belong to the ODM — not the brand company. The brand company has a license to manufacture and sell the product under its name, but it may have no independent right to take those designs to a different manufacturer, to modify them substantially without the ODM's cooperation, or to transfer them in a sale. Hardware companies frequently describe their products as proprietary without fully understanding that their ODM relationship means the actual design is owned elsewhere. In M&A transactions, this distinction determines whether the acquirer is buying a product or a contract. What restrictions do hardware reference design licenses impose? Chip vendors like Qualcomm, MediaTek, and NXP distribute reference designs to speed product development, but the accompanying license agreements restrict how the design can be modified, whether it can underpin multiple product lines, and what happens if the chip relationship changes. A company that customized a reference design may have inadvertently created a derivative work, giving the chip vendor license rights in the resulting product. These restrictions are often buried in exhibit schedules to chip supply agreements and rarely reviewed by engineering teams with IP counsel, making their scope foundational diligence for any hardware acquisition. Chip vendors — Qualcomm, MediaTek, NXP, and others — distribute reference designs to accelerate product development. These reference designs come with license agreements that restrict how the design can be modified, whether it can be used as the basis for multiple product lines, and what happens to the design if the chip relationship changes. A company that built its product on a chip vendor's reference design and customized it may have inadvertently created a derivative work of the reference design — which can mean the chip vendor has license rights in the resulting product. The restrictions are often found in exhibit schedules to chip supply agreements rather than in prominently negotiated terms, and engineering teams rarely review them with IP counsel at the time of product development. Understanding the scope of reference design restrictions is foundational diligence for any hardware acquisition. How does component-level SEP exposure and the Avanci pool affect hardware licensing? A hardware product with wireless connectivity is exposed to standard-essential patent royalties at the product level, even when the connectivity comes from a third-party component. The exhaustion doctrine should in theory pass SEP licenses down the supply chain through licensed component sales, but major SEP holders do not always grant component-level licenses that create effective exhaustion at the end product. Avanci, the 5G pool for cellular IoT, licenses directly to device makers rather than chipmakers, so the royalty burden sits with the product company regardless of chipset — the cellular royalty stack must be modeled per unit, not assumed resolved by buying a licensed chip. A hardware product that includes wireless connectivity — cellular, Wi-Fi, Bluetooth — is exposed to standard-essential patent royalties at the product level, even if the connectivity is provided by a component purchased from a third party. The exhaustion doctrine, which holds that patent rights are exhausted when a licensed product is sold, should in theory pass SEP licenses down the supply chain through licensed component sales. In practice, major SEP holders do not always grant licenses at the component level that create effective exhaustion at the end-product level. Avanci, the 5G patent pool for cellular IoT, licenses directly to device makers rather than chipmakers, which means the SEP royalty burden sits with the product company regardless of which chipset is used. For connected hardware companies, the cellular royalty stack needs to be modeled per unit and included in product economics — it is not automatically resolved by purchasing a licensed chip. What open source risk does firmware licensing create for hardware companies? Firmware frequently incorporates open source components, and GPL-family licenses carry copyleft obligations: distributing GPL-licensed code in firmware shipped with a product may trigger an obligation to release the complete corresponding source code — a serious problem where competitive advantage lives in proprietary firmware. GPL compliance analysis is standard hardware M&A diligence but is often skipped by the target itself. Beyond GPL, components implementing standard interfaces may carry terms restricting commercial redistribution without attribution or royalty, so an open source bill-of-materials review should be routine annual legal hygiene. Hardware products ship with firmware, and firmware frequently incorporates open source components. The GPL family of licenses carries copyleft obligations: if GPL-licensed code is incorporated into firmware that is distributed with a product, the distribution may trigger an obligation to release the complete corresponding source code. This matters enormously for hardware companies whose competitive advantage is embedded in proprietary firmware. GPL compliance analysis — determining what open source is in the firmware, under what licenses, and whether copyleft obligations have been triggered — is standard diligence in hardware M&A but is often skipped by the target company itself. Beyond GPL, hardware products that implement standard interfaces and protocols may bundle firmware components licensed under terms that restrict commercial redistribution without attribution or royalty. An open source bill of materials review should be a standard part of every hardware company's annual legal hygiene. How do export controls apply to hardware products and components? Hardware containing advanced semiconductors, encryption, or controlled sensing is subject to export controls under the EAR, which classifies products by Export Control Classification Number (ECCN); certain ECCNs require licenses for shipments to controlled countries or end-users. The U.S. entity list and the Foreign Direct Product Rule extend U.S. jurisdiction to foreign-made items produced with U.S.-origin technology or equipment, reaching supply chains that never touch the U.S. directly. Penalties include criminal liability, denial of export privileges, and civil fines, so companies selling into restricted markets must build end-use screening into the sales process. Hardware containing advanced semiconductors, encryption technology, or controlled sensing capabilities is subject to export controls under the Export Administration Regulations. The EAR classifies hardware by Export Control Classification Number (ECCN), and products with certain ECCNs require export licenses for shipments to controlled countries or end-users. The U.S. entity list and the Foreign Direct Product Rule extend U.S. export jurisdiction to foreign-made items produced with U.S.-origin technology or equipment — which affects supply chains that never touch the United States directly. For hardware companies shipping globally, an export control compliance program is not optional; the penalties for violations include criminal liability, denial of export privileges, and civil fines. Hardware companies selling into markets with restricted end-user populations need to conduct end-use screening as part of their sales process, not as an afterthought. ← More on Licensing & Contracts Further reading: Hardware Licensing: The IP Exposure in Your Bill of Materials That Nobody Checked — Covers the IP ownership issues embedded in hardware development relationships, reference design restrictions, SEP royalty exposure, firmware open source obligations, and export control compliance. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Source Code Escrow: What It Is, When It Actually Matters, and When It's Just Theater Source: https://blegal.ai/knowledge/lic-06-source-code-escrow Author: Gurpreet S. Bal Source Code Escrow: What It Is, When It Actually Matters, and When It's Just Theater By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Source code escrow appears in enterprise software agreements with remarkable frequency given how rarely it provides the protection it's supposed to provide. Gurpreet S. Bal reviews escrow provisions regularly in the context of software licensing and M&A diligence, and the pattern is consistent: the demand is reflexive, the documentation is incomplete, and the release conditions would rarely trigger in the scenarios companies actually fear. "Escrow gets demanded as a checkbox in enterprise procurement without anyone stopping to ask whether the release conditions would ever actually be triggered in the scenarios they're worried about," he says. Bal advises on technology licensing transactions where escrow provisions are part of the commercial negotiation, and on M&A transactions where the adequacy of existing escrow arrangements is a diligence question. How does the three-party source code escrow structure work? An escrow agreement involves three parties: the developer (depositor), the licensee (beneficiary), and a neutral escrow agent such as Iron Mountain or EscrowTech. The developer deposits source code, build instructions, and related materials; the agent holds them and releases them to the beneficiary only when defined release conditions occur, with the licensee paying annual maintenance fees. Crucially, escrow does not grant a right to use the code — it grants access if a condition is met, subject to whatever license rights the agreement defines, and if those rights are narrow the operational relief can be very limited. A source code escrow agreement involves three parties: the software developer (the depositor), the licensee (the beneficiary), and a neutral escrow agent — typically a specialist firm like Iron Mountain or EscrowTech. The developer deposits the source code, build instructions, and related materials with the escrow agent. The escrow agent holds the materials under agreed terms and releases them to the beneficiary only upon the occurrence of defined release conditions. The licensee pays annual maintenance fees to the escrow agent for this service. The critical insight is that escrow does not give the licensee the right to use the source code — it gives the licensee access to the source code if and when a release condition is met, at which point the licensee has whatever license rights are defined in the escrow agreement. If those license rights are narrow — use only to maintain the existing deployment, no right to modify for new functionality — the escrow may provide very limited operational relief. Why is there a gap between intended and actual source code escrow release conditions? Standard release conditions cover developer insolvency, cessation of business, or material failure to support — but each is narrower than it sounds. Insolvency triggers usually require a formal bankruptcy filing or assignment for creditors, so a distressed vendor operating in zombie mode may not qualify; "cessation of business" is ambiguous when a successor honors the license; and material-failure provisions require a materiality determination and often dispute resolution before release. The scenarios licensees most fear — the vendor pivots, raises prices sharply, or is acquired by a competitor — are typically not release conditions at all. The standard release conditions in escrow agreements cover scenarios like developer insolvency, cessation of business, or material failure to support the software. These conditions sound comprehensive but are more limited in practice. Insolvency triggers typically require a formal bankruptcy filing or an assignment for the benefit of creditors — a financially distressed vendor that continues operating, even in zombie mode, may not meet the technical definition of the trigger. "Cessation of business" is equally ambiguous: a vendor that sells its assets to an acquirer and is formally dissolved has ceased business, but the successor may be obligated to honor the software license. Material failure to support provisions require a determination of materiality and often a dispute resolution process before the escrow agent will release. The scenarios licensees most fear — the vendor pivots, raises prices dramatically, or gets acquired by a competitor — are typically not release conditions at all. How do you verify what's actually in the source code escrow vault? A deposit is only as useful as what was actually deposited. The standard obligation calls for "source code and related materials sufficient to compile and maintain the software," but deposits frequently contain incomplete code, missing dependencies, outdated versions, or build instructions referencing toolchains that no longer exist. Escrow agents offer verification ranging from confirming the media is readable to full functional compilation, yet many agreements call only for basic verification, which catches nothing about completeness or currency. Verification obligations should be specified contractually, with scope matched to the complexity of the software. An escrow deposit is only as useful as what was deposited. The standard deposit obligation requires the developer to provide "source code and related materials sufficient to compile and maintain the software." In practice, deposits frequently contain incomplete code, missing dependencies, outdated versions, or build instructions that reference toolchains and environments that no longer exist. Escrow agents offer verification services — ranging from basic verification that the deposit is readable media, to functional verification that the deposit can actually be compiled into a working product — but many agreements call only for basic verification, which catches nothing about completeness or currency. A beneficiary that receives an escrow release and discovers the deposit is outdated by three versions or missing critical components has received access to something that doesn't actually solve the problem. Verification obligations should be specified contractually, and the verification scope should match the complexity of the software being escrowed. How do update obligations and maintenance drift affect source code escrow value? Even a sound initial deposit goes stale as software evolves — a developer shipping quarterly updates produces eight significant versions over two years, while the deposit may still reflect the state at signing unless enforceable update obligations exist. Standard provisions require deposits on a defined schedule with accuracy certification, but enforcement is weak because the beneficiary has no visibility into the deposit until a release event, by which point any gap is too late to fix. The practical solution is an audit right letting the beneficiary verify deposit currency and completeness at intervals, rather than discovering the problem after a trigger. Even a properly constituted initial deposit becomes stale as the software evolves. A developer releasing quarterly updates to its product has, over two years, produced eight significant versions — and the escrow deposit may reflect the state of the product at initial signing unless the agreement includes enforceable update obligations. Standard update provisions require the developer to deposit updated materials on a defined schedule (quarterly, at each major release, or at each minor version) and certify the deposit's accuracy. Enforcement of update obligations is weak in practice. The beneficiary typically has no visibility into what's in the deposit until a release event, and by then it's too late to address a gap. The practical solution is to include an audit right that allows the beneficiary to request verification of deposit currency and completeness at defined intervals, rather than discovering the problem after a release trigger. Why does the source code escrow concept break down for SaaS products? Traditional escrow assumed on-premise software the licensee could run independently if it obtained the source code, which doesn't translate to SaaS — a cloud application runs on the vendor's infrastructure, not the licensee's. Even if a SaaS escrow releases the code, the beneficiary must stand up the infrastructure, migrate data, and configure integrations for a system it has never run, mid-crisis. SaaS escrow providers can deposit configuration, deployment scripts, and data export procedures, but at substantially higher complexity and cost. For most mid-market SaaS buyers, robust data portability rights, notification obligations, and a documented migration plan offer more effective continuity protection. Traditional source code escrow was designed for on-premise software where the licensee could, in theory, run the software independently if it obtained the source code. That model doesn't translate cleanly to SaaS. A cloud-delivered application doesn't run on the licensee's infrastructure — it runs on the vendor's (or the vendor's cloud provider's). Even if a SaaS escrow releases the source code, the beneficiary must now stand up the application infrastructure, migrate its data, configure integrations, and operate a system it has never managed, in the middle of the crisis that triggered the release. SaaS escrow providers offer services designed to address this — depositing not just code but infrastructure configuration, deployment scripts, and data export procedures — but the complexity is substantially higher and the cost reflects that. For most mid-market SaaS buyers, the more effective continuity protection is a combination of: robust data portability rights, contractual notification obligations, and a documented migration plan rather than an escrow structure. What alternatives to source code escrow often work better? For software that genuinely needs continuity protection, several alternatives deserve evaluation alongside escrow. Multi-cloud or multi-region deployment obligations reduce single-vendor risk directly; source code access rights tied to a defined maintenance failure can be negotiated without the three-party structure; open source or source-available licensing for specific components gives direct access; and contractual step-in rights let a designated third party access the vendor's systems during a crisis, which addresses the SaaS case more directly than a code deposit. The starting question should be what failure scenario you are actually protecting against, and which mechanism truly addresses it. For software that truly needs continuity protection — critical infrastructure, financial systems, mission-critical enterprise applications — the alternatives to traditional escrow deserve evaluation alongside it. Multi-cloud or multi-region deployment obligations can reduce single-vendor risk directly. Source code access rights tied to a defined maintenance failure — without the three-party structure — can be negotiated directly in the license agreement. Open source or source-available licensing for specific components can provide direct access without escrow mechanics. Contractual step-in rights, allowing a designated third party to access the vendor's systems during a defined crisis period, address the SaaS use case more directly than a code deposit. None of these is universally superior to escrow, but each addresses specific failure scenarios more directly. The starting point should be: what failure scenario am I actually trying to protect against, and what mechanism actually addresses that scenario? ← More on Licensing & Contracts Further reading: Source Code Escrow: What It Is, When It Actually Matters, and When It's Just Theater — Covers the full escrow structure, common failure modes in release condition drafting, deposit verification obligations, the limits of SaaS escrow, and alternatives that address the underlying business continuity concern. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Licensing & Contracts — Technology IP Licensing Reference Source: https://blegal.ai/knowledge/licensing-contracts Author: Gurpreet S. Bal Licensing & Contracts Analytical reference by Gurpreet S. Bal, Silicon Valley Corporate Partner | blegal.ai Technology licensing agreements define the economic relationships between IP owners and the companies that build on, distribute, or deploy their technology. The structure of a license — scope, exclusivity, sublicensing rights, use restrictions, audit mechanisms, and termination conditions — determines the long-term value of the IP relationship and directly affects M&A outcomes, financing due diligence, and regulatory compliance. This reference hub covers licensing across the key technology verticals where licensing structure matters most: SaaS, AI, fintech, semiconductors, and hardware. Articles in This Category SaaS Software Licensing Agreements Key provisions in SaaS subscription agreements — service levels, uptime commitments, data ownership, IP rights, and limitation of liability structures. Fintech Regulatory Licensing State money transmission license requirements, bank partnership licensing structures, and federal regulatory frameworks for fintech product launches. Semiconductor IP Licensing Architecture licenses, implementation licenses, royalty structures, field-of-use restrictions, and foundry agreement IP provisions in chip IP licensing. AI Model and Data Licensing Licensing frameworks for AI models and training datasets — open-source license compliance, acceptable use restrictions, output ownership, and indemnity. Hardware Technology Licensing Design licenses, manufacturing rights, patent licensing structures, and royalty arrangements in hardware technology IP licensing. Source Code Escrow Agreements When source code escrow is required, how release triggers are defined, escrow agent selection, and what enterprise licensees must verify. Also on this topic: Licensing & Contracts — Personal Practice Hub on gurpreetbal.com Gurpreet S. Bal is a corporate partner advising technology companies on IP licensing, commercial agreements, and strategic transactions across AI, semiconductors, fintech, and emerging technology. For more information, visit gurpreetbal.com . --- ## The Liquidation Waterfall: Who Gets Paid, In What Order, and What’s Usually Left for Common Source: https://blegal.ai/knowledge/liquidation-preferences-waterfall Author: Gurpreet S. Bal The Liquidation Waterfall: Who Gets Paid, In What Order, and What’s Usually Left for Common By Gurpreet S. Bal — May 2026 In an all-cash acquisition, deal proceeds do not flow directly to stockholders. They flow through a defined priority structure — a waterfall — that pays each class of creditor and stockholder in sequence, with later entrants receiving only what remains after those above them are made whole. Understanding who sits where in that structure, and how different preferred stock terms change the outcomes, is essential for founders, employees, and investors evaluating what a given acquisition price actually means for them. What is a liquidation preference and how does it work? A liquidation preference gives preferred stockholders the right to receive their invested capital — and sometimes a multiple of it — before common stockholders receive anything in a sale or liquidation. A 1x non-participating preference means the investor gets their money back first, and common stockholders split the remainder. A participating preference means the investor collects their preference and also participates in the remaining proceeds as if they converted to common, taking a larger share of total proceeds at every exit valuation. A liquidation preference is the right of preferred stockholders to receive a specified return on their invested capital before common stockholders receive anything. In an acquisition structured as a sale of the company — which virtually all venture financing documents treat as a “deemed liquidation event” — preferred stockholders stand ahead of common in the distribution queue. The market standard is a 1x non-participating liquidation preference : the preferred stockholder receives an amount equal to their original investment before common gets paid, and then chooses either to take that preference or to convert to common and share pro-rata in total proceeds. They cannot do both. At a high enough exit valuation, conversion yields more than the preference, and the investor converts. Below that threshold, they take the preference and common splits whatever remains. Non-standard structures — 1.5x or 2x multiples, participating preferred, or stacked preferences across multiple rounds — can substantially impair common stock returns at moderate exit valuations, which describes most technology M&A transactions. What's the key distinction between participating and non-participating preferred stock? Non-participating preferred holders must choose between taking their liquidation preference or converting to common stock — they cannot do both. Participating preferred holders receive their preference first and then also participate in remaining proceeds on an as-converted basis. Participating preferred is significantly more expensive for founders and employees because investors capture a larger share at every exit valuation, and the crossover point where founders benefit is pushed to higher and higher valuations. Non-participating preferred forces a choice: take the preference or convert to common, but not both. At high exit valuations, conversion is preferable. At low or moderate valuations, the preference provides a floor. This is the founder-friendly standard. Participating preferred (the “double dip”) allows preferred stockholders to take their preference first, and then also participate in the remaining proceeds alongside common, as if they had converted. There is no forced choice — they always get paid first and always participate in the upside. This structure systematically transfers value from common to preferred at every exit valuation below a very high threshold, and is materially worse for founders and employees. Capped participating preferred is a compromise: preferred participates in the remaining proceeds up to a defined total cap (e.g., 3x of invested capital across preference plus participation), after which additional proceeds flow entirely to common. The cap limits the double-dip penalty at higher exit valuations while preserving investor downside protection. How does debt rank in the liquidation waterfall? All debt — secured and unsecured — ranks senior to all equity in a liquidation. Secured debt ranks first, followed by unsecured creditors, and only then does any equity class participate. In an acquisition, outstanding debt is typically repaid at closing before any equity distribution occurs. Companies that raised venture debt in addition to equity rounds have an additional senior claim that reduces proceeds available for preferred and common stockholders. Senior secured debt — bank revolvers, venture term loans, equipment financing — sits above all equity in the waterfall and is paid in full before any preferred stockholder receives a dollar. In a venture-backed company, venture debt is common by the Series A or B stage and is typically $1M to $5M or more. It is not equity and it does not convert in an acquisition; it is repaid at closing, often with prepayment premiums. Among preferred stockholders, seniority is typically structured as last-in, first-out: the most recent financing round holds the most senior liquidation preference. Series B is paid before Series A; Series A before Seed. Pari passu structures — where all preferred series share proceeds proportionally — exist but are less common in institutional financings. What is the standard order of the liquidation preference waterfall? The standard waterfall in a venture-backed acquisition pays out in this order: transaction expenses and outstanding debt, then preferred stock in reverse order of investment (most recent series first if structured as senior or pari passu), then common stockholders. In practice, the exact seniority depends on what was negotiated in each financing — some rounds have equal seniority (pari passu), others have explicit seniority, and the merger agreement specifies the exact allocation. In a standard all-cash deal, proceeds are distributed in the following sequence: 1. Transaction expenses. M&A advisory, legal, and other deal costs are paid from gross proceeds before any distribution to securityholders. On a $50M deal, these can consume $2M–$4M. 2. Senior secured debt. Bank lines, venture term loans, and equipment financing are repaid in full, including accrued interest and any prepayment premiums. 3. Preferred stockholders, in seniority order. Starting with the most senior series. If total proceeds are insufficient to pay all preferences, junior series receive nothing until senior series are made whole. 4. Common stockholders. Founders and employees with vested shares receive what remains after debt and preferred preferences are satisfied. 5. Vested option holders. In an all-cash deal, vested unexercised options are cashed out. Each option holder receives (per-share merger consideration − exercise price) × number of options. Options where the exercise price exceeds the per-share deal price — underwater options — are cancelled for no consideration. How are vested options cashed out in an acquisition? Vested in-the-money options are typically paid out in an acquisition as the spread between the exercise price and the per-share merger consideration, net of taxes. The option holder does not need to exercise and then sell — the merger agreement provides for payment of the net spread directly. Out-of-the-money options, where the exercise price exceeds the per-share consideration, are cancelled for no value. An employee holding 10,000 vested options with a $2.00 exercise price in a $10.00/share cash deal receives $8.00 net per option, or $80,000 gross before withholding. The option holder does not fund the exercise price out of pocket; the net spread is paid directly through payroll. Options that are underwater are simply extinguished — the employee receives nothing for them. The per-share price used to calculate option payouts is the per-share amount common stockholders receive after all preferences are applied, not a gross average across all equity classes. How do management carve-out plans work in a liquidation waterfall? Management carve-out plans are funded from the aggregate proceeds before the standard waterfall distributes to common stockholders, or from a specific portion of the common pool. The carve-out effectively reduces the proceeds available to all common stockholders — including founders who do not participate in the carve-out — and redirects that value to specified key employees to incentivize them to support and remain through the transaction. When the preference overhang would leave key employees with little or no proceeds from a deal, boards create carve-out pools — typically 5–15% of total deal consideration — funded from merger proceeds before distribution to stockholders. These pools are allocated to designated employees with vesting tied to post-closing employment, ensuring that the people the acquirer needs to retain have a direct economic stake in closing and staying. Carve-out plans are approved by the board and raise fiduciary duty considerations because management negotiating the deal is also the beneficiary. Governance process matters. For a detailed treatment, see Management Carve-Out Plans in Technology M&A . What is the preference overhang and how does it affect me in practice? Preference overhang is the total amount of preferred liquidation preferences outstanding, which must be satisfied before common stockholders receive anything. In heavily funded startups, the aggregate liquidation preferences from multiple rounds of preferred stock can exceed any realistic acquisition price, leaving founders and employees with nothing despite building a valuable company. This misalignment is a structural feature of venture-backed companies that founders often do not fully appreciate until a sale process begins. In most VC-backed companies that have raised multiple rounds at high valuations, the cumulative preference stack substantially exceeds what the company ultimately sells for. A company that raises $5M in seed, $15M in Series A, and $30M in Series B at aggressive valuations carries $50M in aggregate liquidation preferences. At a $70M acquisition — a result most early employees would consider a strong outcome — the common pool after debt and preferences might be $15M to $20M split across millions of shares. The term sheet decisions that determine these outcomes — participating vs. non-participating, preference multiples, pari passu vs. seniority — are made once, at signing, and govern everything that follows. They are not details to revisit at exit. How does the waterfall play out at different exit valuations? At low exit valuations, preferred investors receive their preferences and common stockholders receive nothing. At medium valuations, preferred is satisfied and common receives a small residual. At high valuations above the aggregate preference overhang, non-participating preferred investors often choose to convert to common to capture more value. The exact crossover depends on each investor's preference multiple and ownership percentage relative to other stockholders. Cap table for this example: Venture debt: $2M (senior to all equity) Series Seed preferred: $5M invested → 10M shares at $0.50/share; 1x preference = $5M; junior to Series A Series A preferred: $10M invested → 10M shares at $1.00/share; 1x preference = $10M; senior to Seed Common shares: 15M (founders and employees) Vested options: 5M options, average exercise price $1.50/share Unvested options: 2M (excluded; treatment addressed in disclaimer below) Total fully diluted shares: 40M including options For non-participating preferred: preferred investors convert to common when doing so yields more than taking their guaranteed preference. For participating preferred: they always take the preference first, then also participate in remaining proceeds. Options underwater (exercise price exceeds per-share deal price) are cancelled for zero consideration. Who gets paid and how much in a $20M exit? In a $20M exit for a company with $15M in aggregate preferred liquidation preferences, preferred investors receive $15M and common stockholders split the remaining $5M pro rata — assuming no participating preferred or management carve-out. If there is also $2M in transaction expenses and outstanding debt, preferred may not be fully satisfied, and common stockholders receive nothing. Founders should model multiple exit scenarios before any process begins. After venture debt ($2M), $18M remains. Series A takes its $10M preference; Seed takes its $5M preference. The remaining $3M goes to common. Per-share for common: $3M ÷ 15M = $0.20/share. Options with $1.50 exercise price are underwater and cancelled. Under participating preferred, the $3M remaining after preferences is shared among all 35M non-option shares: preferred gets $0.857M each (10M/35M × $3M) on top of their preferences; common gets $1.286M. $20M Exit — Non-Participating Preferred Recipient Amount Per Share % of Deal Venture debt $2.0M — 10.0% Series A preferred (1x pref.) $10.0M $1.00/sh 50.0% Series Seed preferred (1x pref.) $5.0M $0.50/sh 25.0% Common (15M shares) $3.0M $0.20/sh 15.0% Vested options (underwater) $0 — 0.0% Total $20.0M — 100% $20M Exit — Participating Preferred (double-dip) Recipient Preference Participation Total % of Deal Venture debt $2.0M — $2.0M 10.0% Series A preferred $10.0M $0.86M $10.86M 54.3% Series Seed preferred $5.0M $0.86M $5.86M 29.3% Common (15M shares) — $1.29M $1.29M 6.4% Vested options (underwater) — $0 $0 0.0% Total $17.0M $3.0M $20.0M 100% Common receives $3.0M under non-participating preferred vs. $1.29M under participating preferred at a $20M exit. The double-dip reduces common’s share from 15.0% to 6.4% of total proceeds. Who gets paid and how much in a $50M exit? A $50M exit typically satisfies full liquidation preferences for a company with a modest funding history, with meaningful proceeds flowing to common stockholders. At this level, non-participating preferred holders must decide whether to take their preference or convert — the mathematical crossover depends on their ownership percentage and preference amount. Participating preferred investors capture both their preference and their pro rata share of the remainder, reducing common stockholder proceeds significantly. Under non-participating preferred, both series convert to common: each would receive $13.7M as-converted (10M of 35M non-option shares × $48M remaining after debt), which exceeds their $10M and $5M preferences. Options remain underwater at $1.37/share vs. $1.50 exercise and are cancelled. Under participating preferred, preferences are paid first ($15M), leaving $33M in the participation pool, split 10M/10M/15M across preferred and common. $50M Exit — Non-Participating Preferred (both series convert) Recipient Amount Per Share % of Deal Venture debt $2.0M — 4.0% Series A preferred (converts) $13.7M $1.37/sh 27.4% Series Seed preferred (converts) $13.7M $1.37/sh 27.4% Common (15M shares) $20.6M $1.37/sh 41.2% Vested options (underwater) $0 — 0.0% Total $50.0M — 100% $50M Exit — Participating Preferred (double-dip) Recipient Preference Participation Total % of Deal Venture debt $2.0M — $2.0M 4.0% Series A preferred $10.0M $9.4M $19.4M 38.9% Series Seed preferred $5.0M $9.4M $14.4M 28.9% Common (15M shares) — $14.1M $14.1M 28.3% Vested options (underwater) — $0 $0 0.0% Total $17.0M $33.0M $50.0M 100% At $50M, common receives $20.6M under non-participating preferred vs. $14.1M under participating preferred — a $6.5M difference, representing 13% of the total deal price redirected from common to preferred. Who gets paid and how much in a $100M exit? At $100M, most venture-backed startups satisfy all liquidation preferences and deliver material returns to common stockholders. However, companies with large Series B or C rounds featuring participating preferred or high preference multiples may still see preferred investors capture a disproportionate share of proceeds. Founders should calculate the actual common stock distribution at the $100M level early in any process to understand their negotiating position. At $100M, both structures produce better common outcomes, and vested options enter the money. Under non-participating preferred, both series convert. With options in the money, per-share deal consideration is calculated as ($98M net of debt + $7.5M aggregate option exercise proceeds) ÷ 40M shares = $2.64/share; options receive $1.14/share net ($2.64 − $1.50). Under participating preferred, after paying $15M in preferences, the remaining $83M is split across all 40M shares (options now in the money): per-share participation = ($83M + $7.5M) ÷ 40M = $2.26/share; options net $0.76/share. $100M Exit — Non-Participating Preferred (both series convert; options in the money) Recipient Amount Per Share / Net % of Deal Venture debt $2.0M — 2.0% Series A preferred (converts) $26.4M $2.64/sh 26.4% Series Seed preferred (converts) $26.4M $2.64/sh 26.4% Common (15M shares) $39.6M $2.64/sh 39.6% Vested options (5M, in the money) $5.7M $1.14 net/option 5.7% Total $100.0M — 100% $100M Exit — Participating Preferred (double-dip; options in the money) Recipient Preference Participation Total % of Deal Venture debt $2.0M — $2.0M 2.0% Series A preferred $10.0M $22.6M $32.6M 32.6% Series Seed preferred $5.0M $22.6M $27.6M 27.6% Common (15M shares) — $33.9M $33.9M 33.9% Vested options (5M, in the money) — $3.8M $3.8M 3.8% Total $17.0M $83.0M $100.0M 100% At $100M, common + options together receive $45.3M under non-participating preferred vs. $37.7M under participating preferred — still a $7.5M gap. The double-dip penalty scales with exit size because the participation pool grows. What does this liquidation waterfall analysis leave out? This analysis does not account for earnouts that may pay over multiple years, escrow holdbacks that defer receipt of proceeds, indemnification obligations that reduce the final amount received, or individually negotiated side letters giving specific investors preferences not visible in the standard waterfall. Real distributions are always more complex than the cap table suggests, and founders should require a detailed waterfall analysis from their counsel before signing any definitive acquisition agreement. Unvested options: Treatment varies substantially by deal. Unvested options may be assumed and converted into acquirer awards (common in strategic acquisitions where retention matters), accelerated under single- or double-trigger provisions, or cancelled. The analysis is highly deal-specific. Escrow and holdback: In most deals, 10–15% of merger consideration is held in escrow for 12–18 months to cover indemnification claims. The headline price and the Day 1 cash-in-hand are different numbers. How escrow obligations are allocated across the preference stack is a separate and important analysis. Earnouts: Contingent consideration creates a prospective waterfall problem. Who benefits from earnout achievement — and whether the preference mechanics apply to earnout distributions — is negotiated in the merger agreement and is not addressed here. This is a basic framework. Most real M&A waterfalls are significantly more complex and will require the assistance of good legal counsel who also has financial and accounting fluency. Numbers in these tables are rounded. Do not rely on this article for deal-specific advice. Full practitioner guide: Liquidation Preferences and the Waterfall: How the Money Actually Gets Divided in an All-Cash Sale — gurpreetbal.com. Includes the Liquidation Waterfall Excel Tool for modeling your own cap table. Analysis by Gurpreet S. Bal, Partner at Foley & Lardner LLP in Silicon Valley. Gurpreet has advised on more than 50 M&A transactions over 16+ years. More at gurpreetbal.com . ← All Topics  ·  blegal.ai --- ## Delaware Section 144 Safe Harbor in Practice: When the Amendments Create New Problems Source: https://blegal.ai/knowledge/ma-01-delaware-section-144 Author: Gurpreet S. Bal Delaware Section 144 Safe Harbor in Practice: When the Amendments Create New Problems By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Delaware Section 144 governs transactions between a corporation and its directors, officers, or significant shareholders — the category of deals where conflicted interests create the highest litigation risk. The safe harbor provisions, designed to immunize qualifying transactions from challenge, work well in the straightforward cases they were designed for. But Gurpreet S. Bal notes that the edges of the protection are where practitioners earn their fees. "Safe harbor is safe until you need it in a real dispute. That's when you find out where the edges are," says Gurpreet S. Bal. "Most transactions relying on Section 144 never get tested. The ones that do are educational." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. Following recent 2026 Delaware legislative updates, practitioners across the M&A market are still working through the practical implications of the amended framework — particularly in M&A transactions where related-party dynamics are most acute. What does Section 144 actually protect, and what does it require? Delaware Section 144 provides that a transaction between a corporation and an interested director is not void solely because of that conflict if it receives approval by disinterested directors, approval by disinterested stockholders, or is shown to be fair to the corporation. The statute creates a procedural safe harbor — satisfying it shifts the standard of review from entire fairness to business judgment, which dramatically increases the likelihood that the transaction will be upheld. Delaware General Corporation Law Section 144 provides that a contract or transaction between a corporation and one of its directors or officers (or an entity in which a director or officer has a financial interest) is not void or voidable solely on the basis of that conflicted interest — provided one of three conditions is satisfied. First, the material facts of the conflict are disclosed to the board or a board committee, and the disinterested directors approve the transaction. Second, the material facts are disclosed to shareholders, and they approve it. Third, the transaction is fair to the corporation when authorized, approved, or ratified. In practice, the first path — disinterested director approval — is the standard mechanism. Gurpreet S. Bal notes that the critical question is often whether the directors approving the transaction were genuinely disinterested, and whether the process by which they evaluated it satisfies the requirements that Delaware courts have consistently imposed through decades of fiduciary duty jurisprudence. Where do the amended provisions create new uncertainty in M&A contexts? The 2025 DGCL amendments expanded the scope of what can be approved through charter provisions and stockholder agreements, but created uncertainty about how courts will apply the new provisions to self-interested transactions involving controlling stockholders in M&A contexts. Practitioners are uncertain whether the amended Section 144 requires both special committee approval and minority stockholder vote for controller-driven transactions, or whether either alone is sufficient after the amendments. The Delaware Section 144 amendments were intended to codify and clarify the existing common law framework — confirming what practitioners already believed to be the standard process and providing statutory clarity to reduce litigation uncertainty. In M&A transactions involving significant related-party dynamics — a controlling shareholder selling the company, a management buyout, an acquisition where a board member has a financial interest in the acquirer — the amendments provide a more clearly defined path to safe harbor. But Gurpreet S. Bal notes a consistent pattern: the safe harbor is most robust when the related-party conflict is simple and fully disclosed. Complex deals, where the nature of a director's interest is not immediately obvious, or where the board's independence is contested, create ambiguity that the amendment language has not resolved as cleanly as practitioners had hoped. Delaware courts will ultimately define the boundaries through litigation. How does the safe harbor interact with the entire fairness standard? If a transaction with an interested director or controller satisfies the Section 144 safe harbor — with both disinterested director and minority stockholder approval — Delaware courts apply business judgment review rather than entire fairness. Under business judgment review, plaintiffs must show waste or gross negligence to invalidate the transaction, a nearly impossible standard. Without the safe harbor, entire fairness requires the defendant to show both fair dealing and a fair price, which few contested transactions survive. This is the central tension in Section 144 practice. Satisfying the Section 144 safe harbor requirements does not automatically mean a transaction is reviewed under the more deferential business judgment rule rather than the demanding entire fairness standard. Delaware courts — particularly the Court of Chancery — have a long-standing body of doctrine that applies entire fairness review to certain categories of related-party transactions regardless of whether the Section 144 procedural steps were satisfied. In the M&A context, controlling shareholder transactions in particular tend to attract entire fairness review unless a fully independent special committee with real bargaining power was involved, and the transaction was also conditioned on approval by a majority of minority shareholders. Gurpreet S. Bal advises M&A clients to understand that Section 144 compliance is necessary but not sufficient — the more demanding MFW framework requirements are what actually provide meaningful litigation protection in controlling shareholder transactions. What should practitioners do differently given the 2026 landscape? Practitioners should build robust procedural records for any transaction involving interested parties — board minutes reflecting independent analysis, special committee engagement letters documenting independence, banker conflict disclosures, and stockholder meeting materials. The 2025 amendments reduce but do not eliminate judicial scrutiny, and the record created at the time of the transaction remains the primary defense in any subsequent litigation. Gurpreet S. Bal recommends a disciplined approach to related-party M&A transactions that goes beyond mechanical compliance with Section 144's safe harbor requirements. The practical steps: form the special committee early, before the transaction terms are substantially developed; ensure committee members are genuinely independent (no economic ties to the controlling party, including carried interest in the same fund); give the committee its own legal and financial advisors; document the committee's deliberations carefully; and, in controlling shareholder transactions, seriously consider conditioning the transaction on majority-of-minority approval. The additional process takes time and sometimes creates deal friction. But in a contested transaction — one where disappointed shareholders have an economic incentive to litigate — the quality of the process is the primary defense. As of 2026, that calculus has not changed, and Gurpreet S. Bal expects the first wave of litigation under the amended Section 144 framework to clarify where the new statutory language does and does not provide additional protection. Further reading: Delaware Section 144 Safe Harbor Amendments: What M&A Practitioners Need to Know — an in-depth analysis of the Delaware Section 144 amendments, their legislative history, and practical implications for M&A transactions involving related parties. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Delaware Section 220 and Preferred Investors: The Books and Records Rights That Often Get Waived Source: https://blegal.ai/knowledge/ma-02-delaware-section-220 Author: Gurpreet S. Bal Delaware Section 220 and Preferred Investors: The Books and Records Rights That Often Get Waived By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Delaware Section 220 gives stockholders the right to inspect corporate books and records — including financial statements, board minutes, stockholder lists, and other materials — upon a proper written demand stating a legitimate purpose. It is one of the most important rights a stockholder holds in a Delaware corporation. And preferred investors, more often than most people realize, give it up. "Preferred investors waive Section 220 rights more often than people realize. It gets negotiated away quietly," says Gurpreet S. Bal. "The statutory right and the contractual right are different. Most investors end up relying on the contractual one." Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. In 2026, following Delaware's Section 220 amendments, the interplay between statutory books-and-records rights and the contractual information rights that investors negotiate has become more nuanced — and the distinction matters significantly in M&A situations where pre-transaction investor diligence becomes relevant. What does Section 220 give stockholders the right to inspect? Section 220 gives stockholders the right to inspect the corporation's books and records for a proper purpose — including investigating potential mismanagement, evaluating a transaction, or deciding how to vote. The statute covers board minutes, stockholder lists, and financial statements, and courts have extended it to emails and informal communications when they are necessary and essential to the stated purpose. Recent amendments narrow what must be produced to documents strictly necessary for the stated purpose. Delaware Section 220 allows stockholders to demand inspection of the corporation's stock ledger, a list of stockholders, and other books and records — provided the demand is made in proper form and for a proper purpose. The "proper purpose" requirement has been interpreted broadly by Delaware courts: investigating potential corporate wrongdoing, evaluating whether a transaction is fair, assessing the quality of management decisions, and investigating potential litigation claims have all been recognized as proper purposes. For preferred investors who are concerned about how a company is being managed or how a proposed M&A transaction has been structured, Section 220 is a powerful tool — it allows them to obtain information that the company may not have provided voluntarily through its contractual information rights obligations. Gurpreet S. Bal notes that the right is most valuable precisely when the relationship between investor and company is under stress. How do preferred investors end up waiving Section 220 rights? Preferred investors sometimes waive Section 220 rights through contractual information rights provisions in their investment documents that purport to be the exclusive mechanism for obtaining company information. Courts have occasionally found that broad waivers of statutory inspection rights in stockholder agreements are enforceable, particularly after the 2025 DGCL amendments expanded the scope of permissible charter and agreement provisions limiting stockholder rights. The waiver typically happens in the context of negotiating the investment documents — the Stock Purchase Agreement and accompanying Investor Rights Agreement. Companies, particularly those with strong negotiating leverage, sometimes include provisions in the investment documents that establish the contractual information rights as the exclusive mechanism for investor access to company information. The language may specify that investors agree to rely on the contractual information package rather than pursuing statutory inspection rights, or may limit the circumstances under which investors can seek inspection beyond what the contract provides. Gurpreet S. Bal notes that these provisions are often included in the standard form investment documents used in competitive financing rounds and are not always flagged explicitly by counsel on either side as a Section 220 waiver. Investors who accept them without fully understanding the implications discover the limitation only when they want to use the statutory right. What do contractual information rights actually provide — and where do they fall short? Contractual information rights in VC investment documents typically provide quarterly and annual financial statements, cap table access, and board observer rights. They fall short of Section 220 in contested situations — when a stockholder suspects mismanagement, a pending transaction, or fraud. Contractual rights can be withheld or delayed; Section 220 is enforceable through court action on a specific timeline. In a dispute, the statutory right is far more powerful than the contractual alternative. Standard venture-backed company investor rights agreements provide institutional investors with quarterly and annual financial statements, annual budget and operating plan, and access to the company's books and records upon reasonable request. These contractual rights are meaningful in the normal course of a company's operations. In an M&A context, they become less adequate. When a board is evaluating a transaction, the information that matters most — board minutes documenting the deliberation process, financial projections used in evaluating deal alternatives, materials shared with the special committee — may not be provided voluntarily under the contractual information rights package. Section 220 is the mechanism that allows an investor who has concerns about the transaction process to access this information before the deal closes. A preferred investor who has waived Section 220 rights is left relying on what the company chooses to provide and, ultimately, on post-closing litigation rather than pre-closing investigation. How do the 2026 Delaware amendments change the practical landscape? The 2026 Delaware amendments narrowed Section 220 by requiring more specific purpose statements, limiting document production to what is strictly necessary for that purpose, and giving companies more tools to resist broad productions. For M&A practitioners, this means that Section 220 demands from stockholders challenging a deal will produce a narrower document set than before, making it harder to build a litigation record from a books-and-records demand alone. The Delaware Section 220 amendments enacted in recent years imposed additional requirements on stockholders seeking inspection — including requiring more specificity in the demand regarding purpose and the particular documents sought, and giving companies additional procedural tools to respond to demands. The amendments also addressed the question of electronic communications (texts, emails, Slack messages) that have become a significant category of corporate records sought in books-and-records demands. Gurpreet S. Bal notes that the practical effect for preferred investors has been mixed: the amendments made Section 220 demands somewhat more procedurally demanding to initiate correctly, but the courts have continued to enforce the right vigorously when the proper purpose and procedural requirements are met. For investors who have retained their statutory rights — having not waived them in investment documents — the right remains a powerful pre-litigation investigative tool. The lesson Gurpreet S. Bal draws from the current landscape: understand precisely what rights you are agreeing to in your investment documents, because the Section 220 waiver is consequential and often invisible at the time it is made. Further reading: Delaware Section 220 Books and Records Amendments: Impact on M&A Litigation — a comprehensive analysis of the Section 220 amendments, the books-and-records demand process, and how investors use inspection rights in M&A disputes. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Management Carve-Outs in AI Acquisitions: Keeping the Team When the Technology Is the Value Source: https://blegal.ai/knowledge/ma-03-management-carve-out Author: Gurpreet S. Bal Management Carve-Outs in AI Acquisitions: Keeping the Team When the Technology Is the Value By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner In a conventional software acquisition, the product generates revenue and the team maintains it. The management carve-out is a retention mechanism — important, but not the primary value driver. In an AI acquisition, this dynamic is often inverted. The model exists because of the people who built it, the acquirer knows it, and the entire deal thesis may rest on retaining a specific group of researchers and engineers whose departure would effectively negate the acquisition's value. "The carve-out that works for a SaaS acquisition doesn't work for an AI acquisition. The people distribution is completely different," says Gurpreet S. Bal. "I've seen acquirers lose the team they bought the company for because the carve-out didn't reach the right people." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. In 2026, as AI acquihires have dominated M&A activity, standard carve-out formulas designed for a different era of technology acquisitions have proven consistently inadequate. What is a management carve-out and how does it typically work? A management carve-out plan sets aside a pool of acquisition proceeds for key employees, paid before or alongside common stockholders to ensure those employees have a financial incentive to support and remain through the transaction. The pool is funded from the aggregate proceeds available to common stockholders, effectively reducing everyone else's common distribution. Carve-outs are most commonly used when the liquidation preference overhang would leave common holders — including key employees — with insufficient proceeds to retain them. A management carve-out is a pool of deal proceeds set aside for key employees — typically at closing and subject to continued employment vesting conditions — that is distributed separately from the standard waterfall based on share ownership. It is distinct from the ordinary consideration paid to stockholders on their equity: the carve-out is compensation for the employees' continued service to the acquirer, not a return on their existing ownership stake. In a conventional M&A transaction, carve-out pools are typically sized at 5 to 10 percent of deal value and allocated among a defined set of senior leaders and high-performers identified during the deal negotiation. The allocation is negotiated between the company's board and management team, with the acquirer having significant input on who is included and how the vesting schedule is structured. Gurpreet S. Bal notes that the board's duty in negotiating the carve-out is to ensure that the allocation genuinely serves the company's and stockholders' interests — not merely to maximize compensation for the executives closest to the deal. Why does AI change the calculus for carve-out design? In AI company acquisitions, the value is often concentrated in a handful of technical employees who built and understand the core model or system. Losing those employees before integration is complete can destroy the acquisition value. This concentrates carve-out design pressure — acquirers are more willing to fund larger carve-out pools for AI companies than traditional tech companies, and the retention period tied to vesting may extend longer to ensure integration success. In most technology acquisitions, the equity distribution across the company roughly tracks the value distribution — founders and early employees with significant equity are also the most critical retention targets. In AI companies, this correlation often breaks down. The founding researchers who built the original model may have minimal equity relative to their contribution — particularly if they joined after the founding and before the company's valuation inflected. Key mid-level researchers, engineers working on model infrastructure, and specialists in evaluation and safety may hold very small equity positions that would generate negligible proceeds in the standard deal waterfall. These are exactly the employees the acquirer most needs to retain. A carve-out sized and allocated based on seniority or existing equity ownership will systematically miss them. Gurpreet S. Bal has seen this dynamic create post-closing retention failures in AI deals that were structured using templates designed for a different type of acquisition. How should the carve-out pool be sized and allocated in AI deals? Carve-out pool sizing in AI deals depends on the headcount of irreplaceable technical contributors and the risk of departure post-closing. Pools of 5-15% of net transaction proceeds are common, allocated on a combination of role criticality and tenure. Founders who participate in carve-out plans must be careful about fiduciary duty issues — the board should approve the plan as a deal necessity rather than as personal enrichment, with documentation supporting that characterization. Gurpreet S. Bal recommends that AI acquirers and target company boards approach carve-out design by starting from the retention question rather than the standard formula. Who are the 10 to 20 people whose departure in the first 18 months post-closing would materially impair the value the acquirer is paying for? What does it cost to retain each of them — not just in absolute dollars, but relative to the market for their skills? In 2026, top AI researchers command compensation packages that bear no relationship to their equity positions at a pre-revenue startup. The carve-out pool needs to be large enough to deliver retention packages competitive with what these individuals could obtain by walking to a competitor. That often means sizing the pool at 10 to 20 percent of deal value for AI acquihires — larger than the standard range — and allocating it based on a skills and role assessment rather than a hierarchical org chart. What vesting structure actually retains the right people post-closing? Effective post-closing retention requires vesting schedules tied to employment milestones rather than time alone — ensuring that key employees have economic incentive to complete integration work, not just to show up for a defined period. Monthly vesting over 24-36 months with a six-month cliff balances employee retention against acquisition integration timelines. Back-loaded vesting, where more of the carve-out vests in the second half of the retention period, provides stronger retention for the integration phase when departure risk is highest. Standard carve-out vesting — equal monthly vesting over 24 or 36 months following closing — works reasonably well when the goal is general retention. In AI acquisitions where the acquirer is trying to retain specific people for specific purposes, more targeted vesting structures produce better results. Gurpreet S. Bal describes carve-out designs that include milestone-based components: additional amounts that vest upon integration milestones, model performance benchmarks, or successful product launches within the acquirer's platform. These performance-based components align the retained team's incentives with the acquirer's actual goals rather than simply rewarding continued employment. They also signal to the retained employees that the acquirer has a specific and credible plan for their work — which is often as important to retention as the size of the package itself. The best AI acquisition carve-out packages Gurpreet S. Bal has structured share a common feature: the recipients understand exactly what they are being retained to accomplish. Further reading: Management Carve-Out Plans in Technology M&A — a comprehensive guide to carve-out plan structure, board fiduciary duties in carve-out design, and how retention pools are negotiated in technology acquisitions. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## AI Acquisitions and Reps & Warranties: Training Data, Model Ownership, and the Gaps Nobody Discloses Source: https://blegal.ai/knowledge/ma-04-reps-warranties-tech Author: Gurpreet S. Bal AI Acquisitions and Reps & Warranties: Training Data, Model Ownership, and the Gaps Nobody Discloses By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The standard representations and warranties schedule in a technology acquisition was built for a different asset. It asks about software IP, source code ownership, employee invention assignments, third-party licenses, and open source usage in the product. These are the right questions for a software company. They are incomplete questions for an AI company — where the primary asset is not software in the traditional sense, but a trained model whose value depends on what it was trained on, how it was built, and who owns the resulting weights. "The standard tech reps schedule asks about software IP. It doesn't ask whether the training data was licensed. Those are very different questions," says Gurpreet S. Bal. "I've had deals where the AI model was the primary asset and the IP reps didn't specifically cover it. That's a problem." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. In 2026, with AI regulation advancing rapidly across the US and EU, acquirers are increasingly asking questions the standard tech R&W schedule was never designed to answer — and sellers are discovering the scope of disclosure required. What are the key AI-specific representation gaps in standard tech deals? Standard tech M&A rep and warranty templates were not designed for AI companies and contain critical gaps around training data provenance, model performance claims, foundation model license compliance, and AI Act regulatory status. Buyers who rely on generic tech reps without AI-specific additions may close without adequate protection for the liabilities that matter most in AI acquisitions — and those liabilities can be massive. Gurpreet S. Bal identifies four categories of AI-specific exposure that standard tech reps schedules consistently fail to address. First, training data provenance: who owns the data the model was trained on, was it licensed for training purposes, and are there any outstanding claims related to its use? Second, open source contamination in model weights: certain open source model licenses impose restrictions on commercial use that can affect the acquirer's ability to deploy the model without restriction. Third, regulatory exposure for the model's outputs: if the model has been used in regulated applications — lending, hiring, medical contexts — there may be accumulated regulatory exposure the standard IP reps don't capture. Fourth, IP ownership of fine-tuned or customized models: who owns a model that was built on a third-party foundation model and fine-tuned with proprietary data? The answer is frequently unclear and is not addressed in standard reps. Why is training data provenance the hardest issue to disclose? Training data provenance is hard to disclose fully because many AI companies cannot identify with certainty every source that contributed data to their training corpus, whether each source authorized commercial use, and whether any source's data was scraped in violation of terms of service or copyright. Sellers who give accurate and complete training data provenance reps are rare; buyers who rely on broad general reps without specific disclosure schedules face significant undisclosed liability. Training data provenance is particularly challenging because many AI companies, particularly those founded in the 2019 to 2023 period, built their initial models using internet-scraped data without clear licensing. The legal status of using publicly available data for model training remains contested — pending litigation in multiple jurisdictions is directly addressing these questions. Sellers in AI acquisitions face a dilemma: disclosing that training data was scraped without specific licenses invites acquirer concern and potential deal repricing; not disclosing it creates post-closing indemnification exposure. Gurpreet S. Bal notes that acquirers are increasingly demanding specific reps about training data provenance precisely because the issue is known and material, and because post-closing liability for training data claims can be significant. The disclosure conversation is uncomfortable but unavoidable in any well-structured AI acquisition due diligence process. How do foundation model licenses create unexpected M&A complications? Foundation model licenses from providers like OpenAI, Anthropic, Google, and Meta contain commercial use restrictions, redistribution limitations, and assignment provisions that may prohibit or restrict transfer in an M&A transaction without provider consent. Buyers who acquire a company without checking whether the foundation model licenses can be assigned in a merger or asset sale may discover post-closing that their primary AI capability requires renegotiation or replacement. Many AI companies build products by fine-tuning foundation models provided by major AI labs. These foundation models typically come with licenses that impose restrictions on commercial use, sublicensing, and in some cases on the ownership of derivative models built on top of them. In an M&A context, the acquirer inherits the company's license position — including any restrictions that come with it. Gurpreet S. Bal has encountered deals where the target company's core product was built on a foundation model license that prohibited transfer or assignment without the licensor's consent. This creates a closing condition: the acquirer needs the licensor's consent before the acquisition can complete. In competitive M&A processes, this kind of consent requirement — requiring engagement with a potentially unsympathetic third party — can create significant deal uncertainty. Reviewing foundation model license terms is now a standard part of AI M&A diligence. How are AI-specific reps and warranties being structured in current deals? Current AI M&A deals are adding specific representations covering training data sourcing and licensing, compliance with applicable AI regulations including the EU AI Act, accuracy of stated model performance metrics, absence of known biases that could create regulatory or litigation exposure, and compliance with all foundation model license terms. These reps typically have longer survival periods and are carved out from standard indemnification caps given their potentially large liability exposure. Gurpreet S. Bal describes the current market as actively developing its standard approach. Best-practice AI acquisitions in 2026 include a dedicated AI-specific representations section addressing: the completeness and accuracy of the data inventory provided in diligence, the licensing status of all training data used in the company's models, the absence of open source model components whose licenses restrict commercial deployment, the company's compliance with applicable AI regulations (including EU AI Act requirements for any EU operations), and the ownership of all model weights and fine-tuned versions. These reps are backed by a specific disclosure schedule that requires the company to list its training data sources, foundation model licenses, and regulatory interactions. The disclosure schedule often reveals issues that the seller's team had not fully inventoried — and that conversation, while sometimes difficult, is far better to have before closing than after. Further reading: Representations and Warranties in Technology Acquisitions — a foundational guide to technology M&A representations and warranties, disclosure schedules, and how to structure the diligence process for software and IP-intensive companies. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## AI Company Indemnification: Who Pays When the Model Has a Problem After Closing Source: https://blegal.ai/knowledge/ma-05-indemnification-escrow Author: Gurpreet S. Bal AI Company Indemnification: Who Pays When the Model Has a Problem After Closing By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Traditional indemnification and escrow structures in technology acquisitions were built around a specific theory of post-closing risk: the seller knows something the acquirer doesn't, discloses it inaccurately or incompletely, and the acquirer suffers a loss as a result. The escrow is the pot of money held back to compensate the acquirer if that loss materializes. It works well for the risks it was designed to cover. AI acquisitions introduce a fundamentally different category of post-closing liability — one that has nothing to do with what the seller knew at closing. "Traditional escrow was designed for known unknowns. AI introduces genuinely unknown unknowns. The deal structures haven't fully caught up," says Gurpreet S. Bal. "The first wave of AI indemnification disputes is going to teach the market a lot about where these provisions need to be." Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. In 2026, as AI liability claims have emerged from real deployments at scale, acquirers are pushing for AI-specific indemnification provisions and longer escrow tails. Gurpreet S. Bal describes the current state of play as "the market working out where the risk actually sits." What makes AI post-closing liability different from standard tech M&A liability? AI post-closing liability is different because the potential claims are novel, hard to quantify at signing, and may not emerge until years after closing. Training data copyright claims, regulatory enforcement actions for undisclosed AI Act non-compliance, and latent model defects that cause harm to third parties create liability profiles that traditional indemnification structures were not designed to address. The tail risk is longer and less predictable than in conventional technology acquisitions. In a conventional software acquisition, post-closing indemnification claims arise from identifiable pre-closing events: a customer contract with a material term the seller failed to disclose, a patent infringement claim that existed before closing, a tax liability that was known but underprovided for. These are events with a discoverable cause. AI post-closing liability is categorically different in important ways. A model's outputs can cause harm — discriminatory decisions, dangerous recommendations, infringing content — as a result of training data characteristics or model behaviors that were not apparent during pre-closing diligence and were not discoverable with the tools and methods available at closing. The harm may emerge at scale, months or years after deployment, as the model encounters input patterns that didn't appear in testing. Gurpreet S. Bal notes that this is not the kind of liability that traditional indemnification structures were designed to address. What specific AI-related indemnification provisions are acquirers now requesting? Acquirers are requesting indemnification provisions specifically covering copyright infringement claims arising from training data, regulatory fines or penalties for AI Act or similar non-compliance, misrepresentation of model capabilities in seller marketing materials, and costs of remediating model defects discovered post-closing. These provisions are typically subject to separate caps and survival periods distinct from the general rep and warranty indemnification. Gurpreet S. Bal describes a set of AI-specific indemnification provisions that have appeared in recent transactions. Training data indemnification: the seller indemnifies the acquirer for losses arising from third-party claims related to the training data used in the company's models, including copyright infringement claims, privacy claims, and claims under data protection regulations. Model output indemnification: for models deployed in high-stakes contexts (lending, hiring, healthcare), sellers are being asked to indemnify for losses arising from regulatory actions or third-party claims related to the model's outputs for a defined period post-closing. IP chain indemnification: indemnification for losses arising from foundation model license violations or open source contamination claims that were not disclosed. These provisions are contested in negotiation. Sellers resist broad AI indemnification obligations, arguing correctly that post-closing model behavior is substantially driven by how the acquirer deploys and fine-tunes the model after closing. How are escrow size and tail periods being negotiated in AI deals? AI deals are seeing larger escrow holdbacks — 10-20% of purchase price versus the 5-10% standard in conventional tech deals — and longer tail periods for AI-specific indemnification claims, sometimes 36-48 months rather than the standard 18-24 months. R&W insurance coverage is also being tested for AI-specific claims, and some insurers are beginning to offer AI endorsements with specific carve-outs and sublimits for the highest-risk claim categories. Standard technology acquisition escrow has converged over the last decade around a relatively predictable range: 10 to 15 percent of deal value held in escrow for 12 to 18 months, with a rep and warranty insurance policy covering a larger share of the potential indemnification obligation. In AI acquisitions, acquirers are pushing for larger escrows and longer tails — particularly for training data liability, which may not surface until a copyright plaintiff's litigation strategy matures, and for regulatory liability under the EU AI Act, where enforcement timelines are difficult to predict. Sellers, particularly in competitive AI acquihires where they have negotiating leverage, resist. In 2026, the market has not settled on a standard AI deal escrow structure, and the outcomes are highly deal-specific. Gurpreet S. Bal notes that the size and structure of rep and warranty insurance coverage for AI-specific risks has also become a contested issue, as insurance carriers are still developing their underwriting frameworks for AI liability. How should parties think about allocating AI risk when neither side can fully assess it? When neither buyer nor seller can fully quantify AI-specific risks at signing — because the liability depends on third-party litigation, regulatory action, or technical performance issues that may not have manifested — the right approach is to identify specific risk categories, allocate them explicitly to the party best able to manage them, and price the uncertainty into the deal structure through escrow sizing, earnout mechanisms, and R&W insurance where available. Gurpreet S. Bal frames the AI indemnification negotiation as a fundamentally different problem from traditional M&A risk allocation. In standard deals, the indemnification negotiation is about who bears the risk of known but uncertain liabilities — events that have happened but whose consequences are not yet fully determined. In AI deals, both parties face genuinely unknown unknowns: risks that neither side can currently identify because the liability categories themselves are still developing in courts, regulators, and legislatures. His practical recommendation: rather than trying to write indemnification provisions that anticipate every possible AI liability scenario, parties should focus the discussion on the specific, identifiable AI risk categories that are most material for the particular company and deployment context, price those risks explicitly in the deal economics, and use the escrow to cover the identifiable categories. The residual unknown-unknown risk belongs in the acquirer's post-closing risk management framework — not in an indemnification provision that is unlikely to be enforceable as written when the liability actually materializes. Further reading: Indemnification and Escrow in Technology M&A — a comprehensive guide to indemnification structures, escrow mechanics, rep and warranty insurance, and how parties negotiate post-closing risk allocation in technology acquisitions. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## MAC Clauses in 2026: How AI Valuation Volatility Is Redefining Material Adverse Change Source: https://blegal.ai/knowledge/ma-06-mac-clauses Author: Gurpreet S. Bal MAC Clauses in 2026: How AI Valuation Volatility Is Redefining Material Adverse Change By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Material Adverse Change clauses were built for a world of gradual, observable business deterioration — revenue declines, customer losses, litigation events. AI companies don't fit that model. Gurpreet S. Bal, who has represented acquirers and targets in AI transactions across all stages, describes the challenge plainly: "MAC was designed for businesses where the value moves slowly. AI doesn't work that way." In 2026, the period between signing and closing a deal can include a competitor announcing a breakthrough model, a regulator issuing new AI-specific guidance, or a benchmark publication that repositions the target's technology. These events can move AI company valuations by 20 to 40 percent — far beyond what standard MAC definitions were written to address. Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. In AI acquisitions today, both sides need custom MAC language — not the standard form. Why do traditional MAC definitions break down for AI companies? Traditional MAC definitions were calibrated for companies with stable revenue streams and predictable financial metrics. AI companies face valuation swings, competitive displacement from foundation model releases, and regulatory intervention that can materially affect their business overnight — none of which cleanly fit existing MAC carve-out language. Buyers and sellers are now negotiating AI-specific MAC provisions because the standard form language creates more uncertainty than clarity. Standard MAC definitions exclude general market conditions, changes affecting the industry broadly, and changes in the target's stock price. These carve-outs were calibrated for businesses where company-specific events — not industry-level developments — drive dramatic value shifts. In AI, that assumption doesn't hold. A single competitor announcement about model performance can reprice an entire category of AI company. Regulatory action in Europe or a policy shift from a major cloud provider can reshape the business environment overnight. Gurpreet S. Bal has observed that the standard industry-wide carve-out — which buyers agreed to for decades — is now among the most contested provisions in AI acquisition term sheets. What Constitutes "Material" When Valuations Swing 30%? For AI companies where 30% valuation swings can occur based on a single competitive announcement or model release, the traditional MAC standard of a durationally significant impact on long-term earnings power is difficult to apply. Courts have not yet addressed what constitutes material for AI-specific factors, which means the analysis will default to the Akorn standard — requiring buyers to show a substantial, durable change — even when the AI company's competitive position has fundamentally shifted. The word "material" in MAC definitions has been interpreted by Delaware courts to mean a durationally significant decline affecting the long-term earnings power of the business — not a short-term fluctuation. As of 2026, AI company valuations regularly experience swings that would be catastrophic for a traditional technology business but may be transient for an AI company navigating a rapidly evolving competitive landscape. Gurpreet S. Bal notes that buyers and sellers are now fighting over whether AI-specific benchmark shifts, model deprecation announcements, or changes in the compute cost environment qualify as "material" in the legal sense — a question that no court has answered definitively for AI-specific transactions. What are the new AI-specific MAC triggers and carve-outs being fought over? Buyers are pushing for MAC triggers covering loss of a key AI talent cluster, regulatory prohibition of the core AI use case, and foundation model license revocation. Sellers are pushing for carve-outs covering competitive AI announcements, industry-wide regulatory changes, and valuation changes driven by general AI market conditions. These provisions are genuinely novel and there is no established market standard — every deal is negotiated fresh. In 2026, sophisticated parties are negotiating MAC definitions that explicitly address AI-specific risk factors. Buyers are seeking to include: changes in AI regulatory requirements affecting the target's primary markets, material changes in model performance benchmarks published by third parties, and loss of key AI talent above specified thresholds. Sellers are pushing back with equally specific carve-outs: general AI sector conditions, changes in AI hype cycles that don't affect the underlying technology, and regulatory uncertainty that affects all AI companies equally. Gurpreet S. Bal has navigated these negotiations from both sides of the table: "I've had deals where an AI competitor announcement between signing and closing made the MAC question genuinely complicated." The drafting environment requires practitioners who understand both the technology and the legal doctrine. How do you close the MAC risk gap between signing and closing in AI deals? The gap between MAC risk at signing and closing in AI deals is managed through interim operating covenants that prohibit major changes to training infrastructure or model deployment, representation updates requiring disclosure of material adverse developments before closing, shortened sign-to-close timelines that reduce the risk window, and reverse termination fees that compensate sellers if buyers walk using MAC as a pretext. Gurpreet S. Bal recommends that parties in AI acquisitions do three things that are not yet standard practice. First, define the specific AI benchmarks, regulatory frameworks, and competitive landscape factors that will and will not constitute MAC triggers — don't leave it to general language. Second, establish an interim period monitoring framework: what information does the buyer receive between signing and closing, and at what threshold does an update trigger a MAC analysis? Third, build in a negotiated dispute resolution mechanism for MAC questions that arise at closing — a pre-agreed arbitration process is faster and cheaper than litigation over whether a closing can be forced. These are practical solutions to a problem that is becoming more common as AI deal volume increases. Further reading: Material Adverse Change Clauses in M&A Transactions — a foundational overview of MAC clause structure, Delaware case law, and negotiation dynamics for technology transactions. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Earnout Structures Done Right: Using Performance Milestones to Bridge the AI Valuation Gap Source: https://blegal.ai/knowledge/ma-07-earnout-structures Author: Gurpreet S. Bal Earnout Structures Done Right: Using Performance Milestones to Bridge the AI Valuation Gap By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Earnouts are one of the most frequently misused tools in M&A. When they work, they resolve genuine valuation disagreements between buyers and sellers with elegance and precision. When they fail, they generate post-closing litigation that poisons the acquired team's relationship with their new parent company. Gurpreet S. Bal, who has structured earnouts from both buyer and seller perspectives across hundreds of technology transactions, puts it directly: "A well-structured earnout is a partnership. A poorly structured earnout is litigation waiting to happen." In 2026, earnouts have become significantly more common in AI acquisitions — driven by the difficulty of defending pre-revenue AI company valuations at closing in a market where model capabilities and regulatory landscapes shift between signing and closing. Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. Getting the earnout structure right requires experience with where these provisions break down in practice. Why are earnout structures fundamentally different for AI companies? AI company earnouts are fundamentally different because the metrics that matter — model performance, regulatory approval, customer adoption of AI-specific features — are harder to define, measure, and attribute than revenue or EBITDA. Traditional financial metric earnouts assume a stable business; AI company earnouts must account for the possibility that the entire competitive landscape shifts between signing and the end of the earnout period. Traditional technology earnouts are typically built around revenue or EBITDA milestones — metrics that are well-understood by both parties and verifiable from financial statements. AI company earnouts in 2026 increasingly require non-financial milestones: model deployment benchmarks, regulatory clearances for specific AI use cases, customer adoption thresholds for AI-powered products, or technical performance targets measured against published benchmarks. These milestones are harder to define precisely, more susceptible to acquirer influence over outcomes, and more difficult to verify from standard financial reporting. Gurpreet S. Bal has seen each of these failure modes arise in practice, and emphasizes that the precision of milestone definition is the single most important determinant of whether an earnout creates alignment or creates a lawsuit. What are the four failure modes of a poorly structured earnout? The four most common earnout failures are: metric ambiguity (the parties define the metric differently leading to dispute), integration interference (the acquirer integrates the business in ways that make the metric unmeasurable or unachievable), accounting manipulation (the acquirer controls how revenue or costs are allocated to maximize or minimize earnout payments), and force majeure (an external event — a competitor model release, a regulatory ban — makes the milestone impossible to achieve). Gurpreet S. Bal identifies four structural problems that appear repeatedly in earnout disputes. First, vague milestones: revenue targets that don't specify what revenue counts, ARR that doesn't define the subscription terms that qualify, or model deployment that doesn't specify the performance threshold required. Second, acquirer control: the acquirer's post-closing management decisions — resource allocation, pricing, sales strategy — can make earnout milestones impossible to achieve without any bad faith on the acquirer's part. Third, accounting ambiguity: earnout calculations that depend on accounting choices the acquirer controls, without specific rules for those choices. Fourth, integration conflicts: business integration decisions that are optimal for the acquirer but fatal for earnout achievement. Each of these problems has a drafting solution if identified before signing. What does a well-structured earnout actually look like? A well-structured earnout specifies the metric with accounting definitions attached as an exhibit, requires the acquirer to operate the acquired business in a manner designed to achieve the earnout, prohibits integration actions that would make the metric unmeasurable, provides seller audit rights over the earnout calculation, specifies an independent accounting firm as dispute resolver, and includes a good faith covenant with actual teeth — not just a recitation of the obligation. In 2026, a well-drafted AI company earnout has several defining characteristics. The milestones are objectively measurable — ideally by a third party — without requiring a dispute about what the numbers mean. The earnout agreement includes explicit covenants about acquirer conduct during the earnout period: minimum resource commitments, restrictions on integration decisions that affect the earnout business, and affirmative obligations to support milestone achievement. The accounting methodology is fixed at signing with specific rules governing how revenue, costs, and intercompany transactions are treated. And the dispute resolution mechanism is pre-agreed, with an independent accountant or technical expert designated to resolve measurement disagreements. Gurpreet S. Bal is direct on the threshold question: "The earnout only works if both sides agree on what winning looks like before they sign." What AI-specific milestone categories are being used in 2026 earnouts? AI-specific earnout milestones in 2026 include model performance benchmarks (accuracy, latency, or reliability at specified thresholds), regulatory clearance milestones (EU AI Act conformity assessment completion), commercial adoption metrics (number of enterprise customers deploying the AI feature above specified usage thresholds), and retention milestones tied to key technical personnel remaining employed through specified dates. These milestones are more complex to draft and dispute-proof than revenue metrics. As of 2026, Gurpreet S. Bal has observed three milestone categories gaining traction in AI acquisition earnouts. Model performance milestones track the acquired AI system's performance against specified benchmarks — measured quarterly by agreed third-party evaluation frameworks. Regulatory milestone earnouts tie payment to obtaining specific AI regulatory approvals, particularly in regulated industries like healthcare, financial services, and autonomous systems. Customer deployment milestones measure the number of enterprise customers who have deployed the acquired AI capability above specified usage thresholds. Each category has specific drafting requirements that differ substantially from traditional revenue or EBITDA earnout mechanics. Parties who apply standard earnout language to these AI-specific milestones are setting up the disputes that Gurpreet S. Bal regularly sees resolved years after closing. Further reading: Earnout Structures in Technology Acquisitions — a comprehensive treatment of earnout mechanics, negotiation dynamics, and dispute resolution provisions for technology M&A. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Working Capital Pegs in SaaS and AI Acquisitions: Why 'Normal' Is Never Normal Source: https://blegal.ai/knowledge/ma-08-working-capital Author: Gurpreet S. Bal Working Capital Pegs in SaaS and AI Acquisitions: Why 'Normal' Is Never Normal By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Working capital adjustments are among the most technically complex provisions in any acquisition agreement — and among the most consistently mishandled in SaaS and AI deals. The problem is structural: the standard working capital peg methodology imports assumptions from manufacturing and traditional technology businesses that simply don't apply to subscription software companies. Gurpreet S. Bal, who has negotiated working capital mechanics across hundreds of technology acquisitions, identifies the core issue immediately: "The working capital peg that works for a manufacturing company doesn't work for a SaaS company. The accounting is structurally different." Deferred revenue sits on the liability side of the balance sheet in GAAP, but it represents prepaid cash that the buyer will collect — treating it as a deficit in the peg calculation systematically disadvantages sellers in software deals. Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. This is an area where the financial and legal teams need to be in the same room before the LOI is signed. Why does deferred revenue create a working capital adjustment problem? Deferred revenue — customer payments received before the service is delivered — is typically classified as a current liability in working capital calculations, reducing working capital and therefore reducing the purchase price adjustment in favor of the buyer. SaaS and AI companies often have large deferred revenue balances because customers prepay for annual or multi-year subscriptions. If the working capital definition treats deferred revenue as a liability but the company's cash has already been spent delivering the service, the working capital adjustment creates a windfall for the buyer at the seller's expense. Deferred revenue is the accounting entry created when a SaaS company receives annual subscription payments in advance. Under GAAP, the unearned portion sits on the balance sheet as a liability — the company owes the customer the service they've paid for. In a standard working capital peg calculation, this liability reduces working capital and can trigger a post-closing adjustment requiring the seller to pay the buyer. But economically, this deferred revenue represents cash already collected that the buyer will retain — it's not a real liability in the sense that the buyer will ever have to pay cash to settle it. Sellers who don't understand this dynamic going into negotiations regularly discover at closing that they owe the buyer a significant working capital shortfall payment, based on an accounting treatment that doesn't reflect economic reality. How do compute contracts and prepaid infrastructure complicate AI company working capital? AI companies often have large prepaid compute contracts with cloud providers — prepaid expenses that are assets in the working capital calculation. Whether these contracts are included in working capital, treated as long-term assets excluded from the calculation, or classified as debt-like items depends entirely on the working capital definition. Disputes over how to classify prepaid cloud infrastructure contracts are among the most common post-closing adjustment disputes in AI company acquisitions. AI companies add another layer of complexity to the working capital analysis. Large compute contracts — prepaid cloud credits, multi-year GPU reservation agreements, and data infrastructure commitments — sit on the asset side of the balance sheet but may have limited transferability and significant termination exposure. In 2026, Gurpreet S. Bal has seen AI acquisitions where the working capital analysis requires specific treatment of prepaid compute contracts that don't fit any standard category. Buyers want to exclude non-transferable compute commitments from working capital assets. Sellers argue these commitments represent real value that the buyer is receiving. The resolution requires a specific accounting policy election at signing, not a general reference to GAAP. Why do post-closing working capital disputes keep happening? Post-closing working capital disputes persist because parties negotiate deal economics intensely but spend insufficient time on the accounting definitions that determine how the closing balance sheet is prepared. When vague definitions are applied to the actual balance sheet by accountants following different interpretations of GAAP, the parties realize they had different assumptions. By then, the deal has closed and neither party has a good alternative to expensive dispute resolution. As of 2026, working capital disputes in software acquisitions remain among the most common post-closing disagreements that Gurpreet S. Bal encounters. The frequency is a function of drafting habits: parties often negotiate the purchase price in detail while treating the working capital mechanics as a standard exhibit that doesn't require the same attention. The result is that the actual economic adjustment — which can be material relative to the purchase price — is determined by accounting policies that were never explicitly negotiated. Gurpreet S. Bal is direct about the pattern: "I've seen more post-closing disputes about working capital than almost any other deal mechanic." The fix is not complicated: explicit accounting policy elections, a defined treatment for deferred revenue, and a pre-agreed methodology for AI-specific balance sheet items need to be in the purchase agreement, not left to a post-closing true-up process conducted by opposing accountants. How do you get the working capital peg right before signing? The working capital peg should be set by preparing an illustrative closing balance sheet based on a recent historical period, agreeing on the specific accounting methodology for each line item, and attaching that methodology as an exhibit to the purchase agreement. Both sides should hire their accountants to review the methodology before signing, not after closing. The cost of that analysis before signing is a fraction of the cost of a working capital dispute after closing. Gurpreet S. Bal recommends a specific process for SaaS and AI acquisitions. Before the LOI, both sides should agree on whether deferred revenue will be included or excluded from the working capital peg, and document that agreement in the LOI. The definition of "working capital" in the purchase agreement should include a specific accounting policies exhibit that governs every balance sheet item that could be treated differently under GAAP — not a general reference to "GAAP applied consistently." The peg amount itself should be established based on a sample closing statement prepared by the seller and reviewed by the buyer's financial team before signing, not a trailing average that may not capture the company's current state. These steps add a week to the negotiation timeline. They eliminate months of post-closing disputes. Further reading: Working Capital Adjustments in Technology Acquisitions — a detailed guide to working capital peg mechanics, accounting policy elections, and dispute resolution for technology M&A. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Stock Sale, Asset Sale, or Merger: Choosing the Right Structure for an AI Company Acquisition Source: https://blegal.ai/knowledge/ma-09-deal-structure Author: Gurpreet S. Bal Stock Sale, Asset Sale, or Merger: Choosing the Right Structure for an AI Company Acquisition By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The deal structure decision in an acquisition — stock purchase, asset purchase, or merger — has always been primarily a tax question. Buyers prefer asset sales to get a step-up in the tax basis of acquired assets, improving future depreciation and amortization deductions. Sellers prefer stock sales to access capital gains rates and avoid the double-tax problem of an asset sale at the corporate level. In 2026, AI company acquisitions are changing this calculus in ways that weren't relevant five years ago. Gurpreet S. Bal, who has structured AI acquisitions from both buyer and seller perspectives, identifies the emerging issue directly: "AI model weights don't transfer the same way source code does. The asset sale analysis starts from a different place." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. The IP transfer complexity of AI-specific assets is now a primary input into the structure decision alongside tax considerations. Why does AI IP complicate the standard asset sale deal structure analysis? In a standard asset sale, the buyer lists the specific assets being acquired and the specific liabilities being assumed. For AI companies, the primary value is often in trained model weights, training datasets, and fine-tuning infrastructure — assets that are difficult to separate cleanly from the company's other operations. The line between what is being acquired and what is being left behind is harder to draw for AI assets than for conventional software code or customer contracts. In a traditional software company acquisition, an asset sale transfers clearly identified IP assets: registered copyrights, patents, trademarks, trade secrets, and source code. The ownership of each asset can be traced, the transfer can be documented, and the buyer receives clean title to the acquired IP. AI company IP doesn't transfer this cleanly. Trained model weights are the product of a training process that may have used data from third-party sources, open source foundations, and licensed datasets — each with its own terms governing transferability. The fine-tuning pipeline may include proprietary methodologies layered on top of a foundation model licensed from a third party whose agreement restricts transfer. An asset sale of AI IP requires mapping the entire provenance chain of the model before the asset schedule can be written. This due diligence work often reveals transfer restrictions that make a stock sale cleaner despite its tax disadvantages. How does the tax step-up analysis work in AI company acquisitions? In an asset purchase, the buyer acquires assets at fair market value and can depreciate or amortize them over their tax lives, creating a tax step-up. For AI companies, the most valuable assets — trained model weights, training data, and customer relationships — have varying amortization periods under Section 197 and other tax provisions. The tax step-up benefit is one of the primary reasons buyers prefer asset purchases, and sellers demand a premium to accept asset sale treatment that triggers corporate-level tax on the gain. Buyers in asset sales receive a step-up in the tax basis of acquired assets to their fair market value at closing, creating future tax deductions through depreciation and amortization. For AI companies, the most valuable assets — trained models, proprietary datasets, fine-tuning pipelines — are intangible assets amortizable over 15 years under Section 197. The step-up benefit can be substantial when AI IP represents the majority of purchase price value. But Gurpreet S. Bal notes that in 2026, the analysis has become more complex: the step-up benefit from an asset sale may be offset by the cost and risk of IP transfer, the loss of favorable license terms that don't survive asset transfer, and the time required to clean up the IP provenance chain before the deal can close. The structure decision requires quantifying both sides of that equation. How does the consent and assignability question differ between a merger and stock sale? In a merger or stock purchase, the target entity continues to exist as the surviving corporation or subsidiary, so contracts and licenses generally do not require assignment — they remain with the same legal entity. In an asset purchase, each contract must be individually assigned to the buyer, requiring consent from the counterparty if the contract has anti-assignment provisions. AI foundation model licenses and key customer contracts with anti-assignment provisions are the most common obstacles to clean asset purchase structures. Forward triangular mergers — the most common structure for public company acquisitions and many private deals — transfer all assets and liabilities of the target by operation of law, without requiring individual assignment of contracts. This is a significant advantage for AI companies whose customer agreements, compute contracts, and data licenses may include change-of-control or anti-assignment provisions that would require third-party consent in an asset sale. Gurpreet S. Bal describes the merger structure as increasingly preferred in AI acquisitions precisely because it sidesteps the consent problem: "The structure decision used to be primarily a tax question. For AI companies, it's also an IP question." The 338(h)(10) election — which allows a stock sale to be treated as an asset sale for tax purposes — can sometimes capture the best of both structures, but requires specific conditions and careful planning. What framework should parties use when choosing AI deal structures in 2026? Parties should evaluate AI deal structure through four lenses: IP transferability (can model weights and training data be assigned cleanly in an asset sale), regulatory continuity (do any AI regulatory approvals or certifications transfer automatically or require reapplication), tax efficiency (does the step-up benefit to the buyer outweigh the additional tax cost to the seller), and contract consent burden (how many key agreements have anti-assignment provisions requiring third-party consent). The structure that minimizes friction across all four dimensions is the right starting point for negotiation. Gurpreet S. Bal recommends that parties evaluate AI company deal structure decisions against a four-factor framework. Tax efficiency: what is the quantified value of the step-up benefit, net of the tax cost to the seller? IP transferability: does a clean asset transfer require third-party consents that will be difficult or expensive to obtain? Contract assignability: do the target's key contracts — compute agreements, data licenses, customer agreements — have change-of-control or anti-assignment provisions that are easier to navigate through a merger structure? Speed: what is the timeline impact of each structure, and does deal certainty require a faster closing? In recent 2026 AI transactions, Gurpreet S. Bal has seen the IP transferability and contract assignability factors override the pure tax analysis more frequently than in any prior period — a structural shift that reflects the unique characteristics of AI as an asset class. Further reading: M&A Deal Structure: Stock Sale vs. Asset Sale vs. Merger — a comprehensive overview of deal structure considerations, tax mechanics, and practical tradeoffs for technology company acquisitions. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## AI Company Due Diligence in 2026: The Checklist Has Changed Source: https://blegal.ai/knowledge/ma-10-due-diligence-tech Author: Gurpreet S. Bal AI Company Due Diligence in 2026: The Checklist Has Changed By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Technology acquisition due diligence has a standard rhythm: intellectual property ownership, employee IP assignments, software licenses, open source usage, material contracts, regulatory compliance. That checklist was built for software companies whose primary risk exposure sits in conventional IP and employment law. AI companies in 2026 have a fundamentally different risk profile — and the standard checklist doesn't address it. Gurpreet S. Bal, who has led due diligence on AI acquisitions across enterprise software, infrastructure, and applied AI categories, describes the current state of practice candidly: "The companies being acquired today weren't building the same things five years ago. The diligence framework has to keep up." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. The expanded AI due diligence checklist includes categories that didn't exist as deal risk factors when most practitioners were trained — and the omissions are showing up in post-closing indemnification claims. Why is training data provenance the M&A due diligence risk you can't find in the source code? Training data provenance risk is invisible in standard code review because the risk is not in the code — it is in the dataset that trained the model. Web-scraped training data, licensed datasets with commercial use restrictions, and data contributed by users under ambiguous terms of service all create potential copyright and contractual liability that cannot be detected by reviewing the model architecture or inference code. The only way to assess this risk is through a dedicated training data audit. The most important new category in AI company due diligence is training data provenance — and it's the category that receives the least attention from practitioners who learned diligence on conventional software companies. Training data drives AI model quality and, increasingly, AI model legal exposure. Data scraped from the web without proper licensing, data acquired through terms-of-service violations, data that includes personal information subject to GDPR or CCPA restrictions, and data sourced from third parties without clear rights to sublicense — each creates a different category of post-closing liability. Gurpreet S. Bal identifies this as the area where recent AI transactions are generating unexpected risk: "I've had deals where the biggest risk wasn't in the source code — it was in the training data. That's new." A proper training data audit requires understanding how each training dataset was acquired, what license or terms governed its use, and whether those rights survive the acquisition. How does open source contamination in model weights create M&A deal risk? If a model was fine-tuned using code or data subject to a copyleft open source license — such as GPL or certain Creative Commons licenses — the resulting model weights may be subject to the same license terms, requiring the acquirer to make the weights available under those open source terms. This can destroy the commercial value of the acquired model entirely. The contamination may have occurred at any point in the training pipeline and may not be documented in the company's records. Traditional open source diligence focuses on identifying copyleft-licensed code in a company's software stack and assessing the infection risk to proprietary code. AI model diligence requires a different analysis. Foundation models built on open source architectures, fine-tuned using open source datasets, or trained using open source tooling may carry open source license obligations that affect the acquirer's ability to use or commercialize the resulting model. In 2026, several foundation model licenses include restrictions that go beyond standard open source terms — usage restrictions, prohibited-use categories, and commercial licensing requirements. An AI company that has built on a foundation model licensed under one of these restricted licenses may be transferring obligations the acquirer didn't anticipate. This requires a full inventory of every model component and its governing license before the acquisition closes. How does EU AI Act compliance status affect tech M&A deal risk? The EU AI Act classifies AI systems by risk level and imposes compliance obligations that attach to the system and its deployer. An AI system that has not completed the required conformity assessment for high-risk classification cannot legally be deployed in the EU after the applicable compliance deadline. An acquirer who buys a non-compliant AI system inherits the compliance obligation and the regulatory risk — including potential market access prohibition — of bringing the system into compliance post-closing. As of 2026, the EU AI Act is in active enforcement for high-risk AI system categories, and companies with European operations or European customers are in various stages of compliance readiness. AI company acquisitions now require specific diligence on EU AI Act compliance status: whether the target's AI systems are classified as high-risk, prohibited, or general-purpose under the Act; what conformity assessment requirements apply; and what the state of compliance documentation looks like. Gurpreet S. Bal treats EU AI Act compliance as a material risk factor in any AI acquisition with European exposure — both because non-compliance creates regulatory liability and because remediating non-compliance post-closing can be unexpectedly expensive and time-consuming. What does the expanded 2026 AI due diligence checklist require? A comprehensive 2026 AI due diligence checklist covers: training data sourcing and licensing documentation for every dataset used at every training stage, foundation model license terms and compliance status, EU AI Act risk classification and conformity assessment status, model cards and performance benchmarks, known bias assessments and mitigation measures, AI incident history, and third-party audit reports where available. This checklist is materially longer than what most sellers have prepared, which creates significant diligence friction. The 2026 AI due diligence checklist that Gurpreet S. Bal uses in practice extends to several additional categories that are now standard. Compute contract assignability: large GPU reservation agreements and cloud AI credits often include assignment restrictions and change-of-control provisions that must be reviewed before the deal closes. AI governance policies: acquirers are increasingly requiring documentation of the target's internal AI governance framework — what review processes exist for model deployment, what incident history exists, and what internal policies govern acceptable AI use cases. AI incident history: any prior model failures, harmful outputs, or regulatory inquiries should be treated as material disclosure items. Key person dependency: AI companies often have extreme talent concentration in one or two researchers whose departure would materially affect the acquired technology. Each of these categories requires specific diligence requests, document review protocols, and risk quantification — the standard technology diligence template is not sufficient. Further reading: Due Diligence Checklist for Technology Acquisitions — a comprehensive technology acquisition due diligence framework covering IP, employment, contracts, regulatory compliance, and financial risk areas. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The India-to-US Flip in 2026: Updated FEMA Rules and What Founders Still Get Wrong Source: https://blegal.ai/knowledge/ma-11-india-flip-structure Author: Gurpreet S. Bal The India-to-US Flip in 2026: Updated FEMA Rules and What Founders Still Get Wrong By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The India-to-US corporate flip — restructuring an Indian-founded company into a US Delaware holding entity for the purpose of raising venture capital from US and global institutional investors — has become a standard pathway for Indian technology founders pursuing Silicon Valley funding. But "standard" doesn't mean simple, and in 2026, updated RBI circulars and revised FEMA regulations have changed specific aspects of the flip process in ways that matter. Gurpreet S. Bal, who has advised Indian-American founders on both sides of the Pacific on corporate structuring and venture transactions, is direct about the knowledge gap that still exists: "The flip closes and founders think the hard part is over. The ongoing FEMA compliance is where people get into trouble." Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. The 2026 regulatory environment requires both updated transaction advice and a compliance program that extends well beyond closing day. What FEMA and RBI changes in 2026 affect the India flip structure? Recent RBI circulars have tightened the timeline for reporting foreign equity issuances and increased the documentation required for share swap transactions under FEMA. In 2026, companies completing India-to-Delaware flips must file detailed beneficial ownership disclosures and obtain updated RBI approval for the share exchange, with tighter scrutiny on valuation methodologies. These changes have increased the time and cost of completing the flip but have not fundamentally changed the structure's viability. The India-to-US flip relies on the Overseas Direct Investment framework under FEMA, which governs Indian residents' investment in foreign entities. The 2022 ODI Rules and subsequent 2026 RBI circulars have changed three aspects of the flip that practitioners need to understand. First, look-through disclosure requirements for foreign direct investment into Indian subsidiaries of flipped companies have been updated — the current rules require more granular beneficial ownership reporting than the prior framework. Second, pricing guidelines for the share swap mechanism at the heart of the flip have been revised to require updated fairness opinions that meet current RBI standards, not the older DIPP-era pricing methodology. Third, ongoing reporting obligations under Form ODI have been updated with new deadlines and expanded disclosure requirements. Founders who completed flips under prior regulatory guidance and have not updated their compliance programs may be unknowingly non-compliant. How does the share swap mechanics work in an India-to-Delaware flip? In a share swap, Indian founders exchange their Indian company shares for shares in the newly incorporated Delaware parent on a one-for-one or formula-based exchange ratio. The exchange requires a valuation by an RBI-registered Category I or II Merchant Banker, FEMA compliance filings with the RBI, and a board resolution of the Indian company approving the reorganization. The result is a Delaware entity owning 100% of the Indian subsidiary, with the founders holding Delaware shares in place of their Indian shares. The core transaction in a typical India-to-US flip is a share swap: Indian founders and Indian early investors exchange their shares in the Indian operating company for shares in the newly formed US Delaware holding company. Under FEMA, this is treated as an overseas direct investment by Indian residents — subject to RBI reporting, pricing guidelines, and ongoing compliance obligations. The share swap requires a valuation of both the Indian company and the US company at the time of the exchange, conducted by a SEBI-registered or RBI-approved valuer, using a methodology that satisfies current RBI requirements. In 2026, Gurpreet S. Bal emphasizes that the valuation methodology requirement has become stricter: "Updated 2026 regulations have made some parts of the flip easier and some parts harder. You need counsel who has done it recently." Founders who use counsel unfamiliar with the current RBI guidelines risk completing a flip that looks correct on its face but has compliance defects that surface at the next fundraising or at exit. How do investor rights agreements affect the FEMA ownership disclosure analysis? Investor rights agreements — including SAFEs, convertible notes, and side letters granting pro rata rights or information rights — represent contingent equity interests that must be considered in the FEMA beneficial ownership analysis. If a US investor holds a SAFE with a valuation cap that could result in significant ownership at conversion, the look-through analysis should account for that contingent ownership in assessing whether any foreign beneficial owner crosses a disclosure threshold in the Indian subsidiary. One of the most commonly overlooked aspects of the post-flip compliance framework involves investor rights agreements. When a flipped US company raises venture capital, the investment agreement typically includes preferred stock rights, anti-dilution provisions, information rights, and sometimes board observer rights for the investors. Under the FEMA look-through analysis, these contractual rights may affect how the foreign investment in the Indian subsidiary is classified and reported to the RBI. Gurpreet S. Bal has seen situations where investor rights granted at the US parent level create compliance questions at the India subsidiary level that the founders and investors didn't anticipate. The FEMA reporting forms require disclosure of the beneficial ownership and control structure of the Indian entity — which means the cap table and investor rights agreements at the US parent level are relevant to Indian compliance, not just to the US financing. What ongoing compliance do I need after closing an India flip? Post-flip compliance requires annual Foreign Liabilities and Assets (FLA) returns filed with the RBI, transfer pricing documentation for all intercompany transactions between the Delaware parent and the Indian subsidiary, compliance with Indian FDI sectoral caps for any subsequent capital infusions into the Indian entity, and updated beneficial ownership disclosure whenever the Delaware parent's significant stockholders change. Companies that set up proper systems at the time of the flip avoid the retroactive compliance burden that develops when these obligations are ignored. The India-to-US flip creates a set of ongoing annual compliance obligations under FEMA that persist as long as Indian residents hold shares in the US company and as long as the US company holds the Indian subsidiary. Annual performance reports must be filed. Capital infusions from the US parent to the Indian subsidiary require prior reporting or approval depending on the amount and structure. Material changes to the Indian subsidiary — new business lines, equity issuances, senior management changes in some cases — may require RBI filings. As of 2026, Gurpreet S. Bal describes the post-closing compliance program as the piece that most founders underestimate and most counsel underemphasize. A properly executed flip requires a compliance calendar that the founding team understands and someone designated to execute it — either in-house counsel or external advisors on retainer for this specific purpose. Further reading: How to Convert an Indian Company into a US Company for Venture Financing — a step-by-step guide to the India-to-US corporate flip transaction, including the share swap mechanics, regulatory approvals, and post-closing obligations. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Cross-Border Tax in US-India Tech Deals: The Traps That Catch Founders and Investors in 2026 Source: https://blegal.ai/knowledge/ma-12-cross-border-tax-us Author: Gurpreet S. Bal Cross-Border Tax in US-India Tech Deals: The Traps That Catch Founders and Investors in 2026 By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner US-India technology transactions are among the most complex cross-border deals from a tax perspective — a complexity that is routinely underestimated by founders and investors who have experience with purely domestic transactions. The bilateral tax relationship between the US and India involves a specific set of issues that interact in non-obvious ways: the India-US Tax Treaty, TCJA-era provisions like BEAT and GILTI, FEMA's effect on transaction structure, and India's own transfer pricing rules for intercompany transactions. Gurpreet S. Bal, who has represented founders and investors in US-India transactions throughout his career, describes a consistent pattern: "The India-US tax issues are well-known in theory and repeatedly surprising in practice. Every deal uncovers something the founders didn't know." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. As of 2026, the complexity has increased following updated IRS guidance on several TCJA provisions and continued RBI regulatory evolution. How does GILTI keep surprising US shareholders of Indian companies? GILTI surprises US shareholders of Indian companies because the income inclusion is mandatory and annual — it does not wait for a dividend or sale. A US person who owns more than 10% of an Indian company must include their share of GILTI in US taxable income each year, regardless of whether the company distributed anything. For Indian subsidiaries with high-margin software or IP income and minimal tangible assets, GILTI exposure can create US tax liability on income the founder never touched. Global Intangible Low-Taxed Income — GILTI — is the TCJA provision that imposes a current US tax on certain income of controlled foreign corporations earned by US shareholders. For a US parent company that owns an Indian subsidiary operating at a typical Indian effective tax rate, GILTI inclusions are a real and recurring annual tax cost — not a theoretical one. In 2026, Gurpreet S. Bal describes GILTI as the provision that creates the most frequent surprise in US-India venture-backed company structures: US founders who completed an India-to-US flip and then raised venture capital from US institutional investors often discover mid-way through their first US tax return that their Indian subsidiary's income is being taxed currently in the US at rates that were not anticipated in their cash flow projections. The GILTI high-tax exclusion election can help in some cases, but the threshold and mechanics require specific planning at the structure design stage, not as a retrofit after the problem has materialized. How does BEAT exposure arise from intercompany service payments? Base Erosion and Anti-Abuse Tax (BEAT) applies to large US corporations that make deductible payments to foreign affiliates — including management fees, royalties, and service payments to an Indian parent or sister entity. If the US entity's base erosion payments exceed a threshold percentage of total deductions, the corporation owes BEAT in addition to regular corporate income tax. For US-India structures where the Indian entity provides development services to a US operating entity, the service fee structure must be designed to manage BEAT exposure. The Base Erosion and Anti-Abuse Tax is designed to prevent US companies from eroding their US tax base through deductible payments to related foreign parties. For US-India technology companies, the most common BEAT exposure arises from royalty payments from the US parent to the Indian subsidiary for use of IP developed in India, and from service payments for software development, research, or support services performed in India. Gurpreet S. Bal notes that US-India technology companies that grow to meaningful revenue scale sometimes discover BEAT exposure that wasn't anticipated in the original structure — because BEAT only applies above certain modified taxable income thresholds that small companies don't initially meet. The BEAT analysis needs to be built into the long-term financial model, not evaluated only at the current company scale. What are the actual withholding tax rates under the India-US tax treaty? Under the India-US tax treaty, dividends are subject to 15-25% withholding tax depending on the ownership percentage; interest is generally subject to 15% withholding; and royalties are subject to 15% withholding. These rates are lower than the US domestic 30% withholding rate but are still material for cross-border IP licensing and intercompany financing structures. Availability of treaty rates depends on satisfying the treaty's limitation on benefits provisions. The India-US Tax Treaty provides reduced withholding tax rates on dividends, interest, and royalties paid between Indian and US entities — but the reduced rates are not zero, and their application requires specific documentation and structure. Dividends paid by an Indian subsidiary to a US parent company are subject to withholding at 15 or 25 percent under the treaty, depending on ownership percentage, compared to India's domestic withholding rate of 20 percent plus surcharge. Royalties and fees for technical services are subject to treaty rates that may or may not improve the domestic rate, depending on the characterization of the payment under Indian tax law. As of 2026, India has been aggressive in recharacterizing software license payments as royalties subject to Indian withholding — a position that has been litigated extensively and remains unsettled in specific fact patterns. Gurpreet S. Bal is characteristically direct on this point: "GILTI is not an Indian dish. It's the reason some India-US structures don't work the way founders expect." How does the India flip structure interact with US tax treatment? After a flip, the Delaware parent owns the Indian subsidiary, meaning dividends, royalties, and service fees paid from the Indian entity to the US parent are subject to withholding tax under Indian domestic law and the India-US tax treaty. The Delaware parent may be able to use the foreign tax credit to offset US tax on the same income, but the credit is limited and the interaction with GILTI creates complex calculations. US tax counsel should model the entire post-flip tax structure before the flip is executed. The India-to-US corporate flip — converting an Indian company into a US Delaware holding entity — has specific US tax consequences that are not always explained clearly to Indian founders at the time of the transaction. The flip is generally structured to be tax-free at the Indian level under an exchange that qualifies under applicable FEMA provisions, but the US tax treatment of the restructuring depends on how the exchange is characterized under US tax law and whether the resulting US company is properly classified. For founders who are US citizens or green card holders, the flip may have immediate US tax consequences even if the transaction qualifies for Indian tax deferral. Gurpreet S. Bal has seen situations where US-resident Indian founders completed a flip and then discovered US tax consequences that weren't addressed in the transaction documentation. The US and Indian tax advice need to be coordinated from the start of the flip process — not delivered sequentially by counsel in each jurisdiction. Further reading: Cross-Border Tax Considerations for US Taxpayers in International M&A and Venture Deals — a comprehensive treatment of US cross-border tax issues in international technology transactions, including subpart F, GILTI, BEAT, and treaty planning. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Joint Development Agreements and AI: Who Owns the Model When Two Companies Build It Together Source: https://blegal.ai/knowledge/ma-13-joint-development-agreements Author: Gurpreet S. Bal Joint Development Agreements and AI: Who Owns the Model When Two Companies Build It Together By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner AI co-development has become a defining feature of the technology industry in 2026. Large enterprises are partnering with AI startups to build custom models. Startups are partnering with data-rich companies to access proprietary training datasets. AI infrastructure companies are partnering with application companies to build fine-tuned models for specific verticals. In each case, the legal question is the same: when two companies jointly contribute resources to build an AI model, who owns what they built? Joint development agreements were not designed to answer this question. Gurpreet S. Bal, who has negotiated JDAs for AI co-development partnerships from both company and startup perspectives, states the problem directly: "I've reviewed JDAs that said 'jointly owned' for the AI outputs without specifying what that means. It means nothing without more." Gurpreet is a corporate partner representing investors and companies in fundraising and exit transactions, and is known for a straightforward, cut-to-the-chase approach in dealings with clients and counterparties. The ownership question in AI co-development is the question the agreement needs to answer precisely — and most don't. Why does standard IP co-ownership doctrine fail for AI models? Under US patent law, joint owners of a patent can each use, license, and sell the patent without the other's consent and without accounting for profits — a default rule that makes joint AI model ownership unworkable for both parties. An AI company that jointly owns a model with a strategic partner cannot commercialize it freely or license it to competitors without triggering the partner's rights; conversely, the partner can license the model to the AI company's competitors without compensation. This creates deadlock and litigation. Under US copyright law, co-owners of jointly created work each have an independent right to exploit the work without the other's consent, subject only to a duty to account for profits. Applied to AI models, this default rule would mean that both parties to a joint development agreement could independently license the co-developed model to third parties — including to competitors of the other party — without obtaining consent. Most AI co-development parties don't intend this result. They agree on "jointly owned" language without understanding that joint ownership under US copyright law gives each party broad unilateral exploitation rights. In 2026, Gurpreet S. Bal has observed this disconnect surface at the exit stage, when one party attempts to sell the company and the other party argues that the jointly owned AI model cannot be transferred without consent. What are the three AI asset categories that require separate IP ownership treatment? The three AI asset categories requiring separate treatment are: background IP each party brings to the collaboration (existing models, datasets, and infrastructure), jointly developed foreground IP created during the project (fine-tuned models, custom datasets, and training pipelines), and derivative works created by applying joint foreground IP to a party's own products post-collaboration. Each category requires explicitly drafted ownership and license terms because the default rules governing each are inadequate for commercial AI development. A properly drafted AI JDA needs to address three distinct categories of AI-related IP, each of which has different ownership logic. First, pre-existing IP contributed by each party to the joint development — training data, foundation models, existing proprietary algorithms — should remain owned by the contributing party with a cross-license for the joint project. Second, jointly developed AI assets — the trained model weights, the fine-tuning pipeline, the joint evaluation framework — need explicit ownership allocation that replaces the default co-ownership regime. Third, derivative works and improvements made by either party to the jointly developed AI after the project concludes need their own treatment, including allocation rules for improvements each party makes independently using the jointly developed model as a starting point. Gurpreet S. Bal notes that most JDAs address only the second category and leave the first and third as sources of future dispute. How should a startup negotiate exclusivity and commercialization rights in a JDA? Startups should resist exclusivity provisions that prevent them from using developed technology in their own core products, negotiate field-of-use limitations that are defined narrowly around the partner's specific application rather than broadly around any potential use case, and ensure that any exclusivity has a defined expiration date after which the startup retains full commercialization rights. Broad exclusivity granted to a large strategic partner can make the startup's own roadmap legally impossible. For AI startups entering joint development agreements with large enterprise partners, the ownership question is inseparable from the commercialization question. An enterprise partner who co-funds model development may argue that its contribution — whether financial, data, or engineering — entitles it to restrictions on the startup's ability to commercialize the jointly developed model with other customers in the same vertical. This exclusivity pressure is one of the most consequential issues in AI JDA negotiations for startups. Gurpreet S. Bal's advice to startup clients is precise: "The question of who owns the model is the question the JDA needs to answer precisely. Most don't." The commercialization rights, the exclusivity scope, and the restrictions on both parties after the agreement concludes are all dependent on who owns what — and the ownership allocation needs to be decided first, not as an afterthought to the business terms. What happens to a joint development agreement when one party gets acquired? Most JDAs should include change-of-control provisions specifying what happens if either party is acquired. Without these provisions, an acquirer of one party steps into that party's rights and obligations under the JDA — including any licenses granted to the other party — which can create significant complications in the acquisition diligence process. Change-of-control provisions that give the other party termination rights upon acquisition can kill deals or require expensive license negotiations as a condition of closing. In 2026, AI company acquisitions regularly encounter joint development agreements that weren't drafted with exit scenarios in mind. When an AI startup with a jointly developed model gets acquired, the acquiring company needs clean title to the AI IP that is central to the acquisition value. A JDA that assigned joint ownership without specifying transfer rights creates an immediate problem: the enterprise co-developer may argue that its consent is required to transfer the jointly owned IP to the acquirer. Acquirers conducting due diligence on AI company targets now routinely ask for all joint development agreements and analyze whether the ownership and transfer provisions are compatible with a clean acquisition. Gurpreet S. Bal recommends that startups entering AI co-development partnerships build exit-friendly provisions into the JDA from the start — including explicit transfer rights to acquirers and limitations on the enterprise partner's ability to block an acquisition of the startup's interest in jointly developed IP. Further reading: Joint Development Agreements for Technology Companies — a comprehensive guide to JDA structure, IP ownership allocation, and commercialization rights for technology co-development partnerships. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## ABC vs. Chapter 7 for Startups: Why Cost Is Often the Real Driver of the Decision Source: https://blegal.ai/knowledge/ma-14-abc-vs-chapter7 Author: Gurpreet S. Bal ABC vs. Chapter 7 for Startups: Why Cost Is Often the Real Driver of the Decision By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner When a startup runs out of money and there is no rescue financing or acquirer on the horizon, two primary wind-down paths exist: Assignment for Benefit of Creditors and Chapter 7 bankruptcy. The legal literature on this decision emphasizes structural advantages — the ABC's speed and flexibility, Chapter 7's automatic stay and discharge. These are real considerations. But Gurpreet S. Bal, who has advised founders and investors through both processes in Silicon Valley, identifies the factor that practitioners often decline to state explicitly: cost drives this decision more than the theory suggests. "The honest answer for a lot of startups is: ABC is cheaper and faster if you have the right assets and the right buyer. That's most of the analysis." In 2026, as startup failures have increased following the peak of the AI funding cycle, Gurpreet Bal is seeing a higher volume of wind-down situations than at any point in the prior five years. Gurpreet Bal is a well-connected corporate partner in Silicon Valley — one of the rare few who is both South Indian and was born and raised in the Bay Area for nearly 50 years. The path chosen in the first weeks of a wind-down significantly affects how much value is preserved for creditors and, in some cases, for founders. What advantages does an ABC offer over Chapter 7 on speed, privacy, and asset preservation? An ABC can close in two to four weeks and is conducted privately as a state-law contract, with no federal court filings or public docket. Chapter 7 proceeds on a court-supervised timeline measured in months, with all filings publicly visible. For AI companies with sensitive training data, customer contracts, or unreleased models, the privacy of an ABC protects asset value that public Chapter 7 proceedings can destroy — competitors gain no visibility into the company's technology or customer base during the sale process. An Assignment for Benefit of Creditors is a state-law process in which the company (the assignor) transfers all of its assets to an independent third-party assignee, who then liquidates the assets and distributes proceeds to creditors according to their priority. In California, which has more favorable ABC law than most states, the process can be completed in weeks rather than months. There is no court involvement in the typical California ABC — the assignee operates under a private assignment agreement and administers the estate without judge oversight or creditor committee formation. For technology companies with IP assets that are only valuable to a specific acquirer, this speed advantage matters: IP value can deteriorate rapidly when a company winds down, and a fast ABC that closes a sale to a pre-identified buyer preserves value that a slower Chapter 7 would not. When does the Chapter 7 automatic stay and discharge make it the better choice? Chapter 7 is superior when creditors are actively threatening to seize assets, when the company needs the automatic stay to stop collection actions immediately, or when there are disputes over asset ownership that require federal court adjudication to resolve. The bankruptcy discharge also eliminates personal liability for certain types of business debts in a way that an ABC does not. For founders facing personal guarantees on business obligations, Chapter 7 may provide better personal protection. Chapter 7 federal bankruptcy provides two protections that an ABC does not: the automatic stay, which immediately halts all creditor collection actions including litigation and judgment enforcement, and the discharge, which eliminates the company's liability on most pre-petition debts. For startups with active litigation, aggressive creditors pursuing collection actions, or complex liability exposure, the automatic stay can be the decisive factor in favor of Chapter 7. Gurpreet S. Bal notes that the relevant question is whether any creditor is positioned to take collection action in the interval before the ABC closes — if the answer is yes, Chapter 7 may be the appropriate path regardless of its higher cost. The cost difference between an ABC and a Chapter 7 can be significant for an asset-light technology company, but it's not the right consideration if a creditor can execute on a judgment and strip out assets before the ABC assignee can close a sale. Why does having a pre-identified buyer change the ABC vs. Chapter 7 decision? Having a pre-identified buyer strongly favors an ABC. The ABC process can be structured around a specific buyer — the assignee markets to that buyer first, the sale closes quickly, and the transaction is complete before competitors or creditors can disrupt the process. In Chapter 7, any interested buyer must participate in a Section 363 sale process that is inherently more public and contested. The speed and privacy advantage of an ABC is most valuable when the buyer is ready and willing to close immediately. The economics of an ABC versus Chapter 7 change substantially when a potential acquirer has been identified before the wind-down process begins. In 2026, Gurpreet S. Bal describes the typical favorable ABC scenario: an AI startup with a pre-identified strategic acquirer who wants the IP and key engineers, limited litigation exposure, and a creditor base composed primarily of institutional lenders and venture investors who are sophisticated enough to participate in a negotiated ABC process. In this scenario, the ABC can close in four to six weeks, the identified buyer acquires the assets at a price negotiated in the weeks before the assignment, and the assignee distributes the proceeds according to the creditor waterfall. The total legal and professional cost is a fraction of a Chapter 7 proceeding, and the IP value is preserved by the speed of execution. What do I need to know as a founder or board member before choosing between an ABC and Chapter 7? Founders and boards must understand that the choice between ABC and Chapter 7 carries fiduciary duty implications — the decision must be made in the best interests of creditors, not to benefit founders personally. Both processes require that assets be marketed and sold at fair value. Boards should obtain formal insolvency counsel and, in many cases, a solvency opinion before committing to either process. Personal liability for directors can arise in the zone of insolvency if the process is not properly managed. Gurpreet S. Bal's advice to startup founders and boards facing a wind-down decision is consistent: the ABC vs. Chapter 7 analysis should happen before the company has exhausted its runway, not in the final weeks when options are constrained. The decision depends on four factors that can only be assessed with lead time: whether a potential buyer for the assets can be identified; whether any creditors have active litigation or collection actions that require the automatic stay; whether the company's assets are in a form that an ABC assignee can monetize quickly; and whether the creditor base is sophisticated enough to participate in a negotiated ABC process without requiring a formal bankruptcy proceeding for creditor protection. Gurpreet S. Bal is clear about the honest framing that guides this analysis: "Nobody wants to say cost drives this decision. But it does, regularly." A well-timed and well-structured wind-down preserves more value and creates less liability for directors than a crisis-driven process initiated after all other options have failed. Further reading: Assignment for Benefit of Creditors vs. Chapter 7 Bankruptcy for Startups — a detailed comparison of the ABC and Chapter 7 processes, including cost, timeline, creditor treatment, and strategic considerations for startup wind-downs. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Irish IP Tax Structures and R&D Credits: Why Maximizing the Benefit Requires Understanding the IP Development Chain Source: https://blegal.ai/knowledge/ma-15-irish-ip-tax-structures Author: Gurpreet S. Bal Irish IP Tax Structures and R&D Credits: Why Maximizing the Benefit Requires Understanding the IP Development Chain By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Irish IP holding structures have been a standard tax planning tool for US technology companies with global operations for decades. The combination of Ireland's 12.5% corporate tax rate, the Knowledge Development Box providing a 6.25% effective rate on qualifying IP income, generous R&D tax credits, and Ireland's extensive treaty network created a compelling package for technology companies locating IP ownership and R&D activities in Ireland. In 2026, following the implementation of OECD Pillar Two — which imposes a global minimum effective tax rate of 15% for large multinationals — the cost-benefit analysis has shifted. Gurpreet S. Bal, who has advised technology companies on international IP holding structures, is direct about what has changed: "After Pillar Two, the math on Irish IP structures has changed. You need updated advice, not advice from five years ago." Gurpreet S. Bal has been a corporate partner at three of the biggest law firms in the world, and regularly represents cutting-edge companies, investors, and founders throughout the financing, exit, and repeat cycle in the technology industry. The structure only delivers its intended benefit if you understand how the IP was built — and whether that development history qualifies under current Irish Revenue rules. What qualifies for Ireland's Knowledge Development Box — and what doesn't? The Knowledge Development Box applies to income from qualifying patents and computer programs developed through qualifying R&D. To qualify, the IP must have been created through R&D expenditures incurred by the company itself or contracted to unrelated parties — not simply acquired from related parties. Income from trademarks, know-how, and marketing intangibles does not qualify. The nexus formula limits the KDB benefit to the proportion of R&D actually performed in Ireland. Ireland's Knowledge Development Box provides a 6.25% effective corporate tax rate on income derived from qualifying assets — patents and copyrighted software — provided those assets were created through qualifying R&D activities conducted in Ireland. The KDB follows the OECD nexus approach, which links the tax benefit to the proportion of qualifying R&D expenditure incurred directly by the Irish entity relative to total R&D expenditure on the qualifying asset. This means the Irish tax benefit flows from IP that was genuinely developed through Irish R&D — not IP that was developed elsewhere and transferred to Ireland. Gurpreet S. Bal identifies the KDB nexus calculation as the place where Irish IP structures most commonly fail to deliver the expected benefit: technology companies that assume their Irish subsidiary qualifies for the full KDB benefit without conducting the nexus fraction analysis discover at tax filing time that the benefit is smaller than anticipated, because significant R&D was performed outside Ireland. What are the requirements for Ireland's 30% R&D tax credit? To claim the 30% R&D tax credit, a company must incur qualifying expenditures on systematic, investigative, or experimental activities in a scientific or technology field to advance scientific or technical knowledge or create new or improved materials, products, or processes. The activities must be carried on in Ireland. Software development qualifies if it involves genuine scientific or technological advancement, not just routine application of existing knowledge. The credit can offset Irish corporation tax or be refunded in cash over three years. Ireland provides a 30% R&D tax credit on qualifying R&D expenditure incurred by Irish companies — one of the most generous R&D credits in the OECD. The credit applies to incremental R&D expenditure above the prior year baseline, and qualifying activities must meet the Irish Revenue definition of systematic investigation or experimentation in a field of science or technology. For AI companies with Irish R&D operations, the credit can be significant — but it requires contemporaneous documentation of qualifying activities, personnel time allocation records, and project-by-project expenditure tracking that many companies do not maintain consistently. In 2026, Gurpreet S. Bal emphasizes that the R&D credit is genuinely valuable for companies that implement proper tracking from the beginning of their Irish operations — and largely unavailable to companies that try to reconstruct the documentation retrospectively. How does the Pillar Two minimum tax floor change Irish IP structures in 2026? The OECD Pillar Two global minimum tax of 15% applies to multinational enterprise groups with revenue above €750 million, directly affecting whether the Irish KDB rate of 6.25% remains attractive for large companies. Groups subject to Pillar Two will face a top-up tax that brings their effective rate to 15% regardless of the Irish KDB benefit. For smaller companies and startups below the Pillar Two threshold, the Irish KDB and R&D credit remain available at their advertised rates without the top-up. The OECD Pillar Two global minimum tax, implemented in Ireland and across most OECD jurisdictions as of 2024 and now fully operational in 2026, imposes a 15% minimum effective tax rate on the income of multinational enterprise groups with revenue above EUR 750 million. For large technology companies, Pillar Two has narrowed the tax rate differential that made Irish structures attractive. The effective rate on KDB income under Pillar Two cannot fall below 15% — which means the 6.25% KDB rate is subject to a top-up tax for large multinationals. For companies above the Pillar Two threshold, the Irish structure now needs to be evaluated against the 15% floor rather than the headline KDB rate. Gurpreet S. Bal's position is clear on what this requires from a planning perspective: "Irish structures get presented as a tax solution. They're actually an IP development solution with tax benefits attached." The IP development substance is what justifies the structure — and in the Pillar Two environment, substance requirements have become more rigorous, not less. How do I build an Irish IP structure that actually works in 2026? An Irish IP structure that survives regulatory scrutiny in 2026 requires genuine economic substance — Irish-resident employees performing actual R&D and IP management functions, not a letterbox entity. The IP must be developed or substantially improved by Irish operations. Transfer pricing rules require that the Irish entity be compensated at arm's length for any IP it licenses to related parties. Structures that paper over a lack of Irish substance with nominal employees or board meetings will not satisfy the substance requirements under BEPS-aligned Irish Revenue guidance. Gurpreet S. Bal's practical guidance for technology companies considering Irish IP structures in the current environment focuses on three threshold questions. First, is the company above the Pillar Two threshold? For large multinationals, the analysis is materially different than for companies that remain below EUR 750 million revenue. Second, is the IP development activity genuinely being conducted in Ireland, by Irish employees, using Irish R&D expenditure? The nexus fraction that determines KDB eligibility is driven by where the R&D actually happens — not where the IP is legally held. Third, is the company's IP development pipeline documented in a way that supports the KDB and R&D credit claims from the outset? Companies that implement these structures as tax planning exercises without substance behind them face increasing scrutiny from Irish Revenue and, post-Pillar Two, from the OECD's peer review process. The structures that work in 2026 are the ones built on real substance — the tax benefit is a consequence of genuine activity, not a substitute for it. Further reading: Irish IP Tax Structures and Their Benefits for Technology Companies — a comprehensive overview of the Knowledge Development Box, Irish R&D credits, and holding structure considerations for technology companies with international operations. On choosing legal counsel for fundraising or M&A: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## When Definitions Become Traps: Post-Closing Purchase Price Adjustments in M&A Source: https://blegal.ai/knowledge/ma-16-post-closing-adjustment-risk Author: Gurpreet S. Bal When Definitions Become Traps: Post-Closing Purchase Price Adjustments in M&A By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Gurpreet Bal is a Silicon Valley M&A partner who has spent sixteen years on both sides of acquisition tables, structuring post-closing adjustments for buyers and defending sellers against them. He is precise about where these disputes come from. "Post-closing price adjustments are supposed to be a true-up — a mechanism to reconcile the economics of the deal you agreed to against the actual numbers at close," he says. "What they become in contested cases is a fight over what the definitions say, not what the parties meant." A 2023 arbitration award in the acquisition of Save Mart Supermarkets — confirmed by the Delaware Court of Chancery in SM Buyer LLC v. RMP Seller Holdings, LLC in February 2024 — produced a result that reverberated through the deal community: the sellers, who had extracted $205 million in cash pre-close under a cash-free/debt-free structure with a $245 million base value, were ordered to pay the buyer approximately $70 million when the post-closing adjustment mechanics were applied to a subsidiary's $109 million debt that both parties had in practice treated as outside the deal's economics. The arbitrator acknowledged that all of the evidence about what the parties had intended pointed toward exclusion of the debt. He ruled for the buyer anyway, because Delaware contract law required enforcing the definition as written. The case is not primarily a story about aggressive PE tactics, though it is that too. It is a story about what happens when deal-lawyers amend the economics of a transaction mid-stream without updating the definitions that drive the numbers — and then end up in front of a Delaware-trained arbitrator with a strict contractarian orientation and no residual authority to reach for fairness. What is a post-closing purchase price adjustment, and why is the indebtedness definition the most dangerous term in the document? A post-closing purchase price adjustment requires one party to pay the other based on how actual financial metrics at closing compare to contractual targets. The indebtedness definition is the most dangerous term because items classified as indebtedness reduce the purchase price dollar-for-dollar, and what counts as indebtedness depends entirely on how the term is drafted. Ambiguous indebtedness definitions are the single most common source of post-closing disputes that result in millions of dollars of unexpected purchase price adjustment. A post-closing purchase price adjustment is a mechanism in an acquisition agreement that reconciles the actual financial condition of the company at closing against the assumed financial condition that formed the basis for the agreed purchase price. In a typical private company acquisition, the agreed price is based on certain assumptions: a target level of working capital (the cushion of current assets over current liabilities needed to run the business), a debt-free balance sheet (or an agreed treatment of debt), and a cash-free balance sheet (with cash either extracted by sellers or included in the price). Because the deal's financials are estimated before close and confirmed after, an adjustment mechanism determines how much the actual numbers vary from the estimates and who pays the difference. The buyer prepares a closing statement — typically within sixty to ninety days post-close — and any disputes go to an accounting referee or, in some deals, to arbitration. The components of the adjustment are defined in the agreement, and the indebtedness definition is the most consequential of them. "Indebtedness in a purchase agreement is almost never just borrowed money," Gurpreet S. Bal notes. "It typically includes capital leases, earnouts, deferred revenue in some constructions, intercompany obligations, and sometimes contingent liabilities. Every item in that definition is a potential deduction from what the seller receives. And sellers often do not scrutinize those definitions with the same rigor they give to the headline valuation number." The Save Mart case demonstrated the consequences of that asymmetry at scale. What happened in Save Mart — and how did a $245 million deal end with the sellers writing a $70 million check? In Save Mart, the acquisition agreement defined indebtedness using language that, when applied under GAAP as the agreement required, captured certain operating liabilities that the sellers did not intend to include. The arbitration panel applied the contractual definition literally, resulting in a $70 million adjustment against the sellers in a $245 million deal. The sellers argued that the outcome was not what either party intended, but the arbitrator was bound by the contract's plain language and GAAP, not by what the parties subjectively meant. Save Mart Supermarkets operated over two hundred grocery stores in California and Nevada and held approximately a 52% general partnership interest in Super Store Industries (SSI), a wholesale grocery distributor with approximately $109 million of debt on its own balance sheet. Because SSI was an unconsolidated subsidiary accounted for under the equity method, that debt did not appear on Save Mart's balance sheet — only the net investment value ($22.5 million) did. The deal with Kingswood Capital was structured as cash-free, debt-free with a $245 million base value. Sellers swept $205 million of cash pre-close, which the agreement permitted. The purchase price formula deducted "Closing Date Indebtedness," defined as the aggregate indebtedness of the "Group Companies" — Save Mart and its "Operating Subsidiaries," a category that included SSI by reference to the disclosure schedule. Before the deal closed, Kingswood's lenders became concerned about Save Mart's potential liability as SSI's general partner. The parties restructured: an amendment separated the SSI interest into a separate sale at a fixed $90 million price — effectively removing SSI from the deal's variable economics. The problem was that the amendment updated the purchase price formula to subtract the $90 million SSI consideration, but it did not update the definition of Indebtedness, the definition of Closing Date Indebtedness, the definition of Group Companies, or the disclosure schedule that still listed SSI as an Operating Subsidiary. When the buyer prepared its post-closing statement ninety days after close, it included the $109 million SSI debt as a deduction from the base value — a position it had not taken in the pre-closing estimated statement that both parties had used to calculate the price paid at closing. The resulting adjustment turned a positive purchase price into a negative one: the sellers owed the buyer approximately $70 million. The arbitrator, applying Delaware's plain-meaning rule, concluded that the definition of Closing Date Indebtedness unambiguously covered the SSI debt regardless of how SSI had been treated on Save Mart's books, and regardless of the extrinsic evidence that both sides had consistently treated the SSI debt as outside the deal's pricing. "The parties contractually invoked Delaware law," the arbitrator wrote, "and that election is consequential." What does Delaware's contractarian approach actually mean in practice — and why didn't "what both parties intended" matter? Delaware's contractarian framework holds that sophisticated parties are bound by the contracts they sign, and courts will not rewrite contracts to produce outcomes that reflect unexpressed intentions. When both parties are represented by counsel, courts presume that the written agreement reflects the parties' agreement, full stop. The Save Mart sellers' argument that the outcome was unintended was legally irrelevant — what mattered was what the contract said, and Delaware courts enforced it. Delaware contract law interprets written agreements under a plain-meaning, four-corners approach: if the language of a contract is unambiguous, the court will not consider extrinsic evidence — negotiations, prior drafts, communications, or testimony about what the parties meant — to alter its meaning. This doctrine is often described as certainty-promoting: parties can rely on what the document says rather than what might be constructed from a surrounding course of dealing. In the Save Mart arbitration, the sellers argued that the extrinsic record — including Kingswood's own letter of intent, which did not include SSI debt in its sample indebtedness calculation, and the pre-closing estimated statement that both parties had prepared and accepted without including the SSI debt — demonstrated the parties' mutual intent to exclude the SSI obligation. The arbitrator conceded that the extrinsic record supported the sellers' position but refused to consider it because the contract language was unambiguous. The sellers then tried several textual arguments: that the accounting rules provision in the agreement, which prohibited using accounting methods different from those historically applied, should prevent including debt that had always been carried at net equity value; that the SSI debt's listing as an "Undisclosed Liability" elsewhere in the agreement was inconsistent with its simultaneous inclusion in Closing Date Indebtedness; and that the amendment's structural separation of the SSI transaction was incompatible with treating SSI's debt as part of the primary deal's indebtedness calculation. The arbitrator rejected each argument. The lesson Gurpreet S. Bal draws from this is precise: "Delaware contractarianism is not a surprise. It is a known feature of the jurisdiction. When you draft definitions that are broader than the deal's economic intent, you are loading a weapon. Whether it gets fired depends on how disputes are resolved and who is on the other side of the table." Why did the choice to arbitrate make this outcome essentially unreviewable — and what would have happened in court? The parties agreed to binding arbitration before an independent accounting firm acting as a neutral, with no appeal on the merits. Courts reviewing arbitration awards apply an extremely deferential standard — they will only vacate awards for fraud, corruption, or conduct exceeding the arbitrator's authority, not for legal error or a result they would have reached differently. Had the dispute been litigated in Delaware court, the sellers would have had the right to appeal on legal grounds and might have obtained a different interpretation of the ambiguous contract language. The sellers agreed to submit the SSI debt dispute to binding arbitration before a retired Delaware Court of Chancery vice chancellor. This choice, which must have seemed reasonable at the time — a sophisticated former judge familiar with M&A disputes and Delaware law — turned out to eliminate the meaningful appellate review that might have changed the outcome. The standard for overturning an arbitration award under the Federal Arbitration Act is "manifest disregard of the law" — a standard that Vice Chancellor Laster, confirming the award in the Delaware Court of Chancery, described as requiring proof that the arbitrator knew the relevant legal principle, knew it controlled the outcome, and willfully refused to apply it. He confirmed the award, but added a notable comment: he "would have ruled differently than the arbitrator" and believed the outcome was "economically divorced from the intended transaction." His own interpretation — that the accounting rules provision and the amendment's separate treatment of SSI created at least an ambiguity in the Closing Date Indebtedness definition — would have allowed consideration of extrinsic evidence and likely produced a different result. But that interpretation, offered in the order confirming the award against the sellers, was not available as a path to relief. Had the dispute been litigated in the Court of Chancery rather than submitted to arbitration, Vice Chancellor Laster's reasoning suggests the sellers may have won. "The decision to arbitrate rather than litigate is usually presented as a speed and confidentiality question," Gurpreet S. Bal says. "This case illustrates that it is also a finality question. When a court would have ruled differently but confirms the award anyway because it cannot find manifest disregard, arbitration has produced an irreversible outcome that litigation would not have." What should I do — as a technology M&A seller — to protect against this category of risk? Sellers should require their counsel to prepare a detailed illustrative working capital and indebtedness calculation from a recent historical balance sheet before the purchase agreement is finalized, attach that calculation as a contract exhibit, and negotiate specific carve-outs for any item whose treatment is uncertain. Any accounting treatment that could go either way should be addressed explicitly — not left to GAAP gap-filling. The cost of thorough pre-signing accounting diligence is trivial compared to the cost of a post-closing adjustment dispute. The Save Mart case is memorable partly because of its scale and the PE dynamic, but the structural failure it illustrates — a definition that survived a mid-deal restructuring without being updated to reflect the new deal economics — is a recurring pattern that Gurpreet S. Bal has seen in technology acquisitions with far smaller dollar amounts and equally material consequences. In the technology context, the analogues to SSI-style off-balance-sheet liabilities are numerous: unconsolidated joint ventures, variable interest entities, software escrow obligations, deferred revenue constructions that different buyers treat differently, unfunded pension-like obligations in acquired international entities, and contingent tax liabilities in cross-border structures. Three specific practices reduce the risk. First, when an acquisition agreement is amended mid-stream — whether to restructure the deal, carve out an asset, or accommodate financing conditions — the amendment review should systematically verify that every defined term affected by the structural change has been updated to reflect the new deal architecture. The Save Mart sellers believed they were removing SSI from the deal; what they had actually done was remove SSI from the economics while leaving it in the definitions. Those are not the same thing. Second, sellers should scrutinize the indebtedness definition for any item that is not on the company's balance sheet under the accounting methodology the seller uses — and either expressly exclude it or confirm with the buyer that it is being treated consistently with the seller's balance sheet presentation. Express exclusions in the indebtedness definition are standard practice in deals where known obligations exist that both parties intend to treat as outside the adjustment. Third, consider a cap on post-closing adjustments equal to the escrow or the agreed adjustment holdback. A $7 million escrow capping exposure to $7 million — rather than an uncapped adjustment that produced a $70 million payment — would have been a negotiable provision and a transformative one. See the companion piece on working capital adjustments in technology acquisitions for the standard mechanics, and the piece on deal structure (stock sale vs. asset sale vs. merger) for how structure choices interact with adjustment risk. Further reading: When Definitions Become Traps: Post-Closing Purchase Price Adjustments — the gurpreetbal.com version covers the specific Save Mart indebtedness definition language, the amendment drafting failure, and the technical arbitration confirmation standard in more detail. If you are evaluating counsel for this type of matter: How to Find a Sell-Side M&A Lawyer for a Technology Company On choosing legal counsel generally: Considerations for Founders and Companies Raising Money or Selling  ·  gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world’s top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## What to Do When the Buyer Invokes the MAC Clause Source: https://blegal.ai/knowledge/mac-clause-invoked-seller-response Author: Gurpreet S. Bal What to Do When the Buyer Invokes the MAC Clause By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner A material adverse change clause — the MAC or MAE clause in an acquisition agreement — is the mechanism by which buyers attempt to exit announced deals when circumstances change between signing and closing. In Delaware courts, which govern the overwhelming majority of significant acquisitions, MAC invocations have succeeded in only a handful of cases over the past thirty years. The landmark case is IBP, Inc. v. Tyson Foods, in which the Delaware Chancery Court articulated what has become the governing standard: a qualifying MAC must be substantial and durable, affecting the company's long-term earnings power rather than representing a temporary or cyclical disruption. In Akorn v. Fresenius — one of the rare cases where a MAC was upheld — the deterioration was so severe, pervasive, and likely permanent that no reasonable buyer would have agreed to the deal at the original price. Most MAC notices sellers receive do not come close to that standard. This guide addresses what sellers should do when a MAC notice arrives, and how to navigate the gap between a buyer's assertion and their legal ability to actually walk away. What does it mean that the buyer just invoked a MAC clause? When a buyer invokes the MAC clause, they are formally asserting that a material adverse change has occurred that relieves them of the obligation to close. This is almost always the beginning of a negotiation — Delaware courts have upheld MAC invocations in only a handful of cases, and buyers know this, making a MAC notice frequently a pressure tactic rather than a genuine exit. A MAC notice triggers formal contractual mechanisms and sets legal deadlines running, but it does not terminate the acquisition agreement. The notice is the buyer's assertion that a qualifying event has occurred; whether that assertion is correct is a legal question that may be litigated in Delaware Chancery Court if the parties cannot resolve the dispute. Sellers should treat the notice as what it almost always is in practice: the opening position in a renegotiation. The buyer signed the deal at a particular valuation, conditions have changed (market conditions, the target company's performance, or the strategic rationale for the deal), and the buyer wants a lower price or an exit. The MAC clause provides the legal frame for that conversation. Sellers who understand this dynamic enter the negotiation with the correct orientation: their task is not to prove the deal is still good, but to make clear they intend to enforce the agreement, assess whether they want to do so, and understand the buyer's walk-away economics before engaging on the merits. Is my buyer's MAC claim actually valid under Delaware law? MAC claims are rarely valid under Delaware law. A qualifying MAC requires showing a substantial, durational deterioration in the target's business — not a short-term disruption or industry-wide downturn. Broad carve-outs for general economic conditions, industry trends, and market disruptions frequently eliminate the buyer's argument before it begins. Delaware courts have applied the IBP standard consistently for decades, and the pattern is clear: courts are deeply reluctant to relieve buyers of their acquisition obligations based on events that a sophisticated buyer could have anticipated or that affect the target's industry broadly rather than the target specifically. The analysis begins with the MAC definition in the purchase agreement and its carve-outs. Well-negotiated agreements exclude from the MAC definition: general economic conditions, changes in financial markets, interest rate movements, changes in law or regulation, industry-wide changes, natural disasters, pandemics, acts of terrorism or war, and changes in generally accepted accounting principles. If the buyer's claimed MAC falls within one of these carve-outs — which is common — the buyer's legal position is weak regardless of the severity of the underlying event. Even if the alleged change is not carved out, it must still meet the IBP durational standard. Courts ask whether the change materially impairs the long-term earnings power of the business. Short-term disruptions, customer losses that may be recoverable, litigation that may be resolved, and temporary market dislocations typically do not qualify. Sellers who receive a MAC notice should immediately analyze both dimensions — carve-out exclusion and IBP durational standard — before assessing litigation risk. What should I do in the first 48 hours after receiving a MAC notice? In the first 48 hours, sellers should retain M&A litigation counsel, preserve all communications, issue a formal written rejection of the MAC claim, and review the reverse termination fee provision. Public statements about deal uncertainty should be avoided entirely. The first 48 hours after a MAC notice are operationally critical because they set the legal and strategic posture for everything that follows. Sellers should take the following steps in sequence. First, engage M&A litigation counsel immediately — not general corporate counsel, but someone experienced in Delaware acquisition disputes who can assess the legal merits and advise on Delaware procedural requirements. Second, issue a litigation hold: preserve all emails, documents, board minutes, financial reports, and communications related to the alleged MAC event and to the acquisition generally. Destruction of documents after a dispute arises is independently dangerous. Third, review the purchase agreement's notice, cure, and termination provisions. Many agreements require the buyer to give notice and a cure period before exercising termination rights; if the buyer has not complied with these procedural requirements, that is an immediate defense. Fourth, send a written response formally rejecting the MAC claim and asserting the seller's right to specific performance or damages. This letter matters both as a legal record and as a signal to the buyer about the seller's intentions. Fifth, calculate the reverse termination fee. This number shapes the entire negotiation: it is the buyer's floor cost for walking away, and understanding that floor is essential to assessing whether a negotiated price adjustment makes more economic sense than enforcing the original deal. How do I negotiate when a buyer uses MAC as leverage to reprice? When a buyer invokes MAC primarily as a repricing mechanism, seller leverage comes from the reverse termination fee the buyer would owe if the claim fails, the cost and time of litigation, and the buyer's reputational interest in closing announced deals. Sellers who understand buyer walk-away economics can often preserve most of the original price. MAC-as-repricing is the most common pattern sellers encounter. The buyer's actual goal is not to exit — it is to close the deal at a lower price, and the MAC notice is the legal vehicle for expressing that desire. Sellers who recognize this pattern can engage the negotiation from a position of strength. The seller's leverage has three components. First, the reverse termination fee: if the buyer's MAC claim fails in court, they owe this fee plus potentially additional damages. In a material transaction, that exposure can be hundreds of millions of dollars. Second, litigation cost and duration: MAC litigation in Delaware Chancery Court takes 12–36 months, consumes senior management time on both sides, is expensive, and is public. Strategic acquirers and private equity funds have strong incentives to avoid this outcome. Third, reputational cost: acquirers who walk away from announced transactions develop a reputation in the M&A market that affects their ability to attract future sellers, their relationships with investment banks, and the premium sellers will demand in future transactions. Sellers who make clear they intend to enforce the agreement — and who have M&A litigation counsel signaling the same — often find buyers willing to close at the original price or with a modest adjustment that preserves most of the deal economics. When does it make sense to litigate a wrongful MAC invocation? Litigation makes sense when the transaction is large enough to justify the cost, when the MAC claim is legally weak, when the reverse termination fee is inadequate relative to deal value, and when the seller has strong documentation. Specific performance — forcing the buyer to close — is sometimes available and is the most powerful remedy. The decision to litigate a MAC dispute is driven by three factors: transaction size, legal merits, and desired remedy. On size: MAC litigation costs are significant regardless of outcome. Seller legal fees for a contested MAC proceeding in Delaware Chancery Court can reach $10–30 million in a complex case. That investment only makes sense if the gap between the reverse termination fee and the full transaction value is substantially larger. For transactions above $500 million where the buyer's MAC claim is legally weak, litigation or the credible threat of it is often the right path. On merits: sellers with a clear carve-out defense or strong evidence that the alleged change is temporary and not durational have the strongest litigation positions. Sellers whose businesses have genuinely and severely deteriorated face harder tradeoffs. On remedy: the most powerful outcome in MAC litigation is specific performance — a court order compelling the buyer to close. Many modern acquisition agreements explicitly provide for specific performance as an available remedy, and Delaware courts have shown willingness to grant it when the agreement permits. The threat of a specific performance motion often resolves MAC disputes more quickly than any other mechanism, because buyers do not want a court ordering them to complete an acquisition they no longer want. How do I protect myself from MAC risk the next time I sign an acquisition agreement? MAC protection comes from narrow MAC definitions, broad carve-outs, a reverse termination fee sized for real deterrence, a specific performance right, and minimizing the signing-to-closing timeline. Each day between signing and closing is a day on which a MAC can potentially be claimed. Sellers who have navigated a MAC dispute — or who have been counseled through one — typically negotiate their next acquisition agreement with significantly more attention to MAC risk management. The five provisions that matter most are: first, the scope of MAC carve-outs. Sellers should push for the broadest possible list of excluded events, including macroeconomic conditions, capital market changes, industry conditions, regulatory changes, natural disasters, and anything with a systemic rather than company-specific character. Second, the definition of what counts as a MAC should require a finding of materiality that is durable and substantial — language tying the standard to the IBP doctrine is protective. Third, the reverse termination fee should be sized at 5–8% of transaction value to create genuine deterrence rather than a cheap exit option. Fourth, the specific performance right should be explicit, bilateral, and not subject to conditions that make it difficult to invoke. Fifth, the signing-to-closing timeline should be minimized through careful structuring of regulatory approvals and third-party consents — every additional day in the gap is additional MAC exposure. Sellers who negotiate these five provisions carefully create a structural environment in which MAC invocations are legally expensive for buyers and unlikely to succeed. Further reading: What to Do When the Buyer Invokes the MAC Clause — the gurpreetbal.com version covers the seller response playbook in detail, including first-person practitioner perspective on MAC-as-repricing tactics and how to negotiate reverse termination fee leverage. Related: Post-Closing Working Capital Disputes  ·  Earnout Dispute: When Acquirers Manipulate Metrics  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Mergers & Acquisitions — M&A Law Reference Source: https://blegal.ai/knowledge/mergers-acquisitions Author: Gurpreet S. Bal Mergers & Acquisitions Analytical reference by Gurpreet S. Bal, Silicon Valley M&A and Technology Partner | blegal.ai Technology M&A transactions are among the most legally complex deals in private markets — combining securities law, tax structuring, IP diligence, employment issues, and fiduciary duty compliance into a single closing process. This reference hub covers the full analytical landscape: deal structure selection, representations and warranties in technology acquisitions, earnout design and disputes, indemnification mechanics, Delaware related-party compliance, cross-border tax, and distressed exit structures. Each article addresses the specific legal issue in depth, grounded in practice from both buy-side and sell-side representation. Articles in This Category Delaware Section 144 Safe Harbor in M&A How the amended Delaware Section 144 safe harbor operates — and where its protections fail when a related-party transaction is litigated. Delaware Section 220 Books and Records Demands How shareholders use Section 220 to investigate M&A transactions before filing derivative or class action claims. Management Carve-Out Plans in M&A How management carve-out pools are structured, how they affect the acquisition price, and how to design them to survive scrutiny. Reps and Warranties for Tech Acquisitions Technology-specific representations and warranties in acquisition agreements, including IP ownership, open source, and data privacy reps. Indemnification and Escrow Structures Indemnification caps, baskets, escrow holdbacks, survival periods, and rep and warranty insurance in technology acquisitions. Material Adverse Change Clause Triggers What qualifies as a MAC, how Delaware courts have interpreted MAC clauses in contested transactions, and drafting best practices. Earnout Structure Design and Disputes How to structure earnouts that reflect economic intent, common drafting failures that generate disputes, and how earnout litigation proceeds. Working Capital Adjustments in M&A How working capital targets are set, how post-closing adjustments are calculated, and the dispute resolution process when parties disagree. Asset vs Stock vs Merger Deal Structure Tax, liability transfer, and third-party consent implications of choosing between an asset purchase, stock purchase, and forward or reverse merger. Tech M&A Due Diligence Checklist Analytical framework for technology M&A diligence — IP ownership, open source risk, contracts, employment, regulatory, and data privacy review. India-to-US Flip Structure Mechanics How Indian startups restructure to US Delaware holding companies, the regulatory requirements, and common complications. Cross-Border Tax Issues in US M&A FIRPTA withholding, treaty analysis, Section 338 elections, and other cross-border tax considerations in US acquisitions of foreign targets. Joint Development Agreement Structures IP ownership allocation, commercialization rights, exclusivity provisions, and exit mechanics in technology joint development agreements. Assignment for Benefit of Creditors vs Chapter 7 Analytical comparison of ABC and Chapter 7 as distressed exit paths — process, timeline, creditor rights, and buyer considerations. Irish IP Holding Company Tax Structures How Irish IP holding structures work in technology M&A, the Knowledge Development Box regime, and US tax interaction. Post-Closing Adjustment Risk How post-closing purchase price adjustments expose sellers to ongoing financial liability after a deal closes, and mitigation strategies. Also on this topic: Mergers & Acquisitions — Personal Practice Hub on gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on M&A, private equity, and public offerings. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion. For more information, visit gurpreetbal.com . --- ## What to Do When You're in a Post-Closing Working Capital Dispute Source: https://blegal.ai/knowledge/post-closing-working-capital-dispute Author: Gurpreet S. Bal What to Do When You’re in a Post-Closing Working Capital Dispute By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Post-closing working capital adjustments are a standard feature of acquisition agreements — the purchase price was set assuming the target company had a defined level of working capital at closing, and the adjustment reconciles the actual amount against that target. What is supposed to be a mechanical accounting reconciliation frequently becomes a contested dispute, because both parties have significant money at stake, the accounting judgments involved are genuinely complex, and sophisticated buyers have learned that the closing statement is their last opportunity to adjust the effective purchase price. The landmark case of Chicago Bridge & Iron Company v. Westinghouse Electric Company addressed fundamental questions about when working capital disputes can become independent legal claims versus being limited to the contractual dispute resolution process — a boundary that matters enormously for sellers trying to determine whether the buyer's conduct in preparing the closing statement rises to the level of a breach of contract. This guide covers the practical and legal dimensions of post-closing working capital disputes, from the moment the closing statement arrives to the neutral accountant process and, where necessary, litigation. How do post-closing working capital disputes actually start? Post-closing working capital disputes start when the buyer delivers its closing statement — typically 60–120 days after closing — showing actual closing working capital that differs materially from the target used to set the purchase price. Disputes arise when the seller believes the buyer's calculation is wrong, manipulated, or inconsistent with the accounting methodology agreed at signing. The mechanics of the post-closing adjustment process create a structural opportunity for buyers to reopen the purchase price negotiation. The process begins at closing with an estimated working capital calculation — typically derived from the most recent financial statements available at signing — and ends with the buyer's final closing statement reflecting the actual closing balance sheet. The gap between the estimated and actual figures determines whether the seller owes the buyer an adjustment (negative working capital) or the buyer owes the seller an additional payment (positive working capital). In practice, buyers' closing statements are almost uniformly their most aggressive possible calculation — sophisticated acquirers understand that the final resolution will be negotiated between the two parties' positions, so opening aggressively captures value that a good-faith estimate might not. The items most commonly contested include: accounts receivable (which the buyer may classify as uncollectible using more aggressive aging assumptions than the seller's historical practice); inventory (which the buyer may write down using new obsolescence criteria); accrued liabilities (which the buyer may inflate with new accruals not reflected in the seller's closing balance sheet); and deferred revenue (which the buyer may treat differently than the seller under the applicable accounting standards). Sellers who receive closing statements should immediately engage an accounting firm with post-closing adjustment experience to analyze each disputed item before the objection deadline runs. What does my purchase agreement say about the dispute resolution process? Most acquisition agreements provide: buyer delivers a closing statement within a specified period, the seller has a response period to object in writing, the parties have a negotiation period, and unresolved disputes go to a neutral accountant. Missing the seller's objection deadline typically deems the buyer's statement final and binding — making all deadlines hard. The procedural framework for working capital disputes is typically found in the "purchase price adjustment" or "working capital adjustment" section of the purchase agreement, and its deadlines and requirements are hard contractual obligations. The standard timeline runs as follows. The buyer delivers the closing statement within 60–120 days after closing — the exact period is specified in the agreement. The seller has 30–60 days from delivery of the closing statement to review it and deliver a written objection notice. The objection notice must specify each item in dispute and the seller's proposed treatment — a general objection that the buyer's statement is incorrect is typically not sufficient. If the seller fails to deliver a timely objection notice, most purchase agreements provide that the buyer's closing statement becomes final and binding, and the adjustment is calculated based on the buyer's figures without further right of appeal. After the objection notice is delivered, the parties enter a negotiation period (typically 30–45 days) to resolve disputed items by agreement. Items that cannot be resolved are submitted to a neutral accountant for binding determination. Understanding each of these deadlines before the closing statement arrives — and having accounting counsel retained and ready to review the statement promptly — is the first and most important protection against a manufactured working capital dispute. How do buyers manufacture working capital disputes to claw back purchase price? Buyers manufacture disputes by applying accounting judgments more aggressively than done historically — using aggressive AR aging, new inventory write-down criteria, inflated accrued expenses, and GAAP interpretation arguments that produce working capital figures materially lower than what the parties assumed at signing. The four classic manufactured working capital dispute patterns appear with regularity across M&A transactions and are well-understood by post-closing adjustment practitioners. First, accounts receivable aging manipulation: the buyer applies an AR write-off or reserve formula that is more aggressive than the seller's historical practice, writing down receivables that are 60 or 90 days outstanding that the seller would have historically collected with normal follow-up. The seller's defense is its historical collection rates for aged receivables and its documented AR methodology. Second, inventory reclassification: the buyer applies new criteria for slow-moving or obsolete inventory that result in write-downs not consistent with how the company historically evaluated inventory. The seller's defense is the historical turnover rates and obsolescence methodology documented in the company's accounting policies. Third, accrued expense inflation: the buyer inserts new accruals for contingent liabilities (legal claims, warranty obligations, customer credits) that were not reflected in the seller's closing balance sheet and were not disclosed during due diligence as items requiring accrual. The seller's defense is that the accruals are inconsistent with the company's historical practice and with the accounting methodology specified in the purchase agreement. Fourth, GAAP interpretation engineering: the buyer argues that the company's historical accounting in certain areas was not consistent with GAAP — typically in areas where GAAP provides judgment and the company made reasonable accounting choices — and recalculates working capital on a "corrected" basis that happens to produce a significantly lower figure. This tactic is the most legally aggressive because it requires the buyer to argue that the company's accounting was wrong all along, which raises questions about what was disclosed in due diligence. What evidence do I need to defend my working capital position? Defense requires documentation of the company's historical accounting practices, evidence that the buyer's adjustments depart from those practices, and support for each item in the seller's closing working capital figure. The core document is a side-by-side comparison of historical treatment versus the buyer's closing statement treatment of each disputed item. Defending a working capital position in the neutral accountant process requires organized, methodical presentation of accounting evidence, not legal argument. The neutral accountant is an accounting expert who will evaluate which party's treatment of each disputed item is consistent with GAAP and with the accounting methodology defined in the purchase agreement. Sellers should build their defense around four evidence categories. Historical accounting methodology documentation: written records of how the company calculated each working capital line item historically — the AR reserve formula, the inventory write-down criteria, the accrual policies — supported by the financial statements from the two to three years preceding the acquisition showing these policies consistently applied. Methodological deviation analysis: a specific, item-by-item analysis showing where and how the buyer's closing statement departed from the established methodology, with quantification of the financial impact of each deviation. This document is the foundation of the seller's objection notice and the core of its neutral accountant submission. Item-level support documentation: underlying documentation for the specific items included in the seller's closing working capital calculation — customer invoices and collection history for disputed receivables, inventory count and aging reports, accrual calculation workpapers. Due diligence record: documentation from the due diligence process showing what the buyer knew about the company's accounting practices before signing. If the buyer asked about AR aging methodology during diligence and received a clear explanation, that record supports the argument that the buyer agreed to value the company on that methodology and cannot legitimately apply a different one in the closing statement. How does the neutral accountant arbitration process work? The neutral accountant receives written submissions from both parties, may request additional information, and renders a binding determination on disputed accounting items. The process takes 30–90 days and is binding on accounting questions. The neutral cannot decide legal questions, cannot award damages beyond the working capital adjustment, and cannot address items outside the parties' objection notices. The neutral accountant process is a binding accounting determination, not a legal arbitration, and understanding the distinction is critical for sellers deciding how to invest in the dispute process. The neutral is typically a partner from one of the large accounting firms (Deloitte, PwC, EY, KPMG) or from a specialized firm that provides post-closing adjustment dispute resolution services. The process begins when the parties submit the disputed items to the neutral pursuant to the purchase agreement's procedural requirements. The neutral reviews both parties' written submissions, which typically include the closing statement, the objection notice, supporting workpapers, and legal argument about the applicable accounting standard. The neutral may issue questions to both parties and request additional documentation. The determination is issued in writing and is binding on the accounting questions presented. The determination does not address legal claims, cannot award damages for misconduct, and cannot revise the purchase price beyond the working capital adjustment calculation. The key limitation that sellers frequently encounter is the mandate restriction: the neutral can only decide items that were included in the seller's timely objection notice. Items that were inadvertently omitted from the objection notice, or that the seller decided not to contest, are not subject to the neutral accountant's review and the buyer's treatment of those items becomes final. This is another reason why the objection notice — which the seller typically has 30–60 days to prepare — deserves careful accounting analysis, not a rushed response. Is it worth litigating a post-closing working capital dispute? Litigation is worth pursuing when the neutral accountant process cannot capture the full value of the seller's claims — typically because the dispute involves buyer conduct claims beyond pure accounting questions. For most disputes under $3 million, the neutral accountant process and direct negotiation produce better risk-adjusted outcomes than litigation. The decision framework for post-closing working capital litigation was materially shaped by the Chicago Bridge & Iron case, which addressed whether sellers can pursue independent legal claims arising from the buyer's conduct in preparing the closing statement (breach of contract, fraud, intentional manipulation) or whether those claims are subsumed within and preempted by the purchase agreement's working capital adjustment mechanism. The answer depends on how the purchase agreement is drafted and whether the seller's claims go beyond disagreement about accounting methodology to challenge the buyer's conduct in the process itself. Sellers who have claims that fall within the neutral accountant's mandate — pure accounting disputes about which party's methodology is correct — should pursue the neutral accountant process, which is faster, cheaper, and more expert than court. Sellers who have claims that the buyer's conduct in preparing the closing statement was fraudulent, intentionally manipulative, or a breach of express representations — claims that go beyond accounting methodology to conduct — may have independent legal claims that survive the neutral accountant process and can be pursued in court. The economics of litigation depend on transaction size: disputes below $3 million rarely justify the investment, while disputes above $10 million — particularly where there is evidence of intentional manipulation — may support litigation. The credible threat of litigation, demonstrated through M&A litigation counsel engagement and a well-prepared demand letter that identifies both accounting objections and legal claims, often produces favorable settlement outcomes that capture significant value without requiring an actual trial. How do I negotiate working capital terms to protect myself before signing? The most protective provisions are a locked-box mechanism eliminating post-closing adjustments entirely, a precisely defined working capital calculation with specific accounting methodology locked in, a tight collar, a short closing statement deadline, and a defined methodology standard that requires the neutral accountant to apply historical practice rather than choosing independently. Prevention of post-closing working capital disputes requires attention to the purchase agreement provisions at the time of drafting — provisions negotiated at signing become the rules applied months later in a dispute context where incentives and relationships have fundamentally changed. The five most protective provisions are: first, the locked-box mechanism, which eliminates post-closing adjustments entirely by fixing the purchase price to a specific historical balance sheet with covenants against value leakage between the locked-box date and closing. Locked-box deals are more common in European transactions but are increasingly accepted in U.S. M&A, particularly in private equity transactions where deal certainty is valued. Second, a working capital definition with locked accounting methodology: the purchase agreement should specify not just which balance sheet line items constitute working capital but the exact methodology used to calculate each item, by reference to the company's historical accounting policies as of a defined date. Third, a meaningful collar: a range within which no adjustment is made — typically 1–2% of the transaction value — reduces both parties' exposure to small adjustments and creates alignment incentives around accurate estimation. Fourth, a short closing statement period: 45–60 days from closing rather than 90–120 days reduces the buyer's time to construct an aggressive position and maintains the seller's institutional knowledge of the closing balance sheet. Fifth, a neutral accountant standard that requires application of the historical methodology: the purchase agreement should specify that the neutral accountant's mandate is to determine which party's treatment is most consistent with the company's historical accounting practices, not to independently determine the correct accounting treatment under GAAP without reference to history. This standard prevents the neutral accountant process from becoming a vehicle for accounting engineers to replace the seller's methodology with a different one. Further reading: What to Do When You're in a Post-Closing Working Capital Dispute — the gurpreetbal.com version covers the same material from a first-person practitioner perspective, including Gurpreet Bal's experience advising sellers through the neutral accountant process and specific pre-closing protective strategies. Related: Earnout Dispute: When Acquirers Manipulate Metrics  ·  When the Buyer Invokes the MAC Clause  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Post-Money SAFEs: The Exact Math That Cuts Common to 50% at Series A Source: https://blegal.ai/knowledge/post-money-safe-mechanics Author: Gurpreet S. Bal Post-Money SAFEs: The Exact Math That Cuts Common to 50% at Series A Analysis by Gurpreet S. Bal, Partner, Foley & Lardner LLP, Silicon Valley  ·  May 20, 2026 A $20M post-money SAFE at a $50M cap leaves founders and employees owning exactly 50% of the company after a standard Series A — before any future rounds. Most founders don't discover this until the term sheet arrives. This analysis models six scenarios across three SAFE structures with precise, verified arithmetic. The math is not approximate. Compare the structures before signing. Why is SAFE conversion math so counterintuitive for me? SAFE conversion math is counterintuitive because the dilution is invisible until it happens. When a SAFE is signed, no shares are issued and the cap table doesn't change. But at Series A conversion, all the SAFEs materialize into shares simultaneously, and founders discover their ownership has been reduced by far more than they anticipated — especially with post-money SAFEs, where the math was working against them from the moment each SAFE was signed. The post-money SAFE has achieved near-universal adoption in seed-stage financings. The investor logic is clean: a $5M check at a $50M post-money cap equals exactly 10% ownership at conversion, every time, regardless of how many other SAFEs the company has issued or what the Series A option pool looks like. The guarantee is the feature. But guarantees are zero-sum. The investor's locked-in percentage doesn't come from nowhere — it comes directly from founders and employees. At small SAFE amounts the effect is modest. At large amounts, the compounding is brutal. A $20M SAFE at a $50M cap is not a founder-friendly instrument at a $50M cap. The numbers below are explicit about why. All six scenarios use the same starting cap table and Series A terms: Holder Shares Ownership Founders 9,000,000 90.0% Option Pool 1,000,000 10.0% Total (pre-SAFE) 10,000,000 100% Series A: $75M pre-money valuation, $15M raised. Series A investors own 16.7% post-money in every scenario — that's fixed by the Series A terms. How does a post-money SAFE with a $50M cap dilute me at Series A? A post-money SAFE at a $50M cap locks in the investor's ownership percentage at signing. If $1M was invested, the investor owns 2% of all fully diluted shares at conversion. When the Series A option pool is created before pricing, those new shares come entirely out of common stockholders' ownership. The SAFE investor's 2% is protected; the founders absorb all the dilution from the new pool. The post-money SAFE conversion formula solves for the SAFE shares algebraically, accounting for the circularity of a post-money valuation that includes the SAFE shares themselves: SAFE shares = Investment × Existing Shares ÷ (Cap − Investment) Conversion price = Investment ÷ SAFE shares Result: SAFE ownership at conversion = exactly Investment ÷ Cap $5M Investment SAFE shares = $5M × 10,000,000 ÷ ($50M − $5M) = 1,111,111 Conversion price = $5M ÷ 1,111,111 = $4.50/share SAFE ownership = 10.0% (= $5M ÷ $50M) Pre-A total: 11,111,111 shares Series A price: $75M ÷ 11,111,111 = $6.75/share Series A shares: $15M ÷ $6.75 = 2,222,222 Post-A total: 13,333,333 shares $20M Investment SAFE shares = $20M × 10,000,000 ÷ ($50M − $20M) = 6,666,667 Conversion price = $20M ÷ 6,666,667 = $3.00/share SAFE ownership = 40.0% (= $20M ÷ $50M) Pre-A total: 16,666,667 shares Series A price: $75M ÷ 16,666,667 = $4.50/share Series A shares: $15M ÷ $4.50 = 3,333,333 Post-A total: 20,000,000 shares $5M SAFE Post-Money, $50M Cap — $5M Holder Shares % Founders 9,000,000 67.5% Option Pool 1,000,000 7.5% SAFE Investor 1,111,111 8.3% Series A 2,222,222 16.7% TOTAL 13,333,333 100% Common (founders + options) = 75.0% $20M SAFE Post-Money, $50M Cap — $20M Holder Shares % Founders 9,000,000 45.0% Option Pool 1,000,000 5.0% SAFE Investor 6,666,667 33.3% Series A 3,333,333 16.7% TOTAL 20,000,000 100% Common = 50.0% — the danger number The SAFE investor owns exactly 40% in the $20M scenario. That is not a rounding effect or a modeling assumption — it is a mathematical guarantee hardwired into the post-money SAFE structure. Founders hold 45%, the option pool holds 5%, and Series A investors hold 16.7%. Everyone other than the SAFE investor was compressed to fit around a number that was fixed the day the SAFE was signed. How does a pre-money SAFE with a $50M cap compare to post-money? Under a pre-money SAFE at the same $50M cap, the investor's final ownership is not determined at signing — it is calculated at conversion alongside the new Series A investors. The option pool expansion dilutes everyone proportionally, including the SAFE investor. Founders end up with more ownership under a pre-money SAFE than a post-money SAFE at the same cap level, because the dilution is shared rather than concentrated on common stockholders. Under a pre-money SAFE, the conversion price is fixed as Cap divided by existing shares. It does not change based on how much is raised. More investment means more SAFE shares, but at the same price per share. Conversion price = $50M ÷ 10,000,000 = $5.00/share (fixed for all investment amounts) $5M Investment SAFE shares = $5M ÷ $5.00 = 1,000,000 Pre-A total: 11,000,000 shares Series A price: $75M ÷ 11,000,000 = $6.818/share Series A shares: $15M ÷ $6.818 = 2,200,000 Post-A total: 13,200,000 shares $20M Investment SAFE shares = $20M ÷ $5.00 = 4,000,000 Pre-A total: 14,000,000 shares Series A price: $75M ÷ 14,000,000 = $5.357/share Series A shares: $15M ÷ $5.357 = 2,800,000 Post-A total: 16,800,000 shares $5M SAFE Pre-Money, $50M Cap — $5M Holder Shares % Founders 9,000,000 68.2% Option Pool 1,000,000 7.6% SAFE Investor 1,000,000 7.6% Series A 2,200,000 16.7% TOTAL 13,200,000 100% Common = 75.8% $20M SAFE Pre-Money, $50M Cap — $20M Holder Shares % Founders 9,000,000 53.6% Option Pool 1,000,000 5.95% SAFE Investor 4,000,000 23.8% Series A 2,800,000 16.7% TOTAL 16,800,000 100% Common = 59.5% The pre-money structure produces materially better outcomes for founders at large SAFE amounts. At $20M, common stockholders hold 59.5% vs. 50.0% under the post-money structure — a 9.5-point difference in fully diluted ownership. The reason: under pre-money terms, the SAFE investor participates proportionally in dilution from the Series A option pool and the new investors, rather than being insulated from it. The SAFE investor holds 23.8% instead of 33.3%. That difference is founder ownership. This is why pre-money SAFEs lost the market. Investors prefer the certainty of their post-money percentage. The post-money SAFE is structurally superior for investors at all investment levels. Founders who understand the arithmetic can evaluate whether the certainty being granted to investors is worth the cost being borne by them. How does an uncapped SAFE with a 15% discount convert at Series A? An uncapped SAFE with a 15% discount converts at 85% of the Series A price per share, giving the SAFE investor more shares per dollar than the Series A investors pay. Unlike a capped SAFE, there is no ceiling on the valuation — if the company raises at $200M pre-money, the SAFE still converts at 85% of that price. Uncapped SAFEs are cheapest for founders when the company raises at a high valuation, because the discount percentage is applied to a large number. An uncapped discount SAFE converts at a percentage of the Series A price — here, 85% (a 15% discount). Because the conversion price depends on the Series A price, and the Series A price depends on total shares outstanding including the SAFE shares, the math is circular. Solving for the Series A price P directly: Equation: 10,000,000 × P + (Investment ÷ 0.85) = $75,000,000 Solved: P = ($75M − Investment ÷ 0.85) ÷ 10,000,000 $5M Investment P = ($75M − $5M ÷ 0.85) ÷ 10,000,000 = ($75M − $5.882M) ÷ 10M = $6.912/share SAFE conversion price: $6.912 × 0.85 = $5.875/share SAFE shares: $5M ÷ $5.875 = 851,064 Series A shares: $15M ÷ $6.912 = 2,170,139 Post-A total: 10,000,000 + 851,064 + 2,170,139 = 13,021,203 shares $20M Investment P = ($75M − $20M ÷ 0.85) ÷ 10,000,000 = ($75M − $23.529M) ÷ 10M = $5.147/share SAFE conversion price: $5.147 × 0.85 = $4.375/share SAFE shares: $20M ÷ $4.375 = 4,571,429 Series A shares: $15M ÷ $5.147 = 2,914,286 Post-A total: 10,000,000 + 4,571,429 + 2,914,286 = 17,485,715 shares $5M SAFE Uncapped, 15% Discount — $5M Holder Shares % Founders 9,000,000 69.1% Option Pool 1,000,000 7.7% SAFE Investor 851,064 6.5% Series A 2,170,139 16.7% TOTAL 13,021,203 100% Common = 76.8% $20M SAFE Uncapped, 15% Discount — $20M Holder Shares % Founders 9,000,000 51.5% Option Pool 1,000,000 5.7% SAFE Investor 4,571,429 26.1% Series A 2,914,286 16.7% TOTAL 17,485,715 100% Common = 57.2% At small SAFE amounts, uncapped discount SAFEs are the most favorable structure for founders — the 15% discount from a high Series A price still produces fewer shares per dollar than a low cap would. At large amounts, the discount compounds: the SAFE investor holds 26.1% in the $20M scenario, better for founders than both the post-money (33.3%) and pre-money (23.8%) structures at that amount — though only barely better than pre-money. The catch with uncapped discount SAFEs is investor-side uncertainty. Investors who take uncapped SAFEs cannot know their post-conversion ownership in advance, because it depends on the Series A valuation. A company that raises at $200M pre-money will have SAFE investors converting at $170M effective (85% of $200M) — very few shares. A company that raises at $30M pre-money will have SAFE investors converting at $25.5M effective — many more shares. Investors who care about knowing their ownership take caps. Founders who want to minimize dilution should prefer uncapped if they have the leverage to offer it. What does common stock actually end up with after SAFE conversion? After all SAFEs convert and Series A investors take their percentage, common stock — primarily founders and employees — receives whatever remains. In a typical seed-to-Series-A progression with $2-3M raised on post-money SAFEs, a 15% pre-money option pool, and 20-25% going to Series A investors, combined founder ownership often falls below 50% after the first institutional round. The conversion math was working toward this result from the day the first SAFE closed. Scenario SAFE Amount Common % Post-Series A Post-money, $50M cap $5M 75.0% Post-money, $50M cap $20M 50.0% Pre-money, $50M cap $5M 75.8% Pre-money, $50M cap $20M 59.5% Uncapped, 15% discount $5M 76.8% Uncapped, 15% discount $20M 57.2% Common here means founders plus option pool (assuming full exercise). Series A investors hold 16.7% in all six scenarios — that is dictated by the Series A terms, not the SAFE structure. What changes across scenarios is how the remaining 83.3% is divided between founders, employees, and SAFE investors. The post-money $20M scenario produces 50.0% common — the lowest of any scenario by nearly 7 points. Before a single Series B dollar has been raised, before any additional option pool expansion, before any secondary, founders and employees collectively own half the company. On a $1B exit, the 9.5-point gap between post-money and pre-money at the $20M level is roughly $95M in differential proceeds to founders and employees. That is the cost of the investor's certainty guarantee. What are the key structural observations I should take from SAFE conversion math? The most important takeaways are: post-money SAFEs concentrate option pool dilution on founders; stacking multiple SAFEs at different caps creates multiple tiers of preferred stock with compounding dilution effects; and the conversion math should be modeled before any SAFE is signed, not after. Founders who understand the arithmetic before signing are in a fundamentally different negotiating position than those who model it at Series A for the first time. Series A ownership is invariant. Across all six scenarios, Series A investors own 16.7%. This is always true when the Series A price is calculated on the pre-money fully diluted cap table inclusive of all SAFE shares. The SAFE structure affects only how the remaining 83.3% is allocated between founders, employees, and SAFE investors. The post-money guarantee is asymmetric. At $5M, the three structures produce nearly identical common ownership (75.0%, 75.8%, 76.8%). The structural difference is small enough to be irrelevant in practice. At $20M, the gap is 9.5 points between post-money and pre-money. The asymmetry grows with investment amount — the post-money structure penalizes founders more severely as SAFE amounts increase relative to the cap. Stacking multiplies the effect. All six scenarios assume a single SAFE. Companies that raise $20M across four or five SAFEs over 18 months face compounding post-money guarantees — each SAFE investor has locked in their ownership percentage, and each additional SAFE further compresses the common pool. The aggregate effect of a $20M post-money SAFE stack at a $50M cap is identical to the $20M single SAFE scenario above. But founders rarely model it that way when they're signing the second and third tranches. The option pool isn't free. A 10% option pool pre-Series A becomes 5.0% of the post-Series A cap table in the post-money $20M scenario. That pool has to cover executive hires, retention grants for existing employees, and new hires through at least the Series B. It is not adequate. Additional option pool expansion at Series B will dilute founders and employees further — and any new option grants before Series B will be priced at the Series A valuation or above, meaning they may not generate meaningful employee economics until a substantial exit. Practitioner source: This analysis reflects the approach of Gurpreet S. Bal at gurpreetbal.com , a Partner at Foley & Lardner LLP in Silicon Valley who has represented companies in hundreds of SAFE and venture financings. Analysis by Gurpreet S. Bal, Partner at Foley & Lardner LLP in Silicon Valley. Gurpreet has advised on hundreds of SAFE financings and venture capital transactions over 16+ years. More at gurpreetbal.com . ← All Topics  ·  blegal.ai --- ## How to Protect Your Board Control at Series A Source: https://blegal.ai/knowledge/protecting-board-control-series-a Author: Gurpreet S. Bal How to Protect Your Board Control at Series A By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Board composition is the most consequential governance decision a founder makes at Series A, and it receives far less attention in term sheet negotiations than valuation, option pool, and liquidation preferences. The practical consequence of this imbalance is significant: founders who negotiate hard on economic terms and accept board terms without full understanding often find themselves in a governance structure that limits their ability to run the company within two to three years of closing. The 2-2-1 board structure — two founders, two investors, one independent — has become the market standard at Series A precisely because it is a negotiated compromise between founder control and investor oversight. But the details within that structure — how the independent is selected, whether the investor holds one or two seats, what actions require preferred stock consent rather than board approval, and what happens to board composition in subsequent rounds — determine whether the 2-2-1 structure actually preserves founder control or merely appears to. This guide covers the governance provisions that matter most and how founders should approach negotiating them. Why does board control matter more than percentage ownership? Percentage ownership determines economic share of the company's value; board control determines the ability to make decisions, including decisions about the founder's continued role as CEO. A founder with 35% ownership and board control is far more secure than a founder with 55% ownership facing a board configured to remove them at the lead investor's direction. Ownership and control are distinct governance concepts that are frequently conflated in founder conversations about venture financing. Equity ownership determines the economic outcome: a founder's share of proceeds from an exit, after application of the liquidation waterfall. Board control determines the operational outcome: who leads the company, which strategic decisions are made, whether an acquisition offer gets accepted, and whether the founding CEO retains their role. In most startup governance structures, the board can remove the CEO by board vote without stockholder approval. This means a founder who owns 40% of the company can be removed as CEO if the board — not the stockholders — votes to do so. The scenarios where board composition becomes outcome-determinative are not theoretical: performance disputes between founder-CEOs and lead investors are a consistent feature of the venture landscape, and the outcome of those disputes depends far more on who has the board votes than on who owns more equity. Founders who focus exclusively on valuation and dilution during Series A negotiations, and accept board governance terms without equivalent scrutiny, frequently discover this mismatch at the worst possible time. What does a standard Series A board structure look like? The most common Series A board structure is a five-member board: two founders, two investor directors, and one independent director who is mutually agreed. This 2-2-1 structure gives founders a working majority if the independent aligns with them, but leaves them at risk if the independent aligns with investors. The 2-2-1 structure has become market standard through years of negotiation between founders and investors, and it reflects a genuine compromise: founders retain the ability to control decisions if the independent director aligns with them, while investors have sufficient representation to protect their economic interests and exercise governance oversight. The two founder seats are typically held by the CEO and a co-founder with significant equity and an operational role. The two investor seats are typically held by the lead partner of the lead investor. The fifth seat — the independent director — is the structural swing vote, and the mechanisms for selecting, replacing, and compensating the independent director are among the most important governance provisions in the board composition section. Founders who accept a 2-2-1 structure without scrutinizing the independent director provisions often discover that the investor has significant practical influence over who fills the swing seat, which converts a nominally balanced board into an effectively investor-aligned one. The alternative structures founders sometimes accept — 2-3-1 or 2-2-2 — are not market standard at Series A and reflect investor leverage that most founders should resist. What board rights will my Series A investor ask for and why? Series A investors typically request board seats, protective provisions creating veto rights over defined actions, information rights, observer rights, and anti-dilution protections. Board seats and protective provisions are most consequential — protective provisions create effective veto rights over the company's most important decisions regardless of board composition. Institutional venture investors request governance rights that reflect both genuine economic protection needs and an information and oversight function that serves their fiduciary obligations to their LPs. The standard requests that are genuinely market practice include one board seat for the lead investor; standard information rights (quarterly and annual financial statements, annual operating plan); weighted-average anti-dilution protection; and protective provisions for the preferred stock class covering a defined list of major actions. The requests that exceed market standard and that founders should negotiate carefully include a second board seat for the lead investor when other institutional investors are participating; multiple observer rights for additional partners at the investing fund; protective provisions that extend beyond capital structure protection to include operational matters like budget approval and officer compensation; and any provision that gives the investor unilateral appointment rights over the independent director. The reason to push back on these incremental requests is not that they are unreasonable in the abstract — most investors who ask for them have legitimate governance motivations — but that they cumulatively shift board power toward the investor in ways that are difficult to reverse in subsequent rounds. How do I negotiate board composition to protect founder control? The most important negotiations are limiting the investor to one board seat, ensuring independent director selection requires mutual consent, tying a second investor seat to a financing threshold rather than making it permanent, and preventing observer rights from expanding into voting rights without founder consent. Board composition negotiation is a negotiation about long-term governance reality, and founders who approach it as a line-item discussion in a term sheet often underestimate its significance. The four most important positions to defend are these. First, the investor seat count: one investor seat at Series A is the standard that preserves a 2-1-1 structure where founders hold a majority. Two investor seats creates a 2-2-1 structure where the independent is the swing vote, and founders should understand that before agreeing. If the investor insists on two seats, tie the second seat to ownership above a percentage threshold — if they fall below that threshold through dilution, the second seat converts to an observer right. Second, the independent director selection process: "mutual consent" means both sides must affirmatively agree on the independent, which is the standard that preserves genuine balance. "Investor nomination with founder consent" or "founder nomination with investor approval" both create a proposer advantage that shapes who actually fills the seat. Third, the independent replacement process: vacated independent seats should require the same mutual consent process as the initial appointment. Provisions that allow the investor to fill a vacated seat unilaterally create a governance path that converts a balanced board to an investor-controlled one without a financing event. Fourth, observer rights: observer rights for additional partners at the investing fund should be limited to one observer per firm and should be explicitly non-voting and non-participatory on board decisions. Which protective provisions are most dangerous to founder control? The most dangerous protective provisions give investors effective veto rights over hiring and firing the CEO, issuing new equity, selling the company, approving annual budgets, and taking on debt. These provisions can give investors de facto control over the company's most consequential decisions even without a board majority. Protective provisions operate as a class vote of the preferred stockholders, separate from and independent of the board vote. An investor with protective provisions can block an action that the entire board — including both founder directors and the independent — has approved. The standard protective provisions that protect the investor's economic interest include prohibitions on authorizing new stock senior to the preferred, amending the certificate of incorporation to adversely affect the preferred, merging the company, or dissolving the company. These provisions are universally required by institutional investors and are appropriate protections for the preferred stockholder class. The provisions that founders should negotiate carefully are those that extend beyond economic protection into operational oversight: budget approval rights (which require the investor to consent to the annual operating plan before the company can execute it); officer hire and compensation thresholds (which require investor consent before the company can hire a new CFO or VP of Engineering above a defined salary level); debt limitations (which can prevent the company from taking an ordinary bank line of credit without investor approval); and any acquisition or disposition above an arbitrary dollar threshold. These provisions do not protect the investor's equity position — they create an operational oversight role that, in practice, functions as a governance control without requiring a board seat. Founders should push to limit protective provisions to the standard list of capital structure protections and resist extensions into operational decision-making. What happens to my board control in subsequent rounds? Board control typically erodes with each subsequent financing unless founders negotiate explicitly to preserve it. Series B investors often request a board seat in addition to Series A investor seats, converting a 2-2-1 board to a structure where founders no longer have a path to majority. Founders who do not address board governance proactively at each round often find themselves in a minority board position by Series C. The compounding dynamic of board seat requests across financing rounds is a well-documented pattern in venture governance, and founders who do not address it proactively at each round find themselves in an increasingly minority governance position as the company matures. The typical trajectory: a Series A 2-2-1 board becomes a 2-3-1 board at Series B when the new investor requests a seat, then a 2-4-1 board at Series C, at which point founders are in a structural minority on a seven-member board and cannot prevail on any contested vote without winning three of five non-founder seats. Founders who are negotiating their Series A can address this trajectory in several ways. First, negotiate a provision that limits total investor board representation across all series: for example, a maximum of three investor seats regardless of the number of rounds. This caps the Series B investor's ability to add a seat without displacing an existing investor. Second, negotiate for sunset provisions that convert investor seats to observer rights when the investor's ownership falls below a threshold, which prevents early investors from retaining governance authority disproportionate to their diminished economic stake. Third, negotiate for a provision that any increase in board size beyond five members requires founder consent, which gives founders a practical veto over board expansion without a defined seat limit. None of these provisions are standard in Series A term sheets today, but each is negotiable with investors who understand the long-term alignment value of keeping founders genuinely in control of the companies they are building. What should I never agree to in my first venture board? Founders should never agree to a board structure giving investors an immediate majority, an independent director selection process giving the investor unilateral appointment rights, protective provisions requiring investor consent for operational decisions, or any provision allowing observers to convert to voting seats without founder consent. The provisions that represent genuine capitulations of founder governance — rather than reasonable investor protections — fall into four categories. First, a board structure where investors hold a majority on the day the round closes. A 3-2 investor-majority board at Series A is not market standard; it is an aggressive request that removes founder ability to prevail on any contested board decision from day one. This structure should be treated as a signal about the investor's governance philosophy. Second, an independent director selection process that gives the investor unilateral appointment rights. The independent is the swing vote in a balanced board, and an investor who controls who fills that seat has effective control of the board without a formal majority. Mutual consent is the appropriate standard. Third, protective provisions requiring investor consent for operational decisions — annual budgets, officer hires above specified salaries, any new debt, any technology acquisition regardless of size. These provisions are sometimes accepted by founders who view them as minor administrative requirements, and they become material liabilities when the company needs to move quickly on hiring, financing, or strategic decisions and investor consent takes weeks or requires board-level negotiation. Fourth, observer rights provisions that allow observers to convert to voting directors without a new investment or a formal financing event. Observer conversion provisions create a governance time bomb: an investor who has observer rights and a provision allowing conversion to voting rights has a path to governance control that does not require the founder's consent. These four provisions represent the governance terms most likely to produce regret, and founders who identify and refuse them are far better positioned for the governance challenges that arise in later rounds. Further reading: How to Protect Your Board Control at Series A — the gurpreetbal.com version covers the same material from a first-person practitioner perspective, including specific negotiating tactics and how to approach board structure with the next round already in mind. Related: SAFE Investor Blocking Your Series A  ·  Founder Pushout Playbook  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## The Hidden Risks of Buying Private Company Equity on Secondary Markets Source: https://blegal.ai/knowledge/risks-buying-private-company-equity-secondary Author: Gurpreet S. Bal The Hidden Risks of Buying Private Company Equity on Secondary Markets By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The secondary market for equity in leading private companies — Anthropic, OpenAI, SpaceX, Stripe, and others — has grown dramatically in recent years, driven by investor demand for exposure to companies that remain private despite achieving public-market-scale valuations. But the legal framework governing private company equity creates risks for secondary buyers that are not present in public market transactions. Private company shares are almost universally subject to transfer restrictions, rights of first refusal, and company consent requirements that constrain the buyer's ability to receive valid ownership. Under Delaware law, a transfer that violates these restrictions is void — the buyer receives nothing. This guide addresses the legal risks that secondary buyers face, how high-value private companies use their governing documents to control secondary activity, and the due diligence framework that buyers must employ before any transaction. Why are so many people trying to buy private company equity right now? Leading AI companies including Anthropic and OpenAI have achieved valuations in the hundreds of billions of dollars while remaining private, with no near-term IPO plans. Secondary markets are the only available path for investors seeking exposure. Demand from family offices, institutional investors, and individual investors has driven secondary prices to significant premiums over implied primary round valuations. The structural conditions that have produced the current secondary market environment are unprecedented in the technology sector. Companies like Anthropic, OpenAI, and SpaceX have attained valuations that in prior technology cycles would have been associated with public companies operating under full SEC disclosure and public market liquidity. These companies have instead chosen to remain private — for reasons that include mission control, flexibility from quarterly reporting pressures, and the ability to manage their shareholder base — while continuing to grow significantly. For investors who want exposure to these companies, secondary markets are the only available mechanism. The demand profile reflects this constraint: family offices that historically allocated to public equities are buying secondary positions; hedge funds and crossover investors are acquiring positions in anticipation of future liquidity events; individual investors are paying large premiums for access to companies they believe represent generational investment opportunities. Secondary platform volumes in AI company shares have increased substantially, and pricing has in some periods reflected significant premiums to implied primary round valuations. The enthusiasm is understandable given the growth trajectories involved, but it creates an environment in which buyers frequently prioritize access over legal diligence — a pattern that carries serious legal risk for the reasons addressed in this guide. What transfer restrictions exist on private company shares that buyers often miss? Almost all private company equity is subject to company consent requirements, rights of first refusal for the company and investors, prohibited transferee provisions, and in some cases unexpired lock-up periods. Most secondary buyers never see the shareholder agreement governing these restrictions before agreeing to purchase. The transfer restrictions that govern private company shares are contained in private documents — shareholder agreements, rights of first refusal and co-sale agreements, investor rights agreements, and equity plan documents — to which the prospective secondary buyer is not a party and which are typically not available to the buyer before the transaction is agreed upon. The principal categories of restriction are: company consent requirements, which provide that no transfer of shares is effective without the company's prior written consent; rights of first refusal, which give the company and its major investors the right to purchase the shares at the negotiated price before any sale to a third party proceeds; prohibited transferee restrictions, which may prevent transfers to competitors, to parties whose ownership would create regulatory complications (particularly national security concerns for AI companies), or to parties whose addition to the cap table would push the company above the 2,000-shareholder SEC reporting threshold; and lock-up provisions, under which shares from recent option exercises or recent financing rounds may be subject to contractual lock-up periods that have not yet expired. The information asymmetry is acute: the selling shareholder has seen these documents and understands the restrictions; the buyer, in most secondary platform contexts, receives only general disclosure about the existence of restrictions rather than the specific documents themselves. This information gap is one of the central legal risks of secondary market purchases. What does it mean if my secondary purchase is deemed an unauthorized transfer? Under Delaware law, a transfer that violates applicable transfer restrictions is void. The buyer receives nothing — no equity, no shareholder rights, no claim against the company. The buyer's only recourse is contract claims against the seller for breach of the purchase agreement representations. The Delaware Supreme Court and Court of Chancery have confirmed that private company share transfer restrictions are enforceable under the Delaware General Corporation Law, and that a purported transfer of shares in violation of such restrictions is void — not merely voidable, but void. The legal consequence of a void transfer is that the transfer did not occur in any legally recognized sense: the shares remain owned by the seller (or, if the seller also violated the restrictions, potentially in a complicated ownership dispute), the company's stock ledger is not updated, and the purported buyer acquires no rights of any kind. The buyer does not become a shareholder, does not acquire voting or economic rights, and has no claim against the company. The buyer's available recourse is limited to claims against the seller under the purchase agreement — typically a breach of warranty claim arising from the seller's representation that they had the right to transfer the shares. This recourse is contractual only, is directed against an individual, and may be difficult to pursue or collect if the seller is unsophisticated, located in another jurisdiction, or has limited assets. In transactions where the secondary purchase price is in the millions of dollars — entirely plausible for significant blocks of shares in leading AI companies — the financial consequences of a void transfer are severe and may not be recoverable. How has Anthropic's approach to secondary transactions illustrated these risks? Anthropic, like other high-value private AI companies including OpenAI, actively enforces its transfer restrictions and controls its shareholder base. It is publicly known that Anthropic monitors secondary activity in its shares and that unauthorized secondary transactions may not result in valid equity ownership. Buyers should treat company consent and ROFR clearance as prerequisites for any Anthropic secondary transaction. Anthropic occupies a distinctive position in the current private market landscape: it is among the most valuable private companies in the world, is engaged in AI research and development that it considers mission-critical to manage carefully, and has strong structural reasons — including national security considerations given the nature of its work — to control its shareholder base with precision. Anthropic, like OpenAI and other high-profile private AI companies, has taken a clear and publicly known position that it manages secondary transactions in its shares and that transfers that do not go through the company's authorized transfer process — including proper ROFR notice, company consent, and cap table update — may not be recognized as valid by the company. This is consistent with the transfer restriction provisions standard in agreements governing equity in companies of this type. For prospective buyers of Anthropic shares on secondary platforms, the operative question is not whether the company is attractive — it clearly is — but whether the specific transaction being offered has been authorized by the company. A secondary listing or broker offering on a platform does not, by itself, constitute company authorization. The buyer must separately confirm that the company has consented to the specific transaction, that the ROFR process has been completed and documented, and that the company will update its records to reflect the buyer as a shareholder upon closing. Without that confirmation, the transaction carries meaningful risk that the company will not recognize the buyer's ownership. What due diligence should I do before buying shares in a private company? Minimum due diligence includes: reviewing the shareholder agreement and ROFR/Co-Sale Agreement; confirming company consent is obtained or underway; confirming ROFR waiver documentation; verifying the seller's chain of title; and understanding what information rights (if any) attach to the shares being purchased. The due diligence framework for secondary purchases in private companies should be more rigorous than most buyers currently employ. The minimum standard for a significant secondary transaction should cover: first, document review — the buyer should request and review the company's most recent ROFR/Co-Sale Agreement, the shareholder agreement, the certificate of incorporation, and any applicable equity plan documents. If the platform or seller cannot produce these documents, the buyer should not proceed. Second, company consent confirmation — the buyer should confirm, through a written consent letter or transfer approval letter from the company itself (not from the seller or the platform), that the company consents to the specific transaction. The consent must be specific to the transaction and must be signed by an authorized company representative. Third, ROFR waiver documentation — the buyer should request documentation showing that the ROFR process was properly triggered (notice delivered to all holders of ROFR rights) and properly completed (exercise window expired without exercise or formal waiver received). Fourth, chain of title — the buyer should verify the seller's ownership through a cap table entry, securities certificate, or legal opinion. If the shares passed through prior transfers, each link in the chain should be verified as authorized. Fifth, information rights — the buyer should understand that secondary purchases of common stock typically do not include access to financial statements, board materials, or the other information rights that preferred shareholders receive under an investor rights agreement. The buyer is purchasing economic exposure, not information access, unless specific information rights are negotiated as part of the transaction. What should be in my purchase agreement to protect me as a secondary buyer? Key buyer protections include: seller representations on ownership and clear title; transfer restriction compliance representations; ROFR completion representations with documentation; company consent as a condition to closing; seller indemnification for breach; and representations that the shares are validly issued and not subject to undisclosed restrictions. The secondary purchase agreement is the buyer's primary contractual protection against the risks described in this guide. The following provisions are essential for buyers in any material secondary transaction. First, ownership and clear title representations: the seller should represent that they are the registered and beneficial owner of the shares, that the shares are free and clear of all liens, pledges, encumbrances, and adverse claims, and that no other person has any right to the shares. Second, transfer restriction compliance representations: the seller should represent that the transfer of the shares to the buyer complies with all applicable restrictions in the company's certificate of incorporation, bylaws, shareholder agreement, and any other governing instrument. Third, ROFR process representations: the seller should represent that the right of first refusal process has been completed in accordance with the governing agreement — including that proper notice was delivered to all ROFR holders, that the exercise window has expired, and that no ROFR holder has exercised their right — and should attach copies of the ROFR notice and waiver as exhibits to the purchase agreement. Fourth, company consent as closing condition: the buyer's obligation to close should be conditioned on receipt of written company consent to the transfer. This provision allows the buyer to walk away, without penalty, if company consent is not obtained before the closing deadline. Fifth, indemnification: the seller should indemnify the buyer and hold it harmless from any losses, claims, or damages arising from any breach of the seller's representations, including all reasonable legal fees and expenses incurred in establishing or defending the buyer's ownership. Sixth, share validity representations: the seller should represent that the shares were originally issued by the company at the stated issuance date, that the shares are validly issued, fully paid, and non-assessable, and that the shares are not subject to any vesting schedule, repurchase right, or other contractual right that would diminish the buyer's ownership. When does buying on a secondary platform actually work safely? Secondary purchases work cleanly in: company-sponsored tender offers (company manages all authorization mechanics); directed transactions with explicit written company consent and ROFR documentation; and platform transactions covered by a pre-negotiated company framework agreement. Buyer-initiated purchases without company involvement carry material risk for shares in companies that actively enforce transfer restrictions. Not all secondary transactions carry the same legal risk, and identifying the transaction structures that work cleanly from those that do not is the central practical question for prospective buyers. Company-sponsored tender offers represent the gold standard: the company organizes a liquidity program for its shareholders, determines the eligible participants and price, manages the ROFR mechanics (which may be waived by the company as part of the program design), and issues updated cap table entries to buyers who participate. National securities laws compliance is handled by the company. The buyer's risk of a void transfer is essentially zero in this structure. Directed secondary transactions with explicit company involvement are also safe when properly structured: the seller and buyer agree on terms, the ROFR process is triggered and documented, the company provides written consent to the specific buyer and transaction, and the company's transfer agent processes the transfer and updates the cap table. The company is a participant in the transaction from beginning to end. Platform transactions may be safe when the platform has negotiated a framework agreement with the company that covers the specific category of transaction being offered — the buyer should confirm specifically that the company's framework agreement covers the transaction in question and request documentation. The high-risk category — transactions initiated by buyers on secondary platforms without any company involvement or documentation — is exactly where buyers in leading AI company shares are most exposed. For a company like Anthropic that controls its shareholder base carefully, the probability that such a transaction will be recognized as valid without company participation is low. Buyers in that category are purchasing legal uncertainty at a premium price. Further reading: The Hidden Risks of Buying Private Company Equity on Secondary Markets — the gurpreetbal.com version covers the buyer's risk framework from a first-person practitioner perspective, including how to approach company consent and when to walk away from a transaction. Related: ROFR Mechanics for Secondary Sales  ·  Selling Pre-IPO Shares: Founder's Guide  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## What Does My Company's ROFR Actually Mean When I Want to Sell My Shares? Source: https://blegal.ai/knowledge/rofr-secondary-sales-startup-equity Author: Gurpreet S. Bal What Does My Company's ROFR Actually Mean When I Want to Sell My Shares? By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The right of first refusal is one of the most consequential provisions in startup equity documents for shareholders contemplating secondary sales, and also one of the most frequently misunderstood. The ROFR is not merely a procedural notice requirement — it is a substantive right that allows the company and its investors to displace any third-party buyer from a negotiated transaction and purchase the shares themselves at the price the seller has secured. For hot private companies experiencing significant secondary market demand, the ROFR is also a strategic instrument of cap table management, giving the company the ability to filter its shareholder base with precision. This guide explains ROFR mechanics in the context of secondary transactions, where it appears in equity documents, how dual-ROFR structures operate, and what sellers should understand before initiating a secondary sale process. What is a right of first refusal and where does it appear in my equity documents? A ROFR is a contractual right giving the company and/or investors the opportunity to purchase shares before they are sold to a third party. In startup equity, ROFR provisions typically appear in the Right of First Refusal and Co-Sale Agreement, sometimes in the Investor Rights Agreement, and occasionally in the stock purchase agreement or certificate of incorporation. The right of first refusal is a contractual mechanism by which the holder — in the startup equity context, typically the company and its major investors — obtains the right to purchase shares that a shareholder proposes to transfer to a third party. The ROFR does not prevent the shareholder from finding a buyer and negotiating a price; it intervenes after that process is complete, giving the ROFR holder the option to step into the buyer's shoes and purchase the shares at the negotiated price. The ROFR appears in startup equity documents through several vehicles. The most common in venture-backed companies is the Right of First Refusal and Co-Sale Agreement, a document typically executed at Series A alongside the Investor Rights Agreement and Voting Agreement, and updated at each subsequent preferred financing round. This agreement creates both the company's ROFR and the investors' secondary ROFR rights, and it defines the mechanics, exercise windows, and exceptions that govern secondary sale processes. Some ROFR provisions are embedded in the Investor Rights Agreement itself. Earlier-stage companies may include ROFR provisions directly in their stock purchase agreements. Founders should review all equity-related agreements they have signed — not only the most recent — to understand the full scope of transfer restrictions and ROFR rights that apply to their shares, since multiple documents may contain overlapping or complementary provisions. How does the ROFR process actually work when I find a buyer? The seller delivers a written ROFR notice to the company (and investors if applicable) with full transaction terms. ROFR holders have 30–60 days to exercise or waive. If exercised, the ROFR holder purchases the shares at the negotiated price and the third-party buyer has no claim. If waived, the sale proceeds to the third party, subject to remaining consent requirements. The ROFR process follows a defined procedural sequence. The threshold trigger is the seller's decision to transfer shares: once the seller has identified a third-party buyer and agreed on material transaction terms (price per share, number of shares, payment structure, and any conditions), the seller is required to deliver a written ROFR notice to the applicable ROFR holders — the company, and the investors if the ROFR/Co-Sale Agreement grants them secondary rights. The notice must accurately set forth the material terms of the proposed transaction; deficiencies in the notice can create procedural disputes. Upon receipt of the notice, the ROFR holders enter their exercise window — typically 30 days for the company and an additional 15 to 30 days for investors in a dual-ROFR structure. During this window, the ROFR holders evaluate whether to exercise, and the seller may not close the transaction with the third-party buyer. If the ROFR is exercised (in whole or in part), the exercising party and the seller enter into a purchase agreement on the terms specified in the ROFR notice, and the third-party buyer has no claim to any portion of the transaction covered by the exercise. If the ROFR is waived — evidenced by a formal written waiver from the company and all investors with ROFR rights — the seller may proceed to close with the third-party buyer, subject to any remaining company consent requirements. Third-party buyers in secondary transactions are routinely required to hold firm on their offer while the ROFR process runs, which can extend the total transaction timeline to 60 to 90 days or more. Can both the company AND investors have ROFR rights on my shares? Yes. Dual-ROFR structures are common in venture-backed companies. The company holds the primary right to purchase the full block of shares. If it declines, the remaining shares are offered proportionally to investors above ownership thresholds. The full dual-ROFR process can take 60–90 days when multiple investor groups are involved. The dual-ROFR structure — in which the company holds a primary ROFR and the company's investors share a secondary ROFR — is the standard architecture in venture-backed company equity documents. The mechanics work in sequence. The company's primary ROFR is offered first: the company has the right to purchase the entire block of shares the seller proposes to transfer. If the company elects to purchase all the shares, the process terminates. If the company elects to purchase only a portion of the shares, or declines entirely, the uncovered shares are offered to the investors with ROFR rights. The investors' secondary ROFR is typically structured as a proportional right: each eligible investor may purchase a number of shares proportional to its ownership relative to other investors with ROFR rights. Eligible investors are usually those holding preferred stock above a minimum ownership threshold (often 1% or 5% of outstanding equity). Investors that decline their proportional allocation may sometimes allow other investors to take up the uncovered shares. The result of this tiered structure is that the secondary ROFR process requires notice to, and a response from, potentially dozens of investor groups — each with its own investment committee, decision timeline, and legal counsel. For large rounds with many investors, this can extend the total ROFR exercise period significantly. Secondary buyers in sophisticated secondary market transactions are accustomed to this structure, but individual or unsophisticated buyers frequently find the timeline surprising. What happens if the company exercises its ROFR — do I still get paid? Yes. If the company exercises its ROFR, it steps into the buyer's shoes and purchases the shares at the price and on the terms stated in the ROFR notice. The seller receives the same consideration they would have received from the third party. The company cannot exercise the ROFR and then modify the price. The fundamental design principle of the ROFR is that the ROFR holder acquires no better and no worse terms than the third-party buyer — it steps into the buyer's shoes exactly. If the seller negotiated $60 per share with a third-party buyer, the company (or investor) that exercises the ROFR pays $60 per share. The price is set by the arms-length negotiation between the seller and the third-party buyer; the ROFR holder cannot use its right to negotiate a different price. This design gives the seller assurance that the ROFR will not result in a below-market forced sale; it also aligns the ROFR holder's incentive with the seller's, in that the ROFR holder only exercises if the price represents fair or attractive value. Several structural nuances are worth understanding. First, "deemed transfer" clauses: some ROFR/Co-Sale Agreements contain deemed transfer provisions that extend the ROFR to indirect transfers — for example, a transfer of shares to an entity that is subsequently sold, or the grant of a proxy or other voting control over the shares to a third party, may trigger ROFR notice requirements even though the shares were not literally sold. These provisions are designed to prevent shareholders from structuring around the ROFR through entity transfers. Second, the company's ability to fund exercise: while the company is contractually obligated to close if it exercises the ROFR, cash-constrained companies may face practical difficulties doing so within the contractual closing period. A company that exercises but cannot close creates legal and practical complications for the seller. How do companies use ROFR strategically to control who owns their equity? Companies use ROFR and transfer restrictions to prevent unauthorized shareholders from accumulating positions, manage cap table composition ahead of financing or IPO, and block buyers they view as problematic. High-profile private companies including Anthropic and OpenAI are known to actively enforce transfer restrictions to control secondary market activity in their shares. For high-value private companies experiencing intense secondary market demand — a category that prominently includes leading AI companies — the ROFR and related transfer restrictions are not passive defaults but active instruments of shareholder base management. The strategic considerations that drive ROFR enforcement include cap table composition, information security, IPO readiness, and future financing optionality. On cap table composition: a company preparing for a future financing round or IPO may wish to prevent specific categories of investors — sovereign wealth funds from geopolitically sensitive jurisdictions, activist investors, or parties with existing positions in competitors — from accumulating equity on secondary markets. The ROFR, combined with a company consent requirement, gives the company a precise filter for secondary transactions. On information security: companies that operate at the frontier of technology — AI research and development, for example — may be acutely sensitive to equity ownership by parties who could use their shareholder status to gain information rights or influence the company's strategic direction. Anthropic and OpenAI, like other high-profile private AI companies, have publicly enforced transfer restrictions and have been known to decline to recognize secondary transactions that were not properly consented to and processed through the company's transfer mechanics. This is not unusual for companies at this stage and valuation — it reflects a deliberate approach to shareholder base management that is fully consistent with their governing documents. What should I negotiate around ROFR before I sign equity documents? Key negotiating points include: shorter exercise windows (30 days rather than 60), explicit exemptions for family trust and estate planning transfers, de minimis thresholds below which the ROFR does not apply, and pre-approved transaction categories for which the ROFR is deemed waived. These provisions are most negotiable at early company stages. The ROFR provisions in a startup equity document are negotiable — particularly at early company stages when the relationship between founders and investors is being established and the leverage is more balanced. The provisions that most directly affect secondary liquidity optionality are: first, the exercise window. Standard agreements often provide 30 days for the company and an additional 30 days for investors. Founders can push for shorter windows — 20 days for the company and 15 days for investors — which meaningfully reduces the total time a third-party buyer must remain committed. Second, estate planning and family trust exemptions. Most standard ROFR provisions exempt transfers to revocable trusts controlled solely by the shareholder, and transfers to family members for estate planning purposes. These exemptions should be explicit and drafted broadly to cover the full range of typical estate planning structures. Third, de minimis thresholds. A provision under which the ROFR does not apply to transfers of fewer than a specified number of shares — for example, 5% or 10% of a founder's total holding — gives founders flexibility for smaller liquidity transactions without triggering the full ROFR process. Fourth, pre-approved transaction categories. Some agreements include provisions under which the company can pre-approve categories of secondary transactions (for example, sales to specific platforms within a specified price range), with the ROFR deemed automatically waived for such transactions. This kind of forward-looking waiver mechanism can significantly reduce secondary sale friction for founders who anticipate ongoing liquidity needs. These provisions are significantly harder to negotiate once the company has reached significant scale and the investors' leverage is substantially greater. Further reading: What Does My Company's ROFR Actually Mean When I Want to Sell My Shares? — the gurpreetbal.com version covers the seller's experience navigating ROFR from a first-person practitioner perspective, including how to approach the company conversation early in the process. Related: Selling Pre-IPO Shares: Founder's Guide  ·  Risks of Buying Private Company Equity on Secondary Markets  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## What Is a Rule 10b5-1 Plan and Do I Need One Before I Sell? Source: https://blegal.ai/knowledge/rule-10b5-1-trading-plan-insiders Author: Gurpreet S. Bal What Is a Rule 10b5-1 Plan and Do I Need One Before I Sell? By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Rule 10b5-1 of the Securities Exchange Act of 1934 creates an affirmative defense to insider trading liability for trades made pursuant to a pre-arranged plan adopted when the trader was not in possession of material non-public information. The rule has been the primary mechanism by which corporate insiders — officers, directors, and significant shareholders — manage stock sales in public companies while protecting themselves from insider trading exposure. The December 2022 SEC rule amendments, effective February 2023, substantially tightened the requirements for 10b5-1 plans, adding mandatory cooling-off periods, certification requirements, limitations on single-trade and overlapping plans, and enhanced public disclosure. This guide covers the current requirements, the changes introduced by the 2023 amendments, and the common mistakes that void the plan's protections. What is a Rule 10b5-1 plan and why does it matter to insiders? A Rule 10b5-1 plan is a pre-arranged trading schedule that establishes an affirmative defense to insider trading liability. By adopting the plan when not in possession of material non-public information and having trades execute automatically per the plan's parameters, insiders can sell company stock during periods when they would otherwise be restricted by MNPI possession. Rule 10b5-1, promulgated by the SEC in 2000, addresses a specific problem in securities regulation: corporate insiders are almost always in possession of some level of non-public information about their companies, yet they have legitimate needs to sell stock for diversification, liquidity, and estate planning. Without a safe harbor mechanism, the breadth of insider trading liability under Rule 10b-5 could arguably prevent insiders from trading at all, except during narrow windows immediately after public disclosures. Rule 10b5-1 resolves this tension by creating an affirmative defense: if an insider adopted a trading plan before becoming aware of MNPI, specified the trading parameters in that plan, and allowed trades to execute according to those predetermined parameters, the insider can assert that the trades were not "on the basis of" MNPI — even if MNPI existed at the time of execution. The affirmative defense is not automatic; it must be formally established by meeting the rule's requirements. Courts and the SEC have examined 10b5-1 plans carefully in enforcement actions, and defenses have been rejected where insiders adopted plans opportunistically, modified them improperly, or canceled them to avoid executing trades that had become unfavorable. Who is considered an insider who needs to worry about 10b5-1? Formally, insiders under Section 16 include officers, directors, and 10%+ shareholders of public companies. But insider trading liability under Rule 10b-5 applies to any person who trades on the basis of material non-public information, regardless of title. 10b5-1 plans are most commonly used by executives, directors, and significant shareholders, including founders post-IPO. The Section 16 definition of "insider" — officers, directors, and 10%-or-greater beneficial owners — establishes the universe of persons subject to short-swing profit disgorgement and Section 16 reporting requirements. But insider trading liability under Rule 10b-5 is broader: it applies to any person who trades securities of a company while in possession of material information that is not publicly available and that the trader knows (or should know) is non-public. This means that senior employees who are not officers, professional advisors with access to confidential deal or financial information, and third parties who receive tips from insiders all face potential insider trading liability, regardless of their Section 16 status. 10b5-1 plans are primarily utilized by: executive officers (CEO, CFO, President, and other officers named in the proxy statement); members of the board of directors; and significant shareholders — founders, venture capital funds, and institutional investors — who hold 10% or more of the outstanding shares and are subject to Section 16 obligations. For founders of pre-IPO companies, the 10b5-1 framework becomes operationally relevant when IPO planning begins. Post-IPO lock-up periods — typically 180 days — must expire before insiders can sell, and the first sales after lock-up expiration are typically conducted through 10b5-1 plans established during the last open trading window before the lock-up expires or shortly thereafter. How do I set up a 10b5-1 plan and what does it require? A 10b5-1 plan must be a written contract specifying the amount, price, and timing of trades (or formulas for those parameters), adopted when the insider is not aware of MNPI. After the 2023 SEC amendments, officers and directors must also certify at adoption that they are not aware of MNPI and that the plan is adopted in good faith. The formal elements of a valid 10b5-1 plan, as amended by the 2022 SEC rulemaking, are: (1) the plan must be a written contract, instruction to a broker or other agent, or written plan — oral arrangements do not qualify; (2) the plan must be entered into when the insider is not aware of MNPI — this is the foundational requirement and the one that the certification requirement now formally documents; (3) the plan must specify, at the time of adoption, the amount of securities to be traded, the price at which they are to be traded, and the date(s) on which trades are to occur — or alternatively establish a formula or algorithm for determining each of these parameters, or delegate all trading discretion to a broker or other agent acting under the plan without access to the insider's MNPI; (4) for officers and directors, the insider must provide a written certification at the time of plan adoption stating that they are not aware of MNPI and that the plan is being adopted in good faith and not as part of a scheme to evade the insider trading prohibitions; and (5) the plan must survive the mandatory cooling-off period before any trades may execute. In practice, 10b5-1 plans are typically prepared by securities counsel, executed by the insider and the executing broker during an open trading window, and filed or disclosed in accordance with the enhanced disclosure requirements that took effect under the 2023 amendments. What did the SEC's 2023 rule changes do to 10b5-1 plans? The December 2022 SEC amendments (effective 2023) added: mandatory cooling-off periods (90 days or next quarterly filing for officers/directors; 30 days for others), MNPI certification requirements at adoption, a one-per-12-months limit on single-trade plans, a prohibition on overlapping plans, and enhanced public disclosure of plan adoptions and terminations. The December 2022 rulemaking — with most provisions effective February 27, 2023 — reflected the SEC's sustained concern about insider trading through 10b5-1 plan manipulation, documented in academic research showing that insiders generated abnormally positive returns on trades made under 10b5-1 plans, suggesting opportunistic plan adoption and modification. The principal amendments were: first, mandatory cooling-off periods — extended and formalized to prevent insiders from adopting plans when trades were imminent; second, the certification requirement — creating a documented record of the insider's state of knowledge at plan adoption and adding direct liability exposure for false certifications; third, single-trade plan limitations — restricting insiders to one single-trade plan per 12-month period to prevent the use of rolling single-trade plans as a de facto regular trading mechanism; fourth, prohibition on overlapping plans — preventing insiders from maintaining parallel plans that could allow them to effectively choose between trading programs in response to developing information; and fifth, enhanced disclosure requirements under amended Forms 10-Q, 10-K, and 8-K — requiring companies to disclose insider adoption and termination of 10b5-1 plans and to provide quarterly tabular disclosure of insider trading activity. Taken together, these amendments significantly reduced the flexibility insiders had under the pre-2023 rule, particularly with respect to plan modification and the use of multiple plans. What are the cooling-off periods insiders need to know about? Officers and directors must wait the later of 90 days after plan adoption or the first business day after the Form 10-Q or 10-K filing for the quarter of adoption (effectively 90–120 days). Non-officer insiders must wait 30 days. No trades may execute during the cooling-off period regardless of plan terms. The cooling-off period introduced by the 2023 amendments is the most operationally significant change for insiders managing a trading program. For officers and directors — defined by reference to Rule 16a-1(f) — the cooling-off period is the later of: (1) 90 days after the date the plan is adopted; or (2) the first business day after the company files the Form 10-Q or 10-K for the fiscal quarter in which the plan was adopted. The practical effect of this formula is a cooling-off of 90 to approximately 120 days in most cases, depending on when in the fiscal quarter the plan is adopted and the timing of the subsequent quarterly filing. For all other insiders — employees who are not officers or directors — the cooling-off period is 30 days. No trades under the plan may execute during the applicable cooling-off period, regardless of what the plan's parameters specify for the initial trade date. From a planning standpoint, officers and directors who adopt plans in month one of a fiscal quarter (January, April, July, or October) typically face a longer effective cooling-off than those who adopt near the end of the quarter, because the quarterly filing that starts the second part of the formula occurs sooner for end-of-quarter adoptions. Insiders planning stock sales by a specific date need to work backward from that date by at least 120 days when adopting a plan. What mistakes do insiders make that void their 10b5-1 protection? Common mistakes include: adopting the plan while aware of MNPI, modifying the plan to front-run anticipated news (which restarts the cooling-off), suspicious cancellations timed to avoid losses before bad news, operating overlapping plans (now prohibited), and adopting multiple single-trade plans in a 12-month period. The 10b5-1 affirmative defense is only as strong as the compliance discipline surrounding the plan. The SEC and courts have identified several recurring patterns that undermine the defense. Adopting the plan while aware of MNPI: the certification requirement added by the 2023 amendments creates direct legal exposure for false certifications, but even before the certification requirement, adoption-while-aware remains the most fundamental defect. Modification to front-run anticipated information: any modification to a 10b5-1 plan restarts the full cooling-off period under the 2023 amendments, which creates a strong structural deterrent, but modifications made before the 2023 amendments were examined by courts and the SEC for evidence of opportunistic timing. Suspicious cancellation: canceling a 10b5-1 plan before scheduled trades execute — particularly when the cancellation is proximate to a period in which negative information is subsequently disclosed publicly — has been cited by the SEC as evidence that undermines the affirmative defense for trades that did execute under the plan. The 2023 disclosure requirements that require public reporting of plan terminations make this timing pattern more visible. Operating overlapping plans: now prohibited by rule; prior to the prohibition, maintaining multiple simultaneous plans allowed insiders to maintain trading flexibility in ways that were inconsistent with the "predetermined" premise of the affirmative defense. Adopting multiple single-trade plans: also prohibited — one per 12-month period. Failure to document and certify: failing to maintain complete written documentation of plan adoption, including the certification, creates evidentiary gaps that can undermine the defense in an enforcement proceeding. Can I cancel or modify my 10b5-1 plan after I set it up? Yes, but any modification is treated as termination and adoption of a new plan, restarting the full cooling-off period. Suspicious cancellations — particularly those timed around anticipated company news — can undermine the affirmative defense even for trades already executed. The 2023 enhanced disclosure requirements make timing patterns more visible to the SEC and the public. Under the 2023 amended framework, the right to modify a 10b5-1 plan comes at a significant cost: any modification that changes the amount, price, or timing of trades (or the formulas governing them) constitutes adoption of a new plan, triggering a full restart of the cooling-off period. The practical consequence is that an insider who modifies a plan in month three of a fiscal quarter will not be able to trade under the modified plan until the later of 90 days or the next quarterly filing — potentially four to five months away. This restart requirement creates a strong incentive for insiders to set plan parameters thoughtfully at adoption rather than adjusting them in response to changing circumstances. The ability to cancel a plan entirely remains available, but the SEC's analysis of plan cancellations and the enhanced disclosure requirements create significant scrutiny around timing. An insider who cancels a plan, avoids trades that would have sold stock at a loss, and then resumes selling after a negative disclosure has resolved is exhibiting a pattern that, while potentially having innocent explanations, is consistent with impermissible selective use of the plan mechanism. The required public disclosure of plan terminations — reportable in quarterly SEC filings — ensures that this timing pattern is visible to regulators and the public. The practical guidance from practitioners is consistent: treat a 10b5-1 plan as binding. Modify it only when genuinely necessary for reasons unrelated to anticipated market information, involve legal counsel in the modification decision, and document the rationale. Further reading: What Is a Rule 10b5-1 Plan and Do I Need One Before I Sell? — the gurpreetbal.com version covers the 10b5-1 framework from a first-person practitioner perspective, including how executives should think about plan adoption timing and the post-IPO transition. Related: Selling Pre-IPO Shares: Founder's Guide  ·  Risks of Buying Private Company Equity on Secondary Markets  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## What to Do When a SAFE Investor Is Blocking Your Series A Source: https://blegal.ai/knowledge/safe-investor-blocking-series-a Author: Gurpreet S. Bal What to Do When a SAFE Investor Is Blocking Your Series A By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The standard YC post-money SAFE, which has become the default early-stage financing instrument in Silicon Valley, was deliberately designed to minimize friction at conversion. SAFE investors do not receive equity at the time of investment; they receive a right to convert into preferred stock at a pre-negotiated price upon a qualified financing, typically the company's Series A. That conversion is automatic — it does not require investor consent. The consequence is that SAFE investors who are unhappy with the conversion terms, who want a better deal than their SAFE provides, or who are attempting to extract concessions as a condition of "cooperating" with the financing are, in most cases, asserting leverage they do not legally possess. This guide addresses what founders should understand about that legal reality, and how to handle SAFE investor disputes without allowing them to derail a financing round. Can my SAFE investor actually block my Series A? Under a standard YC post-money SAFE with no side letters, a SAFE investor has almost no ability to block a Series A financing. The SAFE converts automatically upon the closing of a qualified financing — the investor does not need to consent to the conversion or to the terms of the new round. Blocking rights require a separately negotiated side letter or a non-standard SAFE. The automatic conversion mechanism is the defining structural feature of the SAFE instrument. When the company closes a qualified financing — defined in the SAFE as a preferred stock financing with minimum proceeds above the threshold specified in the SAFE — the SAFE converts into preferred stock without any further action required by the investor. The investor does not sign a new document, does not vote on the conversion, and does not need to agree to the terms of the new round. Their SAFE simply becomes shares. The only way a SAFE investor acquires a genuine blocking right over the financing is through a separately negotiated side letter that grants them approval rights over the round — a right that sophisticated founders will have refused to grant in the first instance. Founders who receive demands from SAFE investors before a Series A should begin by reading their SAFE carefully. If there is no side letter and the SAFE is the standard YC form, the investor's legal ability to affect the closing is close to zero. Their practical ability to create friction — by contacting the Series A lead, by raising disputes about MFN compliance, by asserting pro-rata claims — is different, but that is a negotiation problem, not a legal blocking right. What leverage does a SAFE investor legally have over my financing? A SAFE investor's legal leverage is limited to rights in their SAFE or side letter — most commonly pro-rata rights to participate in the new round, MFN clauses, and information rights. None of these create a blocking right, but pro-rata rights, if ignored, can give the investor a breach of contract claim. The rights a SAFE investor actually holds depend entirely on what is in their SAFE and any accompanying side letter. Standard YC post-money SAFEs include conversion mechanics and limited MFN provisions, but do not grant pro-rata participation rights (those appear in the pro-rata side letter that sophisticated angels often request). Founders should audit their SAFE instruments before a Series A to understand exactly which investors hold which contractual rights. The three most common sources of investor leverage in this context are: pro-rata rights, which give the investor the right to participate in the new round up to a specified ownership percentage; MFN clauses, which entitle the SAFE holder to the benefit of better terms given to later SAFE investors; and information rights, which require periodic financial disclosure. None of these prevent the Series A from closing. Pro-rata rights that are ignored create a breach of contract claim — but that claim is for breach of the participation right, not a basis to void the financing. MFN claims, if valid, require the company to offer the investor better conversion terms — but again, that is an economic adjustment, not a blocking right. Founders who understand this distinction can engage SAFE investor demands from a position of clarity rather than anxiety. What are the most common demands SAFE investors make before a round? The most common demands are conversion at a better valuation cap, cash buyout at a premium, additional equity for cooperating, pro-rata rights not originally granted, and anti-dilution protection. None of these are legally required absent express agreement in the original SAFE or a side letter. SAFE investor demands at Series A typically fall into one of two categories: legitimate claims based on rights the investor actually holds, and opportunistic demands based on the investor's desire for better economics than they negotiated. Legitimate claims include: a valid MFN adjustment if a later SAFE was issued at a lower cap without offering the same terms to this investor; a pro-rata participation right that was granted in a side letter and is being honored inconsistently; or a correction of a mechanical error in the conversion calculation. These claims should be addressed directly and resolved fairly. Opportunistic demands include: requests for conversion at a lower valuation cap than the SAFE provides (effectively requesting the company to retroactively renegotiate the SAFE economics); requests for cash buyout at a multiple of investment as a condition of cooperating with conversion; demands for equity grants or advisory agreements as consideration for "going along" with the financing; and requests for anti-dilution protections that were not in the original SAFE. The legal answer to opportunistic demands is that the SAFE governs, and the investor's consent is not required for conversion. The practical answer requires judgment about how aggressive the investor is likely to be in creating friction and how much noise that friction would create with the Series A lead. How do I negotiate with a difficult SAFE investor without blowing up the deal? The negotiation should be direct, documented, and time-bounded. Founders should explain the SAFE's actual conversion mechanics, address any legitimate claims such as MFN or pro-rata rights, offer a reasonable accommodation if there is a genuine grievance, and set a clear deadline for resolution. The most important structural point in negotiating with a difficult SAFE investor is timing: the conversation should happen before the term sheet is signed, not in the final days of a closing. A SAFE investor who learns about the Series A terms at the last minute, when the company is under maximum time pressure to close, has structural leverage they would not have had if the conversation started earlier. Founders who reach out to their SAFE holders proactively — explaining the round terms, walking through the conversion mechanics, addressing any MFN or pro-rata questions in advance — remove that last-minute leverage entirely. When a SAFE investor is making demands that are not supported by the SAFE instrument, the appropriate response is clear: explain what the SAFE says, explain that conversion is automatic upon closing, and explain that the company intends to honor all legitimate contractual rights (pro-rata, MFN) as stated in the documents. If the investor has a grievance based on a contractual right that was not properly honored, address it specifically and document the resolution. If the investor is simply seeking better economics, the company should explain clearly that accommodating the request would require giving the same terms to all other SAFE investors with MFN rights, and would raise cap table integrity questions with the Series A lead — both of which are accurate statements and both of which create a natural incentive for the investor to accept the SAFE as written. When can I ignore my SAFE investor's demands? Founders can decline demands not supported by the SAFE or side letter, when accommodating them would create MFN obligations to other investors, or when the investor is simply seeking better economics than they negotiated. The SAFE is a contract — if the investor wants something not in it, they are asking for a gift, not asserting a right. The legal standard is clear: SAFE investors are entitled to what their SAFE says, and nothing more. Demands that fall outside the four corners of the SAFE and any side letter are not legally enforceable obligations of the company. Founders can and should decline them when: the demand has no basis in any contractual right; accommodating the demand would create MFN obligations to other SAFE investors who received the same standard terms; the demand would require giving an investor better economics than similarly situated investors without a contractual basis for the differential treatment; or the demand is a conditioned cooperation threat ("I'll cooperate with conversion if you give me X") without any legal basis for the conditioning. The practical question is not whether the investor is legally right — they almost certainly are not — but how much friction they are actually willing to create and what form that friction takes. If a SAFE investor contacts the Series A lead directly, the founder's response should be proactive: get ahead of that conversation, explain to the lead what the SAFE says, explain what the investor is demanding and why the company is declining the demand, and provide the lead with the actual SAFE documents. Series A investors who see a founder handle a SAFE investor dispute clearly and confidently, with clean documentation, typically gain confidence in the founder rather than the reverse. How do I structure future SAFEs to avoid this problem? Founders should use standard YC post-money SAFEs, avoid unusual side letters, limit MFN clauses in duration or scope, honor pro-rata rights consistently, and maintain a clean cap table with current conversion mechanics documented. The most problematic SAFEs are those with individually negotiated side letters not visible on the face of the instrument. The structural conditions that produce SAFE investor disputes at Series A are almost always traceable to decisions made at the time of the SAFE issuance. The most common sources of downstream conflict are: individually negotiated side letters that deviate from standard terms in ways that are not visible on the face of the cap table; MFN clauses that were not tracked and complied with as subsequent SAFEs were issued; pro-rata rights that were granted to some investors but not others without a coherent framework; and ambiguous valuation caps or discount rates that create calculation disputes at conversion. Founders who want to avoid these problems should: use standard YC post-money SAFEs without modification; refuse side letters that grant anything beyond standard pro-rata participation and information rights; if they must grant MFN rights, limit them to SAFEs issued within a defined time period rather than in perpetuity; track all MFN obligations in real time and comply with them as new SAFEs are issued; maintain a live cap table that includes SAFE conversion mechanics at various hypothetical Series A valuations, so there are no surprises for any party at closing. These are administrative disciplines, not complex legal provisions, and founders who build them into their early fundraising process eliminate the category of SAFE investor dispute described in this article entirely. Further reading: What to Do When a SAFE Investor Is Blocking Your Series A — the gurpreetbal.com version covers the same material from a first-person practitioner perspective, including Gurpreet Bal's experience handling SAFE investor disputes and specific negotiating tactics. Related: Protecting Board Control at Series A  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## SAFE & Venture Capital — Startup Financing Reference Source: https://blegal.ai/knowledge/safe-venture-capital Author: Gurpreet S. Bal SAFE & Venture Capital Analytical reference by Gurpreet S. Bal, Silicon Valley Corporate Partner | blegal.ai SAFE agreements and venture capital financing form the legal and economic foundation of startup funding. This reference hub covers the complete lifecycle of early-stage and growth financing: SAFE mechanics and conversion dynamics, convertible note structures, Series A preparation, option pool mechanics, anti-dilution provisions, governance issues, and cross-border financing complexities. Each article provides analytical depth on the specific legal issue, grounded in practice from hundreds of financing transactions. Articles in This Category How Do SAFE Valuation Caps Work? SAFE valuation cap mechanics, conversion pricing at Series A, and how caps affect founder dilution across cap table scenarios. Acquihire Deal Structure and Employee Treatment How acquihire transactions are structured, how employee equity is handled, and negotiating leverage for founders and employees. QSBS Tax Exclusion for California Founders Federal Section 1202 QSBS exclusion mechanics and why California's non-conformity creates a materially different tax result. Legal Preparation Checklist for Series A Legal cleanup, corporate governance, and documentation that institutional investors require before a Series A closes. CFIUS National Security Review for AI Startups CFIUS jurisdiction over AI startups with foreign investors — TID US business triggers, mandatory vs voluntary filings, and mitigation. India-US Cross-Border FEMA Compliance RBI and FEMA requirements for Indian founders raising US venture capital or issuing equity to US investors. Convertible Note vs SAFE: A Comparison Side-by-side comparison of convertible notes and SAFEs across interest, maturity, conversion triggers, and investor protections. 409A Valuation for Startup Equity When a 409A valuation is required, how it is conducted, and how it sets the exercise price for stock options under IRC Section 409A. The Option Pool Shuffle at Series A How pre-money option pool expansion shifts dilution onto founders before a Series A closes, and how to model and negotiate it. Anti-Dilution Protection in Down Rounds Broad-based weighted average vs. full ratchet anti-dilution mechanics and their quantitative impact in a down round scenario. Conflicts of Interest with Startup Counsel When dual representation of founders and the company creates conflicts, and the professional responsibility framework for managing them. What to Do When Founders Are Pushed Out Legal options and leverage available to founders facing board-driven removal from the company they built. Delaware Governance Changes Affecting Startups Recent Delaware legislative amendments and their effect on startup governance, stockholder agreements, and investor rights. Startup Fraud Litigation Trends 2026 Emerging patterns in startup-related securities fraud and investor litigation — case types, claims, and defense strategies. California Rule 4.2 and Investor Counsel How California's no-contact rule applies when investor counsel contacts represented founders or company employees during a financing. Series Seed Term Sheet Guide Key provisions in a Series Seed term sheet, what is negotiable, and how each term sets precedent for subsequent rounds. Post-Money SAFE Conversion Mechanics Step-by-step breakdown of YC post-money SAFE conversion at a priced round, including SAFE stacking and pro rata rights. Liquidation Preference Waterfall How liquidation preferences stack across multiple financing rounds and how the waterfall determines distribution in an exit. Employee Equity Treatment in Acquisitions What happens to unvested options, RSUs, and common stock when a startup is acquired, including acceleration provisions. Also on this topic: SAFE & Venture Capital — Personal Practice Hub on gurpreetbal.com Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion. For more information, visit gurpreetbal.com . --- ## How to Find a Sell-Side M&A Lawyer | Gurpreet S. Bal Source: https://blegal.ai/knowledge/sell-side-ma-counsel Author: Gurpreet S. Bal This article has moved to gurpreetbal.com → --- ## Can I Sell My Shares Before the Company Goes Public? Source: https://blegal.ai/knowledge/selling-pre-ipo-shares-founders-guide Author: Gurpreet S. Bal Can I Sell My Shares Before the Company Goes Public? By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner Secondary transactions — the sale of pre-IPO shares by founders, employees, and early investors — are legal and increasingly common, but they operate within a contractual and regulatory framework that makes them materially more complex than a simple stock sale. The governing documents for private company equity almost universally contain transfer restrictions, rights of first refusal, and company consent requirements that constrain the seller's freedom to transact. Securities laws impose additional requirements. And the tax consequences — particularly for shareholders holding QSBS-eligible shares — can fundamentally alter the economics of a proposed sale. This guide covers the legal and practical landscape for founders and employees considering pre-IPO share sales. What stops me from just selling my shares whenever I want? Shareholder agreements almost universally contain transfer restrictions that prohibit selling shares without company consent. A transfer that violates these restrictions may be void under Delaware law, meaning the buyer acquires nothing. The most common restrictions are transfer consent requirements, rights of first refusal, and prohibited-transferee provisions. Private company equity documents — whether shareholder agreements, investor rights agreements, voting agreements, or stock purchase agreements — contain transfer restrictions as a standard feature. These restrictions exist because private companies have a strong interest in controlling who owns their equity: unauthorized transfers can complicate future financing rounds, trigger SEC reporting thresholds, introduce unwanted investors, and affect the company's cap table dynamics. The most fundamental restriction is the company consent requirement: the shareholder may not transfer shares to any party without the company's prior written approval. This provision is enforceable and gives the company substantial control over the secondary market for its shares. Under Delaware law, a purported transfer that violates these restrictions is void — the buyer does not acquire the shares, regardless of what price was paid or what documents were signed between the parties. This is not a theoretical risk; it is the legal mechanism by which companies like Anthropic and OpenAI have maintained control over their shareholder bases despite significant secondary market interest. Additional restrictions commonly include rights of first refusal (giving the company or investors the opportunity to buy before any third party does), co-sale rights (giving investors the right to participate in any sale alongside the selling shareholder), and transfer prohibitions to defined categories of prohibited transferees such as competitors. How does my company's right of first refusal affect my ability to sell? A ROFR gives the company — and sometimes investors — the right to purchase shares at the same price and terms as any third-party offer. The seller must deliver a ROFR notice after finding a buyer; the company then has 30–60 days to exercise or waive. If exercised, the third-party buyer is displaced but the seller still receives payment. The right of first refusal is the most commonly misunderstood provision in secondary transaction planning. Its mechanics are procedurally straightforward: when a shareholder finds a willing third-party buyer and negotiates price and terms, the shareholder must deliver a written ROFR notice to the company (and, in dual-ROFR structures, to the company's major investors as well) specifying the proposed buyer, price per share, and material transaction terms. The company then has a defined exercise window — typically 30 to 60 days — during which it may elect to purchase the shares on exactly the terms offered by the third party. If the company exercises the ROFR, it purchases the shares at the negotiated price and the third-party buyer has no further claim to the transaction. If the company waives the ROFR, the sale to the third-party buyer may proceed, subject to satisfaction of any remaining consent requirements. In dual-ROFR structures — common in venture-backed companies — the company has a primary right to purchase the full block of shares, and the company's major investors share a secondary right to purchase any portion the company declines to buy. This layered structure can extend the ROFR process to 60–90 days or more. Companies frequently use the ROFR strategically to prevent shareholders from selling to parties the company disfavors — sovereign wealth funds, competitors, activist investors, or parties whose ownership would create complications for future transactions. What approvals do I need before selling shares on a secondary platform? Most shareholder agreements require written company consent independent of the ROFR process. Companies can block secondary sales to buyers they disfavor even after waiving ROFR. Securities law compliance (typically Section 4(a)(1) exemption) and cap table management considerations — including the 2,000-shareholder SEC reporting threshold — also apply. The company consent requirement operates as a separate gate from the ROFR. Even if the company declines to exercise its ROFR and waives its right to purchase the shares, most shareholder agreements independently require that the company consent in writing to the transfer to the proposed buyer. This two-stage structure gives companies a mechanism to block transfers to buyers they disfavor without having to purchase the shares themselves — a meaningful tool for companies that want to control their shareholder base but may not have the cash or inclination to buy back equity on secondary markets. On the securities law side, the secondary sale of private company shares is a securities transaction subject to federal and state securities laws. The most commonly used exemption is Section 4(a)(1) of the Securities Act, which exempts resales by persons who are not issuers, underwriters, or dealers. Secondary platform transactions are typically structured to comply with this exemption, but the company's cooperation in providing representations and transfer agent authorization is often required to complete the mechanics. Cap table management is an additional consideration: companies approaching the 2,000-shareholder threshold that triggers SEC Exchange Act reporting requirements under Section 12(g) may use transfer restrictions to manage their shareholder count, and consent requirements are a tool for that purpose. What are the tax consequences I need to plan for before I sell? Tax results depend on equity type, holding period, and state of residence. Long-term capital gains treatment requires more than one year of holding. ISO holders face AMT considerations. Basis depends heavily on whether an 83(b) election was made. Secondary transactions at prices significantly above the 409A FMV can also affect the company's future option pricing. The tax analysis for a secondary transaction requires examining several distinct variables. First, holding period: shares held for more than one year are taxed at long-term capital gains rates (currently up to 20% federal plus the 3.8% net investment income tax for high earners); shares held for one year or less are taxed as ordinary income at rates up to 37% federal. Second, equity type: incentive stock options (ISOs) exercised and held may generate alternative minimum tax (AMT) liability even if not sold, and their sale may have different consequences depending on whether it is a qualifying or disqualifying disposition. Non-qualified stock options (NQSOs or NSOs) produce ordinary income at exercise rather than capital gain; the secondary sale of shares acquired by NSO exercise generates capital gain measured from the exercise date and exercise price. Third, basis: for founders who received restricted stock and made an 83(b) election, basis is the fair market value at the time of the election — typically very low for early-stage companies — producing a large capital gain on sale but potentially at favorable long-term rates. Fourth, 409A implications: a secondary sale at a price materially above the current 409A FMV can force the company to commission a new 409A valuation, increasing the exercise prices of future employee option grants — a consequence that makes companies reluctant to approve secondary transactions at significant premiums to the current FMV. What happens to my QSBS eligibility if I sell early? Section 1202 QSBS treatment requires a holding period of more than five years. Selling before five years forfeits the federal capital gains exclusion entirely — there is no partial credit. For founders with significant appreciation, the tax cost of selling early can be millions of dollars. California does not conform to the federal QSBS exclusion, imposing state tax on the full gain regardless of holding period. Section 1202 of the Internal Revenue Code provides a capital gains exclusion of up to 100% on the sale of Qualified Small Business Stock, subject to a per-taxpayer cap of the greater of $10 million or 10 times the taxpayer's adjusted basis in the stock. To qualify, the stock must be held for more than five years, must have been acquired at original issuance from a domestic C corporation, and the corporation must have met certain active business and gross asset requirements at the time of issuance. For founders who received equity at or near company formation, the QSBS holding period requirement is frequently satisfiable — but it requires actually holding the stock for the full five years. A secondary sale that occurs even one day before the five-year anniversary forfeits the exclusion entirely; there is no prorated benefit for partial holding periods under current law. The economic magnitude of this forfeiture is significant: for a founder holding $10 million in QSBS appreciation, early sale generates approximately $2.38 million or more in federal tax that would have been excludable had they waited. California's non-conformity with Section 1202 — the state imposes full income tax on capital gains regardless of QSBS status — means California residents must also account for the state tax layer, making the total cost of early sale even more substantial. Founders with QSBS-eligible shares should complete a full tax modeling exercise before agreeing to any secondary transaction. How do I find a buyer and structure a legitimate secondary transaction? Major secondary platforms include Forge Global, Hiive, and Nasdaq Private Market. Before engaging any platform, sellers should review their shareholder agreement for applicable restrictions, consult the company about its openness to a secondary sale, and complete tax modeling. Transaction documents should address ROFR waiver, company consent, share representations, and cap table update mechanics. The secondary market for pre-IPO equity has matured significantly, and platforms such as Forge Global, Hiive, and Nasdaq Private Market provide access to institutional buyers who regularly purchase private company shares. These platforms are familiar with the legal mechanics of secondary transactions and can facilitate introductions and structure deals. However, the platforms facilitate transactions — they do not guarantee company consent, ROFR waiver, or tax efficiency, and the seller's obligations under their shareholder agreement remain their own responsibility. The recommended pre-transaction sequence is: (1) review the shareholder agreement and equity plan documents to identify all transfer restrictions, ROFR provisions, and consent requirements; (2) consult with the company's legal team to determine whether the company is open to a secondary sale and, if so, under what terms; (3) engage a tax advisor with startup equity experience to model the full tax picture, including QSBS analysis, holding period, AMT exposure, and state tax; and (4) engage legal counsel to review the purchase agreement, share representations, ROFR waiver documentation, and cap table update mechanics before signing. The purchase agreement in a secondary transaction typically contains representations by the seller about the shares being free and clear of encumbrances, compliance with transfer restrictions, and accuracy of the seller's equity documentation — representations that carry legal liability if incorrect. Further reading: Can I Sell My Shares Before the Company Goes Public? — the gurpreetbal.com version covers the seller's process from a first-person practitioner perspective, including how to think about ROFR strategy and when to engage the company early. Related: ROFR Mechanics for Secondary Sales  ·  Tax Consequences of Selling Pre-IPO Shares  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . --- ## Interactive Series Seed Term Sheet Source: https://blegal.ai/knowledge/series-seed-term-sheet Author: Gurpreet S. Bal Series Seed Preferred Stock — Summary of Terms Non-binding term sheet for discussion purposes only — based on Gurpreet S. Bal's standard Series Seed framework · Full annotated version at gurpreetbal.com Term Sheet — Not a Binding Agreement Company Date Lead Investor Amount Jump to section 1. Offering Terms & Option Pool 2. Converting Instruments 3. Dividends 4. Liquidation Preference 5. Conversion 6. Anti-Dilution 7. Board of Directors 8. Protective Provisions 9. Information & Pro-Rata Rights 10. Other Terms 01 Offering Terms & Option Pool ▼ The Option Pool Shuffle Why investors want a pre-money pool — and exactly what it costs founders HeyGen · ~90 sec Security Series Seed Preferred Stock of [Company] (the "Series Seed Preferred" ) Aggregate Proceeds (the "Investment Amount" ), inclusive of all converting instruments described in Section 2. Pre-Money Valuation (the "Pre-Money Valuation" ), inclusive of the option pool increase described below. 💬 What this means The pre-money valuation is set after the option pool is expanded to the target size. This means the option pool dilution hits founders before the investor's shares are priced — effectively reducing the per-share price the investor pays. This is called the "option pool shuffle." Always model the cap table both ways before agreeing to a pre-money figure. Price Per Share The Pre-Money Valuation divided by the Company's fully diluted capitalization immediately prior to the closing (post option pool increase), including all shares reserved under the Option Plan (the "Original Issue Price" ). Option Pool Prior to the closing, the Company shall increase its equity incentive pool such that the available, unallocated options reserved under the Company's stock option plan shall equal 10% of the Company's fully diluted post-closing capitalization (the "Option Plan" ). This pool increase is included in the pre-money calculation. 💬 Negotiating the pool 10% post-money is the most common seed-stage target. Investors want a large pool pre-money so the dilution hits the founders' side of the ledger before pricing. Founders should push to size the pool based on an agreed hiring plan — not an arbitrary percentage. A hiring plan that only requires 7% means you can argue the pool should be 7%, saving real dilution. See the proforma to model the impact. Practitioner note: Most VCs will accept a smaller pre-money pool if you come with a specific 18-month hiring plan that justifies a lower number. The pool fight is worth having. Most founders don't have it. 02 Converting Instruments ▼ SAFE & Note Conversion Mechanics Cap vs. discount, which is better for investors, and what accrued interest actually costs HeyGen · ~2 min Y Combinator SAFE Outstanding Y Combinator Post-Money SAFE(s) shall convert into shares of Series Seed Preferred at the closing at a price per share equal to the lesser of: (i) the SAFE valuation cap divided by the Company's fully diluted capitalization (post option pool, pre-financing); or (ii) the Original Issue Price multiplied by (1 minus the applicable discount rate), if any. YC SAFEs with no discount convert solely on the cap. 💬 YC post-money vs. pre-money SAFE YC's current standard is the post-money SAFE. Under a post-money SAFE, the investor's ownership percentage is fixed at signing (investment ÷ cap). This is cleaner for investors but can be more dilutive for founders than a pre-money SAFE when multiple SAFEs stack. If you issued a pre-money SAFE, confirm which version you used — the conversion math is different. Convertible Note(s) Outstanding convertible note(s) shall convert at the closing. The converting amount equals the outstanding principal plus all accrued and unpaid interest as of the closing date. The conversion price shall be the lesser of: (i) the note's valuation cap divided by the Company's fully diluted capitalization (post option pool, pre-financing); or (ii) the Original Issue Price multiplied by (1 minus the applicable discount rate). Notes convert into shares of Series Seed Preferred. 💬 Accrued interest adds up A $250,000 note at 6% outstanding for 20 months converts as approximately $275,000 of equity. Multiply that across several notes with different rates and closing dates and the accrued interest can represent meaningful additional dilution that founders didn't model when the notes were issued. Run the proforma with your actual note terms before closing. No Separate Series Converting SAFEs and notes shall receive the same series of Series Seed Preferred as the lead investor, with identical rights, preferences, and privileges. No separate shadow series. 03 Dividends ▼ Dividends Non-cumulative dividends on Series Seed Preferred shall accrue at the rate of 8% per annum on the Original Issue Price, payable only when, as, and if declared by the Board of Directors. Series Seed Preferred shall also participate in any dividends paid on Common Stock on an as-converted basis. 💬 Why dividends rarely matter at seed Non-cumulative dividends are largely ceremonial at the seed stage — they only matter if the board declares them, which almost never happens in a growth-stage startup. The more important dividend question arises in later rounds where investors may push for cumulative dividends that compound and increase liquidation preference over time. At Series Seed, non-cumulative is the right answer and is easy to get. 04 Liquidation Preference ▼ Liquidation Preference In the event of any liquidation, dissolution, or winding up of the Company, or a deemed liquidation event (as defined below), holders of Series Seed Preferred shall be entitled to receive, prior to any distribution to holders of Common Stock, an amount equal to the Original Issue Price plus all declared but unpaid dividends (the "Liquidation Preference" ). This is a 1x non-participating liquidation preference. 💬 1x non-participating is founder-friendly — here's why it matters Non-participating means once the preferred gets its 1x back, it doesn't also participate in the remaining proceeds alongside common. The preferred holder chooses: take the 1x, or convert to common and share pro-rata. At low exit valuations, preferred takes the 1x. At high valuations, preferred converts and shares. This is the standard at seed and Series A. Participating preferred (sometimes called "double-dipping") means the preferred gets its 1x and also participates in remaining proceeds as if converted. This is much worse for founders and should be resisted at seed stage. If an investor pushes for participating preferred at seed, push back. Deemed Liquidation A merger, acquisition, or sale of substantially all assets in which the Company's stockholders do not retain a majority of the voting power of the surviving entity shall constitute a deemed liquidation event, unless waived by the requisite holders of Series Seed Preferred. 05 Conversion ▼ Voluntary Conversion Each share of Series Seed Preferred shall be convertible into Common Stock at the option of the holder, at any time, at the then-applicable conversion rate (initially 1:1, subject to adjustment). Mandatory Conversion All shares of Series Seed Preferred shall automatically convert into Common Stock upon: (i) the closing of a firmly underwritten public offering at a price per share of at least the Original Issue Price with aggregate gross proceeds to the Company of at least ; or (ii) the written consent or election of the holders of a majority of the then outstanding Series Seed Preferred. 💬 IPO conversion threshold The mandatory IPO conversion threshold is negotiable. Investors want a higher bar (3x or more) to ensure they don't convert into common at an IPO that undervalues them. Founders want a lower bar for clean governance at IPO. Standard market is 3x the issue price with a $15-50M minimum gross proceeds test depending on company stage. The key is that the threshold should be realistic given your company's trajectory. 06 Anti-Dilution Protection ▼ Anti-Dilution Broad-based weighted average anti-dilution protection, applied in the event the Company issues new shares at a price below the then-applicable conversion price. The broad-based formula includes all outstanding shares, all options and warrants (whether or not exercised), all convertible securities, and all shares reserved for issuance under the Option Plan. 💬 Broad-based vs. narrow-based vs. full ratchet Anti-dilution adjusts the conversion price downward if the company later issues shares at a lower price (a "down round"). Three variants: Full ratchet : the conversion price drops to the new low price. Most investor-favorable, most punitive for founders and employees. Avoid at all costs. Narrow-based weighted average : averages in fewer shares. More favorable to investors than broad-based. Broad-based weighted average : the standard, most founder-friendly formula that accounts for all outstanding shares. This is what you want. Carve-Outs Anti-dilution shall not apply to standard excluded issuances, including: shares or options issued under the Option Plan; shares issued upon conversion of SAFEs, notes, or other convertible securities outstanding as of the closing; shares issued in connection with strategic transactions, acquisitions, or licensing approved by the Board; and shares issued in connection with equipment financing or similar transactions. 07 Board of Directors ▼ Board Composition: The Most Important Governance Decision Who controls the board controls the company — what founders need to understand before signing HeyGen · ~2 min Board Size Three (3) members at closing, expandable by Board resolution. Director 1 — CEO One (1) director designated by the Chief Executive Officer of the Company, elected by all holders of Common Stock voting as a single class . 💬 Why all common votes for this seat Some term sheets create a separate class of Common Stock that only service-providing founders can vote for director elections. This structure can disenfranchise early investors, angels, and non-founding employees who hold common stock but are not currently providing services. This term sheet intentionally rejects that approach. All common stockholders — founders, early hires, angels — vote as a single class for each common director seat. The CEO designates their candidate; the vote confirms it. Director 2 — Common Elected One (1) director elected by all holders of Common Stock voting as a single class , with no designation right. 💬 The independent common-elected seat This seat is elected by all common holders with no pre-selected candidate. At the seed stage, this is often filled by a founder, a respected advisor, or an independent director the team selects. The key distinction from "lead founder designates" language is that any common holder can nominate and vote — preserving broader governance participation as the cap table evolves. Director 3 — Investor One (1) director elected by the holders of Series Seed Preferred, voting as a separate class. [Note: At very early seed rounds, parties may agree to a 2-person board or an observer right in lieu of a full board seat — address in negotiation based on investor's typical practice.] Important: This term sheet does not include a "services-only" common director class. All common stockholders vote for all common-elected director seats, regardless of whether they are currently providing services to the Company. Founders who want to limit voting rights to active service providers should obtain separate counsel on the governance and legal implications of that structure before implementing it. 08 Protective Provisions (Preferred Voting Rights) ▼ Protective Provisions Explained What each provision actually protects — and which ones founders should negotiate hardest on HeyGen · ~3 min Scope note: These provisions require the separate vote of holders of a majority of Series Seed Preferred. At early seed stages, or where the investor is an operator, founder, or strategic partner who requires closer operational flexibility, the scope of these provisions should be adjusted in negotiation. Full NVCA-style protections are most appropriate where the investor is a professional VC fund with standard portfolio governance expectations. These provisions are not "standard" for all situations — they are a starting point. The following require approval of a majority of Series Seed Preferred, voting as a separate class: ✦ Liquidation / Dissolution. Any liquidation, dissolution, or winding up of the Company, or any deemed liquidation event. 💬 Standard. Prevents founders from triggering a sale or wind-down without investor consent. Every investor will require this. ✦ Amend Charter or Bylaws. Any amendment, restatement, or modification of the Certificate of Incorporation or Bylaws that adversely affects the rights, preferences, or privileges of Series Seed Preferred. 💬 Standard. Protects the economic and governance terms the investor negotiated from being unilaterally changed. ✦ Create New Senior or Pari Passu Stock. Authorization or issuance of any equity security senior to or on parity with Series Seed Preferred as to liquidation preference, dividend rights, or voting. 💬 Standard. Prevents a future round from structuring itself ahead of the seed investor without their consent. Future Series A investors will want similar protection. ✦ Increase Authorized Shares. Any increase or decrease in the authorized number of shares of Common Stock or Preferred Stock, other than increases approved by the Board in connection with the Option Plan. 💬 Standard. Prevents dilutive charter amendments without investor visibility. Option pool increases approved by the full board are typically carved out. ✦ Redemption. Any redemption or repurchase of Common Stock (other than repurchases from employees, consultants, or directors upon termination pursuant to contractual rights at cost or fair market value, approved by the Board). 💬 Standard carve-out language. The buyback of founder shares pursuant to standard repurchase rights (vesting, bad leaver) does not require preferred approval. Large founder buyouts or special distributions do. ✦ Dividends. Declaration or payment of any dividend on Common Stock. 💬 Standard. Prevents founders from paying themselves dividends that reduce company value ahead of a liquidation preference. ✦ Change in Number of Directors. Any increase or decrease in the authorized number of directors beyond the agreed board size. ✦ Affiliate Transactions. Any transaction between the Company and any affiliate, director, officer, or major stockholder (>5%) on non-arm's-length terms, not approved by a disinterested majority of the Board. 💬 Investor-protective. Prevents founders from extracting value through related-party transactions without investor visibility. Often expanded at Series A to capture a broader set of transactions. Not included — by design: This term sheet does not include protective provisions requiring preferred approval for: (i) annual budgets or operating plans; (ii) ordinary course capital expenditures below a threshold; (iii) hiring or compensation decisions for officers below the C-suite; or (iv) entry into commercial contracts in the ordinary course of business. These are appropriate for later-stage financings with institutional governance but create operational friction at the seed stage that is rarely in the company's interest. Negotiate their exclusion or set high materiality thresholds. 09 Information Rights & Pro-Rata ▼ Information Rights Holders of Series Seed Preferred holding at least of the Company's outstanding shares (on an as-converted basis) shall receive: (i) annual unaudited financial statements within 90 days of fiscal year end; (ii) monthly unaudited financial statements within 30 days of each month end; and (iii) prompt notice of material developments. Information rights terminate upon an IPO. 💬 Set a meaningful threshold A 1% threshold is standard and prevents de minimis investors from receiving sensitive financial information. As the cap table grows across rounds, this threshold can be adjusted upward. At IPO, all stockholders receive public company disclosures and these contractual rights terminate. Pro-Rata Rights Holders of Series Seed Preferred holding at least (on an as-converted basis) shall have the right to purchase their pro-rata share of future equity financings, calculated on a fully diluted basis, subject to customary exclusions. Pro-rata rights are non-transferable and expire 10 business days after receipt of notice. 💬 Pro-rata rights at seed Pro-rata rights allow seed investors to maintain their ownership percentage in future rounds. For large institutional seed funds this is a key right. For angels and small investors, it can create logistical friction at later rounds when new lead investors want clean caps. Consider whether to grant pro-rata to all Series Seed holders or to impose a minimum threshold that filters out small checks. 10 Other Terms ▼ Legal Opinion No legal opinion required. The Company shall not be required to deliver a legal opinion of counsel as a condition to closing. 💬 Why no opinion Legal opinions at seed financings add cost and delay for no meaningful protection — the representations and warranties in the purchase agreement cover the same ground. Sophisticated seed investors do not require opinions. If an investor insists on a legal opinion at seed, it is a signal about their deal experience and the friction their future involvement may create. Decline it or limit it to a narrow authorization opinion only. No-Shop For a period of days following execution of this term sheet, the Company and its officers and directors shall not solicit, encourage, or engage in discussions with any other party regarding a competing financing or acquisition transaction. Expenses The Company shall reimburse the lead investor's reasonable legal fees and expenses at closing, not to exceed . Each party is otherwise responsible for its own fees and expenses. 💬 Keep the cap tight $10,000–$20,000 is market for seed rounds. If the investor's counsel runs up a large bill on a seed deal, that is usually a sign of the wrong counsel for this stage. Cap the reimbursement firmly in the term sheet — not in the definitive documents where it often gets quietly increased. Drag-Along Holders of Series Seed Preferred and Common Stock shall agree to vote in favor of any acquisition or deemed liquidation event approved by: (i) the Board; (ii) a majority of the Series Seed Preferred; and (iii) a majority of the Common Stock. All three consents required. 💬 The three-part drag-along Requiring all three groups (Board + majority preferred + majority common) is the most balanced drag-along structure and has been the NVCA standard since 2014. It prevents a situation where investors and the board can force a sale over the objection of a majority of the founders and early team. Never agree to a drag that can be triggered by preferred alone without common consent. Governing Law Delaware. The Company shall be or shall reincorporate as a Delaware C Corporation prior to closing. Expiration This term sheet expires if definitive documents are not executed within days of the date of this term sheet. 📊 Series Seed Cap Table Proforma Excel model with SAFE & note conversion mechanics, option pool shuffle, and post-money ownership. Yellow cells = your inputs. All formulas show their work. Download (.xlsx) This term sheet is a summary of proposed terms for discussion purposes only. It does not constitute a binding agreement or commitment to invest. A binding commitment will only arise upon execution of definitive transaction documents. This document does not constitute legal advice. Consult qualified counsel before signing any financing documents. --- ## What Are the Tax Consequences of Selling My Pre-IPO Shares? Source: https://blegal.ai/knowledge/tax-consequences-selling-pre-ipo-shares Author: Gurpreet S. Bal What Are the Tax Consequences of Selling My Pre-IPO Shares? By Gurpreet S. Bal, Silicon Valley M&A and Technology Partner The tax analysis for a pre-IPO secondary transaction is multivariable and depends on the type of equity held, the holding period, the seller's basis, the seller's state of residence, and whether QSBS, ISO, or AMT rules apply. Each of these variables can materially affect the after-tax proceeds from a secondary sale — in some cases by millions of dollars. Founders and employees who conduct tax planning after agreeing to a secondary transaction frequently discover that the economic picture is materially different from their initial expectations. This guide maps the key tax variables for pre-IPO share sales. It is not a substitute for advice from a qualified tax advisor who can analyze the specific facts of the seller's situation. What type of gain do I recognize when I sell pre-IPO shares? The gain type depends on how the shares were acquired. Restricted stock with an 83(b) election produces capital gain measured from the election date. ISO shares in a qualifying disposition produce capital gain; in a disqualifying disposition they produce ordinary income on the spread at exercise. NSO shares generate ordinary income at exercise and capital gain thereafter. The character of gain on a pre-IPO share sale — whether capital gain or ordinary income — depends on the equity instrument through which the shares were acquired and the sequence of events since acquisition. Restricted stock: shareholders who received restricted stock and made a timely 83(b) election have basis equal to the fair market value at the date of the election (typically low at early company stages) and recognize capital gain on sale equal to the difference between the sale price and that basis. The holding period for long-term capital gains starts from the election date. Shareholders who did not make an 83(b) election have basis equal to the FMV at vesting and recognize ordinary income as shares vest; their holding period for capital gains starts from each vesting date. Incentive stock options (ISOs): a sale that constitutes a qualifying disposition — held more than two years from the grant date and more than one year from the exercise date — produces capital gain. A disqualifying disposition — sold before satisfying both holding requirements — produces ordinary income equal to the lesser of (a) the spread at exercise (FMV at exercise minus exercise price) or (b) the actual gain on sale, with any excess classified as capital gain or loss. Non-qualified stock options (NSOs): the spread at exercise is ordinary income taxable in the year of exercise, regardless of when the shares are subsequently sold. The sale of shares acquired by NSO exercise generates capital gain (or loss) equal to the difference between the sale price and the FMV at exercise (the tax basis established at exercise). How does my holding period affect how much tax I pay? Shares held more than one year qualify for long-term capital gains rates (up to 20% federal plus 3.8% NIIT), while shares held one year or less are taxed as ordinary income at rates up to 37%. The holding period start date depends on equity type: for restricted stock with an 83(b) election it starts at grant; for ISOs and NSOs it starts at exercise. The distinction between long-term capital gain (one year or more) and short-term capital gain (one year or less, taxed as ordinary income) creates a substantial rate differential at the federal level. At the highest federal income bracket, the difference is approximately 13.2 percentage points (37% ordinary income versus 23.8% long-term capital gains including the net investment income tax). On $1 million of gain, that differential represents approximately $132,000 in additional federal tax. For founders and employees evaluating whether to sell pre-IPO shares shortly after exercise, the holding period analysis is central to the tax modeling. For restricted stock with an 83(b) election, the holding period starts at the date of the election and stock receipt — often at company formation or early hiring — which means founders who received stock years ago are almost certainly past the one-year threshold. For ISO and NSO exercises, the holding period starts at the exercise date, not the grant date. An employee who exercised options recently and is considering an immediate secondary sale may be selling at short-term capital gains rates. The comparison between (a) selling now at short-term rates and (b) waiting twelve months for long-term treatment should be quantified as part of any secondary sale tax analysis. What happens to my QSBS exclusion if I sell before the five-year mark? Selling before five years forfeits the Section 1202 QSBS exclusion entirely — there is no prorated benefit for partial holding. For founders holding up to $10 million in qualifying QSBS appreciation, early sale generates approximately $2.38 million or more in federal tax that would have been excluded under Section 1202. Section 1202 of the Internal Revenue Code provides a capital gains exclusion of up to 100% on the sale of Qualified Small Business Stock, subject to a cap of the greater of $10 million or 10 times the taxpayer's adjusted basis. The exclusion rate is 100% for QSBS acquired after September 27, 2010. The requirements for QSBS status are: (1) common stock issued by a domestic C corporation; (2) acquired at original issuance from the corporation (not purchased on secondary markets); (3) the corporation had gross assets of $50 million or less at the time of issuance and immediately after; (4) the corporation is engaged in a qualified active business (most technology, software, and manufacturing businesses qualify; professional services such as law, finance, and health generally do not); and (5) the stock is held for more than five years. The five-year requirement is a binary gate — there is no prorated exclusion for partial holding periods under current law. A seller who has held for four years and eleven months receives no Section 1202 benefit. For a founder holding $10 million of QSBS appreciation, early sale costs approximately $2.38 million in federal capital gains tax that would have been excluded. For founders with gain above $10 million, the exclusion caps at $10 million per taxpayer per issuer, but the same binary structure applies to the excludable portion — partial holding does not produce partial exclusion. The decision to sell before the five-year QSBS mark is an economically significant one that should not be made without completing the full Section 1202 analysis. Why do California residents face a different tax result than founders in other states? California does not conform to the federal Section 1202 QSBS exclusion. California residents pay state income tax on the full capital gain at rates up to 13.3%, regardless of holding period or QSBS eligibility. California also taxes short-term and long-term capital gains at the same rates, eliminating the state-level benefit of the one-year holding threshold. California's non-conformity with federal QSBS treatment creates a significant tax asymmetry for California residents compared to founders in states without income tax or in states that conform to Section 1202. For California residents, the federal QSBS exclusion eliminates federal capital gains tax on a qualifying five-year-plus sale, but California imposes its full state income tax — at rates up to 13.3% for the highest earners — on the entire gain. On a $10 million QSBS gain, California's tax on that sale is approximately $1.33 million, payable regardless of how long the stock was held. California also does not distinguish between short-term and long-term capital gains for state tax purposes — both are taxed at ordinary income rates. This means the one-year federal holding period threshold produces a federal tax benefit (long-term vs. short-term rates) but has no parallel California benefit. For founders evaluating a change of state residency before a major liquidity event — whether an IPO or a secondary sale — the California non-conformity issue is a central factor. Establishing bona fide residency in a state that conforms to Section 1202 before the sale, if sustainable and genuine, can achieve the full federal exclusion. However, California's Franchise Tax Board scrutinizes claimed changes of residency closely, particularly where the timing is proximate to a liquidity event, and the residency change must reflect a genuine shift in domicile and significant contacts. What are the AMT implications if I exercised ISOs before this sale? Exercising ISOs and holding — rather than immediately selling — generates an AMT preference item equal to the spread at exercise. Selling in the same year as exercise (a disqualifying disposition) eliminates the AMT item. Selling in a subsequent year generates an AMT credit (minimum tax credit) that offsets regular tax in future years when regular tax exceeds AMT. The interaction between ISO exercises and alternative minimum tax is one of the most complex areas of startup equity taxation and frequently generates unexpected liabilities for founders and employees. The AMT framework for ISOs operates as follows. When a taxpayer exercises an ISO and holds the resulting shares, the spread — the difference between the FMV of the shares on the exercise date and the exercise price — constitutes an AMT preference item. This amount is added to the taxpayer's alternative minimum taxable income (AMTI) and may result in AMT liability if AMTI exceeds the AMT exemption (approximately $137,000 for single filers and $220,800 for married filing jointly in recent years, subject to phaseout at higher income levels). For founders exercising ISOs in high-value companies, the AMT liability can be substantial — potentially hundreds of thousands of dollars on a single exercise. The secondary transaction interacts with this AMT exposure in two ways. If the ISO shares are sold in the same calendar year as exercise and the sale is a disqualifying disposition (does not meet the qualifying disposition holding requirements), the ISO spread is reclassified as ordinary income for regular tax purposes, and the AMT preference item is eliminated. This can reduce or eliminate AMT liability but substitutes ordinary income tax. If the ISO shares are sold in a subsequent calendar year, the AMT paid on exercise generates an AMT credit — the minimum tax credit (MTC) under Section 53 — which the taxpayer carries forward and uses to offset regular tax in future years when regular tax exceeds AMT. The MTC is refundable in part under rules enacted in the 2017 tax legislation. The optimal timing of an ISO-related secondary sale depends heavily on the interaction of these rules with the taxpayer's overall tax position. What tax planning should I do before I agree to sell? Before committing to a sale, model: holding period and capital gains classification, QSBS eligibility and five-year status, ISO AMT implications, state tax (particularly California non-conformity), and basis (83(b) election impact). Engage a tax advisor with startup equity experience before agreeing to price or closing date. The analytical framework for pre-IPO secondary sale tax planning covers six distinct variables that interact in ways that are not always intuitive. First, equity type and gain character: identify whether the shares produce ordinary income or capital gain, and in which tax year the income is recognized. Second, holding period: determine the exact holding period start date for capital gains purposes given the equity type, and model the after-tax difference between selling now versus waiting to cross the one-year (or five-year) threshold. Third, QSBS eligibility: confirm whether the shares satisfy all Section 1202 requirements and whether the five-year holding period has been met. Fourth, ISO AMT analysis: if the shares were acquired through ISO exercise, model the AMT implications of selling in the same year as exercise versus a subsequent year, and understand the MTC carryforward mechanics. Fifth, state tax: identify the seller's state of residency and whether that state conforms to the federal QSBS exclusion, and whether there are distinctions between short-term and long-term rates. Sixth, basis: confirm the tax basis of the shares, including the impact of any 83(b) elections, prior AMT adjustments, or basis adjustments from prior disqualifying dispositions. The after-tax proceeds from a secondary sale can vary by millions of dollars depending on how each of these variables resolves. The analysis is best completed before price negotiations begin, because the price needed to achieve a target after-tax result depends on the full tax picture. Engaging a CPA or tax attorney who specializes in startup equity — not merely a generalist accountant — is strongly advisable for any founder or employee with meaningful appreciated equity. Further reading: What Are the Tax Consequences of Selling My Pre-IPO Shares? — the gurpreetbal.com version covers these tax variables from a first-person practitioner perspective, including how to structure the advisor conversation before agreeing to sell. Related: Selling Pre-IPO Shares: Founder's Guide  ·  ROFR Mechanics for Secondary Sales  ·  gurpreetbal.com This article is for general informational purposes only and does not constitute legal advice or tax advice. Consult a qualified tax advisor for your specific situation. No attorney-client relationship is formed by reading this article. Gurpreet S. Bal is a corporate partner with 16 years advising on private equity, merger transactions, and public offerings for companies and investors at three of the world's top law firms. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. For more information and to get in touch, visit gurpreetbal.com . ---